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Abstract 
 
Mass spectrometry-based proteomics has the potential to offer new qualitative and quantitative 
insights into a wide array of biological questions. The work presented in this thesis, including the 
associated submitted papers, evidences my contribution to this field.  Paper 1 demonstrates the 
successful identification of post translational modifications imparted upon histones following DNA 
damage. Papers 2-4 employ a label-free quantification approach to study the immunomodulation 
molecules endemic parasites use to impair host resistance.  Paper 5 uses an isobaric tagging 
approach to quantify changes in immune response when dendritic cells are exposed to medically 
important antigens. Paper 6 displays the power of mass spectrometry in identifying a novel co-
factor, which could not be identified by X-ray crystallography.  In paper 7 mass spectrometry is 
used to show that the remaining unidentified enzyme in the morphinan biosynthetic pathway is 
expressed as a fusion protein composed of two distinct enzymes.  These studies are all linked in 
their reliance on my use of mass spectrometry-based proteomics to make original contributions 
to knowledge and understanding within their fields.  
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Integrative Chapter 
Introduction 
The seven publications presented cover a range of biological investigations yet all are bound by 
their reliance on mass spectrometry-based proteomics – the aspect that I performed. In each case 
my proteomic analyses were vital to the study.  
In paper 1 I identified novel acetylated proteoforms of Arabidopsis histones using LC-MS/MS, 
database searching and manual validation of product ion spectra.1 
In papers 2-4 I employed emPAI quantification to provide qualitative differences between somatic 
and excreted proteomes of medically important parasites.2-4 
Paper 5 describes my use of iTRAQ quantification to compare proteomes of dendritic cells 
exposed to antigens known to illicit different immunological responses.5 
Paper 6 presents my identification of the novel protein co-factor S-adenosyl-S-carboxymethyl-L-
homocysteine using Fourier transform ion cyclotron resonance mass spectrometry.6  
In paper 7 I used a combination of 15N metabolic labelling and 1D-PAGE to prove that the final 
enzyme in the morphinan biosynthetic pathway is naturally expressed as a fusion of two distinct 
enzymes.7  
This integrative chapter details my contribution to each study, setting the background and 
incorporating additional material that was not included in the publications for reasons of focus or 
brevity.  Collectively the work evidences the power of mass spectrometry based-proteomics to 
reveal novel biological insights.  
Proteomics has progressed significantly in the eight years spanning the publications. I therefore 
present my work in the context of the knowledge and technology of the time but also reflect in 
the present day, discussing limitations and detailing how the studies could be improved.  This 
chapter offers discussion of key concepts, technologies, analysis regimes and limitations of 
proteomics. 
  
12
Proteomics background 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), where proteins are separated in 
gel by both pI and physical length8,9 was the key enabling technology for proteomics.  The 
technique was widely applied following first use of the term ‘proteomics’ in Wilcox’s 1994 PhD 
thesis and subsequent 1996 paper.10 Resolving by pI is achieved by applying proteins to an 
immobilized pH gradient in the presence of electric potential; proteins migrate across the gradient 
until they reach their pI and become uncharged.  In the second dimension, proteins coated with 
SDS are loaded onto a polyacrylamide gel.  Electric potential is applied causing proteins to 
migrate, with speed dictated by molecular length: shorter sequences have lower frictional forces 
and so migrate further per unit time.11 Protein length is considered proportional to molecular 
mass. Proteins can be visualised by staining to produce gel spots.12,13 If quantitative stains are 
used, intensity is proportional to protein amount.14 Although quantification is implicit, 
identification is not; migration of standards can be compared for simple mixtures or known 
targets probed by western blotting15 but for unknowns direct identification is intractable.   
Mass spectrometry coupled with genomic sequencing proved pivotal to delivering identification 
with biologically amenable protein amounts.16 Peptide mass fingerprinting (PMF) was developed 
as a rapid and robust protein identification technique. Protein spots excised from the gel are 
treated with endoprotease of defined specificity to generate peptides.17 For instance, trypsin 
cleaves amide bonds C-terminal to arginine or lysine residues, provided they are not N-terminal to 
proline.18 Expected cleavage positions are used to calculate theoretical peptide sequences and so 
masses for proteins of known sequence. Predicted masses can be compared in silico for protein 
identification based on numbers of spectrum features matching theoretical values.19 Software 
packages automate searches and provide estimations of significance based on these features.20-22   
If precursors are isolated and fragmented in the mass spectrometer, information on the 
constituent amino acid sequence can be revealed.23,24  CID fragmentation, which is most 
frequently used for peptides, 25,26   produces b- and y-ions as dominant features, resulting from 
cleavage of the amide bond27,28 (ion-type nomenclature was proposed by Roepstorff29 and 
developed by Biemann).30  Fragmentation position is explained by the mobile proton 
hypothesis,31-33 which states protonation occurs on basic residues before transferring to the 
amide carbonyl, driving fragmentation.  Analogous to PMF, peptide product ion spectra can be 
searched against calculated m/z values of fragment ions to provide peptide matches, from which 
peptide matches and thus protein identification can be inferred.34 Unlike PMF where a single 
diagnostic value is obtained per peptide (its m/z), fragmentation produces multiple data points 
increasing identification specificity. 
If complex mixtures of peptides are analysed by mass spectrometry only the most 
abundant/amenable components are sampled.  Less abundant or responsive analytes can be 
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missed due to limitations in mass resolution, isolation resolution, acquisition speed/duty cycle 
and ion response/suppression.  Fractionation ameliorates these effects, affording deeper 
penetration into proteome space.35 Peptide-level fractionation can remove the necessity for 2D-
PAGE, which is limited by irreproducibility and incompatibility with extreme pH or low solubility 
proteins.36 
LC-MS/MS has overtaken 2D-PAGE as the method of choice in most proteomic laboratories. Liquid 
chromatography can be performed on- or off-line with mass spectrometry.  In off-line approaches 
collected fractions are analysed sequentially making them amenable to MALDI, where sample is 
mixed with matrix prior to ionisation.37 On-line approaches couple elution to the mass 
spectrometer increasing throughput.38 Electrospray ionisation is the typical on-line ionisation 
mode.39 Chromatography for proteomics mostly uses reversed-phase C18 columns, separating 
peptides by relative affinities for stationary and mobile phases resulting from different 
hydrophobicities.  Peptides are loaded in aqueous-dominated mobile phase before elution over a 
gradient of increasing organic content.38,40 Orthogonal multi-dimensional chromatography can 
provide further separation, with SCX, HILIC and high pH reversed phase C18 all used.41-43 
Mass spectrometry is not implicitly quantitative; analyte response is dependent on amount but 
also less predictable factors including physico-chemical analyte properties, ion suppression effects 
and solvent composition.44 These factors must be compensated for quantification. For absolute 
quantification, an internal standard (IS) is added in known amount and analyte response relative 
to the IS measured.45 The IS should be as similar as possible to the analyte and yet distinguishable, 
either chromatographically or in mass; isotopically heavy analogues are ideal. Isotopically labeled 
samples are combined before LC-MS/MS, with imparted mass differences providing the link from 
spectra to provenance. Although isotopically different, labeled peptides are otherwise chemically 
identical, promoting equal response.45 In vivo labeling strategies such as SILAC46 and 15N metabolic 
labeling47 offer the least technical variance because samples are combined earliest.48  For 
individual peptides, heavy variants can be synthesised.49  Absolute quantification of a range of 
proteins is possible using a QconCAT approach, whereby quantotypic peptides are selected as 
representatives for multiple proteins and combined to generate a concatamer gene. The gene is 
transfected into an expression system to produce a concatamer protein containing the 
quantotypic peptides.50 Expression in heavy growth medium can produce heavy labelled peptides.  
QconCAT protein is added to sample before enzymatic digestion, allowing potential quantification 
of all proteins with peptides common to the QconCAT. 
While in vivo labeling techniques offer lowest technical variance, they have reduced applicability 
than in vitro approaches.51 A variety of in vitro labelling techniques is available including methods 
employing well characterized, low cost chemical reactions52,53 and more elaborate commercial 
approaches facilitating higher multiplexing.54-60 Two of the most frequently used are SCIEX’s 
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iTRAQ54,55 and Thermo’s TMT,56-60 each of which add isobaric tags to free amines at peptide N-
termini and lysine residues.  Mass spectra of differentially-labelled samples appear identical as 
tags are isobaric, but unique m/z reporter ions are released upon fragmentation, enabling 
quantification.54-60 
Quantification is also possible without labelling. Label-free approaches do not combine samples 
before LC-MS/MS acquisition; instead samples are analysed successively and relative responses 
extracted from datasets.61 Response can be measured by precursor and/or product ion 
chromatogram peak areas,62 which necessitates software to align chromatograms and overlay 
peptide identifications.63  Alternatively, response can be inferred from spectral counts;64  for 
product ion spectra triggered by intensity, the greater the relative abundance of analyte, the 
more frequently it is selected for fragmentation.63-67 
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Paper 1 - Dynamics of plant histone modifications in response to 
DNA damage 
Paper 1 presents my identification of acetylated and methylated forms of Arabidopsis thaliana 
histones after plant exposure to ionising radiation. The study began in 2010 when I was contacted 
by University of Leeds postdoctoral researcher Georgina Drury (GD), who had purified a set of 
wild type Arabidopsis thaliana proteins and was aiming to sequence these. GD provided the 
samples as two Coomassie stained bands and I performed in-gel digestion with trypsin following 
reduction with dithioerythritol and S-carbamidomethylation with iodoacetamide.  I analysed the 
resulting peptide mixtures by LC-MS/MS using a maXis qTOF mass spectrometer and peak lists 
produced were searched against the Arabadopsis thaliana subset of the UniProt database using 
the Mascot search program.  Both bands matched histone sequences, one H3 and the other H4.  
Coverage for H3 was reasonable at 52% but only two peptides were identified in H4 giving a 
sequence coverage of just 24% (figure 1). 
Band 1 – H3, 52% sequence coverage 
1 MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RFRPGTVALR 
51 EIRKYQKSTE LLIRKLPFQR LVREIAQDFK TDLRFQSSAV AALQEAAEAY 
101 LVGLFEDTNL CAIHAKRVTI MPKDIQLARR IRGERA 
 
 
Band 2 – H4, 24% sequence coverage 
1 MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL 
51 IYEETRGVLK IFLENVIRDA VTYTEHARRK TVTAMDVVYA LKRQGRTLYG 
101 FGG 
    
Figure 1. Sequence coverage achieved following trypsin digestion of Coomassie-stained bands. Bands 1 
(top) and 2 (bottom) were identified as histones H3 and H4, respectively.  Amino acid sequence from 
peptides identified through Mascot database searching of product ion spectra highlighted in red. 
 
Examining the sequences, I observed the high frequency of R and K (trypsin cleavage sites) would 
produce many peptides below optimum mass for analysis.  I advised GD that more could be done 
to improve coverage.  GD explained that histone proteins were her intended target and the aim 
was to characterise the post translational modifications (PTMs) of these proteins following 
treatment with ionising radiation. 
Post translational modifications (PTMs) are chemical alterations to amino acids in proteins that 
occur during or after protein synthesis. PTMs can play crucial roles in biological processes such as 
cell signalling and disease response.68-70 Mass spectrometry is well placed to identify PTMs by 
measuring mass difference caused by modification, ideally at the individual amino acid level in 
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product ion mass spectra.71 PTM identification can be built into database searching workflows by 
appending the mass increment to a dataset against which the experimental data are searched.  
PTM searches are usually run as variable modifications, so that both modified and unmodified 
variants are considered.72  
Characterising post translational modifications of histones is important because of their effects on 
the structure and function of chromatin.73 The chromatin complex packages DNA in eukaryotic 
nuclei and is vital for DNA stability, mitosis and genome maintenance.74 Ionising radiation is a 
known effector of DNA damage, causing double strand breaks. Acetylation of histones H3 and H4 
has been demonstrated as an epigenetic marker of chromatin remodelling in response to DNA 
damage in both mammals and yeast75,76. This was the target of GD’s work.  Acetylation of the N-
terminal region of histones is especially crucial as the point of interaction with DNA.  
Unfortunately, in my initial LC-MS/MS analysis the N-terminal region of H4 was not observed. 
I explained that sequence coverage may be improved by changing to an alternative protease that 
would produce more N-terminal peptides of amenable mass.  In-silico digestions suggested that 
endoprotease Arg-C should produce suitable peptides (figure 2). 
H3, 88% theoretical coverage 
1 MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RFRPGTVALR 
51 EIRKYQKSTE LLIRKLPFQR LVREIAQDFK TDLRFQSSAV AALQEAAEAY 
101 LVGLFEDTNL CAIHAKRVTI MPKDIQLARR IRGERA 
 
 
H4, 85% theoretical coverage 
1 MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL 
51 IYEETRGVLK IFLENVIRDA VTYTEHARRK TVTAMDVVYA LKRQGRTLYG 
101 FGG 
    
Figure 2. Theoretical peptides generated on Arg-C digestion of histones H3 (top) and H4 (bottom). Amino 
acid sequence from in-silico digest products between 500 and 4,000 Da highlighted in blue. 
 
GD provided further samples and I repeated LC-MS/MS analysis following Arg-C digestion.  
Knowing now the proteins contained no cysteine residues, the reduction and alkylation steps 
were omitted. Close to 50% coverage was achieved for both histones (figure 3).  Unfortunately, I 
still did not observe the N-terminus of H3. 
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H3, 54% sequence coverage 
1 MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RFRPGTVALR 
51 EIRKYQKSTE LLIRKLPFQR LVREIAQDFK TDLRFQSSAV AALQEAAEAY 
101 LVGLFEDTNL CAIHAKRVTI MPKDIQLARR IRGERA 
 
 
H4, 49% sequence coverage 
1 MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL 
51 IYEETRGVLK IFLENVIRDA VTYTEHARRK TVTAMDVVYA LKRQGRTLYG 
101 FGG 
    
Figure 3. Sequence coverage achieved after Arg-C digestion of histones H3 (top) and H4 (bottom). Amino 
acid sequence from peptides identified through Mascot database searching of product ion spectra 
highlighted in red. 
 
Arg-C digestion improved peptide sizes, but many contained a large number of positively charged 
amino acids (figure 4) imparting hydrophilicity, and reducing binding to C18 media used in the 
analytical and trap columns.  If peptides do not bind to the trap they flow to waste and are not 
sampled.   
H3 
1 MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RFRPGTVALR 
51 EIRKYQKSTE LLIRKLPFQR LVREIAQDFK TDLRFQSSAV AALQEAAEAY 
101 LVGLFEDTNL CAIHAKRVTI MPKDIQLARR IRGERA 
 
 
H4 
1 MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL 
51 IYEETRGVLK IFLENVIRDA VTYTEHARRK TVTAMDVVYA LKRQGRTLYG 
101 FGG 
    
Figure 4. Abundance of positively charges residues in histones H3 (top) and H4 (bottom). Positive amino 
acids arginine, histidine and lysine highlighted in green.  
 
I considered loading directly onto the analytical column. However, in my literature research, I 
found reports that chemical modification of peptides by propionylation can reduce hydrophilicity, 
leading to increased coverage in histones.77 I thus propionylated the remainder of the Arg-C 
digests using the protocol developed by Syka.77 LC-MS/MS analysis of the propionylated peptides 
produced very good N-terminal coverage (figure 5). 
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H3, 47% sequence coverage 
1 MARTKQTARK STGGKAPRKQ LATKAARKSA PATGGVKKPH RFRPGTVALR 
51 EIRKYQKSTE LLIRKLPFQR LVREIAQDFK TDLRFQSSAV AALQEAAEAY 
101 LVGLFEDTNL CAIHAKRVTI MPKDIQLARR IRGERA 
 
 
H4, 69% sequence coverage 
1 MSGRGKGGKG LGKGGAKRHR KVLRDNIQGI TKPAIRRLAR RGGVKRISGL 
51 IYEETRGVLK IFLENVIRDA VTYTEHARRK TVTAMDVVYA LKRQGRTLYG 
101 FGG 
    
Figure 5. Sequence coverage achieved after Arg-C digestion and propionylation of histones H3 (top) and 
H4 (bottom). Amino acid sequence from peptides identified through Mascot database searching of 
product ion spectra highlighted in red. 
 
Knowing suitable N-terminal coverage could be obtained, GD then extracted histones from plants 
exposed to 160 Gy of ionising radiation. 
My analysis of histones from treated plants was conducted using Arg-C and propionylation (paper 
1). Database searching was performed to consider five variable modifications of lysine: 
acetylation, methylation, di-methylation, tri-methylation and propionylation. I assumed tri-
methylation would be difficult to distinguish from acetylation because mass additions imparted 
are separated by just 36 mDa: acetylation 42.0106 Da; tri-methylation 42.0470 Da.  However, 
accuracy of the maXis instrument was sufficient to exclude tri-methylation for all identified 
peptides, with maximum precursor mass error being 8 mDa.  I additionally observed a number of 
lysine residues were not propionylated.   
 
Although Mascot is capable of identifying modified peptides and provides expect scores showing 
the confidence of the match, validation of site assignment is crucial.  Without interrogation, 
incorrect site assignment may be accepted.  For instance, in a peptide with two potentially 
modifiable amino acids located close together, ion series from residues preceding and succeeding 
these may localise the modification to those positions but the data may not allow distinction 
between them. In such cases the Mascot score will be equal for both possibilities but one will be 
listed top and displayed in the search result.  Incorrect assignments can also occur where ions 
from different series coincidently have the same m/z as potentially diagnostic ions.  It is important 
to consider the possibility of chimeric spectra containing product ions from two or more co-
selected precursors – positional isomers are especially prone to co-selection as their 
hydrophobicities and hence retention times are often similar. For large datasets, setting global 
stringencies for site assignment, such as delta score78-80 can be valuable but, where tractable, few 
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methodologies beat manual validation.  For these data I used Mascot for initial identifications 
then located the corresponding MS2 spectrum using Bruker’s data analysis software. I looked for 
crucial ions for expected sequences that could distinguish positional assignments.  I identified 14 
different acetylated or methylated peptides (table 1). Post validation, spectra were annotated for 
publication using ProPhoSI,81 which provides more aesthetic images than manually annotated 
DataAnalysis spectra and better labelling than Mascot for less frequently observed ion types, 
including loss of water (0-ions) and loss of ammonia (*-ions). My summary of the site assignments 
is in figures 6-8. Suffixes ac, me and me2 are used to denote acetylated, methylated and di-
methylated lysines respectively. 
Histone Peptide Modified sites Expect Value Mass error (mDa) 
H3 K9STGGKAPR17 K14 2.0×10−7 5 
H3 K9STGGKAPR17 K9, K14 1.6×10−4 6 
H3 K18QLATKAAR26 K23 3.3×10−5 4 
H3 K18QLATKAAR26 K18, K23 9.8×10−6 8 
H3 K9STGGKAPR17 K9 2.8×10−4 5 
H3 K9STGGKAPR17 K9, K14 7.8×10−3 5 
H4 G4KGGKGLGKGGAKR17 K8 5.0×10−5 1 
H4 G4KGGKGLGKGGAKR17 K16 1.5×10−7 6 
H4 G4KGGKGLGKGGAKR17 K5, K16 1.2×10−5 2 
H4 G4KGGKGLGKGGAKR17 K8, K16 1.3×10−6 7 
H4 G4KGGKGLGKGGAKR17 K12, K16 6.4×10−6 5 
H4 G4KGGKGLGKGGAKR17 K5, K12, K16 5.2×10−8 <1 
H4 G4KGGKGLGKGGAKR17 K8, K12, K16 3.0×10−4 2 
H4 G4KGGKGLGKGGAKR17 K5, K8, K12, K16 2.7×10−6 3 
Table 1. Table of acetylated and methylated peptides identified in histones H3 and H4 after plants 
received 160 Gy dose of ionising radiation.  Acetylated lysine residues coloured red, methylated lysine 
residues are coloured green and dimethylated lysine residues are orange.  Identification performed using 
the Mascot search engine following LC-MS/MS acquisition of propionylated endoprotease Arg-C-derived 
peptides.  Expect values taken from Mascot results. 
H3 Acetylated 
K9STGGKacAPR17 – strong b- and y-ion series observed, lacking only the lowest m/z ion in each 
series (Figure 6A). 
K9acSTGGKacAPR17 – with only two lysine residues in the peptide and two acetylations determined 
from the precursor mass no positional ambiguity exists.  Identification is strengthened by strong 
b- and y-ion series, with the latter missing only the y1-ion (Figure 6B). 
K18QLATKacAAR26 – continuous y-ion series lacking only y1. b2 and b3 also demonstrate acetylation 
is not on the N-terminal lysine K18 (Figure 6C). 
K18acQLATKacAAR26 – precursor mass shows acetylation of both lysine residues. Intense and 
continuous y-ion series supports identification (Figure 6D). 
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  A. K9STGGKacAPR17 
 
  B. K9acSTGGKacAPR17 
 
  C. K18QLATKacAAR26 
 
  D. K18acQLATKacAAR26 
 
Figure 6A-D. Spectral annotations showing identified mono- and di-acetylations in histone H3 peptides.  
Tandem mass spectra were re-drawn and annotated using ProPhoSI to show matches to predicted b- and 
y-ions. Bold black lines in amino acid sequences indicate that a b- (purple) or y-ion (green) is observable in 
the spectrum.  Acetylated lysines are coloured red, propionylated lysines blue and N-terminal 
propionylation labelled Pr and coloured blue. 
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H4 Acetylated 
G4KGGKacGLGKGGAKR17 – acetylation at K8 shown by mass difference of 170.1 m/z units between 
ions b4 and b5, and between y9 and y10 (Figure 7A). 
G4KGGKGLGKGGAKacR17– y2 localises mono-acetylation to K16. Further evidence is provided by b10 
and b13 that constrain addition of acetyl to residues G14AK16, in which only modification of lysine is 
rational (Figure 7B). 
G4KacGGKGLGKGGAKacR17 – evidence of acetylation at K5 derived from b2, b3, y10, y11 and y12, 
which all require acetylated K5 to reconcile either their own mass (b-ions) or the delta-mass to the 
precursor (y-ions). Acetylation at K16 produced y2, y4 and y5 ions consistent with mono-acetylation 
C-terminal to A15 (Figure 7C). 
G4KGGKacGLGKGGAKacR17 – strong b- and y-ion series localises positions of acetylation. 
Specifically, b4, b5, y9 and y10 for K8 and y2, y11 and y13 for K16 (Figure 7D). 
G4KGGKGLGKacGGAKacR17 – intense y-ions at positions y5 and y9 localise acetylation to K12 and K16, 
respectively, with additional lower intensity ions supporting the assignment (Figure 7E). 
G4KacGGKGLGKacGGAKacR17 – continuous ion series between b2-b7 and y7-y12 consistent with K8 
as the only non-acetylated lysine residue in the peptide.  Although further evidence is provided by 
the product ions, the remaining three lysine residues must be acetylated to reconcile the 
precursor mass (Figure 7F). 
G4KGGKacGLGKacGGAKacR17 – intense y5, y7, y9 and y11-ions localise the three acetylation 
positions predicted by the precursor mass to the lysines at positions K8, K12 and K16. The ions b2-b4, 
excludes the possibility of acetylation at K5 (Figure 7G). 
G4KacGGKacGLGKacGGAKacR17 – precursor mass indicates tetra-acetylation, with no positions of 
ambiguity. Expected product ions validate identification (Figure 7H). 
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 A. G4KGGKacGLGKGGAKR17 
 
 B. G4KGGKGLGKGGAKacR17 
 
  C. G4KacGGKGLGKGGAKacR17 
 
  D. G4KGGKacGLGKGGAKacR17 
 
Figure 7A-D. Spectral annotations showing identified acetylations in histone H4 peptides.  Tandem mass 
spectra were re-drawn and annotated using ProPhoSI to show matches to predicted b- and y-ions. Bold 
black lines in amino acid sequences indicate that a b- (purple) or y-ion (green) is observable in the 
spectrum.  Acetylated lysines are coloured red, propionylated lysines blue and N-terminal propionylation 
labelled Pr and coloured blue. 
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 E. G4KGGKGLGKacGGAKacR17 
 
 F. G4KacGGKGLGKacGGAKacR17 
 
 G. G4KGGKacGLGKacGGAKacR17 
 
 H. G4KacGGKacGLGKacGGAKacR17 
 
Figure 7E-H. Spectral annotations showing identified acetylations in histone H4 peptides.  Tandem mass 
spectra were re-drawn and annotated using ProPhoSI to show matches to predicted b- and y-ions. Bold 
black lines in amino acid sequences indicate that a b- (purple) or y-ion (green) is observable in the 
spectrum.  Acetylated lysines are coloured red, propionylated lysines blue and N-terminal propionylation 
labelled Pr and coloured blue. 
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H3 Methylated 
K9meSTGGKAPR17 – continuous y-ion series from y3 demonstrates both propionylation and 
methylation of the N-terminal lysine residue K9, when compared with precursor mass (Figure 8A). 
K9me2STGGKacAPR17 – mass difference between precursor and y-ion series N-terminal to y3 infers 
propionylation and di-methylation at N-terminal lysine, K9. There is a significant amount of 
unannotated ion intensity in the spectrum; although some compromise in fragment ion intensity 
can be attributed to the extent of the unfragmented precursor ion, additional positional forms 
cannot be excluded (Figure 8B).  However, no additional forms could be inferred from unassigned 
signals, which are likely background noise resulting from selection of low intensity precursor. 
 A. K9meSTGGKAPR17 
 
 B. K9me2STGGKacAPR17    
 
Figure 8A-B. Spectral annotations showing identified methylations in histone H3 peptides.  Tandem mass 
spectra were re-drawn and annotated using ProPhoSI to show matches to predicted b- and y-ions. Bold 
black lines in amino acid sequences indicate that a b- (purple) or y-ion (green) is observable in the 
spectrum.  Acetylated lysines are coloured red, mono-methylated lysines green, dimethylated lysines 
orange, propionylated lysines blue and N-terminal propionylation labelled Pr and coloured blue. 
For the two acetylated peptides identified from H3, K9STGGKAPR17 and K18QLATKAAR26, mono-
acetylated versions are observed acetylated exclusively at positions K14 or K23. Di-acetylation was 
observed for each peptide but no evidence was obtained for acetylation of K9 in the absence of 
K14 acetylation or modification of K18 without K23 acetylation, suggesting that acetylation occurs at 
K14 prior to K9, and at K23 before K18. Although absence of observation does not exclude presence, 
it is difficult to explain why the MS response of either positional mono-acetylated isoform would 
change significantly compared with its isoform. Inspection of product spectra from the mono-
acetylated forms of K9STGGKAPR17 (figure 7A) and K18QLATKAAR26 (figure 7C) contain good 
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evidence for the positions assigned, with little ion intensity remaining that could suggest a second 
position of mono-acetylation from a co-selected precursor.  
My results correlate with previous work on untreated Arabidopsis H3 that reported a relatively 
high frequency of detection for acetylation at K14 and no observation of the mono-acetylated 
peptide K9acSTGGKAPR17.82 That study also showed the di-acetylated peptides K9acSTGGKacAPR17 
and K18acQLATKacAAR26 to be some of the least observed forms in untreated plants, potentially 
suggesting these forms may be enriched by ionising radiation.   
I identified the H4 peptide G4KGGKGLGKGGAKR17 in nine different proteoforms, from unmodified 
to tetra-acetylated, with two positional isoforms for mono- and tri-acetylation and three distinct 
positional isoforms for di-acetylation (figure 8A-H).  Previous studies have identified only the 
tetra-acetylated form in untreated higher plants, although work by Zhang has identified 
modification at each of the positions in shorter peptide sequences.83 Figure 5 presents the H4 
acetylation positions identified in my data compared with those of Zhang.   
 
Figure 9. Representation of the acetylation forms of the H4 peptide GKGGKGLGKGGAKR. Forms observed 
following treatment of plants with ionizing radiation (1-9) compared with forms observed by Zhang et al 
(a–f). 83 Acetylation of lysine residues 5, 8, 12 and 16 is indicated by open circles. 
In Zhang’s analysis, shorter trypsin-generated peptide sequences yield less information on the 
concomitant nature of acetylation at positions K5, K8, K12 and K16, although all bar one of their 
identifications can be considered consistent with my results. The exception is identification of di-
acetylated peptide form G4KacGGKacGLGKGG14 (figure 9).  In my analysis, the variant where K5 
and K8 are acetylated while K12 remains unmodified is not observed.  Other studies have 
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suggested that acetylation of H4 occurs first at position K16 and proceeds sequentially towards the 
N-terminus.84 My data show that, although acetylation at K16 is frequently observed, multiple 
acetylation forms of K5, K8 and K12 are present, which are inconsistent with the suggested 
sequential addition from the C-terminal direction, demonstrating identification of novel 
proteoforms.   
With the acetylation pattern characterised from irradiated plants, the next step would have been 
to quantitatively compare untreated and treated plants but this was not pursued because of 
limited grant funds. As a lower cost option GD used antibodies to probe relative abundances of 
identified acetylation forms from control and irradiated plants as described in paper 1.  
Had further funds been available, either intensity-based label-free or isotopic labelling strategies 
could be considered.   However, as positional isoforms are known and likely to elute at similar 
retention times, I would avoid isobaric labelling options such as iTRAQ or TMT where 
quantification is derived from common MS2 reporter ions. Deconvolution of overlapping mass 
spectral peak areas from closely eluting peptides is more tractable than deconvoluting reporter 
ion intensities from chimeric product ion spectra, especially where dynamic exclusion is used and 
so very few MS2 spectra would be sampled across the elution profile.  
Any approach should also determine the relative amounts of common unmodified peptides to 
distinguish changes in protein expression from site occupancy. It would also be valuable to 
include samples exposed to different levels of irradiation to track trends of de/acetylation with 
increasing exposure.   
Ultimately, any bottom-up approach where protease-derived peptides are analysed is limited by 
peptide length. True proteoform analysis would require a top-down alternative where intact 
proteins are analysed mass spectrometrically.85 For example, I have demonstrated the peptide 
G4KGGKGLGKGGAKR17 exists in a minimum of nine proteoforms, but this amino acid sequence 
makes up only 14% of the protein sequence. Using a bottom-up approach, how the different 
proteoforms relate to the remaining 86% of the sequence is unknown.   Top-down approaches 
have recently been demonstrated capable of identifying over 1,000 proteoforms from complex 
mixtures using on-line HPLC separation.86,87   
Although potential exists for expansion, my proteomics analysis successfully identified novel 
acetylation forms and paved the way for the first observation of H4 de-acetylation at positions K12 
and K16 following double strand breakage in irradiated plants.  The paper added to the public 
knowledge base on histone modifications and has been well received with six citations since 
publication,88-93 including a PLOS Biology review by Karen T. Smith and Jerry L. Workman entitled 
Chromatin Proteins: Key Responders to Stress.88  
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Paper 2 – The secretome of the filarial parasite, Brugia malayi: 
proteomic profile of adult excretory-secretory products 
Paper 3 – Proteomic analysis of secretory products from the model 
gastrointestinal nematode Heligmosomoides polygyrus reveals 
dominance of Venom Allergen-Like (VAL) proteins 
Paper 4 – Secretion of protective antigens by tissue-Stage 
nematode larvae revealed by proteomic analysis and vaccination-
induced sterile immunity 
Papers 2-4 detail my mass spectrometry-based analysis of helminth excretory-secretory 
proteomes (ES).  The work is also unified by collaboration with University of Edinburgh 
postdoctoral researcher James Hewitson (JH).  In each study, extracted proteins were prepared by 
JH for me to analyse by mass spectrometry. 
Helminths impose a significant burden upon humanity – around one billion people are estimated 
to be infected.94 These parasites are remarkably tolerant of the immune response and known to 
persist for long periods in immunocompetent patients.95 It is rational that parasite excretions are 
significant to immunomodulation96 and it has been demonstrated that such excreted products can 
elicit sterilizing immunity in hosts exposed prior to infection.97 Elucidation of ES proteins can 
therefore present a valuable list of targets for therapeutic intervention.  The work I present 
studies the murine intestinal nematode parasite Heligmosomoides polygyrus98 and human filarial 
nematode Brugia malayi. 99   
My collaboration with JH began in 2007 when he asked me to identify proteins from 2D-PAGE 
spots derived from a comparison of Brugia malayi ES (BES) and somatic protein extract (BmA).  On 
discussion, JH had hoped to see deeper into the proteome than he was achieving by 2D-PAGE and 
I suggested LC-MS/MS may facilitate this.  JH provided me with extracted BES and BmA proteins 
and I analysed these by LC-MS/MS as detailed in paper 2.  As hoped, LC-MS/MS gave deeper 
penetration, increasing the number of proteins identified in BES from 23 to 82 (paper 2, table 1 
and figure 2D). Crucially, all 23 proteins identified using 2D-PAGE were present in my LC-MS/MS 
dataset.  By modern standards 82 proteins is modest, and can be attributed to the LC-MALDI-
MS/MS technique employed. The key drawback is that fractionation is limited to the number of 
positions on the MALDI target plate. In contrast, on-line LC-ESI-MS/MS is only limited by the 
resolution of the column and the speed of the mass spectrometer.   
I took the same approach in paper 3 where Heligmosomoides polygyrus ES was analysed by both 
2D-PAGE and LC-MS/MS.  Here, the number of identifications increased from 53 to 374 with LC-
ESI-MS/MS using a maXis qTOF mass spectrometer (paper 3, tables 1 and 2). Again, all 2D-PAGE 
identified proteins were present in my LC-MS/MS dataset. 
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Although the mass spectrometry-safe silver staining used for the 2D-PAGE work is not truly 
quantitative, relative intensity between spots can provide an approximation of inter-protein 
amount.100 I hoped a similar quantitative estimation could be obtained from the LC-MS/MS data 
and advised using Mascot-calculated emPAI values to achieve this.101 emPAI values are calculated 
from the relative proportion of observed (Nobs) to theoretically observable (Ntheo) peptides 
(equation 1). 
(1)     ݁݉ܲܣܫ = 10(ே೚್ೞ ே೟೓೐೚)⁄ − 1 
Equation 1. Calculation of emPAI 
Considering spectral count as a proportion of theoretically observable peptides with respect to 
mass range and hydrophobicity is intended to compensate for bias towards longer proteins with 
unmodified spectral counting. 
It should be noted there are imperfections in Mascot’s calculation of emPAI values.  Unlike 
Ishihama’s implementation, individual peptides are not classed as observable based on measured 
masses and hydrophobicities. Instead Ntheo is approximated from protein molecular mass and the 
total number of enzymatic cleavage positions in the database.  Mascot also makes no estimation 
of hydrophobic retention compatibility.  
Even disregarding Mascot’s approximations, spectral counting is now considered less accurate 
than intensity based approaches.  A better alternative is the more recently developed iBAQ, which 
calculates protein abundance by dividing total protein MS1 response by Ntheo.102 Another viable 
alternative is the ‘top three’ method,103 which compensates for varying peptide number and 
unpredictable response by considering only intensity of the three most highly responding 
peptides per protein.  
Intensity-based approaches outperform spectral counting because they are less reliant on 
stochastic product ion selection.  The amplitude of measurement for intensity-based 
measurement is also less discrete; i.e. for spectral count to increase, an additional peptide must 
be sampled.  In contrast, continuity of amplitude in intensity-based approaches is limited only by 
detector measurement.   Such fine measurements are especially crucial where small numbers of 
peptides are identified for a given protein. 
In addition to using emPAI for intra-sample, inter-protein quantification I also used it for inter-
sample relative protein quantification of the same protein between ES and somatic extracts.  The 
same limitations exist here vs intensity-based approaches, although when comparing the same 
protein inter-sample, the imperfections of Mascot’s derivation apply consistently between the 
two comparators and effectively cancel out. 
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Compositional differences measured in my LC-MS/MS datasets were highly divergent for ES vs 
somatic extracts.  For instance, in paper 3 where HES was compared with soluble somatic protein 
extract (HEx), only 28% (104) of the proteins I identified in HES were also seen in HEx.3 The 
relative abundance of the 104 common proteins as estimated by relative emPAI values was also 
highly divergent (table 2). 
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 Table 2. Relative quantification of proteins common to HES and HEx determined by relative emPAI values.  
Proteins measured as upregulated in HES annotated with red emPAI values and upregulation in HEx in 
blue.  Intensity of colour is proportional to magnitude of change. 
Protein
HES/HEx 
emPAI
Protein
HES/HEx 
emPAI
VAL-2.1 (isotig03106) 70 Nucleoside diphosphate kinase (isotig05236) 0.80
TTR-1 Transthyretin-related (isotig04612) 34 TTR-6 Transthyretin related (isotig05212) 0.70
VAL-1.3 (isotig06456) 33 Rab GDP dissociation inhibitor (isotig06129) 0.70
VAL-7.5 (isotig01526) 32 Chondroitin family member (isotig06559) 0.70
VAL-1.1 (isotig06320) 23 Vitellogenin (contig00199) 0.70
NAS-3.1 Astacin protease (isotig01799) 17 Myoglobin (isotig11742) 0.70
VAL-3.1 (isotig05790) 15 Enolase (isotig06965) 0.70
VAL-7.1 (isotig01524) 14 Transaldolase (isotig07176) 0.70
NSN-1 Novel secreted protein, No SP (isotig18405) 13 Vitellogenin (contig00203) 0.70
Astacin protease family member (isotig01791) 12 Aldolase (isotig04899) 0.70
CSP-4 Conserved secreted protein with SP (isotig13290) 11 Vitellogenin (fragment) (sing00711) 0.60
VAL-4 (isotig10387) 9.7 Myoglobin (isotig05169) 0.60
Aspartyl protease (necepsin) (isotig06497) 6.5 Myoglobin (isotig04274) 0.60
Kunitz inhibitor (isotig01217) 6.3 TTR-11 Transthyretin related (isotig04258) 0.60
VAL-12 (isotig06637) 5.4 Ribosomal protein 60S L40 / Ubiquitinn (isotig13199) 0.60
Astacin protease family member (fragment) (isotig01219) 5.2 Serpin (isotig02225) 0.60
Superoxide dismutase (isotig09104) 4.7 Vitellogenin (contig00212) 0.50
C-type lectin mannose receptor-like (isotig00496) 4.2 Vitellogenin (contig00211) 0.50
MFH-1 Ascaris MFP2b homologue (isotig07283) 4.0 Chondroitin family member (isotig04525) 0.50
Cystatin (isotig02700) 3.4 Fatty acid/retinol binding protein (isotig11475) 0.50
CSP-2 Conserved secreted protein with SP (isotig09016) 2.9 Fatty acid/retinol binding protein (fragment) (sing12372) 0.40
Motile sperm domain containing protein (isotig16097) 2.3 Phosphatidylethanolamine-binding protein (isotig05126) 0.40
Galectin (isotig09082) 2.2 Independent phosphoglycerate mutase (isotig01699) 0.40
TIL domain-containing protein (isotig00779) 2.1 Vitellogenin (Hp_ADY_001G11) 0.40
Arginine kinase (isotig05009) 2.0 Cyclophilin (isotig11124) 0.40
Motile sperm domain containing protein (isotig16375) 1.7 Thioredoxin peroxidase (isotig05188) 0.30
ERM family member (isotig02815) 1.6 Enolase (fragment) (isotig18996) 0.30
Cyclophilin (isotig09088) 1.6 Glutathione S-transferase (isotig11588) 0.30
Actin depolymerising factor (isotig07522) 1.5 HSP70 (fragment) (isotig13132) 0.30
Macrophage migration inhibitory factor (isotig14093) 1.5 Myoglobin (isotig11356) 0.30
TTR-5 Transthyretin-like (isotig13207) 1.5 Calreticulin (Hpb-CRT) 0.30
MFH-3 Ascaris MFP2b homologue (isotig07980) 1.4 Lipocalin domain-containing protein (isotig05316) 0.30
TTR-10 Transthyretin-like (isotig11792) 1.4 Myoglobin (isotig11666) 0.30
NSP Novel isotig12701 (isotig12701) 1.4 CSN-5 Conserved secreted protein, No SP (isotig03664) 0.30
Chondroitin family member (isotig01493) 1.3 Aldolase (isotig04915) 0.30
Ferritin (isotig15727) 1.0 Major sperm protein (isotig01565) 0.20
NSP-39 Novel secreted protein with SP (isotig16333) 1.0 HSP60 (isotig06093) 0.20
Vitellogenin (contig00207) 1.0 Piwi domain-containing protein (isotig04875) 0.20
Myoglobin (fragment) (isotig19571) 1.0 14-3-3 family member (isotig07975) 0.20
Calmodulin (isotig07710) 1.0 CSN-2 Conserved secreted protein, No SP (isotig04423) 0.20
Cathepsin-B like cysteine protease (isotig07017) 1.0 Actin (isotig08340) 0.20
Galectin (isotig09713) 1.0 Cytochrome C (isotig11144) 0.20
Kunitz inhibitor (isotig02721) 1.0 Actin (isotig01640) 0.10
Kunitz inhibitor (isotig02378) 1.0 Eukaryotic translation elongation factor 2 (isotig05363) 0.10
ML-domain containing protein (isotig10098) 1.0 Protein disulfide isomerase (isotig01916) 0.10
Motile sperm domain containing protein (isotig16212) 1.0 Eukaryotic translation elongation factor 1A (isotig02523) 0.10
NSP-59 Novel secreted protein with SP (isotig13319) 1.0 Protein disulfide isomerase (isotig05787) 0.10
Triose phosphate isomerase (isotig05016) 1.0 HSP70 (isotig07134) 0.10
VAL-15 (isotig02149) 1.0 Glutathione S-transferase (isotig10292) 0.10
Chondroitin family member (isotig08745) 1.0 Malate dehydrogenase (isotig05076) 0.10
NPA-1 Nematode polyprotein allergen (isotig02438) 0.90 Ribosomal protein 60S P0 (isotig01358) 0.10
Vitellogenin (contig00471) 0.80 Retinol binding protein (Hpb-RBP) 0.00
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 Biological replicates were not analysed due to limited protein availability from parasitic systems.  
Lack of replication was commonplace at the time but would be virtually unpublishable today.   In 
this respect, a greater understanding of the statistical nature of data and resulting robustness is 
possibly the most impactful change proteomics has made in the past decade.  
Without replication it is impossible to determine if changes are significant or symptomatic of 
underlying variance.  Technical replication (i.e. repeated protein extraction or LC-MS/MS 
acquisitions from a common sample) only measures variance in the step replicated and is typically 
lower than biological variation.104 Technical replication can be useful for assessment of variance at 
different procedural positions, especially during method development.105 Biological replication is 
key to showing differences as biologically consistent.  Biological replicates encompass underlying 
technical variation meaning technical replication can often be omitted.  Biological analyses must 
also contain appropriate controls to ensure that observations result from the stimulus applied 
rather than more generic pleotropic or stress responses.106   
By current standards, the work presented in papers 2-4 should be viewed as qualitative rather 
than quantitative.  However, my ‘qualitative’ mass spectrometry analysis was ultimately 
successful in suggesting gross differences in ES protein extracts that have been subsequently 
validated by orthogonal techniques or through repetition in similar studies. 
HES was dominated by venom allergen/ancylostoma secreted (VAL) proteins – 14 of the top 20 
and 26 of the top 100 proteins in HES were VALs when ranked by emPAI (paper 3).  In contrast, 
only VAL 3.1 was present in the top 100 HEx emPAI-ranked proteins. GO analysis indicated 
translation as the most common biological process term for HEx, and structural component of 
ribosome the most common molecular function. In HES, proteolysis and metalloendopeptidase 
activity were the most common biological process and molecular function terms respectively. 
Proteolysis and peptidase activity may protect against host immune response by reducing 
hydrolytic activity towards the nematodes and responding with their own hydrolytic attack 
against mediators of immune response. 
In paper 2 relative emPAI comparison of BES with somatic extract (BmA) estimates >10-fold 
enrichment of triose phosphate isomerase, leucyl aminopeptidase, γ-glutamyltranspeptidase and 
N-acetylglucosaminyltransferase in BES.  Enrichment of peptidases is consistent with the HES 
results from paper 3. Several glycolytic enzymes were measured as highly abundant in BmA but 
only two are identified in BES: enolase and triose phosphate isomerase, the latter showing a 17-
fold enrichment in BES (paper 2).  At time of publication the role of triose phosphate isomerase at 
the helminth–host interface was unknown. However, my identification of triose phosphate 
isomerase in the LC-MS/MS data led to work by Hewitson et. al.107 demonstrating that adult 
female Brugia malayi helminths release triose phosphate isomerase, promoting creation of an 
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ovum increasing the number offspring. Hence, antibody targeting and neutralisation of triose 
phosphate isomerase inhibits reproduction and reduces the microfilarial burden.  Such an 
observation makes triose phosphate isomerase a target for immunological and pharmacological 
intervention against filarial infections. 
Further proteins, ranked highly by emPAI score in BES, were at undetectable levels in BmA. An 
indication of the disparity is presented in figure 10.   It was noted that galectins were highly 
prominent in the list of BES protein identifications when ranked by emPAI.  Again, the observation 
is common between BES and Heligmosomoides polygyrus ES studied in paper 2.  A study by Kim 
et. al. published subsequent to the presented work has shown that exposure to an expressed 
homolog of galectin-9 prior to Toxascaris leonina infection can inhibit intestinal inflammation.108 
Such findings add further weight to targeting galectins for further study in parasitic systems. 
 
Figure 10. Venn diagram comparing the count of unique and overlapping proteins identified from somatic 
(BmA) and secreted-excreted (BES) fraction of Brugia malayi. 
Paper 4 is as an extension of paper 3 in which adult Heligmosomoides polygyrus ES is compared 
with larval stage four secreted analogue (L4), and egg-released material (ERM).  L4 is a key 
infection stage where parasites migrate from submucosa to lumen.  It would be advantageous to 
target antigens present at the larval stage with the hope of countering the infection before egg 
production and proliferation within the body.  
Figure 11 illustrates the overlap of protein identifications between the HES, L4 and ERM extracts.   
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 Figure 11. Venn diagram comparing the count of unique and overlapping proteins identified from 
secreted-excreted L4 larval (L4), adult (HES) and egg released material (ERM) from Heligmosomoides 
polygyrus. 
Although VAL proteins are highly abundant in HES and L4, my emPAI comparison suggests there 
are differences in VAL composition.  Notably, VAL-2 was measured as less abundant in L4 – VAL-
2.1, 2.2 and 2.3 are ranked 11th, 1st and 41st respectively in adult ES but only VAL-2.3 was detected 
in L4 and was ranked 124th.  JH validated VAL-2 quantification by ELISA, with the results showing 
consistent low abundance in L4 ES.  
My LC-MS/MS data also indicated L4 ES contained high abundance acetylcholinesterases, 
lysozymes and apyrases.  Subsequent work by JH, also presented in paper 4, showed antibodies 
extracted from mice inoculated with L4 and HES are antigenic to VAL-1 and acetylcholinesterase-
1, suggesting that these extracts may be especially important in immune modulation. 
Papers 2-4 have been extremely well received with over 250 citations collectively (PubMed). They 
led to deeper insights into helminth immunomodulation, including identification of new potential 
targets for therapeutic investigation, which have since been validated by subsequent 
investigations. In each case my LC-MS/MS identification and qualitative comparison was vital to 
the discovery of these targets and improving the understanding of the field. 
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Paper 5 – Plasma membrane proteomes of differentially matured 
dendritic cells identified by LC-MS/MS combined with iTRAQ 
labelling 
Paper 5 highlights my use of isobaric tags for protein quantification applied in an immunological 
setting.   
I was approached by University of York postdoctoral researcher Stéphanie Ferret-Bernard (S-FB), 
who wanted to compare relative proteomes of dendritic cells (DCs) exposed to bacterial LPS or 
schistosome egg antigen (SEA).  LPS, which forms an outer layer on gram-negative bacteria109 
induces the inflammatory type 1 immune response (Th1).110 In contrast, schistosomes, which are 
parasitic helminths, generate anti-inflammatory type 2 immune repose (Th2). Th1 proceeds 
through recognition of antigens by DC surface proteins inducing a mature state where antigen is 
adhered to cell surface and trafficked for presentation to host immune system.  At the time of 
study Th2 type response was much less understood than Th1 and although it had been shown to 
proceed via a non- or partially-maturated DC profile, little was known of the molecular 
mediators.111  
At time of publication, studies comparing proteomic changes in DCs upon exposure to helminth 
infection relied upon 2D-PAGE work-flows, limiting observation of membrane proteins.112 Analysis 
of the less amenable hydrophobic membrane component was essential to provide full 
understanding of the system. 
SF-B intended to prepare a centrifugal membrane preparation of DC cells exposed to either SEA 
(SEA-DCs) or LPS (LPS-DCs), with control samples exposed to culture medium (MED-DCs).  Before 
proceeding to quantification we decided to test membrane enrichment.  SF-B performed 
enrichment and I analysed the samples by LC-MALDI-MS/MS after tryptic digestion as detailed in 
the paper.  The number of proteins identified varied between treatments with 119 proteins in 
MED-DCs, 149 proteins in SEA-treated and 61 proteins after LPS treatment.  Gene ontology (GO) 
showed proteins attributed to plasma membrane were most frequently identified in each sample, 
although this was conspicuously different between the treatments; 32% of proteins were assigned 
as membrane in SEA-DCs and 52% in LPS-DCs (figure 12).  Despite the differences, we decided to 
proceed to quantitative analysis. 
 
35
  
Figure 12. Classification of identified proteins by GO terms, showing proteins assigned to the plasma 
membrane to be the most commonly identified in all samples. 
 
At the time, the only mass spectrometry option available to me was the Applied Biosystems 4700 
MALDI-TOF/TOF instrument.  MALDI-MS response is strongly affected by crystallisation113 making 
label-free comparison difficult, so I suggested an iTRAQ approach.  iTRAQ relative peptide 
quantification is derived from reporter ions in product ion spectra of co-selected isobaric 
peptides, which are exposed to identical crystallisation and ionisation conditions.  iTRAQ 
multiplexing also saves on instrument time. 
SF-B explained that LPS treatment would likely cause a more pronounced change than SEA and 
comparison of SEA vs MED control was equally if not more important than SEA vs LPS.  I 
recommended SEA and LPS analyses be separated into individual comparisons vs MED control, 
reducing the chance of LPS high magnitude change swamping modest SEA change.  We agreed on 
three biological replicates and to assess technical variance caused by digestion and labelling I 
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advised splitting the MED-DC samples into two aliquots before labelling. Table 3 details the 
labelling design. 
                    Label 
Experiment 
114 115 115 
1 MED LPS MED 
2 MED SEA MED 
3 MED LPS MED 
4 MED SEA MED 
5 MED LPS MED 
6 MED SEA MED 
 
Table 3. MED vs LPS or SEA labelling design. Each experiment number derived from a separate biological 
preparation.  
I performed LC-MALDI-MS/MS analysis on the combined iTRAQ samples as detailed in the paper.  
Repeating GO analysis on pooled iTRAQ results provided a similar distribution of cellular 
components (figure 13) to unlabelled samples, suggesting labelling was not changing the 
distribution of protein types identified.  It should be noted the relative observation of nuclear 
proteins in SEA-DC samples is consistent with the unlabelled data, but remains suspicious from an 
enrichment viewpoint. 
    
 
Figure 13. Classification of identified proteins by GO terms after iTRAQ labelling. 
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I used the ‘Whetton plot’ approach to determine differences in relative quantification based on 
variation in MED-DC controls.114 Log10 ratios of MED-DC(iTRAQ114)/MED-DC(iTRAQ116) labelling 
replicates across all six biological replicates (n = 355) were plotted against number of identified 
peptides (figure 14). The Whetton plot provides an empirical estimation of the technical variance 
from which thresholds can be selected on the assumption that variance among experimental 
conditions will be approximately equal to variance in controls. Subjective values of 0.1 and 0.04 
were chosen as high and low stringency thresholds respectively, based on the number of control 
protein measurements (false positives) exceeding these values.  Proteins called as changing were 
required to have a 95% confidence interval for the mean (± 1.96 SE) exceeding Whetton plot 
thresholds.  Retrospectively applying the thresholds to the MED-DC/MED-DC controls gives a 
global 5% FDR at the higher threshold and a 20% FDR with the low stringency cut-off.  
 
 
Figure 14. Whetton plot, showing protein level log10 fold change vs number of peptides identified for all 
technical replicates in the six iTRAQ analyses.  Values of 0.1 (dark grey shaded region) and 0.04 (light grey 
shaded region) taken as high and low stringency thresholds respectively. 
 
Tables 4 to 7 list proteins designated as differently abundant. A total of 60 proteins exceeded the 
lower threshold in the SEA-DCs vs MED-DCs comparison, with 35 remaining at the higher-
stringency cut-off.  Filtering requiring mean ± 1.96 SE to exceed the fold-change threshold reduces 
the number of changes to 50 at lower stringency and 23 at the higher threshold. 
Fewer changes were observed in LPS-DCs vs MED-DCs than in the SEA equivalent, with 18 values 
above the 0.04 log10 fold change threshold, dropping to 17 when the 95% confidence interval for 
SEM is applied. At the higher threshold 14 proteins exceed the 0.1 cut-off, reducing to nine 
applying ± 1.96 SE boundaries. 
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 Protein 
Mean log10  
(SEA-DCs/MED-DCs) 
Mean - 1.96 SE (95% CI) 
H2B histone family, member A 0.34 0.25 
H3 histone, family 3A 0.30 0.20 
Histone protein, family H2A 0.30 0.23 
Histone H4 0.27 0.23 
Histone 1, H4i 0.26 0.18 
Histone H1.2 0.25 0.20 
Heat shock protein HSP90-b 0.23 0.17 
Histone H1.5 0.20 0.13 
H2A histone family, member Z 0.19 0.19 
Peptidyl-prolyl cis-trans isomerase 0.18 0.15 
Vimentin 0.18 0.15 
Tubulin b5 0.17 0.17 
Histone H1.4 0.16 0.16 
Heat shock protein HSP90-a 0.15 0.13 
Protein disulfide isomerase related 
protein 
0.14 0.14 
Elongation factor 1-a1 0.14 0.11 
S100 A9, calgranulin B, MRP-14 0.14 0.10 
Heat shock cognate 71 kDa protein 0.13 0.09 
Clathrin, heavy polypeptide 0.13 0.12 
Pyruvate kinase 3 0.12 0.10 
Non-musical heavy chain myosin II-A 0.12 0.09 
Malate dehydrogenase 0.11 0.10 
14-3-3 protein b/a 0.11 0.10 
Talin-1 0.10 0.09 
Lymphocyte cytosolic protein 1, 65 kDa 
macrophage protein 
0.10 0.07 
Peroxiredoxin 1 0.10 0.07 
Heat shock cognate 71KDa protein 0.10 0.09 
Coactosin-like protein 0.09 0.04 
Elongation factor 2-b 0.09 0.08 
Peptidyl-prolyl cis-trans isomerase 0.08 0.07 
Ras-related protein Rab-7 0.07 0.03 
Lysozyme C, type M precursor 0.06 0.06 
Arginosuccinate synthase 0.06 0.02 
Table 4. Proteins upregulated in SEA-DCs vs MED-DCs. Bold indicates log10 ratios greater than 0.1. Yellow 
and green shading highlights values with mean – 1.96 SE >0.04 and >0.1 respectively. 
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Protein 
Mean log10  
(SEA-DCs/MED-DCs) 
Mean + 1.96 SE (95% CI) 
 Coronin, actin binding protein 1A    -0.05 -0.03 
 FceRI -0.05 -0.03 
 Cofilin 1, non-muscle -0.05 -0.04 
 Ras GTPase-activating-like protein  -0.05 -0.03 
 Transgelin -0.06 -0.03 
 Ras-related protein Rap-1B -0.06 -0.04 
 Guanine nucleotide-binding protein, b-
2 subunit 
-0.06 -0.02 
 Murine Carbonic Anhydrase IV -0.07 -0.04 
 Radixin -0.08 -0.03 
 Hematopoietic cell specific Lyn 
substrate 1 
-0.08 -0.05 
 Ezrin -0.08 -0.06 
 CD44 -0.08 -0.05 
 Moesin (Membrane-organizing 
extension spike protein) 
-0.08 -0.05 
 Guanine nucleotide-binding protein 
G(i), -3 subunit  -0.09 -0.04 
 Myosin light chain, alkali, non-musical -0.09 -0.05 
 Annexin A2, calpactin I heavy chain  -0.09 -0.06 
 Guanine nucleotide-binding protein 
G(i), -2 subunit  -0.09 -0.07 
 Annexin A1, calpactin II -0.10 -0.08 
 Actin, , cardiac -0.11 -0.07 
 H-2 class II histocompatibility antigen, A 
 chain precursor -0.11 -0.11 
 Actin, b, cytoplasmic -0.11 -0.08 
 Actin-related protein 2/3 complex 
subunit 2 
-0.12 -0.12 
 -actin -0.12 -0.08 
 Calmodulin 2 -0.13 -0.07 
 Lymphocyte specific 1 -0.15 -0.11 
 S100 A10, calpactin I light chain -0.15 -0.15 
 22 kDa neuronal tissue-enriched acidic 
protein, NAP-22, BASP-1, CAP-23 
-0.21 -0.15 
 
Table 5. Proteins down regulated in SEA-DCs vs MED-DCs. Bold indicates log10 ratios greater than 0.1. 
Yellow and green shading highlights values with mean + 1.96 SE <-0.04 and <-0.1 respectively. 
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 Protein 
Mean log10  
(LPS-DCs/MED-DCs) 
Mean - 1.96 SE (95% CI) 
H-2 class II histocompatibility antigen, 
A-B a chain precursor 
0.32 0.31 
Transgelin 2 0.27 0.11 
H-2 class II histocompatibility antigen, A 
b chain precursor 
0.16 0.07 
CD29, Integrin b-1 precursor (Integrin 
VLA-4 b-subunit) 
0.14 0.13 
22 kDa neuronal tissue-enriched acidic 
protein, NAP-22, BASP-1, CAP-23 
0.13 0.06 
CD98 heavy chain (4F2), lymphocyte 
activation antigen 
0.10 0.09 
Annexin A4 0.09 0.02 
-2-microglobulin precursor 0.07 0.06 
Table 6. Proteins upregulated in LPS-DCs vs MED-DCs. Bold indicates log10 ratios greater than 0.1. Yellow 
and green shading highlights values with mean – 1.96 SE >0.04 and >0.1 respectively.  
Protein 
Mean log10  
(LPS-DCs/MED-DCs) 
Mean + 1.96 SE (95% CI) 
S100 A10, calpactin I light chain -0.05 -0.04 
CD18, Integrin -2 precursor (LFA- 
1/CR3/P150,95 -subunit) -0.13 -0.09 
Prosaposin -0.15 -0.05 
ATP synthase a chain, mitochondrial 
precursor 
-0.18 -0.14 
Phosphate carrier protein, 
mitochondrial precursor 
-0.19 -0.07 
ATP synthase b chain, mitochondrial 
precursor 
-0.24 -0.14 
CD44 -0.28 -0.26 
Cathepsin D precursor -0.29 -0.27 
Secretory protein YM-1 precursor -0.33 -0.31 
Moesin (Membrane-organizing 
extension spike protein) 
-0.33 -0.33 
Table 7. Proteins down regulated in LPS-DCs vs MED-DCs. Bold indicates log10 ratios greater than 0.1. 
Yellow and green shading highlights values with mean + 1.96 SE <-0.04 and <-0.1 respectively. 
The common MED-DCs sample used in both the SEA-DC and LPS-DCs analyses allowed relative 
SEA-DC vs LPS-DC protein ratios to be calculated (equation 2). 
(2) log10(SEA-DCs/LPS-DCs) = log10(SEA-DCs/MED-DCs) - log10(LPS-DCs/MED-DCs) 
Equation 2. Calculation of SEA-DC vs LPS-DC protein ratios. 
Four proteins were upregulated in SEA-DCs at the higher Whetton plot-derived fold-difference 
threshold, while eight proteins were upregulated in LPS-DCs (table 8).  Two further proteins 
showed greater expression in LPS-DCs at the lower stringency 0.04 threshold. 
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Protein 
Mean log10  
(SEA-DCs/LPS-DCs) 
Moesin 0.26 
CD44 0.21 
CD18 0.11 
Rab-7 0.11 
Rap-1B -0.08 
Actin,  -0.09 
Actin,  -0.10 
S100 A10 -0.11 
-2-microglobulin precursor -0.11 
Annexin A4 -0.12 
Annexin A1 -0.13 
 H-2 class II histocompatibility antigen, A 
b chain precursor 
-0.27 
 22 kDa neuronal tissue-enriched acidic 
protein, NAP-22, BASP-1, CAP-23 
-0.29 
Transgelin 2 -0.33 
Table 8. Proteins differently regulated in SEA-DCs vs LPS-DCs. Bold indicates log10 ratios greater than 0.1. 
 
Although published in 2010 the work for this paper was performed in 2007.  The field has changed 
significantly in the intervening time and of the studies presented, this is the analysis I would 
change most if I were to repeat it today, almost a decade on. 
Number of proteins identified was relatively modest, but as with paper 2 this is attributed to the 
LC-MALDI-MS/MS instrumentation available. MALDI-TOF/TOF mass spectrometers are also less 
suited to iTRAQ analyses because of the relatively wide precursor selection window mandated by 
the use of a precursor ion selector voltage gate.115 Increasing precursor ion selection width 
increases propensity for co-selection and generation of chimeric spectra that have been shown to 
lead to attenuation of iTRAQ ratios.  Modern ion-trap instruments can improve quantitative 
accuracy with isobaric tagging analyses by acquiring MS3 spectra to sample reporter ion intensity, 
improving specificity of measurement.116,117  
In retrospect, the design would be improved by including SEA and LPS treatments in the same 
labelling set, allowing direct comparison.  Thermo now produce 10-plex isobaric labelling reagents 
that could compare three biological replicates of SEA-, MED- and LPS-treated DCs in a single 
acquisition.  The number of biological replicates required could be estimated using power analysis 
once biological variation was measured in a scoping experiment.118 If greater than three replicates 
were needed, successive 9-plex iterations could be performed, although optimally all samples 
should be produced simultaneously to minimise variance.   
While well adopted at the time, the Whetton plot approach is now rarely used.  The regime forces 
assumption that variance is equal between controls and comparator.  In practice, variance differs 
protein-to-protein within sample, let alone inter-sample.  Modern approaches assess variance for 
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individual proteins among biological replicates and either compare transformed ratios to a null 
hypothesis of normality or allow direct comparison of normalised reporter ion intensities.119-121 
Such methods calculate protein level p-values indicating statistically significant differences.  
Where data can be shown normally distributed, Welch’s t-test can be applied (equation 3), to 
compare means ( തܺ) and variance (s) for N observations. Unlike Student’s t-test Welch’s does not 
assume equal variance between comparators.  
(3)     ݐ =  
ܺଵതതത − ܺଶതതത
ඨݏଵ
ଶ
ଵܰ
 + 
ݏଶ
ଶ
ଶܰ
 
Equation 3. Welch’s t-test. 
If the data are non-normal, non-parametric tests such as Wilcoxon signed-rank test can compare 
relative ranks R between populations (equation 4).   
(4)      ܹ =  ෍[sin(ݔଶ,௜
ேೝ
௜ୀଵ
− ݔଵ,௜) ∙ ܴ௜] 
Equation 4. Wilcoxon signed-rank test. 
Whichever test is chosen, multiple test-correction should be used to ensure false significance is 
not obtained through virtue of testing repetition.  The Bonferroni (equation 5) or less stringent 
Hochberg and Benjamini approaches (equation 6) can calculate multiple-test corrected q-values 
or FDRs respectively. 
(5)             ݍ = ݌ ∙  ݊݋. ݐ݁ݏݐݏ 
Equation 5. Bonferroni multiple test correction. 
(6)     ܨܦܴ =  
݌ ∙  ݊݋. ݐ݁ݏݐݏ
ݎܽ݊݇
 
Equation 6. Hochberg and Benjamini calculation of false discovery rate. 
Considering that GO analysis of the SEA and LPS treated samples shows different proportions of 
membrane and nuclear proteins (figure 12) and the highest ranked proteins in SEA vs MED DCs 
were non-membrane proteins (table 4 – note prevalence of nuclear histones), the variation 
imparted by the membrane enrichment must be questioned.  While replicates could be used to 
determine preparation variance, a better approach would be to move from iTRAQ or TMT to a 
SILAC approach.  With SILAC, samples are combined prior to membrane enrichment, removing it 
and subsequent digestion steps as points of inter-sample variation.105 
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Validity of any enrichment should also be considered.  For instance, if a protein is of lower 
abundance in the membrane preparation one cannot know whether expression of the protein has 
reduced globally or if the protein has been trafficked from the membrane into the soluble 
component.  Using modern LC-MS/MS instrumentation in conjunction with protein or peptide 
fractionation it may be possible to sample deeply enough to obtain membrane penetration 
without enrichment. If enrichment is required, the soluble fraction should also be analysed to test 
for spatial differences.  True spatial proteomics is only now becoming tractable. Kathryn Lilley is 
pioneering the field with development of LOPIT,122 which uses a combination of isotopic labelling, 
density gradient fractionation and principle component analysis to assign organelle localisation by 
comparison with marker proteins of known organelle location. 
A positive aspect of paper 5 was the orthogonal validation performed by SF-B using flow 
cytometry for 11 proteins with commercially available antibodies (table 9). Three proteins were 
not identified in my proteomic analysis. Of the remaining 19 comparisons, 12 were in agreement, 
either both showing significant differences or showing no change. Seven measurements showed 
significant change in only one technique.  There were no cases where quantifications determined 
significant differences with the two approaches that were contradictory.  
Protein SEA vs MED iTRAQ 
SEA vs MED 
Flow 
Cytometry 
LPS vs MED 
iTRAQ 
LPS vs MED 
Flow 
Cytometry 
IA-b MED No change LPS LPS 
CD98 No change SEA LPS LPS 
Galectin No change No change No change No change 
IA/IE MED No change LPS LPS 
MGL No change No change No ID No ID 
CD29 No ID No ID LPS LPS 
CD18 No change SEA MED No change 
Rab7 No change No change No change No change 
S100 A10 MED MED No change LPS 
CD44 MED No change MED MED 
YM-1 No ID No ID MED MED 
Table 9. Validation of iTRAQ results using flow cytometry. Shading indicates: green, upregulation in SEA-
DCs; blue upregulation in MED-DCs; pink, upregulation in LPS-DCs; grey, no significant change; white, 
protein not identified in iTRAQ data set. iTRAQ significance taken as log mean ratio ± 1.96 SE >0.04 or <-
0.04. Flow cytometry significance = p<0.05. 
 
In spite of the imperfections of the instrumentation and experimental design, biologically 
meaningful results were still obtained. LPS-DCs showed increase in H-2 class II histocompatibility 
antigen relative to both MED-DCs control and SEA-DCs, which is consistent with the maturation of 
DCs leading to Th1 response.  Downregulation of the same protein upon SEA treatment is 
evidence of alternative Th2-type response.  Surprisingly, NAP-22, a neuron-enriched protein 
localized mainly in the synaptic vesicles,123 was shown to be the most down-regulated protein 
upon SEA treatment.  NAP-22 regulates neurite outgrowth, synaptogenesis and growth-cone 
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guidance during development of the nervous system124 but has not been reported in dendritic 
cells. Its identification in my data is confident with five unique peptides matched. Such a gross 
difference between treatments and unexpected observation calls for further analysis, although to 
date no immunological effect of NAP-22 has been reported in DCs. 
My proteomic data determined clathrin as upregulated in SEA-DCs.  A publication two years later 
by Srivastava observed the same effect in a similar SEA-directed Th2-type immune response 
analysis.125 Srivastava also measured upregulation of Rab7.  Although increase of Rab7 was not 
significant in my SEA-DCs vs MED-DCs data set, Rab7 was calculated to have the fourth highest 
magnitude change between SEA-DCs vs LPS-DCs, suggesting a potentially important distinction 
between Th1-type and Th2-type response.  Both clathrin and Rab7 are functional in 
endocytosis,125 the incorporation of molecules within a cell.126 Further evidence for upregulation 
of antigen uptake was evidenced by increases in heat shock protein 90 and heat shock conjugate 
71, both of which are involved in protein folding.127 
SEA-treated DCs showed upregulation of several enzymes (peptidyl-prolyl cis-trans isomerase, 
protein disulfide isomerase, pyruvate kinase 3, malate dehydrogenase, peroxiredoxin 1, peptidyl-
prolyl cis-trans isomerase, lysozyme C and argininosuccinate synthase), suggesting greater 
metabolic activity. Increase in histones implies increased protein synthesis, which may aid cell 
proliferation.74 No corresponding upregulation of enzymes or histones was observed for LPS-DCs.  
It should be noted that, as observed in paper 1, histones are commonly modified and the changes 
in regulation here may be confounded by PTM differences. 
While the study appears naïve by today’s standards, my proteomic dataset added to the 
expanding knowledge that Th2 response induced by SEA-DCs progresses through limited 
maturation of DC cells.112 In addition, my proteomic analysis yielded deeper penetration into the 
membrane component than was possible with previous gel-based studies and has subsequently 
been cited ten times.128-137 
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Paper 6 – S-adenosyl-S-carboxymethyl-L-homocysteine: a novel co-
factor found in the putative tRNA modifying enzyme CmoA 
Paper 6 centres on my mass spectrometric identification of a novel protein co-factor. The work 
began in 2010 when I was contacted by Fiona Whelan (FW) and Fred Antson (FA), a post-doctoral 
researcher and Professor respectively, at University of York who were collaborating with Robert 
Byrne (RB) of Oxford University.  They were studying CmoA, an enzyme that catalyses 5-
methoxyuridine to uridine-5-oxyacetic acid conversion (figure 10).  The conversion is part of the 
uridine to uridine-5-oxyacetic acid biosynthetic pathway138 in bacterial tRNA (figure 15).  
Nucleoside modification in tRNA transforms the macromolecule into its mature state and 
conversion to uridine-5-oxyacetic acid aids translation by altering anticodon stem loop 
conformation, lowering the entropic increase required for remodelling.139  
 
Figure 15. Biosynthetic pathway of uridine to uridine-5-oxyacetic acid conversion in bacterial tRNA. 
The researchers’ studies had culminated in the resolution of CmoA crystal structure using X-ray 
crystallography but there remained unexplained intensity in the data.  They hypothesised the 
intensity could derive from a co-factor, but it was incongruent with the expected ligands S-
adenosylmethionine or S-adenosylhomocysteine involved in similar biosynthetic methylations.140-
142 The density instead favoured an S-adenosylmethionine derivative where the methyl group was 
substituted with a group of trigonal planar geometry.  I explained that if the ligand could be 
observed by FTICR-MS the accuracy afforded should be sufficient for empirical formula 
determination.  
FTICR-MS uses the principle that ions exposed to a magnetic field undergo cyclotron motion with 
angular frequency (ωc) proportional to magnetic field strength (B) and inversely proportional to 
m/z (equation 7). 
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(1)       ߱௖ =
ݖܤ
݉
 
Equation 7. Calculation of cyclotron angular frequency. 
Although costly high strength magnets are required, angular frequency can be measured with 
very high precision providing unparalleled mass accuracy compared with other mass analysers. If 
the analyte could be fragmented, the product ion spectrum may provide information on the 
ligand’s structure.   
FW provided a purified extract of E. coli-expressed CmoA that I analysed using FT-ICR-MS as in 
paper 2. Under denaturing conditions (aqueous 50% (v/v) acetonitrile containing 1% (v/v) formic 
acid) signal was observed for the protein (figure 16).  Deconvolution using Bruker’s sophisticated 
numerical annotation procedure (SNAP) provided a mass of 27,763.2 Da, 0.3 Da mass error from 
the predicted mass of CmoA. SNAP uses an averagine algorithm to pick masses from isotopic 
patterns by comparing with predicted patterns for combinations of predefined atoms. 
 
Figure 16. FTICR-MS spectrum of purified CmoA. Deconvoluted mass measured = 27,763.2 Da. 
I repeated acquisition with parameters adjusted to facilitate observation of the lower mass ligand.  
Source accumulation was increased from 0.01 to 0.2 s and flight time to acquisition cell reduced 
from 1.2 to 0.6 ms. Figure 17 presents the resulting spectrum. 
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 Figure 17. FTICR-mass spectrum of purified CmoA, with instrument tuning to favour observation of low 
m/z signal. The ion at m/z 443.1333 is starred. 
Multiple ions were observed between m/z 300 and 600. I selected the most intense precursors for 
fragmentation using CID in the hexapole collision cell (qCID).  Precursor and product ions were 
submitted to SmartFormula3D™ in Bruker DataAnalysis software to assign empirical formulae. 
Mass errors were restricted to 1 mDa and C, H, N, O and S atoms were considered.  
Searching the PubChem database for compounds structurally similar to S-adenosylmethionine or 
S-adenosylhomocysteine within a 0.5 m/z unit of the observed precursor ions provided a single 
match to a derivative in which the methyl group is replaced by a carboxymethyl group:  S-
adenosyl-S-carboxymethyl-L-homocysteine; m/z 443.1343 [M+H]+. 
S-adenosyl-S-carboxymethyl-L-homocysteine is within 1 mDa of the precursor ion at m/z 443.1333 
(starred figure 17).  The qCID spectrum for this precursor produced product ions at m/z 250.0925 
and 342.0863 (figure 18). SmartFormula3D™ suggested two empirical formulae that could 
reconcile all three m/z values (table 10).  When ranked by fit to isotopic pattern (mSigma) the top 
hit (C16H23N6O7S) is consistent with S-adenosyl-S-carboxymethyl-L-homocysteine.  
In addition to the precursor m/z, suggested empirical formulae for both product ions of the top 
ranked match are consistent with fragmentation of S-adenosyl-S-carboxymethyl-L-homocysteine 
at C-S bonds (figure 19). 
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 Figure 18. qCID FTICR-mass spectrum of precursor m/z 443.1333. Product ion m/z measurements are 
annotated. 
Result Rank Precursor Formula mSigma m/z Error mDa 
1 
C16H23N6O7S 25.9 443.13434 0.71 
Product Formula m/z Error mDa 
C10H12N5O3 250.09347 0.93 
C12H16N5O5S 342.08667 0.32 
Result Rank Precursor Formula mSigma m/z Error mDa 
2 
C14H21N9O6S 22.7 433.13300 -0.64 
Product Formula m/z Error mDa 
C8H10N8O2 250.09212 -0.42 
C12H16N5O5S 342.08667 0.32 
Table 10. SmartFormula3D™ results table generated from m/z values observed upon qCID fragmentation 
of ion at m/z 433.1333.  Table suggests two possible empirical formulae consistent with the precursor ion 
and the two dominant product ions measured at m/z 342.08667 and 250.09347. The suggested empirical 
formulae must be within 1 mDa of the measured values, with product ion formulae subsets of the 
precursor formula. Results ranked by mSigma, a measure of how well the observed isotopic pattern 
matched the theoretical pattern for the suggested precursor.  
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 Figure 19. Illustration of fragmentation positions in S-adenosyl-S-carboxymethyl-l-homocysteine, showing 
masses and formulae consistent with values measured by FTICR-MS.   
Subsequent re-analysis of the X-ray crystallography data by RB and FA, modelling S-adenosyl-S-
carboxymethyl-L-homocysteine as the co-factor produced good alignment with the observed 
densities, confirming my mass spectrometry identification. 
I observed no signal for either S-adenosylmethionine (m/z 399.1445) or S-adenosylhomocysteine 
(m/z 385.1289) in the mass spectrum of CmoA (figure 17). Other signals in the low m/z region 
could not be rationalised against S-adenosylmethionine or S-adenosylhomocysteine derivatives or 
hybrids and no further components were suggested from the crystallography data.  Additional 
signals in the mass spectrum are most likely environmental contaminants rather than additional 
cofactors.  
It should be noted that my mass spectrometry data in isolation do not prove complexation of S-
adenosyl-S-carboxymethyl-L-homocysteine with CmoA, rather their co-localisation in the extract.  
I hoped to observe the complex in the gas phase but this remained elusive.   In addition to 
denaturing analysis I prepared the same sample in aqueous 35 mM ammonium acetate pH 7.5 at 
a range of concentrations from 1-100 M.  I also added between 0.5-5 % acetonitrile to help spray 
stability but under none of the conditions was I able to observe the complex within the mass 
spectrometer.  I could only maintain signal by increasing source accumulation and in-source decay 
to a level where the dissociated ligand and protein were observed.  I hypothesise that maintaining 
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the complex may have been difficult because the native form is a homodimer of two CmoA 
proteins and without maintaining protein dimerization, ligand affinity may be lost. 
If the complex had been maintained in the gas phase my plan was to isolate a single charge state 
ion and fragment the intact protein in the ICR cell to release the ligand, simultaneously proving 
complexation and generating m/z measurements for identification.  As it stands, the combination 
of my mass spectrometry and RB’s and FA’s X-ray crystallography provide good evidence for S-
adenosyl-S-carboxymethyl-L-homocysteine being the co-factor of CmoA. 
Had X-ray data not been available alternative methodologies such as surface plasmon 
resonance,143,144 analytical ultracentrifugation145 or isothermal titration calorimetry144,146 could be 
used to test CmoA and S-adenosyl-S-carboxymethyl-L-homocysteine binding affinity. 
My identification of S-adenosyl-S-carboxymethyl-L-homocysteine as the cofactor of CmoA 
provides a novel and unexpected insight into tRNA modification. It is currently hypothesised that 
the cofactor may assist in uridine-5-oxyacetic acid formation through either (i) transfer of the 
carboxyl group onto the methoxy group of 5-methoxyuridine or (ii) substitution of the methyl 
group side chain in 5-methoxyuridine by the entire carboxymethyl group (figure 20).  These 
hypotheses could be tested by feeding the system with isotopically labelled S-adenosyl-S-
carboxymethyl-L-homocysteine and following incorporation of labelled carbons in the enzyme 
product. 
 
Figure 20.  Hypothesised roles of cofactor S-adenosyl-S-carboxymethyl-L-homocysteine in the modification 
of 5-methoxyuridine. Modification could involve either (i) the addition of a carboxyl group (red) onto the 
methoxy group of 5-methoxyuridine or (ii) substitution of the methyl group of 5-methoxyuridine for the 
entire carboxymethyl group (red). 
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Following S-adenosyl-S-carboxymethyl-L-homocysteine’s identification in complex with CmoA, RB 
has shown homologous intensity in the X-ray structure of H. influenza YecO protein which on re-
interrogation better fits with the same co-factor, suggesting the substrate may be more widely 
used in nature. 
The paper has been cited five times since publication with the citing studies mostly referencing 
the identification of S-adenosyl-S-carboxymethyl-L-homocysteine, which was achieved through 
my mass spectrometry analysis.147-151 
  
52
Paper 7 – Morphinan biosynthesis in opium poppy requires a P450-
oxidoreductase fusion protein 
Paper 7 identifies the novel fusion protein STORR as the final non-elucidated step in the 
morphinan biosynthesis pathway.  My role was to use mass spectrometry to prove the proposed 
fusion protein was naturally expressed as a single contiguous sequence. 
At date of publication (2014) all but one of the genes responsible for morphinan synthesis were 
known,152-154 leaving elucidation of the final component, which epimerizes (S)- to (R)-reticuline, 
critical to full understanding and potential exploitation of the biological system.  The pathway is 
the basis of opiate production in the opium poppy (Papaver somniferum), which was first 
demonstrated in 1806155 and remains the commercial source of production.  
Investigation of an in-house expressed sequence tag (EST) library from opium poppies by 
University of York postdoctoral researchers Thilo Winzer (TW) and Marcello Kern (MK) suggested 
the final gene product in the pathway was a contiguous assembly comprising a cytochrome P450 
monooxygenase 3ʹ-linked to an oxidoreductase.  The contiguous assembly was designated STORR 
((S)- to (R)-reticuline).  The EST sequence suggested constituent protein subunits are fused 
through the linker peptide KPCVQSAASERD.  Although the genomic data indicated a novel fusion it 
was vital to show that the fusion was translated and expressed in wild type plants. TW had 
attempted to raise an antibody against the STORR fusion but it had proved unsuccessful for 
purification or western blotting.  TW and MK asked whether I could demonstrate the contiguous 
fusion in wild type plants using a mass spectrometry approach. 
I first attempted to identify the fusion using 2D-PAGE, which although declining in usage is still 
unrivalled for resolution of intact proteins.  If a single spot could be isolated containing sequences 
from both protein subunits it would be strong evidence for the fusion.  Protein extracts from 
Papaver somniferum stems were provided by MK and I separated the material using 2D-PAGE.  
The resulting Coomassie-stained gel is shown in figure 21. An E. coli expressed recombinant 
version of STORR had been produced by Jared Cartwright (JC) for the purpose of antibody 
production. My intention was to run the recombinant protein into an analogous 2D-PAGE gel to 
localise position of the protein in the wild type extract for excision.  Unfortunately, the 
recombinant protein proved to be insoluble in isoelectric focusing loading buffer.  In the absence 
of a control, localisation of STORR was difficult.  The theoretical molecular mass and pI are 100.5 
kDa and 6.48 respectively, and although I considered speculatively excising spots around these 
values my focus instead turned to a 1D-PAGE approach.   
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 Figure 21. Coomassie-stained gel image resulting from 2D-PAGE separation of proteins from Papaver 
somniferum stems. 
Although lower resolution than 2D-PAGE, if the protein subunits could be co-localised within a 1D-
PAGE segment at the expected mass of STORR it could still provide strong indication of the fusion. 
I asked MK to provide another protein extract, which I ran into a 1D-PAGE gel (figure 22). I 
fractionated the gel unevenly to create finer gradation around the expected position of STORR at 
100 kDa (fraction 4). To look for the presence of unfused cytochrome P450 monooxygenase and 
oxidoreductase, narrow fractions were also taken around 65 kDa and 35 kDa, consistent with the 
theoretical masses of these two enzymes.  I subjected proteins in the 15 excised fractions to in-gel 
trypsin digestion after reduction with dithioerythritol and S-carbamidomethylation with 
iodoacetamide, prior to LC-MS/MS acquisition using a maXis qTOF mass spectrometer. Searching 
peak lists against an in-house Papaver somniferum database using the Mascot search engine I 
identified 2,853 proteins at 1% FDR.  FDR was estimated by comparing relative proportions of 
matches obtained in the forward database against a randomised database with equal distribution 
of amino acids, protein lengths and cleavage site frequency.  
250
150
100
75 
50 
37 
25 
20 
15 
10 
kDa
54
 Figure 22.  1D-PAGE of high-morphine cultivar protein extracts. Fractions shown were excised for tryptic 
digestion.  
Fraction 4, at the expected mass of the fusion, yielded 76% sequence coverage for the fusion with 
peptides spanning the length of the protein (figure 23). Crucially, coverage included the linker 
peptide KPCVQSAASERD, fused at the N-terminus to P450 monooxygenase (IKPCVQSAASER 
positions 559-579) and C-terminally to oxidoreductase (DMESSGVPVITLGSGK positions 580-595).  
The linker peptide is unique in the Papaver somniferum and NCBInr databases, meaning 
identification cannot be dismissed as homology with an incidental protein. With termini flanked 
by supporting sequences it is strong evidence for the expression of the STORR fusion protein. The 
two peptide matches spanning the linker peptide are made with good expect scores and show 
good correlation with predicted sequence (figures 24 and 25). 
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1 MELQYISYFQ PTSSVVALLL ALVSILSSVV VLRKTFLNNY SSSPASSTKT 
51 AVLSHQRQQS CALPISGLLH IFMNKNGLIH VTLGNMADKY GPIFSFPTGS 
101 HRTLVVSSWE MVKECFTGNN DTAFSNRPIP LAFKTIFYAC GGIDSYGLSS 
151 VPYGKYWREL RKVCVHNLLS NQQLLKFRHL IISQVDTSFN KLYELCKNSE 
201 DNHGNYTTTT TTAAGMVRID DWLAELSFNV IGRIVCGFQS GPKTGAPSRV 
251 EQFKEAINEA SYFMSTSPVS DNVPMLGWID QLTGLTRNMK HCGKKLDLVV 
301 ESIINDHRQK RRFSRTKGGD EKDDEQDDFI DICLSIMEQP QLPGNNNPSQ 
351 IPIKSIVLDM IGGGTDTTKL TTIWTLSLLL NNPHVLDKAK QEVDAHFRTK 
401 RRSTNDAAAA VVDFDDIRNL VYIQAIIKES MRLYPASPVV ERLSGEDCVV 
451 GGFHVPAGTR LWANVWKMQR DPKVWDDPLV FRPDRFLSDE QKMVDVRGQN 
501 YELLPFGAGR RVCPGVSFSL DLMQLVLTRL ILEFEMKSPS GKVDMTATPG 
551 LMSYKVIPLD ILLTHRRIKP CVQSAASERD MESSGVPVIT LGSGKVMPVL 
601 GMGTFEKVGK GSERERLAIL KAIEVGYRYF DTAAAYETEE VLGEAIAEAL 
651 QLGLVKSRDE LFISSMLWCT DAHADRVLLA LQNSLRNLKL EYVDLYMLPF 
701 PASLKPGKIT MDIPEEDICR MDYRSVWAAM EECQNLGFTK SIGVSNFSCK 
751 KLQELMATAN IPPAVNQVEM SPAFQQKKLR EYCNANNILV SAISVLGSNG 
801 TPWGSNAVLG SEVLKKIAMA KGKSVAQVSM RWVYEQGASL VVKSFSEERL 
851 RENLNIFDWE LTKEDHEKIG EIPQCRILSA YFLVSPNGPF KSQEELWDDE 
901 A 
    
Figure 23. Sequence coverage for endogenous STORR fusion protein excised from between 95-105 kDa in 
gel (fraction 4, figure 22). Identification performed by Mascot database searching post LC-MS/MS 
analysis of trypsin derived peptides. Colour indicates amino acids contained in peptides identified with 
expect scores of 0.05 or lower. Red sequences are attributable to the P450 monooxygenase module. 
Green sequences are from the oxidoreductase module.  Purple amino acids belong to linker sequence. 
Figure 24. Annotated product ion spectrum for peptide identification IKPCVQSAASER (linker peptide pos 
559-579).  Mascot expect score = 9.8e-07. Spectrum annotated with matches to theoretical b- (red) and y-
ion series (blue). 
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Figure 25. Annotated product ion spectrum for peptide identification DMESSGVPVITLGSGK (linker peptide 
pos 580-595).  Mascot expect score = 4e-09. Spectrum annotated with matches to theoretical b- (red) and 
y-ion series (blue). 
STORR peptides were not unique to fraction 4, with identification in 12 of the 15 fractions 
analysed. However, a clear spike in identification frequency was measured at the expected 
position (100 kDa – fraction 4), when measured in terms of sequence coverage, spectral counts or 
number of unique peptide sequences (table 11).  
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Fraction 
Peptide IDs from 
sequences of: 
Sequence 
coverage (%) 
Spectral 
matches 
No. peptide 
sequences 
1 P450 1 1 1 
2 P450 + OxR 17 12 11 
3 P450 + OxR + Linker 49 41 35 
4 P450 + OxR + Linker 76 149 55 
5 P450 + OxR + Linker 46 38 32 
6 P450 + OxR + Linker 17 11 11 
7 P450 + OxR 14 11 10 
8 P450 + OxR 10 8 7 
9 P450 + OxR 17 11 11 
10 N/A 0 0 0 
11 OxR 5 6 5 
12 OxR 1 2 2 
13 N/A 0 0 0 
14 N/A 0 0 0 
15 OxR 0 1 1 
Table 11.  Comparison of sequence coverage, spectral counts and unique peptide sequences obtained in 
the 15 fractions excised from in-gel fractionated high-morphine cultivar protein extracts. Depth of red 
shading is proportional to the maximum value in the column. 
I explained to TW and MK that while the spectral counting approach to in-gel localisation (table 
11) was consistent with a contiguous fusion there were imperfections in relative quantification 
between fractions.  Spectral counting is reliant on duty cycle limitation providing a measure of 
quantification based on the number of times a peptide can be sampled during the acquisition.  If 
the background complexity differs, as would be expected amongst 1D-PAGE fractions, the cycle 
time available to sample the targeted peptides will change, reducing quantitative accuracy.  I 
further explained that to provide accurate relative inter-fraction quantification a common internal 
standard was required to normalise relative responses between fractions, the ideal standard 
being an isotopically heavy version of the STORR protein.   
Subsequently, JC prepared a 15N-labeled recombinant version of STORR protein.  I ran the heavy 
protein into a 1D-PAGE gel, excised the band and digested as for the fractionated plant extract. I 
took aliquots of the remaining digest from fraction four and aliquoted a dilution series of the 15N-
labeled digest to determine the amount achieving an approximately equal ratio of light to heavy 
protein as measured by mass spectral response.  I then spiked equal aliquots of the heavy digest 
into each 1D-PAGE fraction and repeated the original LC-MS/MS analysis.  
58
Five peptides were chosen for relative quantification of the fusion protein.  These peptides 
spanned the sequence of the subunits and linker peptide.  The quantified peptides were free of 
observed variable modifications such as oxidation or deamination in any of the light or heavy 
protein acquisition data sets.  The peptides were also unique to the sequence of STORR. Relative 
peptide abundances between gel fractions were determined by comparing extracted ion 
chromatograms for MS peptide peak areas obtained from the endogenous and 15N-labeled 
recombinant STORR digests (figure 26).   
Results were consistent with the spectral counting analysis, showing a clear spike in abundance 
for all five quantified peptides in fraction 4, the expected mass of the fusion (figure 26). 
 
Figure 26. Quantification of STORR peptides through 1D gel. For relative quantification, a constant 
amount of a tryptic digest of 15N-labeled recombinant STORR was spiked into the in-gel digest of each 
SDS-PAGE fraction before LC-MS/MS. Ratios of peak areas from extracted-ion chromatograms of light 
(endogenous) to heavy (labelled recombinant) versions of five peptides across the STORR protein 
sequence were compared. Ratios of normalized peak areas from extracted-ion chromatograms were 
converted to binary logarithms.  
Upon peer review of the paper the editor requested the inter-fraction quantification be repeated 
to include biological replicates.  TW produced three further high-morphine cultivar protein 
extracts, which I ran into a 1D-gel alongside an aliquot of the 15N-labeled recombinant STORR 
protein (figure 27).  Gel fractionation, digestion, spiking of heavy standard, LC-MS/MS acquisition 
and quantification data analysis were repeated as detailed in the paper. Normalised peak areas 
were converted to binary logarithms for calculation of means and standard errors of the mean. 
Figure 28 displays relative abundances of the five peptides monitored in each fraction. 
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 Figure 27.  1D-PAGE of replicate high-morphine cultivar protein extracts (a-c), and 15N-labeled 
recombinant STORR (d).  Fractions from (a)-(c), as shown, were excised for tryptic digestion.  
 
Figure 28. Quantification of STORR peptides through gel. For relative quantification, a constant amount of 
a tryptic digest of 15N-labeled recombinant STORR was spiked into the in-gel digest of each SDS-PAGE 
fraction before LC-MS/MS. Ratios of peak areas from extracted-ion chromatograms of light (endogenous) 
to heavy (labelled recombinant) versions of five peptides from across the STORR protein sequence were 
compared. Ratios of normalized peak areas from extracted-ion chromatograms were converted to binary 
logarithms for the calculation of means and standard errors of the mean. Only measurements where the 
respective peptides were found in all three biological replicates are shown. 
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Highest relative abundance for all five peptides is in fraction four, around 90-105 kDa, which fits 
the predicted size of the STORR fusion protein (100.5 kDa) and where the 15N-labeled 
recombinant version runs. It is likely that the resolution of the gel was insufficient to confine the 
protein to a single fraction with the amount of material loaded, although the presence of 
hydrolytic products cannot be discounted.  Gel resolution may have been improved by loading 
less material. The gel quantification produces no evidence to support individual expression of the 
two proteins in un-fused forms, suggesting if the individual forms are present they are of low 
abundance. 
Absolute quantification through the gel was not possible because the absolute amount of 15N-
labeled recombinant STORR was unknown.  As shown in figure 27, the purified protein (d) 
contained a significant product around 35 kDa that restricted quantification of the recombinant 
product.  Analysis by LC-MS/MS of the 35 kDa band in the recombinant expressed sample showed 
it to be the N-terminal portion of cytochrome P450 monooxygenase, containing the His-tag. 
Although further purification could be attempted were absolute quantification required, relative 
quantification through the gel was sufficient for size determination. 
While my mass spectrometry analysis provides strong evidence for STORR being an expressed 
fusion, it is limited by the ambiguities of a bottom-up approach. Peptides spanning the length of 
the sequences are derived from the same gel fraction but there is no direct evidence that they 
result from a single proteoform, as following digestion peptides are no longer linked. The ideal 
analysis would be to purify the intact protein so that it could be observed as a continuous full 
length sequence in the mass spectrometer. Had an antibody been available this may have been 
possible using immune precipitation156 or pull-down approaches.157 In the absence of an antibody, 
intact protein LC-MS could be attempted,85,86 but without further fractionation the complexity of 
the sample would make analysis difficult. The use of 2D-FT-ICR-MS/MS, where ICR pulse 
sequences are used to align product and precursor ions in co-fragmented mixtures, is an 
intriguing option with vast potential.158 However, the technique is still in its infancy, with few 
practitioners and has only been published for relatively simple mixtures to date. 
My contribution was vital to the publication of the paper as evidenced by the editor’s 
requirement for the proteomics to be repeated with biological replicates to accept the 
manuscript.  The work has been published in Science, has already been cited 19 times159-178 and 
clearly has very high potential impact. 
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Conclusion 
The presented work demonstrates my use of mass spectrometry to: identify post translational 
modifications of histones (paper 1); employ a label free emPAI methodology to study the 
immunomodulation molecules used by two endemic parasites to modify host immune response 
(papers 2-4); quantify the changes in immune responses of dendritic cells (paper 5); identify a 
novel co-factor in uridine-5-oxylacetic acid biosynthesis (paper 6) and demonstrate the fusion 
protein structure of the remaining unidentified enzyme in the morphinan biosynthetic pathway 
(paper 7).  While varied in their applications my proteomics analyses were vital to each of these 
studies. As a collection and in combination with this integrative chapter the work demonstrates 
both the power of mass spectrometry-based proteomics and my significant contribution to the 
field. 
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Appendices 
 
Appendices 1A-7C are the submitted papers and declarations from co-authors attesting to my 
contributions. 
Appendix 1A 
Submitted paper 1 – Dynamics of plant histone modifications in response to DNA damage. 
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Dynamics of plant histone modifications in response to DNA damage
Georgina E. DRURY*, Adam A. DOWLE†, David A. ASHFORD†, Wanda M. WATERWORTH*, Jerry THOMAS†
and Christopher E. WEST1*
*Centre for Plant Sciences, University of Leeds, Woodhouse Lane, Leeds LS2 9JT, U.K., and †Proteomics Technology Facility, Department of Biology, University of York,
York YO10 5DD, U.K.
DNA damage detection and repair take place in the context of
chromatin, and histone proteins play important roles in these
events. Post-translational modifications of histone proteins are
involved in repair and DNA damage signalling processes in
response to genotoxic stresses. In particular, acetylation of
histones H3 and H4 plays an important role in the mammalian
and yeast DNA damage response and survival under genotoxic
stress. However, the role of post-translational modifications to
histones during the plant DNA damage response is currently
poorly understood. Several different acetylated H3 and H4 N-
terminal peptides following X-ray treatment were identified using
MS analysis of purified histones, revealing previously unseen
patterns of histone acetylation in Arabidopsis. Immunoblot
analysis revealed an increase in the relative abundance of the H3
acetylated N-terminus, and a global decrease in hyperacetylation
of H4 in response to DNA damage induced by X-rays. Conversely,
mutants in the key DNA damage signalling factor ATM
(ATAXIA TELANGIECTASIA MUTATED) display increased
histone acetylation upon irradiation, linking the DNA damage
response with dynamic changes in histone modification in plants.
Key words: Arabidopsis, DNA double-strand break, DNA repair,
epigenetics, recombination.
INTRODUCTION
Repair of DNA DSBs (double-strand breaks), one of the most
cytotoxic forms of DNA damage, takes place in the context of
chromatin. Histones form the protein component of chromatin,
and play critical roles in all aspects of DNA metabolism and
genome maintenance. A total of eight histone proteins form the
core nucleosome particle, around which 147 bp of DNA wraps
in a left-handed superhelix to form the lowest-order structure of
chromatin [1]. Each nucleosome is composed of two each of H2A,
H2B, H3 and H4, 11–22 kDa proteins, in a tripartite assembly with
a central (H3/H4)2 tetramer flanked by two H2A/H2B dimers.
Localized to the outer surface of the assembled nucleosome
octamer, the N-terminal tails of H3 and H4 are rich in basic amino
acids which confer a positive charge and high-affinity binding with
negatively charged DNA [2].
Histones are subject to post-translational modification which
residue-specific modification determines chromatin structure or
function, including acetylation, phosphorylation, methylation,
ubiquitination, SUMOylation and ADP-ribosylation. Post-
translational histone modifications contribute to the varied
and dynamic configuration of chromatin [3]. Post-translational
modifications also orchestrate interaction of the histone tails
with other proteins, as combinations of multiple modifications
impart a histone ‘code’ that signals specifically to interacting
protein partners. Chromatin configuration is intrinsically linked
to gene expression and is tightly regulated during growth and
development, displaying dynamic responses to changes in the
environment [4].
Chromatin remodelling activities have been shown to be
important in both the signalling and repair of DSBs in mammalian
and yeast systems [5]. However, our understanding of chromatin
modifications and their importance in plant DNA repair is
limited to the phosphorylation of S139 (single-letter code has
been used for amino acids) of the histone variant H2AX by
the DSB signalling kinase ATM (ATAXIA TELANGIECTASIA
MUTATED) [6]. This is a well-characterized and highly
conserved response to induction of DNA DSBs, dependent on
upstream MRN [MRE11 (meiotic recombination 11)–RAD50
(radiation sensitive 50)–NBS1 (Nijmegen breakage syndrome 1)]
complex signalling in plants, yeast and animals [7,8]. In animals,
H2AX phosphorylation has been shown to function in establishing
stable repair foci at the site of DNA DSBs [9].
Chromatin remodelling during DNA repair in yeast and
mammals involves hyperacetylation of H3 and H4 as early
epigenetic changes to chromatin following DNA damage [5,10].
In addition to altering localized chromatin structure, these
modifications function in DNA repair signalling pathways;
histone H3 acetylation on K14 (H3K14 acetylation) stimulates
autophosphorylation of ATM [11]. In contrast, there are no data
concerning histone acetylation in the plant response to DSBs,
although acetylation has been reported after UV-treatment of
plants, which predominantly induces formation of cyclobutane
pyrimidine dimers and 6-4 photoproducts. UVB-tolerant maize
lines showed high levels of covalent changes to histones compared
with the UVB-sensitive lines. Hyperacetylation of H3 (diacetyl)
and H4 (tetracetyl) N-termini in UVB-tolerant lines were
enriched in the promoter and transcribed regions of genes
associated with UVB response, implicating acetylation in the
transcriptional response to UV-induced DNA damage [12].
Previous studies utilized MS analysis of plant histones in
Arabidopsis [13,14], alfalfa [15] and soybean [16] to identify
methylated and acetylated histone isoforms. In the present study
we have used a LC (liquid chromatography)–MS/MS (tandem
MS) approach to analyse post-translational modifications that are
present on H3 and H4 following DNA-damage induction by IR
(ionizing radiation), which results in a range of damage products
including SSBs (single-strand breaks) and DSBs. We identify
Abbreviations used: ac, acetylated; ATM, ATAXIA TELANGIECTASIA MUTATED; CID, collision-induced dissociation; DDR, DNA damage response; DSB,
double-strand break; DTT, dithiothreitol; HDAC, histone deacetylase; IPI, International Protein Index; IR, ionizing radiation; LC, liquid chromatography; me,
methylated; MS/MS, tandem MS; TCA, trichloracetic acid; TFA, trifluoroacetic acid.
1 To whom correspondence should be addressed (email c.e.west@leeds.ac.uk).
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several novel forms of acetylated H3 and H4 and demonstrate
dynamic changes in the relative abundance of specific histone
modifications upon induction of DNA damage in Arabidopsis.
EXPERIMENTAL
Plant growth
Wild-type Columbia-0 seeds were sterilized in 70% ethanol for
5 min, and resuspended in sterile 0.1% agar. Seeds were plated
individually in Murashige and Skoog (Sigma) medium (20 g/l
sucrose, 0.5 g/l Mes and 8 g of phytoagar; Duchefa). After a cold
treatment of 2 days at 4 ◦C, plates were transferred to a growth
chamber (16 h of light and 8 h of dark cycle) and grown for
2 weeks before harvesting. IR treatment was delivered using a
320 kV X-ray irradiation system (NDT Equipment Services).
Nuclei isolation
Seedlings were ground in liquid nitrogen to a fine powder and
further homogenized in homogenization buffer [25 mM Pipes
(pH 7.0), 10 mM NaCl, 5 mM EDTA (pH 8.0), 250 mM sucrose,
0.5% Triton X-100, 20 mM 2-mercaptoethanol, 0.2 mM PMSF
and 1/50 ml protease inhibitor tablet (Roche catalogue number
04693132001)] for approximately 1 min in a Waring blender. The
homogenate was filtered through 300 μm, 100 μm and 56 μm
Sefar Nitex membrane layers and the filtrate was centrifuged
at 4600 g for 15 min at 4 ◦C and the supernatant removed. The
pellet was then washed in homogenization buffer and centrifuged
at 1000 g for 10 min at 4 ◦C a further two times. The nuclear
pellet was then resuspended in nuclei storage buffer [50 mM
Hepes (pH 7.6), 110 mM KCl, 5 mM MgC12, 50% (v/v) glycerol
and 1 mM DTT (dithiothreitol)]. For protein samples used in
immunoblotting, the nuclear pellet after the first centrifugation
was suspended in nuclei electrophoresis buffer [5% SDS, 0.5 M
Tris (pH 6.8) and 1 mM DTT].
Acid extraction of histones
Nuclei were centrifuged at 1000 g for 10 min at 4 ◦C and the
supernatant removed. The remaining pellet was resuspended in
prechilled extraction buffer (0.5 M HCl and 0.2 mM PMSF) and
vortexed. Samples were placed on a rotator at 4 ◦C for between
30 min and overnight. Samples were then centrifuged at 16000 g
for 10 min at 4 ◦C, and the supernatant removed and mixed 2:1
with prechilled 100%TCA (trichloracetic acid)/water (final TCA
concentration was 33%). Samples were mixed well and placed on
ice for between 30 min and overnight. Samples were centrifuged
at 16000 g for 10 min at 4 ◦C and the supernatant poured off.
The pellet was washed twice with 100% prechilled acetone and
centrifuged at 16000 g for 5 min and then left to dry. Samples
were stored at − 80 ◦C.
Tricine-SDS/PAGE gel electrophoresis
Protein samples were separated using 10% acrylamide/
bisacrylamide (19:1) Tricine gels containing ethylene glycol
(30%, v/v) according to [17] using the Protean II xi Cell
electrophoresis system (catalogue number 165-1834, Bio-Rad
Laboratories). Protein samples were dissolved in Laemmli buffer
(5% SDS, 5% 2-mercaptoethanol, 10% glycerol, 0.1 M Tris
(pH 6.8) and 0.1% Bromophenol Blue) and denatured at 90 ◦C
for 10 min, and loaded on to the gel alongside Precision Xtra Plus
protein marker (161-0377, Bio-Rad Laboratories) and calf thymus
histones (catalogue number 10223565001, Roche). Proteins were
electrophoresed at 100 V for 24 h using Tricine electrophoresis
buffer (catalogue number B48, Fermentas). Proteins were stained
with Instant Coomassie (Expedeon ISB01L) for between 30 min
and 1 h. The protein bands were excised and overlaid with
20% acetic acid and 5% methanol in 1.5 ml microfuge tubes.
For immunoblotting, protein samples were separated on 16%
acrylamide/bisacrylamide (19:1) minigels and electrophoresed
for 2.5 h at 150 V.
Western blotting
Protein concentrations in resuspended nuclear pellets were
quantified using the Lowry protein assay (Bio-Rad Laboratories)
with BSA as a standard. After electrophoresis, proteins were
transferred on to a nitrocellulose membrane (catalogue number
10402495, Whatman) for 1 h at 100 V. The blots were probed
with the following rabbit polyclonal primary antisera: anti-
H3 (1:10000 dilution; catalogue number H0164, Sigma);
anti-H3K18acK23ac (1:10000 dilution; catalogue number 17-
615, Millipore); anti-H4K5acK8acK12acK16ac (1:5000 dilution
catalogue number 06-598, Millipore); anti-H4K8ac (1:10000
dilution; catalogue number 06-760-MN, Millipore); anti-
H4K12ac (1:5000 dilution; catalogue number 06-761-MN,
Millipore); or anti-H4K16ac (1:10000 dilution; catalogue
number 06-762-MN, Millipore). Immune complexes were
detected by alkaline-phosphatase-conjugated anti-(rabbit IgG)
(1:30000 dilution; catalogue number A2556, Sigma–Aldrich) and
developed in BCIP (5-bromo-4-chloroindol-3-yl phosphate)/NBT
(Nitro Blue Tetrazolium) solution (Invitrogen).
Arg-C digestion
In-gel Arg-C digestion was performed after reduction
with DTE (dithioerythritol) and S-carbamidomethylation with
iodoacetamide. Gel pieces were washed twice with 50% (v/v)
aqueous acetonitrile containing 25 mM ammonium bicarbonate,
then once with acetonitrile and dried in a vacuum concentrator for
20 min. Gel pieces were rehydrated by adding 10 μl of 0.02 g/l
Arg-C solution in 25 mM ammonium bicarbonate, and after
10 min sufficient 25 mM ammonium bicarbonate solution was
added to cover the gel pieces. Digests were incubated overnight
at 37 ◦C.
Propionylation
The digest supernatant was removed and adjusted to pH 10 by
the addition of aqueous ammonium hydroxide, followed by the
addition of 10 μl of propionic anhydride and incubation at 60 ◦C
for 1 h. Post-propionylation the samples were acidified with TFA
(trifluoroacetic acid), dried down and reconstituted in 0.1%
aqueous TFA.
MS
HPLC was performed using a nanoAcquity UPLC system
(Waters) equipped with a nanoAcquity Symmetry C18, 5 μm trap
(180 μm×20 mm; Waters) and a nanoAcquity BEH130 1.7 μm
C18 capillary column (75 m×250 mm; Waters). The trap wash
solvent was 0.1% aqueous formic acid and the trapping flow rate
was 10 μl/min. The trap was washed for 5 min after sample load-
ing before switching flow to the capillary column. The separation
used a gradient elution of two solvents: solvent A (0.1% formic
acid) and solvent B (acetonitrile containing 0.1% formic acid).
The flow rate for the capillary column was 300 nl/min, column
temperature was 60 ◦C and the gradient profile was as follows: ini-
tial conditions 5% solvent B (2 min), followed by a linear gradient
to 35% solvent B over 20 min and then a wash with 95% solvent
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 1 Isolation of histones and peptides for identification by MS
Histones were isolated from Arabidopsis seedlings and analysed by peptide digestion and MS/MS. (A) Coomassie Blue-stained Tricine gel. (B) Schematic overview of preparation of H3 and H4
N-terminal peptides for LC–MS/MS. (C) Immunoblot with H3 antisera. Lane 1 and 2, plant histones; lane 3, calf thymus. (D) H3 amino acid sequence with identified peptides in bold and underlined.
(E) H4 amino acid sequence with identified peptides indicated as bold underlined text.
B for 2.5 min. The column was returned to initial conditions and
re-equilibrated for 25 min before subsequent injections.
The nanoLC system was interfaced to a maXis UHR-
QTOF (ultrahigh-resolution quadrupole-time-of-flight) mass
spectrometer (Bruker Daltonics) with a nano-electrospray source
fitted with a steel emitter needle [180 μm outside diameter ×
30 μm inside diameter; Proxeon). Positive-ion MS and CID
(collision-induced dissociation)–MS/MS spectra were acquired
using AutoMSMS mode. Instrument control, data acquisition
and processing were performed using Compass 1.3 SR3 software
(micrOTOF control, Hystar and DataAnalysis, Bruker Daltonics).
Instrument settings were: ion spray voltage, 1500 V; dry gas,
6 l/min; dry gas temperature, 160 ◦C; and ion acquisition range
m/z, 50–2200. AutoMSMS settings were for MS 0.5 s (acquisition
of survey spectrum) and for MS/MS (CID with N2 as collision
gas) ion acquisition range m/z, 350–1400; 0.1 s acquisition for
precursor intensities above 100000 counts; for signals of lower
intensities down to 1000 counts acquisition time increased linearly
to 1.5 s; the collision energy and isolation width settings were
automatically calculated using the AutoMSMS fragmentation
table; three precursor ions; absolute threshold 1000 counts;
preferred charge states; and 24 singly charged ions excluded. Two
MS/MS spectra were acquired for each precursor and previously
selected target ions were excluded for 60 s.
Database searching
MS/MS data were submitted to database searching using a
locally running copy of the Mascot program (version 2.3, Matrix
Science), through the Bruker ProteinScape interface (version 2.1).
Spectra were searched against the IPI (International Protein Index)
Arabidopsis database (37150 sequences and 14876683 residues).
The search criteria specified were: enzyme, Arg-C; fixed
modifications, carbamidomethyl (C); variable modifications,
acetylation (K), oxidation (M), propionylation (K, N-term);
peptide tolerance, 10 ppm; MS/MS tolerance, 0.1 Da. Peptides
with an expect value of 0.05 or lower were considered significant.
RESULTS
Isolation of Arabidopsis histones and preparation for LC–MS/MS
Histones isolated from Arabidopsis seedling tissue and separated
by electrophoresis were identified by immunoblotting with
H3 antisera (Figures 1A and 1B). Discreet bands of H4 and H3
were excised from the gel and samples were reduced, alkylated
and digested in-gel with Arg-C protease rather than trypsin
which produces suboptimal histone peptides for MS due to
their high lysine and arginine content. Endoproteinase Arg-C
cleaves at arginine residues only, producing histone peptides of
3–14 residues in length (Figure 1C). Propionylation of H3 and
H4 peptides was carried out to modify the ε-amino groups of
lysine residues and the N-termini to increase the hydrophobicity
and retention of peptides on the C18 column prior to MS/MS.
Following LC–MS/MS, the spectra were searched against the
IPI Arabidopsis database, and the expected histone was the top-
scoring match in each instance. We obtained sequence coverage
of 45% and 54% of H3 and H4 respectively, with the N-termini
of both H3 and H4 being well covered (Figures 1D and 1E).
Identification of acetylated lysines in histones H3 and H4 following
DNA damage
Acetylation of lysine residues has been shown to be both involved
in the DDR (DNA damage response) in mammals and yeast
[18,19] and in the transcriptional response to UV-irradiation
in maize [12]. To investigate global acetylation patterns after
DNA damage in Arabidopsis, we investigated the acetylation
of H3 and H4 N-termini following a 160 Gy dose of X-rays.
Good coverage of the N-terminal regions of both H3 and H4
was achieved by LC–MS/MS and Mascot searching to identify
peptides (Figures 1D and 1E). Several criteria were used to
confirm the assignment of sites of acetylation within peptides.
Acetylation could readily be distinguished from trimethylation,
which gives a mass increase that is 36 mDa higher than
acetylation, using the high mass accuracy of the Bruker maXis.
Low mDa differences between measured and calculated peptide
masses were obtained (Table 1), which were consistent with
acetylation and ruled out trimethylation. Mascot assignments
of acetylation positions along with the spectra were submitted
to the Prophossi spectrum annotation tool (http://www.compbio.
dundee.ac.uk/prophossi/bin/prophossi-cgi.pl) [20], which labels
spectra with product ions, and also matches all low-abundance
and doubly charged product ions. Finally, manual inspection was
performed to ensure the presence of crucial b- and y-type product
ions in the MS/MS spectra (Figures 2 and 3).
Acetylated peptide isoforms for two N-terminal H3 peptides,
K9STGGKAPR17 and K18QLATKAAR26, and one N-terminal H4
peptide, 4GKGGKGLGKGGAKR17, were identified in DNA-
damage-treated plants (Table 1). Both mono- and di-acetylated
c© The Authors Journal compilation c© 2012 Biochemical Society
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Table 1 Acetylated peptides from H3 and H4 N-termini identified by LC-CID–MS/MS
Acetylated lysines are indicated by Kac. Ion scores and expect values are from Mascot. Measured peptide masses are monoisotopic values calculated from masses of doubly charged precursor ions
that can include propionyl groups (see Figure 3). Mass errors are differences between measured and theoretical masses.
Histone Peptide Acetylation sites Ion score Expect value Measured mass (Da) Mass error (mDa)
H3 K9STGGKacAPR17 K14 80 2.0 × 10− 7 998.551 5
H3 K9acSTGGKacAPR17 K9 K14 51 1.6 × 10− 4 984.535 6
H3 K18QLATKacAAR26 K23 58 3.3 × 10− 5 1083.640 4
H3 K18acQLATKacAAR26 K18 K23 63 9.8 × 10− 6 1125.651 8
H4 G4KGGKacGLGKGGAKR17 K8 55 5.0 × 10− 5 1535.879 1
H4 G4KGGKGLGKGGAKacR17 K16 80 1.5 × 10− 7 1423.832 6
H4 G4KacGGKGLGKGGAKacR17 K5 K16 60 1.2 × 10− 5 1521.864 2
H4 G4KGGKacGLGKGGAKacR17 K8 K16 70 1.3 × 10− 6 1465.843 7
H4 G4KGGKGLGKacGGAKacR17 K12 K16 63 6.4 × 10− 6 1465.841 5
H4 G4KacGGKGLGKacGGAKacR17 K5 K12 K16 84 5.2 × 10− 8 1451.820 <1
H4 G4KGGKacGLGKacGGAKacR17 K8 K12 K16 46 3.0 × 10− 4 1507.849 2
H4 G4KacGGKacGLGKacGGAKacR17 K5 K8 K12 K16 67 2.7 × 10− 6 1493.829 3
Figure 2 Identification of mono- and di-acetylated peptides from histone H3
CID–MS/MS spectra were redrawn and annotated using ProPhoSI (http://www.compbio.dundee.ac.uk/prophossi/bin/prophossi-cgi.pl). Precursor ion m/z values and measured masses are indicated;
all precursor ions were doubly charged. A bold black line indicates that a b- (purple) or y-ion (green) is observable in the spectrum. Acetylated lysine residues are in red; propionylated lysine residues
are in blue; and N-terminal proprionylation is labelled Pr.
forms of the two H3 peptides were present in addition to the
non-acetylated forms. Their presence indicates that each of
the lysines K9, K14, K18 and K18K23 were incompletely acetylated
in histone H3. In this analysis, acetylation of K9 is only observed in
combination with K14 acetylation, and likewise, acetylation of K18
is only identified where K23 is acetylated. In the case of the single
N-terminal H4 peptide, G4KGGKGLGKGGAKR17, there were
eight acetylated isoforms identified (two monoacetylated, three
diacetylated, two triacetylated and one tetra-acetylated), which
demonstrated acetylation of lysines K5, K8, K12 and K16 in histone
H4 in different combinations and all four simultaneously. Of the
eight different acetylated forms of the H4 N-terminal peptide
isolated from irradiated Arabidopsis, CID–MS/MS evidence for
only the tetra-acetylated isoform in higher plants has been
published [12,21].
The MS/MS evidence for monoacetylated K9STGGKacAPR17
(where ac indicates an acetylated residue) from histone H3
is very strong, with both b- and y-ion series observing that
they lack only a single ion each (Figure 2A). The spectrum
of K9acSTGGKacAPR17 also contains a y-ion series that lacks
only one ion (the y1), plus a series of four b-ions (Figure 2B).
The evidence for K18QLATKacAAR26 and K18acQLATKacAAR26
is also strong, with both y-ion series missing only the y1 ion
(Figures 2C and 2D).
For the two monoacetylated G4KGGKGLGKGGAKR17 H4
peptides, convincing evidence for the assigned sites of acetylation
was contained in the extensive b- and y-ion series observed
(Figures 3A and 3B). Likewise, spectra of all three of the
diacetylated peptides contain y-ion series that are complete
except for the y1 ion (Figures 3D and 3E), and two also
contain extensive b-ion series (Figures 3D and 3E). Assignment
of the sites of acetylation in G4KGKacGLGKGGAKacR17 is
supported by the prominent y5, y7 and y12 ions at m/z 530,
771 and 1409 respectively (Figure 3C). Two triacetylated
histone H4 peptides, G4KGKacGLGKacGGAKacR17 and
G4KacGKGLGKacGGAKacR17, were also identified by Mascot
with expect values of 5.2 × 10− 8 and 3.0 × 10− 4 respectively
(Table 1). The y-ion series for these two peptides are
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 3 Identification of mono-, di-, tri- and tetra-acetylated peptides from histone H4
CID–MS/MS spectra were redrawn and annotated using ProPhoSI (http://www.compbio.dundee.ac.uk/prophossi/bin/prophossi-cgi.pl). Precursor ion m/z values and measured masses are indicated;
all precursor ions were doubly charged. A bold black line indicates that a b- (purple) or y-ion (green) is observable in the spectrum. Acetylated lysine residues are in red; propionylated lysine residues
are in blue; and N-terminal proprionylation is labelled Pr.
nearly complete, and the N-terminal b-ion series that are
also present confirm the absence of acetylation of K8 or K5
in the two isoforms (Figures 3F and 3G respectively). The
hyperacetylated form with acetyl modifications present at each
of the four lysine residues (G4KacGKacGLGKacGGAKacR17),
has previously been identified in UV-irradiated maize by Casati
et al. [12]. Their published CID–MS/MS spectrum is very similar
to that of the N-terminally propionylated version we obtained,
which contains a nearly complete series of y-ions, plus a series of
five b-ions from the N-terminus (Figure 3H).
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Table 2 Methylated peptide isoforms from H3 and H4 N-termini identified by LC-CID–MS/MS
Acetylated lysine is indicated by Kac and dimethylated lysine by Kme2. Ion scores and expect values are from Mascot. Measured peptide masses are monoisotopic values calculated from masses of
doubly charged precursor ions that include propionyl groups (see Figure 4). Mass errors are differences between measured and theoretical masses.
Histone Peptide Modification sites Ion score Expect value Measured mass (Da) Mass error (mDa)
H3 K9meSTGGKAPR17 K9 41 2.8 × 10− 4 1026.587 5
H3 K9me2STGGKacAPR17 K9 K14 35 7.8 × 10− 3 1026.581 1
Figure 4 Identification of methylated and acetylated peptides from histone H3
CID–MS/MS spectra were redrawn and annotated using ProPhoSI (http://www.compbio.dundee.ac.uk/prophossi/bin/prophossi-cgi.pl). Precursor ion m/z values and measured masses are indicated;
all precursor ions were doubly charged. A bold black line indicates that a b- (purple) or y-(green) ion is observable in the spectrum. Acetylated lysine residues are in red; propionylated lysine residues
are in blue; dimethylated lysine residues are in orange; and N-terminal proprionylation is labelled Pr.
Identification of methylated lysines in histone H3 following
DNA damage
Methylation of lysine residues can be associated with gene
silencing, for example, H3K9 methylation is necessary for
silencing and the dimethylated form is associated with regions
of heterochromatin, whereas trimethylated H3K27 and H3K9
are both found in euchromatin [3,14,22]. The highest levels of
methylation were identified in the histone H3 isoform H3.1,
including monomethylation of lysine residues K9 and K27,
consistent with the role of H3.1 in packaging heterochromatin
[13]. Analysis of methylated lysine residues in a peptide
sequence was manually validated by confirming the presence
of the diagnostic b- and y-type product ions in the MS/MS
spectrum. The mass difference between b- and y-type product
ions indicating trimethylation will result in addition of 42.047 to
the mass of lysine, whereas acetylation will only add 42.011
Da. The accuracy of the mass measurements in the present
study was sufficient to discriminate the 36 mDa mass difference
between these two modifications (Table 2). We identified
two unique methylated peptides of H3 from irradiated plants.
One isoform was dimethylated at K9, which is enriched in
heterochromatic regions [22], was concomitantly acetylated at
K14 (K9me2STGGKacAPR17; where me indicates a methylated
residue); the assignment is supported by a series of y-ions that
lacks only the y1 ion, plus intense b4 and b7 ions (Figure 4A).
The other was monomethylated at K9 (K9meSTGGKAPR17); the
assignment is supported by a series of y-ions that lacks only the
y1 ion (Figure 4B).
Increase in acetylation of the H3 N-terminus following DNA damage
Previous reports indicate that the diacetylated forms for
histone H3 K9acK14ac and K18acK23ac constitute some of
the lowest abundance detectable modifications in plants [13].
Monoacetylated H3 peptides varied in relative abundance, K14ac
being most abundant, then K18K23, whereas K9ac was not
detected [13]. In the present study, four acetylated peptides
on the H3 N-terminus were identified. The Arg-C digest after
propionylation generated two peptides, K9STGGKAPR17 and
K18QLATKAAR26, which display acetylation at each of the four
lysine residues (K9, K14, K18 and K23). However, our analysis
does not reveal whether residues K14 and K18 are both acetylated
within a single molecule of histone H3. The hyperacetylation of
the H3 N-terminus was observed in response to DNA damage
in mammals by the use of antisera specific to each lysine
modification [23], but this analysis also did not reveal whether
concurrent acetylation of multiple residues occurs in the same
molecule. To further characterize hyperacetylation following X-
ray treatment in Arabidopsis, a commercially available antibody
to K14acK18ac was used to investigate whether K14 and K18,
the residues spanning the two peptide fragments generated
by the Arg-C digest, were both acetylated in irradiated
tissue by immunoblotting. The antibody was used to detect
differences in relative abundance of lysine modifications in protein
samples from irradiated and unirradiated tissues (Figure 5A).
Diacetylation of K14 and K18 was detected in all tissues,
and was shown to increased abundance following IR in Col-0
(Figure 5B). Acetylation of K14 and K18 is therefore detectable
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Figure 5 Relative abundance of H3K14acK18ac and acetylated forms of H4 N-terminus increases following IR
(A) Coomassie Blue-stained Tricine-SDS/PAGE gel. (B) Western blot analysis using H3K14acK18ac. (C) Coomassie Blue-stained Tricine-SDS/PAGE gel. (D) Immunoblot for tetra-acetylated
H4K5acK8acK12acK16ac. (E) Coomassie Blue-stained gel (F). Western blots with anti-H4K5ac (G), anti-H4K12ac (H), anti-H4K16ac antibodies. Lane 1, Col-0 unirradiated; lane 2, Col-0 160 Gy
IR; lane 3, atm-3 unirradiated; and lane 4, atm-3 160 Gy IR.
as an epigenetic mark present on histones in the absence of
genotoxic stress that increases in response to DSB induction. A
similar response was shown in the atm-null mutant background;
however, a band of greater intensity is present following IR
treatment, indicating that acetylation persists in the absence of
a fully functioning DDR, and suggests that diacetylation of K14
and K18 occurs independently of ATM-mediated signalling.
Loss of tetra-acetylated H4 tail following DNA damage: K16 and
K12 most likely targets for deacetylation
Hyperacetylation of the H4 tail has been shown to localize
to transcription start sites of loci implicated in the DDR in
maize [12], and be an epigenetic modification at DSB sites in
studies with mammalian cells undergoing DDR [24]. Our MS
analysis of Arabidopsis histones isolated from tissues undergoing
repair of DSBs following X-ray treatment revealed the tetra-
acetylated form was present, along with seven other isoforms.
The tetra-acetylated peptide was found to decrease in abundance
following X-ray treatment in Col-0, but increase in abundance in
the atm-null mutant background, again illustrating that acetylation
persists in the absence of a fully functioning DDR (Figures 5C and
5D). To identify deacetylation sites in Col-0 histones following
IR, we used antibodies against each individual acetylated lysine
residue; histones displayed consistent levels of acetylation on K5
(Figure 5F), whereas K12 and K16 show a decrease in relative
abundance after irradiation and therefore represent candidate sites
for deacetylation during the DDR (Figures 5G and 5H).
DISCUSSION
We used an LC–MS/MS approach to investigate acetyl and
methyl modifications of Arabidopsis histones following DNA
damage induction by X-ray treatment and investigated the DNA-
damage specific modification of individual peptides through
Western blot analysis.
Our MS analysis provided good sequence coverage of both
H3 and H4 (around 50% coverage) through the inclusion
of Arg-C digestion and propionylation steps. The four H3
acetylated isoforms peptides described in the present study
were also identified in a nucleosome-wide characterization
of Arabidopsis histones, which additionally identified the
monoacetylated peptide K18acQLATK23 [14]. In addition, a study
of the relative abundance of peptide isoforms of histones isolated
from Arabidopsis inflorescence tissue showed that the unmodified
H3 peptide K18QLATKAAR26 was the most abundant isoform,
followed by the K18ac, K18acK23ac and then K23ac isoforms
[13]. The MS analysis the present study was not quantitative,
however we identified the two least abundant forms, K23ac and
K18acK23ac, demonstrating the sensitivity of our analysis
and confirming the presence of these isoforms following
genotoxic stress. Studies of Arabidopsis using quantitative MS
analysis in addition to an immunological detection report that
K9ac accounts for a few per cent of the total histone population
[13], and in human cells, H3K9ac levels are reduced in response
to DNA damage [18]. This is consistent with the failure to
detect this species in X-ray treated plant tissues, whereas the
mutually exclusive methylated peptide was identified in the
present study. The present study also detected the dimethylated
and acetylated H3 peptide K9me2K14ac, previously shown to be
low in abundance in both Arabidopsis [13] and alfalfa [15].
To investigate whether any hyperacetylated forms are
associated with the plant response to genotoxic stress,
immunoblotting was performed using antiserum specific against
acetylated histone peptides. Acetylation of H3K14acK18ac
increased in response to X-ray induction relative to untreated
controls, indicating potential roles for chromatin modification in
the plant DDR. Similar increases in H3K14ac were observed
in yeast cells following UV treatment [25]. Although acetylation
confers structural changes to chromatin, the relationship of
these covalent modifications in the DDR is complex, as the
combination of covalent histone marks also initiates ATP-
dependent remodelling activities [24], with acetylation of the H3
tail dramatically increasing nucleosome repositioning by the
RSC complex [26]. Although the present study demonstrates
hyperacetylation of Arabidopsis H3 in response to DNA damage,
this acetylation occurs in the absence of ATM indicating
that this modification is independent of (or upstream of) the well-
characterized ATM-kinase mediated DDR in plants.
Extensive acetylation of Arabidopsis histone H4 was
detected in the present study, including nine forms of H4
G4KGGKGLGKGGAKR17 and unmodified, mono-, di-, tri- and
tetra-acetylated peptide isoforms represented (Figure 6, residues
1–9). Zhang et al. [14] identified acetylation sites by LC–MS/MS
on six smaller tryptic peptides that are contained within the
sequence GKGGKGLGKGGAKR (Figure 6, peptides a–f). Their
analysis identified modified peptides in common with the present
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 6 Summary of peptides from histone H4 observed by LC–MS/MS
The nine GKGGKGLGKGGAKR peptides observed in the present study, one unmodified and eight
acetylated, are labelled 1–9. Smaller peptides included within the sequence GKGGKGLGKGGAKR
that were observed by Zhang et al. [14] (labelled a–f) are also shown for comparison. Sites of
acetylation at lysine residues 5, 8, 12 and 16 are indicated by open circles.
study, which additionally demonstrates the acetylation of K5
without concomitant acetylation of K8 (Figure 6, peptides 8
and 9). This result contrasts with previous models of acetylation
in plants [21], in which acetylation of K5, K8, K12 and K16
in Brassica oleracea was proposed to occur sequentially
beginning with K16 and proceeding towards the N-terminal K5. In
addition, peptides 2 and 7 (Figure 6) are also inconsistent with the
proposed model, but suggest that acetylation of K16 is common.
The tetra-acetylated H4 tail has been shown to increase in
abundance following UV exposure in UV-resistant maize [12],
and is present specifically at transcription start sites of UV-
tolerance-associated genes. In mammals, hyperacetylation of
H4 occurs at endonuclease-induced DSBs; H4K8ac is enriched
at break sites downstream of γ -H2AX, and two subunits
of acetyltransferase NuA4 complex were also present [27].
Substitution of lysine resides of H4 at K5, K8, K12 and K16
by glutamine rendered cells more sensitive to DNA damage and
impaired NHEJ (non-homologous end-joining) repair of DSBs
demonstrating the importance of these residues in the mammalian
DSB response [19]. Furthermore, tetra-acetylation is required for
accumulation of BRCA1 (breast cancer 1) and Rad51 at DSB
foci, and can extend for several kb either side of the DSB [27,28].
In contrast, the present study demonstrated that plants display a
slight global decrease in relative abundance of tetra-acetylated
H4 following 160 Gy IR. Interestingly this is not observed in atm
mutants, which display a pronounced increase in the levels of
tetra-acetylated H4 after exposure to X-rays. Mutant atm plants
are deficient in the detection and signalling response to DSBs
[6,29], and observed hyperacetylation of H4 in these lines after
irradiation may be indicative of the accumulation of DSBs in the
atm mutant background. Furthermore, the increased acetylation
of H4 in atm mutants clearly indicates that hyperacetylation
is upstream of ATM signalling. The observed deacetylation in
irradiated plants may require functional ATM, as mammalian
ATM interacts with the deacetylase HDAC (histone deacetylase) 1
in vivo with increased association following IR [30], and HDAC1
and HDAC2 have been shown to regulate acetylation and promote
DSB repair [31].
Summary
Using LC–MS/MS we have identified several different acetylated
H3 and H4 N-terminal acetylation states following X-ray
treatment, including four not previously described in Arabidopsis.
Western blot analysis demonstrated hyperacetylation of histone
H3 and a global decrease in H4 acetylation in response to X-rays.
Acetylation levels were greater in an atm-null background, clearly
showing that histone acetylation occurs in the absence of ATM,
although deacetylation activity may be compromised. Future work
investigating the hyper- and hypo-acetylation response of H3 and
H4 will determine the significance of these epigenetic changes
during genotoxic stress and repair.
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1. Introduction
Helminthparasites continue tobeamajor global healthproblem
with over 2 billion people infected across the world [1]. Their per-
sistence is, in part, due to their success in escaping host immunity
and surviving for years within the human body. Their long lifespan
is considered to reﬂect the evolution of highly successful immune
evasion strategies [2]. Manipulation of the host immune system is
most likely to be mediated by molecules released from live para-
sites, and hence the deﬁnition of parasite secretomes will identify
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78ncoded by the parasite fulﬁll their function in the host milieu. The ‘exten-
parasite, Brugia malayi, is of particular interest because of the evidence
down-modulation of the host immune response. We collected B. malayi
teins from adult parasites and using a combination of shotgun LC–MS/MS
ntiﬁed 80 B. malayi and two host proteins in BES, of which 31 (38%) were
act (BmA). Products which were enriched in BES relative to BmA included
ding protein (PEB), leucyl aminopeptidase (LAP, homologue of ES-62 from
nema viteae), N-acetylglucosaminyltransferase (GlcNAcT) and galectin-1,
scribed major surface glycoprotein, glutathione peroxidase (gp29, GPX-1)
acrophage migration inhibitory factor (MIF-1). One of the most abun-
se phosphate isomerase (TPI), yet many other glycolytic enzymes (such
ound only in the somatic extract. Among the more prominent novel pro-
et of 11 small transthyretin-like proteins, and three glutamine-rich-repeat
evidencewas found of any secreted protein corresponding to the genome
t present in B. malayi. Western blotting with anti-phosphorylcholine (PC)
that GlcNAcT, and not the ES-62 homologue, is themajor PC-bearing pro-
human ﬁlariasis sera showed preferential reactivity to galectin-1 and to
Overall, this analysis demonstrates selective release of a suite of newly
sly suspected to be involved at the host–parasite interface, and provides
the biology of the ﬁlarial parasite.
© 2008 Elsevier B.V. All rights reserved.
candidate molecules involved in immune modulation [3]. Further,
if the function of parasite secretions can be blocked by host anti-
bodies, than secreted antigens may be critical in the formulation
of future vaccines against parasitic helminth infections [4,5]. For
these reasons, we have analysed the spectrum of proteins secreted
by adult parasites of the human ﬁlarial nematode, Brugia malayi,
aided by the recent release of the draft genome sequence of this
pathogen [6].
In both human populations and experimental model systems,
ﬁlarial infections with B. malayi and the closely related Wuchere-
ria bancrofti are associated with immunological down-regulation.
In infection, there is a dominance of regulatory cytokines, such as
IL-10 and TGF-, which inhibit parasite-speciﬁc T cell proliferation
and effector function [7,8], leading to a diverted Th2 phenotype
characterised by high IL-4 and IgG4 isotype antibodies, but low
levels of eosinophil-activating IL-5 and of reagenic IgE antibody [9].
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T cells from infected individuals are associatedwith the presence of
a number of markers linked to regulatory T cells [10,11]. Defects in
theantigenpresentingcell (APC)populationarealsoevident [12], as
exempliﬁed by reducedmonocyte responsiveness to inﬂammatory
stimuli [13]. Studieswithmousemodels conﬁrmthat, as inhumans,
both innate and adaptive arms of host immunity are targetted by
ﬁlarial parasites [14–16].
The molecular basis of helminth-induced hyporesponsiveness
hasyet tobedeﬁned.Oneapproach to investigate this is to characte-
rise the molecules at the host–pathogen interface, given that these
will have the opportunity to interact with, and potentially subvert,
host immune cells. Early work used radiolabelling techniques to
characterise the major surface and secretory products of adult B.
malayi [17,18]. Subsequent in vivo studies have shown that B.malayi
excretory–secretory (ES) products (hereafter referred to as BES) can
inhibit parasite-speciﬁc proliferative responses [19], perhaps via
the induction of a suppressive macrophage population [20].
More recently, as a result of large-scale parasite sequencing
(genomic and EST) projects (http://www.sanger.ac.uk/Projects/
Helminths/), the proteomic identiﬁcation of helminth ES products
has become possible. Among nematodes, numerous ES products
from Haemonchus contortus [3], Trichinella spiralis [21], and Tela-
dorsagia circumcincta [22] have been identiﬁed by reference to
EST datasets. Schistosoma mansoni secretions from larvae [23,24],
eggs [25] and adult guts [26], have also been determined by refe-
rence to transcriptomic data. However, proteomic studies on the
secretions of ﬁlarial parasites revealed few matches to ESTs (Har-
cus, Curwen, Wilson and Maizels, unpublished). The release of the
draft genome of B. malayi [6] has offered the opportunity for a
more systematic characterisation of BES, and we now report on
the use of two parallel proteomic approaches, gel-free (shotgun)
LC–MS/MS and 2D gel electrophoresis to probe the adult B. malayi
secretome.
2. Materials and methods
2.1. Parasites
B. malayi, obtained originally from TRS Laboratories, was main-
tained throughAedes aegyptimosquitoes andMeriones unguiculatus
gerbils. Adultwormswere recovered from theperitoneumapproxi-
mately 4 months post-infection.2.2. In vitro culture and collection of BES and BmA
Culture medium comprised serum-free RPMI-1640 supple-
mented with 25mM HEPES, 100U/ml penicillin, 100g/ml
streptomycin (all Gibco) and 1% glucose (Sigma). Male and female
parasites were washed extensively with culture medium, and then
cultured at approximately 50 worms/50ml medium at 37 ◦C in 5%
CO2. Spent media were collected ﬁve times over an 8-day culture
period. Media were ﬁltered through a 0.22-m syringe ﬁlter (Sar-
torius) to remove microﬁlariae, and then stored at −20 ◦C. Media
from 2–3 batches of worms were concentrated and then diaﬁl-
trated into 20mM Tris–HCl pH 7.3 using an amicon ultraﬁltration
cell with regenerated cellulose 3000MW cut-off (MWCO) ﬁlter,
followed by further concentration using an centrifugal ﬁlter with a
5000 MWCO (all Millipore). Somatic extract of adult worms (BmA)
was prepared by homogenisation of male and female worms on
ice in 20mM Tris pH 7.3, followed by centrifugation at 10,000× g
for 20min at 4 ◦C. Protein concentrations were determined using
Commassie Plus (Pierce) and samples were stored at −80 ◦C
until use.
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2.3. 1D gel electrophoresis
Independently prepared batches of BES or BmA (2g) were
heated at 95 ◦C for 10min in NuPAGE LDS sample buffer (Invitro-
gen) with 0.5M 2-mercaptoethanol (Sigma), and then separated
on NuPAGE 4−12% Bis–Tris gels using an X cell Surelock Minicell
system with NuPAGE MES SDS running buffer (all Invitrogen) for
40min at constant 200V. Gels were silver stained using PlusOne
(AmershamBiosciences,modiﬁed according toRef. [27]) then scan-
ned using a Linoscan (Heidelberg).
2.4. 2D gel electrophoresis
Parasite protein (10–20g) was diluted into a ﬁnal volume of
125lwith rehydration solution (7Murea, 2Mthiourea (bothBDH),
4% CHAPS (Sigma), 65mM DTE (Fluka), 0.8% IPG buffer 3–10 (GE
healthcare), trace bromophenol blue (Sigma)), and used to rehy-
drate 7 cm pH 3–10 IPG strips (Immobiline; GE healthcare) for 14h
at 20 ◦C. Isoelectric focusing was carried out (500V for 30min;
1000V for 30min; gradient to 8000V for 5h; total ∼20kVh) using
an IPGphor (Pharmacia Biotech). Stripswere reduced and alkylated
as previously described [28] before electrophoresis in the second
dimension using NuPAGE 4–12% Bis–Tris ZOOM gels and NuPAGE
MES SDS running buffer (both Invitrogen) for 2h 10min at constant
100V. Gels were silver stained and scanned as described above.
2.5. MALDI-ToF/ToF and LC–MS/MS
Protein spots were excised, destained in Farmer’s reagent (20%
sodium thiosulphate, 1% potassium ferricyanide), washed twice in
50% acetonitrile with 25mM ammonium bicarbonate, and once
with acetonitrile before vacuum drying. Samples were digested
overnight at 37 ◦Cwith 10l of 0.01g/l sequencing grademodi-
ﬁed trypsin (Promega) in 25mM ammonium bicarbonate, and
then added to a MALDI target plate with an equal volume of -
cyanohydroxycinnamic acid (5mg/ml; Sigma) in 50% acetonitrile
containing0.1%TFA. For LC–MS/MS, sampleswerediluted to100L
with 0.5M triethylammoniumbicarbonate. Disulphide bondswere
reduced with 5mM tris-(2-carboxyethyl)phosphine and thiols
modiﬁed with 10mM methyl methanethiosulphonate, then pro-
teins were digested overnight at 37 ◦C with 1/20 (w/w) trypsin.
Samples were acidiﬁed (pH 2.5) with TFA, passed through a strata
C18-E solidphaseextraction cartridge (55m,70A, Pheonomenex),
and then dried and reconstituted in 10l 0.1% TFA. Peptides (3l
aliquots)were injectedonto apolystyrene-divinylbenzenepolyme-
ric monolithic column (200m i.d.×5 cm; LC Packings, NL) linked
to an Ultimate nano-HPLC system (Dionex), and separated using
a linear gradient of 3–51% acetonitrile in 0.1% heptaﬂuorobutyric
acid over 20min (3l/min ﬂow rate). UV absorbance at 214nm
was monitored. Fractions were collected every 6 s onto a MALDI
target plate, using a probot microfraction collector (Dionex), fol-
lowed by post-column addition of 0.9l/min matrix and 6mg/ml
-cyanohydroxycinnamic acid in 60% acetonitrile.
Positive-ion MALDI mass spectra were obtained using an
Applied Biosystems 4700 Proteomics Analyzer (Applied Biosys-
tems, Foster City, CA, USA) in reﬂectron mode. MS spectra were
acquired over a mass range of m/z 800–4000 and monoisotopic
masses were obtained from centroids of raw, unsmoothed data.
CID-MS/MSwas performed on the 20 strongest peaks with a signal
to noise greater than 50 for both the gel spots and each LC–MS/MS
fraction. For the latter, a fraction-to-fraction precursor exclusion of
200ppm was used. For CID-MS/MS, a source 1 collision energy of
1 kV was used, with air as the collision gas. The precursor mass
window was set to a relative resolution of 50, and the metas-
table suppressor was enabled. The default calibration was used for
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MS/MS spectra, which were baseline-subtracted (peak width 50)
and smoothed (Savitsky-Golay with three points across a peak and
polynomial order 4); peak detection used aminimumS/N of 5, local
noise window of 50m/z, and minimum peak width of 2.9 bins. Fil-
ters of S/N 20 and 30 were used for generating peak lists from MS
and MS/MS spectra, respectively.
2.6. Database searching and bioinformatics
Mass spectral data from protein spots were submitted to data-
base searching using a locally running copy of the Mascot program
(Matrix Science Ltd., version 2.1). Batch-acquired MS/MS data was
submitted to a MS/MS ion search through the Applied Biosystems
GPS Explorer software interface (version 3.6) toMascot. Mass spec-
tral data from LC–MS/MS were submitted to database searching
using TS2Mascot (Matrix Science, version 1.0.0) and Mascot 2.1.
Search parameters allowed a maximum of one missed cleavage,
the modiﬁcation of cysteine, the possible oxidation of methio-
nine, peptide tolerance of 100ppm and MS/MS tolerance of 0.1Da.
Spectra were searched against both a recent version of the NCBI
non-redundant protein database and a Brugia coding sequence
database composed of both genomic (http://www.tigr.org/tdb/
e2k1/bma1/intro.shtml) andEST (http://compbio.dfci.harvard.edu/
tgi/cgi-bin/tgi/gireport.pl?gudb=b malayi) sequences. The signiﬁ-
cance threshold was set at p<0.05, and identiﬁcation required
that each protein contained at least one peptide with an expect
Table 1
Proteins present in BES identiﬁed by LC MS/MS
Name Pub locus TI
Cytosol stress response/chaperones
1 14-3-3-like protein 2 Bm1 10970 13
2 Chaperonin-10kDa Bm1 56470 15
3 Heat shock protein 70kDa Bm1 43675 14
4 Small heat shock protein P27 XXX XX
Anti-oxidants
5 Glutathione peroxidase, major surface antigen gp29 Bm1 40465 14
6 Oxidoreductase, aldo/keto reductase Bm1 28070 14
7 Superoxide dismutase XXX XX
8 Superoxide dismutase precursor (Extracellular) XXX XX
9 Thioredoxin peroxidase 2 XXX XX
10 Translationally controlled tumor protein Bm1 31480 14
Cytosol energy metabolism
11 Enolase Bm1 24115 14
12 Glycosyl hydrolases family 31 protein Bm1 40580 14
13 Inorganic pyrophosphatase Bm1 16955 14
14 MF-1 antigen (endochitinase) Bm1 17035 14
15 6-Phosphofructokinase Bm1 01930 12
16 Triose phosphate isomerase Bm1 29130 14
Structural/cytoskeletal
17 Actin Bm1 16810 14
18 Actin 1 Bm1 34925 14
19 Calmodulin Bm1 50415 14
20 Calsequestrin family protein Bm1 40185 14
21 Lethal protein 805, isoform d Bm1 12945 13
22 Major sperm protein Bm1 55755 15
23 Major sperm protein 2 Bm1 13600 14
24 Major sperm protein 3 Bm1 16920 14
25 Muscle positioning protein 4 XXX XX
26 Muscle positioning protein 4 Bm1 05930 13
27 Myotactin form B Bm1 53510 15
28 Secretory protein (LS110p) XXX XX
29 Tropomyosin family protein Bm1 02060 12
Protein digestion and folding
30 Calreticulin precursor Bm1 23560 14
31 Cyclophilin-2 cyp-2 Bm1 55850 15
32 Cyclophilin-5 cyp-5 Bm1 24035 14
33 FKBP-12 Bm1 49010 14
34 -Glutamyltranspeptidase family protein Bm1 09950 13
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value <0.05. By using a decoy database, the LC–MS/MS false disco-
very rate for single peptide matches was estimated to be 6.1% for
BES and 4.7% for BmA. Single peptide matches are marked (*) in
Tables 1 and 2 . For each protein match identiﬁed by MASCOT, the
programme calculated the corresponding exponentially modiﬁed
protein abundance index (emPAI) as the transformed ratio of the
number of experimentally observed peptides to the total number
of peptides that can theoretically be detected within the opera-
tingmass range and retention range of the instrument. To establish
whether the proteins present in BES contained predicted signal
sequences, sequences were analysed using SignalP [29] and Secre-
tomeP [30]. ClusterW sequence alignment and phylogenetic tree
construction (bootstrap, midpoint, 1000 replications) was perfor-
med using MacVector version 9.5.2.
2.7. Western blotting
BES was separated by 2D gel electrophoresis as described
above, transferred to nitrocellulose membrane (Biorad) using
an Xcell II blot module (90min, 30V; Invitrogen), and blocked
overnight at 4 ◦C (Starting Block T20; Pierce). To detect phos-
phorylcholine (PC)-bearing proteins, membranes were probed
with 1/1000 Bp-1 [31] overnight at 4 ◦C, washed extensively
in TBS with 0.05% tween (TBST), and incubated with 1/2000
rabbit anti-mouse Ig HRP (1h, room temperature; DakoCytoma-
tion). To assess the binding of human IgG to BES, sera from
GR locus Gene index Score SS? emPAI Spot
662.m00125 74 No 0.43
397.m00021 34* No 0.35
977.m04983 113* SS 0.33
X TC7940 33* NCSS 0.18
972.m07803 150 SS 1.31
922.m00060 52 No 0.12
X TC8075 191 No 1.07
X AA509030 64 SS 0.30
X TC7730 45 NCSS 0.72
955.m00256 39* NCSS 0.21
703.m00079 346 NCSS 0.83 13
972.m07829 69 SS 0.11
271.m00285 51 SS 0.14
274.m00229 TC8062 115 SS 0.19
616.m00133 39 No 0.05
940.m00172 796 No 11.11 5, 6, 7,8
258.m00140 60 No 0.13
965.m00431 59 No 0.28
992.m10856 34* NCSS 0.35
972.m07743 41 SS 0.24
929.m00009 166 SS 0.62 17
304.m00111 125 NCSS 0.21
015.m00090 281 NCSS 4.40
269.m00019 44 No 0.31
X AI783143 88* NCSS 0.20
207.m00046 45 NCSS 0.17
059.m00091 194 No 0.08 21, 22, 23
X TC9625 173 SS 2.22
630.m00063 69 No 0.34
677.m00169 71 SS 0.36
309.m00029 139 No 0.53 4
702.m00390 38 SS 0.26 1
990.m07926 55 NCSS 1.41
531.m00015 TC8816 431 SS 4.91 14, 15, 16
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Table 1 (Continued )
Name Pub locus TIGR locus Gene index Score SS? emPAI Spot
35 Leucyl aminopeptidase Bm1 56305 15373.m00009 568 SS 2.18 18
36 Protein disulphide isomerase Bm1 39250 14972.m07552 36 SS 0.09
37 Serine carboxypeptidase Bm1 43130 14977.m04868 71* SS 0.10
38 Ubiquitin Bm1 25395 14761.m00205 95 No 0.35 1
39 Ubiquitin-like protein SMT3 Bm1 45210 14979.m04551 59 NCSS 1.32
Lectins and glycosyltransferases
40 N-Acetylglucosaminyltransferase Bm1 07275 13311.m00333 TC7929 370 NCSS 3.70 20
41 C-Type lectin domain containing protein Bm1 40520 14972.m07815 45* NCSS 0.08
42 Galectin Bm-GAL-1 Bm1 24940 14731.m01012 556 No 6.13 9, 10
43 Galectin Bm-GAL-2 Bm1 46750 14981.m02389 101 No 0.18
Protease inhibitors
44 Cystatin CPI-2 XXX XXX TC7871 62 SS 0.22
Lipid binding
45 Nematode polyprotein allergen (gp15/400), NPA-1 Bm1 50995 14992.m10973 274 No 0.45
46 Phosphatidylethanolamine-binding protein 1 Bm1 41005 14973.m02599 279 NCSS 8.36
47 Phosphatidylethanolamine-binding protein 2 Bm1 31500 14956.m00481 44 NCSS 0.71
Host cytokine homologues
48 Macrophage migration inhibitory factor 1 Bm1 28435 14930.m00337 176 NCSS 2.38 2
Nuclear
49 DNA repair protein Rad4 containing protein Bm1 03115 12787.m00392 39 NCSS 0.06
50 Snf5 homologue Bm1 46120 14980.m02744 71 NCSS 0.19
51 High mobility group protein Bm1 25620 14768.m00190 46 No 0.33
Transthyretin-like family proteins
52 Transthyretin-like family protein Bm1 26590 14830.m00078 194 SS 1.58
53 Transthyretin-like family protein XXX XXX TC7985 182 SS 1.11
54 Transthyretin-like family protein XXX XXX TC8258 161 SS 3.24
55 Transthyretin-like family protein XXX XXX TC8116 131 SS 1.35 3
56 Transthyretin-like family protein XXX XXX TC7986 86 SS 2.29
57 Transthyretin-like family protein XXX XXX AA592049 59* TRUN 0.32
58 Transthyretin-like family protein Bm1 20065 14486.m00069 AI105565 50 SS 0.33
59 Transthyretin-like family protein Bm1 15250 14164.m00122 53 SS 0.86
60 Transthyretin-like family protein Bm1 04380 12984.m00011 48* SS 0.25
61 Transthyretin-like family protein Bm1 26585 14830.m00077 41 SS 0.87
62 Transthyretin-like family protein Bm1 06445 13250.m00031 TC8095 35 SS 0.30
Proteins of undetermined function
63 Conserved cysteine-glycine protein 1 Bm1 38150 14972.m07327 124 SS 0.52
64 Conserved hypothetical protein Bm1 19065 14396.m00009 35 No 0.06
65 DJ-1 family protein Bm1 07685 13325.m00230 49 No 0.68
66 Fasciclin domain containing protein Bm1 17270 14284.m00379 50 No 0.08
67 G15-6A protein-related Bm1 49930 14990.m08112 35 SS 0.22
68 Hypothetical protein Bm1 57465 15533.m00023 TC7900 107 No 0.09
69 Hypothetical protein Bm1 19875 14469.m00102 65 TRUN 0.42
14
13
12
1370 Hypothetical protein Bm1 46475
71 Hypothetical (mucin-like) protein Bm1 11505
72 Hypothetical (mucin-like) protein Bm1 01245
73 Hypothetical (mucin-like) protein Bm1 09845
74 Immunogenic protein 3 Bm1 07780 13
75 Immunoglobulin I-set domain containing protein Bm1 45475 14
76 Immunoglobulin I-set domain containing protein Bm1 35295 14
77 Major allergen XXX X
78 PDZ-domain protein scribble Bm1 33310 14
79 Recombinant antigen R1 Bm1 11105 13
80 SXP-1 protein Bm1 42870 14
Name Pub locus Locus
Host
81 Fibronectin n/a P11276
82 Serum albumin n/a P02769
Pub locus is the stable gene ID, where the draft genome sequence includes the gene locus
index indicates an EST, and is given either when the genomic sequence appears truncated
the presence of a classical N-terminal signal sequence (“SS” from signalP), an internal non
negative for both signalP and secretomeP). TRUN indicates that the sequence is truncated a
Exponentially modiﬁed protein abundance index (emPAI) gives an approximate quantiﬁc
* Indicates single peptide hits.
previously characterised microﬁlaraemic or pathology individuals
[32] were pooled (ﬁve representative individuals per group). Nor-
mal human sera were obtained from non-exposed UK residents.
Membranes were probed with 1/500 sera dilutions in TBST over-
81980.m02820 36 SS 0.20
734.m00156 207 No 0.24
551.m00090 188 No 0.31
513.m00023 145 No 0.31
333.m00082 TC8120 133 SS 1.09
979.m04613 73 No 0.02
968.m01452 63 NCSS 0.26
XX TC8813 272 SS 2.13 11, 12
961.m05155 35 No 0.04
673.m00035 35 SS 0.23
975.m04515 125 SS 1.10
Gene index Score SS? emPAI Spot
352 n/a 0.10
256 n/a 0.25 19
; XXX denotes gaps in the draft genome. TIGR locus is the original annotation. Gene
compared to an EST or is not present. Score refers to the mascot score. SS? shows
-classical sequence (“NCSS” from secretomeP), or the lack of a signal sequence (“no”
t the N-terminus and so the presence of signal sequences could not be determined.
ation of the protein. Spot refers to the spot number in Fig. 2C.
night at 4 ◦C,washed in TBST, and thenwith 1/2000HRP conjugated
rabbit anti-human IgG (1h room temperature; DakoCytomation
P0214). Following furtherwashing in TBST, all blotswere developed
using ChemiGlow West, according to the manufacturers instruc-
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Table 2
Proteins present in BmA identiﬁed by LC–MS/MS
Name Pub locus TIGR locus Gene index Score emPAI Ratio
Cytosol stress response/chaperones
1 14-3-3-like protein 2 Bm1 10970 13662.m00125 82 1.46 0.3
2 Chaperonine protein HSP60 Bm1 56580 15413.m00008 52* 0.16 xxx
3 Heat shock protein 70 Bm1 43675 14977.m04983 TC7686 613 1.56 0.2
4 Heat shock protein 70C Bm1 17800 14318.m00070 98 0.16 xxx
5 HSP-like 86.9 kDa C30C11.4 Bm1 23190 14656.m00228 96 0.19 xxx
6 Heat shock protein 90 Bm1 51495 14992.m11078 269 0.65 xxx
7 Small heat shock protein Bm1 19805 14459.m00246 TC8028 52 0.47 xxx
8 Small heat shock 19.4 kDa protein ZC395.10 Bm1 30230 14950.m01862 52* 0.27 xxx
9 Small heat shock protein OV25-1 Bm1 14535 14083.m00056 95 0.68 xxx
10 Small heat shock protein P27 XXX XXX TC7940 242 0.98 0.2
Anti-oxidants
11 Glutathione peroxidase, major surface antigen gp29 Bm1 40465 14972.m07803 47* 0.19 6.9
12 Oxidoreductase, aldo/keto reductase Bm1 28070 14922.m00060 94 0.27 0.4
13 Thioredoxin Bm1 46700 14981.m02379 TC7847 80* 0.22 xxx
14 Thioredoxin peroxidase 2 XXX XXX TC7730 63 0.47 1.5
Cytosol energy metabolism
15 Adenylate kinase isoenzyme 1 Bm1 13790 14037.m00196 148 0.61 xxx
16 Carbohydrate phosphorylase Bm1 16060 14231.m00144 119 0.25 xxx
17 Enolase Bm1 24115 14703.m00079 TC7838 541 0.65 1.3
18 Fructose-bisphosphate aldolase 1 Bm1 15350 14176.m00093 306 0.65 xxx
19 Glyceraldehyde 3-phosphate dehydrogenase Bm1 41940 14975.m04318 TC7820 206 0.49 xxx
20 Inorganic pyrophosphatase Bm1 16955 14271.m00285 51* 0.15 0.9
21 Phosphoenolpyruvate carboxykinase (GTP) Bm1 25195 14749.m00214 86 0.23 xxx
22 Phosphoglycerate kinase Bm1 01925 12616.m00132 117 0.43 xxx
23 Triosephosphate isomerase Bm1 29130 14940.m00172 390 0.65 17.1
Structural/cytoskeletal
24 Actin 1 Bm1 34925 14965.m00431 482 0.65 0.4
25 Actin Bm1 16810 14258.m00140 432 0.65 0.2
26 Calponin protein 3 XXX XXX TC8546 295 0.65 xxx
27 Major sperm protein Bm1 55755 15304.m00111 TC7970 96* 0.22 1.0
28 Major sperm protein 2 Bm1 13600 14015.m00090 112 0.90 4.9
29 Myosin essential light chain XXX XXX TC7908 104 0.40 xxx
30 Myosin heavy chain Bm1 40715 14972.m07860 TC7898 52 0.05 xxx
31 Myosin regulatory light chain 1 Bm1 40180 14972.m07742 TC8201 117 0.26 xxx
32 Proﬁlin family protein Bm1 21620 14590.m00346 57 0.43 xxx
33 Secretory protein (LS110p) XXX XXX TC9625 52* 0.27 8.2
34 Tropomyosin family protein Bm1 02060 12630.m00063 88 0.35 1.0
35 Troponin-like EF hand family protein Bm1 48810 14990.m07885 TC7791 42 0.27 xxx
36 Tubulin alpha chain Bm1 38680 14972.m07435 TC7853 67 0.20 xxx
37 Tubulin alpha chain Bm1 12120 13818.m00233 43 0.11 xxx
38 Tubulin beta chain Bm1 25780 14773.m00919 TC7923 86 0.09 xxx
Protein digestion and folding
39 Cyclophilin-2 cyp-2 Bm1 55850 15309.m00029 TC7957 108 0.53 1.0
40 Cyclophilin-5, cyp-5 Bm1 24035 14702.m00390 83* 0.26 1.0
41 FKBP-12 Bm1 49010 14990.m07926 TC8539 50* 0.32 4.4
42 -Glutamyltranspeptidase family protein Bm1 09950 13531.m00015 TC8816 83 0.36 13.6
43 Leucyl aminopeptidase Bm1 56305 15373.m00009 56 0.12 18.2
44 Proteasome subunit alpha type 1 Bm1 17805 14318.m00071 59 0.20 xxx
45 Protein disulphide isomerase Bm1 39250 14972.m07552 TC8291 49 0.09 1.0
46 Transglutaminase Bm1 28935 14937.m00487 96 0.10 xxx
47 Ubiquitin Bm1 09050 13432.m00246 61 0.27 xxx
48 Ubiquitin-like protein SMT3 Bm1 45210 14979.m04551 49* 0.53 2.5
Lectins and glycosyltransferases
49 N-Acetylglucosaminyltransferase Bm1 07275 13311.m00333 TC7929 42 0.33 11.2
Protease inhibitors
50 Cystatin CPI-2 XXX XXX TC7871 77 0.23 1.0
Lipid binding
51 Nematode polyprotein allergen (gp15/400), NPA-1 Bm1 50995 14992.m10973 332 0.65 0.7
52 Phosphatidylethanolamine-binding protein Bm1 41005 14973.m02599 TC8147 107 0.41 20.4
Nuclear
53 Nucleosome assembly protein 1 Bm1 27810 14919.m00204 TC8159 50 0.15 xxx
Proteins of undetermined function
54 AT19640p-related Bm1 34700 14963.m01811 43* 0.11 0.9
55 Conserved cysteine-glycine protein 1 Bm1 38150 14972.m07327 108 0.15 3.5
56 Disorganized muscle protein 1 Bm1 40320 14972.m07771 68 0.16 xxx
57 Dosage compensation protein dpy-30 XXX XXX TC9176 64 0.19 xxx
58 G15-6A protein-related Bm1 49930 14990.m08112 TC8020 65 0.50 0.4
59 Hypothetical protein Bm1 06545 13257.m00082 39 0.04 xxx
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able to identify 80 B. malayi and 2 host proteins in BES (Table 1),
and a further 63 B. malayi proteins in BmA (Table 2). Of the 82 posi-
tively identiﬁed BES proteins, 38% (31/82) were also detected in
BmA. Thirty spots were subjected to individual LC–MS/MS analysis
and produced adequate spectra for database searching (Fig. 2C); of
these 23 were positively identiﬁed (Fig. 2D). All identiﬁed proteins
spots were also present in the LC–MS/MS analysis (Table 1). One
spot (19) corresponded to host serum albumin.
We also compared the relative abundance of proteins in BES
and BmA by their emPAI values (exponentially modiﬁed Protein
Abundance Index [33]). While this measure may not deﬁne the
absolute abundanceof differentproteins, it is ausefulmeansof esti-
mating abundance of the same protein in different mixtures. Such
analysis has been previously used to estimate changes in bacterial
protein expression during different growth conditions [34]. Hence,
wewere able to infer that the concentration of a number of proteins
differed substantially between BES and BmA, as graphically repre-
sented in Fig. 3. Speciﬁcally, phosphatidylethanolamine-binding
protein (PEB Bm1 41005, 20-fold enrichment in BES), leucyl ami-
nopeptidase (LAP, 18-fold), -glutamyltranspeptidase (14-fold)J.P. Hewitson et al. / Molecular & Bi
Table 2 (Continued )
Name Pub locus
60 Immunoglobulin I-set domain containing protein Bm1 3529
61 Thrombospondin type 1 domain containing protein Bm1 1394
62 TPR domain containing protein Bm1 4610
63 Tumor domain containing protein Bm1 5224
Pub locus is the stable gene ID, where the draft genome sequence includes the gene
index indicates an EST, and is given either when the genomic sequence appears tru
proteins detected in both BES and BmA (BES: BmA). Identities are from Brugia malay
searched against the NCBI database.
* Indicates single peptide hits.
tions (Alpha Innotech) and imaged using a FluorChem SP (Alpha
Innotech).
2.8. RT-PCR of N-acetylglucosaminyltransferase
Total RNA was extracted from adult mixed sex worms using
TRIzol (Invitrogen), and reverse transcribed with MMLV reverse
transcriptase (Stratagene) using standard protocols. GlcNAcT was
ampliﬁed using a forward primer speciﬁc for the 5′-end of the
gene coding sequence Bm1 07275 (ATGCGTTTACTGCCTCTCATT)
and a reverse primer speciﬁc for the 3′-end of EST TC7929
(TAGCACTCAAACATTGATATATT). An N-terminal extension to the
protein was predicted from an open-reading frame in the desi-
gnated non-coding sequence of Bm1 07275, and ampliﬁed using
the above reverse primer and the forward primer ATGAAACCT-
GAAATGTTCTCG. PCR conditions were as follows: 40 cycles of 95 ◦C
30 s, 60 ◦C 30 s, and 72 ◦C 2min. Reaction products were separated
on 1% agarose gels and visualised using ethidium bromide.
3. Results and discussion
3.1. Comparison of BES with whole worm extract (BmA)
The secretions of in vitro cultured adult B. malayiwere collected
under serum-free conditions using previously optimised protocols
[18]. Preliminary 1D SDS-PAGE analysis (Fig. 1) of several different
batches of concentrated BES revealed a general consistency, both
in protein concentration and composition, although minor diffe-
renceswere evident. Protein yields fromdifferent batches averaged
51±4g/L culture media, which is equivalent to ∼30ng per worm
per day. To address the question of whether adult B. malayi worms
selectively secrete a speciﬁc subset of proteins,we compared BES to
a solublewormhomogenate (BmA). 1Dgel electrophoresis revealed
that BES andBmAhaddistinct bandingpatterns (Fig. 1). 2Dgel elec-
trophoresis conﬁrmedthedifferingproteincompositionsof the two
parasite preparations (Fig. 2A and B), although visual inspection
reveals a number of common proteins. Importantly, 2D gel elec-
trophoresis shows that BES (comprising approximately 20 strongly
staining spots and 70+ additional molecular species) is markedly
less complex than BmA (in excess of 200 spots). This is consistent
with the adult parasites differentially secreting a deﬁned set of pro-
teins, and argues against the ES simply reﬂecting non-speciﬁc lea-
kage of proteins from the worms during the in vitro culture period.
To identify the proteins present in BES, selected spots were
picked from 2D gels and subjected to MALDI-ToF/ToF analysis
(Fig. 2C shows spots; Fig. 2D gives identities). Because 2D gel elec-
trophoresis does not favour the identiﬁcation of less abundant
protein species or thosewith extremes of pI, we performed shotgun
LC–MS/MS as a complementary approach, which allows the simul-
taneous identiﬁcation of multiple proteins in a complex mixture.
LC–MS/MS was also carried out on BmA to conﬁrm differences in
protein composition compared to BES, as suggested by 1D and 2D
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TIGR locus Gene index Score emPAI Ratio
14968.m01452 TC7669 145 0.51 0.5
14041.m00077 48 0.05 xxx
14980.m02740 49 0.18 xxx
14992.m11233 36 0.04 1.0
; XXX denotes gaps in the draft genome. TIGR locus is the original annotation. Gene
compared to an EST or is not present. Ratio refers to the ratio of emPAI values for
ng sequence database; no host proteins were detected in BmA when peptides were
gel electrophoresis (Figs. 1, 2A and B). By using LC–MS/MS,wewereFig. 1. One-dimensional SDS-PAGE of BES and BmA. Six independent batches of BES
were compared to BmA by 1D SDS-PAGE; each lanewas loadedwith 2g of protein.
Molecular weight markers are indicated on the left.
14 J.P. Hewitson et al. / Molecular & Biochemical Parasitology 160 (2008) 8–21Fig. 2. Two-dimensional SDS-PAGE of BES and BmA. (A) BES (20g) was separated by
SDS-PAGE electrophoresis. Molecular weight markers are indicated on the left. Gel is rep
2D SDS-PAGE as shown in (A), with identiﬁed proteins circled in black and numbered in a
(2a) could not be unequivocally identiﬁed although it was a weak match to MIF-1 (cf. spo
pep refers to the number of matching peptides identiﬁed. *Unique peptides from spot ma
overlap signiﬁcantly (data not shown) and so are likely to be the same protein. Score is der
GlcNAcT as detailed in Supplementary Fig. 1.
and N-acetylglucosaminyltransferase (11-fold) appear to be pre-
ferentially secreted proteins, given that they are substantially
over-represented in BES when compared to BmA. Furthermore,
several proteins that are highly represented in BES, as judged by
both 2D gel electrophoresis and emPAI (Fig. 2C and Table 1), such
as the galectin Bm1 24940 (spots 9 and 10) andmacrophagemigra-
tion inhibitory factor-1 (MIF-1) (spot 2)were at undetectable levels
in BmA using LC–MS/MS.
As might be expected, the majority of full-length parasite pro-
teins identiﬁed in BES (66%; 52/78) have some form of predicted
84isoelectric focusing on immobilized pH 3–10 gradients and by second dimension
resentative of six different batches of BES. (B) BmA (20g) separated as in (A). (C)
ccordance with Table 1, whereas non-identiﬁed spots are circled in blue. One spot
t 2). (D) Table of 23 spots identiﬁed from gel C. Score refers to the mascot score and
tched two different genomic sequences (13507.m000111 and 13929.m00009) that
ived from putative full-length consensus. **Score derived from putative full-length
signal sequence, either classicalN-terminal (33/78) ornon-classical
internal (19/78). However, the remaining 33% of proteins lacked
detectable signal sequences, including triose phosphate isomerase
(TPI), which is the most abundant protein in BES, as judged by 2D
gel spot intensity (Fig. 2C, spots 5–8), consistentwith its high emPAI
value (Table 1). It has been suggested that this is the result of signal
peptide prediction programs being optimised using mammalian,
rather than worm, proteins [25]. Alternatively, such proteins may
be released into BES as a result of holocrine secretion, whereby
the entire contents of a cell are released into the surroundings, as
ochemJ.P. Hewitson et al. / Molecular & Bi
has been previously described in S. mansoni [24]. Although holo-
crine secretion may be occurring to a certain extent, it cannot fully
explain the abundance of TPI in BES (17-fold enrichment compared
to BmA), given that the only other glycolytic enzyme detected in
BES, enolase, is not particularly preferentially secreted (1.28 emPAI
ratio BES:BmA). Additionally, abundant glycolytic enzymes, such
as GAPDH and aldolase, present in BmA at similar levels to TPI,
are undetectable in BES. TPI has been previously described in the
secretions of schistosome larvae [23,24] and eggs [25], as well as
adult H. contortus [3], indicating that it may play an important, as
yet undiscovered, role at the helminth–host interface. These results
also show it is inappropriate to use the lack of a detectable signal
sequence as a reason to exclude a parasite protein from potentially
fulﬁlling a role in the extracellular environment.
3.2. Abundant proteins in BES
The majority of BES comprises a relatively small number of
abundant proteins (Fig. 2A). Prominent amongst these is the galec-
tin Bm1 24940 (GAL-1), identiﬁed by both LC–MS/MS and 2D gel
electrophoresis (Table 1 and Fig. 2C, spots 9 and 10). A second less
abundant galectin (GAL-2; Bm1 46750) was also detected using
LC–MS/MS. Galectins are an extensive family of sugar-binding pro-
teinswithanafﬁnity forN-acetyllactosamines, throughaconserved
carbohydrate-recognition domain (CRD) [35]. Galectins have pre-
viously been identiﬁed in other helminths, with B. malayi GAL-1
being most similar to an O. volvulus galectin (AAA20541 [36]), and
GAL-2 to a H. contortus homologue (O44126 [37]) (Fig. 4A). Both B.
malayi galectins are tandem-repeat types, with duplicated CRDs;
in each case, the C-terminal CRD contains a full sugar-binding
consensus sequence [38], while N-terminal domains are divergent
(Fig. 4B).No functionhasyetbeenascribed toanyhelminthgalectin,
Fig. 4. Comparison of secreted B. malayi galectins with parasitic and human galectins. (A)
elegans are included for comparison. Values indicate % occurrence of relevant nodes. (B) S
(Hs) galectin 1 and 10 are included for comparison. Dark grey boxes indicate identity and
to interact with carbohydrate ligands [38]. Thick black lines indicate tryptic peptide frag
indicated.
85ical Parasitology 160 (2008) 8–21 15Fig. 3. Relative abundanceofproteins inBESandBmA.Bivariantplot of emPAI values
of proteins from BES and BmA. Proteins over-represented in either BES or BmA are
highlighted.
but it is interesting to note that a number of mammalian galectins
have the ability to inhibit both Th1 and Th2-mediated inﬂamma-
tion [39,40]. Moreover, the suppressive phenotype of regulatory T
cells is dependent on their preferential expression of galectins 1
and 10 [41,42].
The binding of mammalian galectins to their target gly-
coproteins is determined by the availability of their poly-
lactosamine ligands. In turn, this is regulated by the acti-
vity of Golgi-resident glycosyltransferases, such as core 2
-1,6-N-acetylglucosaminyltransferase (core 2 GnT) and -1,6-
N-acetylglucosaminyltransferase V (GnT V), which promote the
addition of polylactosamine to O- and N-linked glycans, respec-
tively [43]. These enzymes allow galectins to bind and cross-link
Phylogenetic tree of parasitic nematode galectins. Closely related galectins from C.
equence alignment of BES galectins with their closest identiﬁed homolog. Human
light grey boxes indicate similarity. Red circles indicate conserved residues known
ments for the B. malayi galectins. Each CRD (carbohydrate recognition domain) is
16 J.P. Hewitson et al. / Molecular & Biochemical Parasitology 160 (2008) 8–21Fig. 5. Detection of putative full-length N-acetylglucosaminyltransferase. (A) Expression
Left panel: ampliﬁcation using primers speciﬁc for the draft genome predicted N-terminus
TC7929 (R1). Right panel: ampliﬁcation of putative full-length GlcNAcT cDNA with prime
C. elegans GlcNAcT, and R1 as in left panel. PCR product size is indicated by DNA ladder o
(H41C03.3) and human core 2 GnT1. Dark grey boxes indicate identity and light grey bo
malayi protein.
cell surface proteins, creating galectin–glycoprotein lattices, which
can contribute to immune down-regulation by increasing the
signalling threshold required for T cell activation [44,45]. In this
regard, another abundant protein in BES was identiﬁed as N-
acetylglucosaminyltransferase (GlcNAcT; Fig. 2C, spot 20), with
different peptides assigned to either draft genome sequence
(Bm1 07275) or to an overlapping EST consensus (TC7929)
(Supplementary Fig. 1). We ﬁrst veriﬁed by RT-PCR that these
sequences corresponded to a single, longer gene (Fig. 5A). Inspec-
tion of upstream genome sequence indicated a further, N-terminal,
Fig. 6. Attachment of PC-residues to N-acetylglucosaminyltransferase. (A) 2D SDS-PAGE
blotted and probed with anti-PC Bp-1 monoclonal antibody. The PC-bearing spot was ide
were unable to identify the minor PC positive proteins (arrows).
86of the predicted GlcNAcT mRNA was conﬁrmed by RT-PCR of adult B. malayi cDNA.
of Bm1 07275 (F1) and the predicted C-terminal coding sequence of EST consensus
r F2, for upstream N-terminus based on homology between genomic sequence and
n the left. (B) Sequence alignment of B. malayi GlcNAcT with C. elegans homologue
xes indicate similarity. Red boxes indicate potential N-glycosylation sites of the B.
exon that was again conﬁrmed by RT-PCR (Fig. 5A), allowing us to
infer the complete sequence of B. malayi GlcNAcT (Supplementary
Fig. 1). The discrepancy between the calculated (54kDa) and obser-
ved size (∼98kDa) of this protein may be explained by substantial
post-translational modiﬁcations—the protein contains eight N-
glycosylation consensus motifs (N-X-S/T), and none of these
sequences were identiﬁed as tryptic peptides by MALDI-ToF/ToF,
consistent with their modiﬁcation (Fig. 5B and Supplementary
Fig. 1). The B. malayi GlcNAcT protein has signiﬁcant homology to
human core 2 GnT, as well as to a hypothetical protein from C. ele-
gel of BES (10g). Circles indicate GlcNAcT and LAP. (B) Duplicate of (A), Western
ntiﬁed as GlcNAcT (Fig. 2C). Representative of two independent batches of BES. We
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gans (Fig. 5B). As yet, it is not known whether B. malayi GlcNAcT is
capable of inducing protein glycosylation (and galectin binding) in
the extracellular milieu, given that glycosyltransferases are usually
functional in the Golgi. It is also possible that GlcNAcT may have
an alternative extracellular function, as had been demonstrated for
a secreted form of human GnT V, which can promote angiogenesis
[46].
The B. malayi homologue of Acanthocheilonema viteae ES-62,
LAP, was readily detectable in BES (Fig. 2C, spot 18). The anti-
inﬂammatory properties of ES-62 are well known [47], and are
dependent on its modiﬁcation with phosphorycholine (PC) side
chains [48]. Furthermore, the attachment of PC to B. malayi pro-
teins allows themtomodulate immunecells, demonstratedby their
inhibition of mitogen-dependent T cell proliferation [49]. To probe
LAP for PC side chains, we used the anti-PC monoclonal antibody
Bp-1 [31] on 2D Western blots of BES (Fig. 6A and B). Surprisin-
gly, we could ﬁnd no evidence for the attachment of PC to LAP.
Instead, we identiﬁed the most prominent PC-bearing species in
BES as the GlcNAcT described above. This is consistent with pre-
vious detection of a ∼90kDa PC-conjugated protein in BES [50].
We were unable to identify the less intense PC-bearing proteins of
45–55kDa by MALDI-ToF/ToF. It has previously been noted that B.
pahangi secretes3-fold less LAP thanA. viteaedoesofES-62 [51], and
our data indicate that in B. malayi, themajority of PC is coupled to a
different carrier protein than LAP. Further functional comparisons
between PC-conjugated proteins from the two species will doubt-
less yield extremely interesting results, and experiments designed
to assess the ability of BES tomodulate inﬂammatory diseases may
also be warranted.
Also prominent in BES are two proteins, -glutamyltrans-
peptidase (Fig. 2C, three isoforms, spots 14–16) and a protein desi-
gnated as “major allergen” (two isoforms, spots 11 and 12), that
are known to be targets for host IgE, either in experimental animal
models or human infection [52,53]. The function of “major aller-
gen” is unknown, although it has weak homology to two proteins
from C. elegans (ZC412.3 and T10G3.3).
3.3. Potential immune evasion proteins
B.malayi release anumberofproteinswhose functionappears to
directly interferewithhost effectormechanisms. Prominent among
these are several anti-oxidant proteins, which can detoxify the
potentially damaging reactive oxygen and nitrogen intermediates
produced by immune cells. Both the cytoplasmic and extracellu-
lar forms of superoxide dismutase were detected (Table 1; [54]).
The major cuticular protein of adult B. malayi, gp29 (glutathione
peroxidase; [55,56]), which may protect parasite lipids from reac-
tive oxygen attack [57], was also released. Additionally, thioredoxin
peroxidase 2 [58] was identiﬁed using LC–MS/MS. As well as the
above enzymes, two scavenger proteins are present in BES which
can act as an anti-oxidants in a non-enzymatic manner: transla-
tionally controlled tumour protein [59], and host albumin [60]. It
is unclear how host albumin comes to be associated with adult B.
malayi, although previous studies have detected it on the surface of
the microﬁlarial stage of other ﬁlarial parasites [61,62].
Another mechanism by which ﬁlarial parasites may dampen
the immune response is through the release of protease inhi-
bitors [63]. B. malayi encodes three cysteine-protease inhibitors,
cystatins (CPI-1, -2 and -3 [64]), and CPI-2 was identiﬁed in BES
through LC–MS/MS (Table 1). CPI-2 homologues are prominent
in the secretions of a range of ﬁlarial nematodes (reviewed in
Ref. [63]). Bm-CPI-2 can inhibit host proteases involved in antigen
processing and presentation, including the key enzyme aspara-
ginyl endopeptidase [65]. Two PEB proteins identiﬁed in BES by
LC–MS/MS (Table 1; Bm1 41005 and Bm1 31500) may represent
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additional protease inhibitors. Mouse PEB, to which the B. malayi
proteins share signiﬁcant sequence similarity (Supplementary Fig.
2), has been shown to be a novel type of serine protease inhibitor
[66]. However, it is not yet knownwhether the B.malayiproteins, or
homologues from other helminths (such as O. volvulus Ov-16 [67]
and Toxocara canis TES-26 [68]) share this inhibitory function.
B. malayi secrete three members of the immunophilin family
(Table 1), speciﬁcally two cyclophilins (CYP-2 (see also Fig. 2C,
spot 4) and CYP-5) and FKBP (FK506-Binding Protein)-12. Immu-
nophilins are characterised by peptidyl-propyl cis–trans isomerase
activity, and have roles in protein folding and as molecular cha-
perones [69]. It is unclear what, if any, role these proteins have
in parasite immune evasion, although secreted cyclophilins have
been identiﬁed in the ES of H. contortus [3],and schistosome larvae
and eggs [67]. Of note, a cyclophilin (CYP-18) from the protozoan
parasite Toxoplasma gondii is directly involved in host–parasite
crosstalk, as it can stimulate protective Th1 responses through its
binding to the chemokine receptor CCR5 [70].
A wide variety of pathogens, from viruses to helminths, are able
to subvert the host immune response through the production of
host cytokine mimics [71]. B. malayi produces two homologues of
macrophagemigration inhibitory factor (Bm-MIF-1 and -2) [72,73].
In our analysis, MIF-1 is readily detectable in BES through both
LC–MS/MS and 2D gel electrophoresis (Table 1 A and Fig. 2C, spot
2). It is known that MIF-2 is expressed at a lower level [73], and
so its release may be below our lower limit of detection. Simi-
larly, we have not detected the expression of homologues of host
TGF- (Bm-TGH1 and TGH-2), although secretion of the latter has
been reported [74]. TGF- familymembers are potent at extremely
low concentrations, and again may be present below our lower
detection threshold. There was also no evidence of secretion of
two recently assigned cytokine homologues, similar to IL-16 and
IL-17, which have recently been identiﬁed at the genomic level
[6].
3.4. Newly identiﬁed secretory proteins and unidentiﬁed proteins
Thebeneﬁt of applying aproteomic-based approach to the study
of BES is it can identify previously undiscovered secretory proteins.
In this respect, we have found that adult B. malayi secrete 11 mem-
bers of the transthyretin-like protein (TLP) family (Table 1). The B.
malayi draft genome reveals 15 TLP genes [6], of which 6 are detec-
ted in BES. The remaining ﬁve proteins (TC8116 – also identiﬁed as
spot 3, Fig. 2C – as well as TC7985, TC8258, TC7986, AA592049) are
tentative consensuses or ESTs from theB.malayi gene index project,
and have no match in the current draft version of the genome. TLP
are distantly related to both the classical transthyretin (TTR) and
transthyretin-related protein (TRP) families (Fig. 7) [75]. TTR is res-
ponsible for the transport of thyroid hormones, as well as vitamin
A and its derivative retinoic acid [76]. TLP are also secreted by the
cattle helminths Ostertagia ostertagi (AJ31875; [77]) and H. contor-
tus (BM139192, BM138829, BF423163 [3]), although their function
is currently unknown.
In addition to newly discovered secreted proteins with close
matches from other parasites, 7 ES products matched predicted
proteins in the draft genome with no known homologue. Three
closely related hypothetical proteins (Bm1 11505; Bm1 01245;
Bm1 09845) were identiﬁed, which are unusual in being compo-
sed of multiple homologous repeats of ∼70 amino acids, including
an acidic tract (QEEEEEEE), as well as being rich in serines and
threonines (Supplementary Fig. 3). Together these characteristics
support the assignation of mucin-like proteins in Table 1. Four
other hypothetical proteins were identiﬁed, of which two had
weak homology to entries from either C. elegans (Bm1 46475 to
KO1A11.1) or C. briggsae (Bm1 19065 to CBG09470).
18 J.P. Hewitson et al. / Molecular & BiochemFig. 7. Transthyretin-like proteins. Phylogenetic tree of TLP, TRP and TTR from B.
malayi (Bm), H. contortus (Hc), O. ostertagi (Oo), C. elegans (Ce) and mouse. Values
indicate % occurrence of relevant nodes.
As is normal with LC–MS/MS analysis, many peptide masses
could not be unequivocally assigned to an individual gene product.
However, we were surprised that 7 out of 30 spots from 2D analy-
sis also could not be matched, despite generating good spectra and
exhaustive searching of genomic and EST datasets (Fig. 2C, blue
Fig. 8. Recognition patterns of anti-BES IgG in B. malayi infected patients. (A) One of 4 rep
sera from non-exposed “naı¨ve” individuals. (C) Replicate, Western blotted and probed w
with sera from elephantiasis pathology patients. Immunogenic proteins are circled in (A)
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circles). Because the draft genome is estimated to be 90% complete,
it may be that these proteins corresponded to genes that have yet
to be identiﬁed at the genomic level. However, as sufﬁcient sample
quantities become available, de novo peptide sequence deduction
will be carried out, fromwhich experimental searching of genomic
DNA with degenerate primers may allow us to isolate the corres-
ponding gene sequences.B. malayi contains a rickettsial endosymbiont,Wolbachia (wBm),
which is essential for the survival and reproduction of the parasite
[78]. It has also been postulated that Wolbachia-derived products
may impact upon the host immune system. We therefore, speci-
ﬁcally searched for matches to the 1.1Mb genome of wBm [79],
but found none. Hence, in our system at least, Wolbachia proteins
are not strongly represented in the secretions of viable adult para-
sites. It is, of course, very likely that dying parasites would release
Wolbachia proteins, and the relative inﬂuence of parasite and endo-
symbiont products on host immunity remains to be determined.
3.5. Human sera recognition
To deﬁne which, if any, of the identiﬁed BES proteins were tar-
gets for immune recognition in human ﬁlarial infections, Western
blots were carried out using two pools of characterised sera from
Indonesian ﬁlariasis patients. We have previously reported on the
reactivity of individualmembers of these pools to extracts ofwhole
worm [32], which will measure immune responses to the totality
of somatic antigens, many of which are likely to be presented only
after parasite demise. Immunoreactivity toBES, however, is likely to
licate 2D gels of BES, silver stained. (B) Replicate, Western blotted and probed with
ith sera from microﬁlaraemic patients. (D) Replicate, Western blotted and probed
and are numbered as in Fig. 2C with identities in Table 1.
ochem
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reﬂect the immune response directed against live parasites. A parti-
cularly important question is whether clinical outcome can be cor-
related to the recognition of a particular antigen/group of antigens.
To begin to answer this question, we probed 2D blots of BES
with pooled sera from ﬁlariasis cases and control individuals. The
silver-stained replicate of BES proteins in this analysis is shown in
Fig. 8A, and no signiﬁcant reactivity was observed with sera from
uninfected UK residents (naı¨ve; Fig. 8B). However, asymptomatic
microﬁlaraemic (MF+; Fig. 8C) or elephantiasis (pathology; Fig. 8D)
serumpools both reactedwith a number of common proteins. Ove-
rall, it is clear that sera from elephantiasis patients bind a broader
spectrumof proteins than sera frommicroﬁlaraemic individuals. In
general, protein abundance and immunogenicity correlated poorly.
For instance, the most abundant protein in BES, TPI, was not a tar-
get for human sera (Fig. 8C and D). Instead, the most immunogenic
protein in both groups was identiﬁed as myotactin form B, which
is present as spots 21–23 (Figs. 2 and 8).
It is notable that myotactin B is represented by three distinct
spots of 70–90kDa on 2D gels. However, the predicted B. malayi
myotactin B gene (Bm1 53510) encodes a much larger protein of
285kDa. Analysis of the tryptic peptides generated by MALDI-
oF/ToF shows that the spots represent different regions of the
full-length myotactin B protein; spot 21 peptides corresponding
to amino acids 303–677, spot 22 to 983–1539, and spot 23 to
1020–1347 (Supplementary Fig. 4). This proﬁle is likely to reﬂect
proteolytic processing of the full-length protein, either directly
from the parasite or following its secretion, although alternative
splicing cannot be excluded. Another immunogenic protein (spot
17) was identiﬁed as lethal protein 805d. Both this protein and
myotactin B are related to C. elegans myotactin (also known as
lethal protein 805), a protein that links the contractile apparatus
of the worm to its hypodermis [80]. The signiﬁcance of this pro-
tein’s secretionbyB.malayi is unclear, although its immunogenicity
in infected patients is consistent with a role as a decoy for the
host immune response. Galectin Bm1 24940 was also an antibody
target in both groups of ﬁlariasis patients, although perhaps sur-
prisingly, it was recognised to a greater extent by (the generally
less immunoreactive) MF+ sera (Fig. 8C). This work paves the way
for future studies to analyse at the individual level the response
of different human antibody isotypes, particularly IgG4 and IgE, to
speciﬁc identiﬁed BES antigens.
4. ConclusionsThe secretome of the long-lived mammalian stage of a success-
ful parasite will encompass a spectrum of proteins required for
every facet of the parasitic life-style, from metabolism, reproduc-
tion, and modiﬁcation of the physiological environment, as well
as immune evasion. For some of the adult BES proteins we have
identiﬁed (such as the cystatin, CPI-2), a speciﬁc role in immune
modulation has already been established [63,65]. Our analysis
greatly extends thenumber of candidate immuneevasionproducts,
including a number of unexpected players, such as the galectins,N-
acetylglucosaminyltransferase, the transthyretin-like proteins, and
the phosphatidylethanolamine-binding proteins, each of which
fully warrant further investigation.
Many of the additional secreted proteins identiﬁed here, howe-
ver, have no obvious role in the host–parasite immune interaction.
It is likely that some act in other arenas, for example in aiding para-
site co-location and reproduction, but if so then they may serve
equally well as the target of an antibody-inducing vaccine aimed
at preventing transmission. Inevitably, some of the products desi-
gnated as ‘secretory’, may in fact simply be cellular proteins which
are sufﬁciently abundant and soluble to be released by live para-
[
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sites over time. Nevertheless, if such release occurs in vivo, then the
immunological consequences may be signiﬁcant, not only as host
innate immune receptors may have evolved to recognise these as
pathogen-associated molecular patterns, but also (as in the case of
ﬁlarial tropomyosin) because they may also be effective targets of
vaccine-induced immunity [81,82]. It will be interesting to test TPI
as a potential vaccine target in the same manner.
The analysis reported here has been limited in that quantities of
BES proteins were, in some instances, less than desired; and also
because both genomic and EST datasets offer incomplete cove-
rage. Currently the draft B. malayi genome covers around 90% of
coding regions (13 of 80, or 16%, of identities we report match
ESTs but not genomic data). As the sensitivity of mass spectrome-
try increases, and the scope of ﬁlarial database informationwidens,
additional BES proteinswill be identiﬁed. The identiﬁcation of indi-
vidual ES proteins will now facilitate discovery of complementary
host receptors, and host cell types, with which parasite products
may interact. In terms of the wider molecular biology of parasite
secretions, future work should also expand on our knowledge of
post-translational modiﬁcations, in particular glycosylations and
other side chains such as PC [48] and DMAE [83]. Attention should
be paid to the source of ES, perhaps using identiﬁed proteins as
markers (for example, wheremonoclonal antibodies are available),
looking particularly to distinguish dedicated secretory organs such
as the amphid glands, from the uterine contents of gravid females
whichmay be voided togetherwith newly releasedMF. Finally, and
perhaps most importantly, the study of ﬁlarial ES proteins should
encompass the immature stages, the blood-dwelling MF and the
infective L3 stage, to complete our understanding of the B. malayi
secretome.
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doi:10.1016/j.jprot.2011.06.002A B S T R A C TAvailable online 29 June 2011 The intestinal helminth parasite, Heligmosomoides polygyrus bakeri offers a tractable
experimental model for human hookworm infections such as Ancylostoma duodenale and
veterinary parasites such as Haemonchus contortus. Parasite excretory–secretory (ES) products
represent the major focus for immunological and biochemical analyses, and contain
immunomodulatory molecules responsible for nematode immune evasion. In a proteomic
analysis of adult H. polygyrus secretions (termed HES) matched to an extensive transcriptomic
dataset,we identified374HESproteinsbyLC–MS/MS,whichweredistinct fromthose insomatic
extract HEx, comprising 446 identified proteins, confirming selective export of ES proteins. The
predominant secreted protein families were proteases (astacins and other metalloproteases,
aspartic, cysteine and serine-type proteases), lysozymes, apyrases and acetylcholinesterases.
Themost abundant products weremembers of the highly divergent venom allergen-like (VAL)
family, related toAncylostoma secreted protein (ASP); 25 homologueswere identified, withVAL-
1 and -2 also shown to be associatedwith the parasite surface. The dominance of VAL proteins
is similar to profiles reported for Ancylostoma and Haemonchus ES products. Overall, this study
shows that the secretions of H. polygyrus closely parallel those of clinically important GI
nematodes, confirming the value of this parasite as a model of helminth infection.
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Infection with intestinal nematode parasites such as hook-
worm, whipworm and Ascaris remains an enormous global
health problem, with over 25% of the world's populationology and Infection Resea
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95infected [1]. Moreover, similar pathogens account for major
morbidity and economic loss among livestock in temperate
climates [2]. The high prevalence and longevity of these
parasites in immunocompetent hosts reflects a sophisticated
array of mechanisms to modulate, disrupt and divert the hostrch, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT,
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ular mediators of parasite immunomodulation is still at an
early stage [5–7]. For these reasons, the recent expansion in
genomic [8–11], transcriptomic [12–21] and proteomic [22–30]
analyses of parasitic nematodes provides an exciting platform
for new discoveries.
A major theme in helminth research is the analysis of
products released by live parasites which are likely to fulfil the
many biological imperatives faced by a pathogen, including
invasion of the host, creation of a suitable niche, and evasion of
host immunity. These molecules, termed excretory–secretory
(ES) products, have been the particular target of proteomic
studies aimed at characterising the “secretome” of the major
human [25–27] and veterinary [22,23,28–30] parasites. In addi-
tion, many prominent individual ES proteins have been
identified, most notably members of a large multi-gene
Venom Allergen-Like (VAL) family [28,31,32], first characterised
in ES of the canine nematode Ancylostoma caninum and named
Ancylostoma Secreted Protein (ASP) [33]. Members of this gene
family include effective vaccine molecules in experimental
models [34], indicating also the potential for ES proteins as new
immunoprophylactics against helminth infections in man and
animals.
Because themajorhuman intestinal helminthspecies donot
normally infect laboratory animals,model systemswithnatural
rodent nematode parasites are invaluable in gaining insights
into the factors regulating infection and immunity. Themurine
intestinal nematode parasite, Heligmosomoides polygyrus, pro-
vides a widely studied system [35], and much is now known of
the immunology of infection and the immune components
which combine to protect the host [36–40]. Parasite-infected
mice feature multiple levels of immunosuppression, including
amelioration of allergy [41,42], autoimmunediabetes [43,44] and
colitis [45–48]. At least part of the immunosuppression can be
accounted for by expanded regulatory T cell activity [42,49–51]
and suppressive B cell populations [52] in infected mice, which
are also able to transfer immunosuppression to uninfected
recipients [42,52].
Significantly, the immunomodulatory effects of live H.
polygyrus infection can be reproducedwith the soluble products
(HES) collected from adult parasites cultivated in vitro. HES
converts naivemurineT cells into suppressive regulatory T cells
[53], interferes with the ability of dendritic cells to stimulate
effector T cells and suppresses antibody responses to unrelated
antigens [54], and can prevent the development of airway
allergy in mice (O'Gorman, McSorley et al., manuscript in
preparation). Hence the nature of the HES products is of intense
interest for potential novel immunomodulators that might be
exploited in therapyof allergyandautoimmunity.Morebroadly,
intestinal nematodes co-habit a complex ecosystem with
commensal microbes, and bacterial–parasite interactions are
also likely to be important in the establishment of a long term
nematode infection [55].
Despite the sophistication of the cellular immune analyses
of H. polygyrus infection, few molecular products from this
parasite have yet been described [24,56–60]. Indeed, genomic
and transcriptomic datasets are only now being developed for
this organism (Harcus et al., manuscripts in preparation).
Taking a proteomic approach, we have identified the majority
of proteins secreted by adult H. polygyrus, and show that there96is a predominance of VAL/ASP-like products, which demon-
strates that the overall composition and functional profile of
HES closely parallels those of Ancylostoma and Haemonchus
parasites. These results pave the way to use the mouse model
for more precise determination of the role of many individual
proteins in the biological processes of infection, intestinal
establishment, andmanipulation of thehost immune response.2. Materials and methods
2.1. Parasites and HES
The original stock of H. polygyrus bakeri used in these studies
was kindly supplied to us by Professor JM Behnke, University of
Nottingham,UK. The life cycle ofH. polygyruswasmaintained in
CBAxC57BL/6F1 mice infected with 500 infective larvae by
gavage, and adult worms were recovered 14 days later. Adult
worms were washed extensively before incubation in serum-
freeRPMI1640mediumsupplementedwith1%glucose, 100 U/ml
penicillin, 100 μg/ml streptomycin, 2 mM L-glutamine, and
100 μg/ml gentamicin (Gibco). Culture supernatants were recov-
ered at 3–4 day intervals and replaced each time with fresh
mediumover a 3 weekperiod.Worms remained viable through-
out this time frame. Pooled supernatants were diafiltrated into
PBS over a 3000 MWCO Amicon membrane, and the resultant
HES (H. polygyrus excretory/secretory products) material stored
at −80 °C [59]. The profile of proteins released each week did not
differ significantly (Supplementary Fig. A1). Soluble somatic
extracts of adultworms (H. polygyrus extract; HEx)were prepared
by homogenisation in a ground-glass hand-held homogeniser
(VWR-Jencons, UK) in ice-cold PBS, followed by centrifugation at
13,000 g for 30 min, from which the supernatant was collected
and stored at −80 °C until use.
2.2. 2-D gel electrophoresis and spot identification
HES andHEx (25 μg per gel) were separated and silver stained as
previously described [25], then scanned with a Linoscan 1450
(Heidelberg). Protein spots of interest were prepared for mass
spectrometry analysis as before [25], and positive-ion MALDI
mass spectra were obtained using a Bruker ultraflex III in
reflectronmode, equippedwith aNd:YAG smart beam laser. MS
spectra were acquired over a mass range of m/z 800–4000, and
monoisotopic masses were obtained using a SNAP averaging
algorithm.The tenstrongest peaksof interest,withaS/Ngreater
than 30, were selected for MS/MS fragmentation in LIFT mode.
Bruker flexAnalysis software (version 3.3) was used to perform
the spectral processing and peak list generation for both theMS
and MS/MS spectra.
2.3. LC–MS/MS
Tryptic HES peptides were prepared essentially as before [25]
and then loaded onto a nanoAcquity UPLC system equipped
with a nanoAcquity Symmetry C18, 5 μm trap (180 μm×20 mm)
and a nanoAcquity BEH130 1.7 μm C18 capillary column
(75 μm×250 mm; all Waters). The trap was washed for 5 min
with 0.1% (v/v) formic acid at 10 μL/min. Subsequently, flow
1575J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 1 5 7 3 – 1 5 9 4was switched to the capillary column, and peptides were
separated by gradient elution (Solvent A=0.1% (v/v) formic
acid; Solvent B=acetonitrile with 0.1% (v/v) formic acid; Initial
gradient conditions 5% solvent B (2 min), then a linear gradient
to 35% solvent B over 120 min, followed by a linear gradient to
50% solvent B over 5 min, and finally wash with 95% solvent B
for 10 min. Flow rate was 300 nL/min and column temperature
was 60 °C). The nanoLC system was interfaced with a maXis
UHR-TOF mass spectrometer (Bruker Daltonics) with a nano-
electrospray source fitted with a steel emitter needle (180 μm
O.D.×30 μm I.D.; Proxeon). Instrument control, data acquisi-
tion and processing were performed using Compass 1.3 SR3
software (microTOF control, Hystar and DataAnalysis; Bruker
Daltonics). Positive ESI–MS & MS/MS spectra were acquired
using AutoMSMS mode. Instrument settings were: ion spray
voltage: 1500 V, dry gas: 6 L/min, dry gas temperature 160 °C,
ion acquisition range: m/z 50–2200. AutoMSMS settings were:
MS: 0.5 s (acquisition of survey spectrum), MS/MS (CID with N2
as collision gas): ion acquisition range: m/z 300–1500, 5
precursor ions, absolute threshold 1000 counts, acquisition
time: 0.1 s for precursor intensities ≥100,000 counts increasing
linearly to 1 s for precursor intensitities of 1000 counts,
collision energy and isolation width settings were calculated
automatically using the AutoMSMS fragmentation table,
preferred charge states: 2–4, singly charged ions excluded,
one fragmentation spectrum was acquired for each precursor
and former target ions were excluded for 30 s.
2.4. Database searching and bioinformatics
Tandemmass spectral data were submitted to database search-
ing using a locally-running copy of the Mascot program (Matrix
Science Ltd., version 2.1), through the Bruker ProteinScape
interface (version 2.1). Search parameters required trypsin
specificity, the carbamidomethylation of cysteine, allowed a
maximum of one missed cleavage, and the possible oxidation of
methionine. Spectrawere searched against an in-house database
composed of >460,000 cDNA sequences from both normalised
and non-normalised libraries made from adult worm mRNA
(Harcuset al.,manuscript inpreparation; http://www.nematodes.
org/nembase4/overview.shtml). Thedatabasewas supplemented
with existing NCBI depositions for H. polygyrus. Sequencing was
performed on a Roche 454 instrument yielding reads of ~200 nt,
and assembled into isotigs each representing a distinct transcript
using Newbler 2.5. For gel spot identifications a peptide tolerance
of250 ppmandMS/MStoleranceof0.5 Dawereemployed. ForLC–
MS/MSMascot searches, MudPit scoring was usedwith a peptide
tolerance of 10 ppm and MS/MS tolerance of 0.1 Da. The
significance threshold was set at p<0.05, and hits weremanually
inspected for the presence of open reading frames. All LC–MS/MS
data were filtered to only accept peptides with expect values
<0.05, and single peptide hits were further filtered requiring
expect values <0.01.All proteinmatcheswere required to contain
at least one unique peptide sequence notmatched in any higher
ranked proteins. The LC–MS/MS data were also searched against
a Mascot generated decoy database, containing a random set of
sequences with the same average amino acid composition and
sequence length as the target database. Comparison of the
numberof sequences identified in the target anddecoydatabases
estimated a false discovery rate of 2.01% HES and 2.94% for HEx97for peptidematches above identity threshold. Spectrawere also
searched against Swiss-Prot to identify potential murine or
bacterial proteins present in HES and HEx. Here the false
discovery rate was higher (33.1% for HES and 6.92% for HEx),
likely reflecting the paucity of H. polygyrus sequences in the
database, and their low level of sequence identity with other
species. The exponentially Modified Protein Abundance Index
(emPAI) for each identification was calculated according to the
ratio of observed and observable peptides for each protein.
Identified protein sequences were subject to analysis by
SignalP3.0 to ascertain presence of predicted signal peptide [61].
In some instances, protein sequences were judged to be
truncated, by the absence of a start methionine and/or by
homology to known protein sequences from other organisms.
Proteins and conserved domains were identified by BLAST, and
gene ontology (GO) categories determined with Interproscan
version 31.0 (http://www.ebi.ac.uk/Tools/pfa/ iprscan/). Protein
sequences lacking conserved domains, but with significant
similarity (BLAST score >40) to nematode proteins were labelled
conserved nematode proteins (CSN=Conserved Secreted, No
signal peptide; CSP=Conserved Secreted with signal-Peptide;
CXN=Conserved eXtract, No signal peptide; CXP=Conserved
eXtract with signal-Peptide). Novel sequences (BLAST score <40)
were labelled NSN, NSP, NXN and NSP as described above.
ClustalWsequencealignmentswereperformedusingMacVector
version 11.1.1. To identify potentialN- andO-glycosylation sites,
NetNGlyc 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc/) and
NetOGlyc 3.1 (http://www.cbs.dtu.dk/services/NetOGlyc/) were
used respectively. Accession numbers given for nucleotide and
protein sequences are those deposited with ENA or NCBI.
2.5. Antibody generation and Western blotting
HES (1 μg) was separated by 2-D gel electrophoresis as described
above, blotted as before [25], and then blocked in 5% skimmed
milk powder (Marvel)-TBSwith 0.05% Tween 20 (TBST) for 2 h at
room temperature. Polyclonal antibodies to Hp-VAL-1, -2 and -4
weregenerated to6-His-taggedrecombinantproteinsexpressed
in pET21 (Novagen)-transformed E. coli, solubilised in 8 M urea
and purified by metal chelating chromatography under the
samechaotropic conditions; ratswere immunisedwith 100 μg of
recombinant proteinco-precipitatedwithalum, boostedondays
28 and 35 with 100 μg protein in alum, and serum collected on
day 42. To assess binding to HES, membranes were probed with
1/1000 sera dilutions in block solution overnight at 4 °C, washed
extensively in TBST, and then with 1/2000 rabbit anti-rat Ig (1 h
room temperature; DakoCytomation). Following further wash-
ing in TBST, blots were developed using ChemiGlow West,
according to the manufacturer's instructions (Alpha Innotech)
and imaged using a FluorChem SP (Alpha Innotech).
2.6. Surface radio-iodination, immunoprecipitation and
surface staining
Adult H. polygyrus were surface radio-labelled as described in
earlier publications [62] but using Pierce Iodination Reagent
(Iodogen) as the catalyst for generating nascent iodine [63].
Eppendorf tubes (1.5 ml) were coated with 200 μl of a 1 mg/ml
solution of Iodination reagent (Pierce) in chloroform, dried,
washed with PBS, before transfer of approximately 500 adult
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was incubated with frequent agitation for 10 min, quenched
by the addition of a saturated solution of L-tyrosine (Sigma),
and surface radio-labelled parasite material produced as for
HEx as described above, except that parasites were homo-
genised in PBS containing 1.5% nOGdetergent and 1% protease
inhibitor cocktail (Sigma P8340). Surface labelled parasite
proteins were then separated by 2-D gel electrophoresis as
above, and then dried and autoradiographed as before [62].
Immunoprecipitates were performed following pre-clearing of
radiolabelled parasite extract with Protein G agarose beads
(Millipore, 16–266) in the presence of MOPC 31 C IgG1 isotype
control (for mouse anti-VAL monoclonal antibodies) or naïve
rat serum (for rat anti-VAL polyclonal serum) for 30 min at
room temperature. Unbound parasite material was then
incubated with 2 μg of mAb to VAL-1 (clone 3–36), VAL-2
(clone 4-S4), VAL-4 (clone 2–11) or MOPC 31 control IgG1 in
non-denaturing IP buffer (20 mM Tris pH 8, 150 mM NaCl,
1 mM EDTA, 10% glycerol, 1% Triton-X100) for 2 h, then with
Protein G agarose beads overnight, at 4 °C with rotation.
The production and specificity of anti-VAL mAb from the
spleens of infected mice is to be described elsewhere [64].
Alternatively, 5 μl polyclonal anti-VAL-1, 2, 4 rat sera ornaïve rat
sera was used. Beads were washed 5×5 min in IP buffer, and
bound proteins eluted by boiling in NuPAGE LDS sample buffer
(Invitrogen)/0.5 M 2-mercaptoethanol, before separation on 1-D
SDS-PAGE and autoradio graphas before [64]. For sections, adult
H. polygyrus worms were snap-frozen on dry ice in Cryo-M-Bed
mountant (Bright Instruments), cryostat sections (5 μm;Leica) cut
onto Polysine™ slides (VWR), dried and then fixed in 100%
acetone for 10min. Sections were washed twice with PBS for
10 min, and then incubatedwith themousemAbdescribedabove
(50 μg/mL in 1% FCS/PBS) for 2 h at room temperature, washed
twice in PBS as before, and then incubated with secondary anti-
mouse Ig TRITC (1/100 in PBS) for 1 h at room temperature.
Sections were washed extensively and then mounted in anti-
fadeVectashieldmountant (Vector Labs), before imagingwith an
Olympus fluorescent microscope.3. Results
3.1. Mass spectrometric identification of HES proteins
from 2D PAGE gels
H. polygyrus adult excretory–secretory (HES) products were
collected from parasites cultured in serum-free medium and
concentrated over a 3000 MW cut-off membrane. To determine
the identity of HES proteins, we used both 2-dimensional gel
electrophoresis (2DGE) and ‘shotgun’ proteomics approaches.
HES contained over 100 discernable polypeptides when ana-
lysed by silver staining of 2DGE (Fig. 1A), in a pattern clearly
distinct from that ofH. polygyrus somatic soluble protein extract
(HEx, Fig. 1B). Analysis of 53 of the spots visible by 2DGE of HES
(Fig. 1C) provided identities when matched against an in-
house transcriptomic database of adult H. polygyrus mRNA
(composed of 466,844 Roche 454 sequence reads, Harcus et al.,
manuscript in preparation). Additional spots were examined
but did not provide sufficient material for MS identification
(data not shown).98The most abundant products, as judged by intensity of
silver staining,were found to bemembers of the VAL/ASP gene
family (e.g. spots 4–9, 20–25, 35, 38–40), as well as apyrases,
lysozymes, myoglobins and proteases. Table 1 summarises
the full list of parasite proteins identified in this manner,
which also includes a galectin, vitellogenin, chitinase, enolase
and two novel gene sequences. We also observed that some
proteins were present in multiple spots (e.g. variants of VAL-1
and VAL-2 were present in spots 20–24 and 5–9, respectively,
and apyrase-2 in spots 31–33). Consistent with this, a
polyclonal rat serum generated against recombinant VAL-1.1
recognised a chain of at least 8 spots by Western blot (Fig. 1D).
Although several secreted HES proteins show micro-variation
at the amino acid level (see below), this does not fully account
for the observed differences in pI, as the same variant may be
present in several different spots (e.g. VAL-1.2 is present in
spots 21–24), and conversely more than one sequence variant
was often seen in the same spot (see Table 1 and Supplemen-
tary Fig. A2), as the amino acid polymorphisms identified do
not lead to large changes in predicted pI (data not shown).
3.2. Mass spectrometric identification by LC–MS/MS
For a more exhaustive analysis of HES components, we
employed LC–MS/MS on a total of 40 μg of HES, resulting in the
identification of a total of 374 secreted HES proteins; 100 of the
most abundant (as ranked by Mascot score) are presented in
Table 2, with the full listing given in Supplementary Table A1.
Among theHES proteins identifiedwere a selection of proteases,
particularlymetalloproteases (zincmetalloproteases and a large
number of astacins), cysteine proteases (cathepsin B, legumain
and necpain), aspartyl proteases (necepsin), and various serine
proteases (cathepsin A, dipeptidyl peptidase four, serine car-
boxypeptidases and trypsin family proteins). Several other
classes of enzymes were abundantly secreted, including rela-
tively high levels of acetylcholinesterases, apyrases, chitinases
and lysozymes. Protease inhibitors (cystatins, Kunitz inhibitors
and serpins), transthyretin-related (TTR) proteins, chondroitin
proteoglycans, and lectins (both C-type lectins and galectins)
were also detected, as were a large number of proteins of
unknown function with homologues in other nematodes (con-
servednematodeproteins) andnovel proteins as yet unidentified
in other helminths. In addition, as discussed further below, no
fewer than 25 distinct VAL proteins were identified. Most of the
abundant proteins had been localised by 2DGE to specific spots,
as indicatedwhereappropriate inTable2. SearchingofLC–MS/MS
dataagainstSwiss-Prot revealed thatHEScontained twodifferent
Ig kappa light chains (accession numbers P01654 andP01837) and
a single IgG1 heavy chain (P01869). No significant matches were
found to any bacterial protein sequences. We confirmed the
presence of trace amounts of host immunoglobulin by ELISA,
which showed that 1 μg of HES contains 0.135±0.010 ng murine
IgG1 (datanot shown). It is likely that thisantibody isboundto the
adult worm in vivo, and subsequently dissociates from the
parasite during the in vitro culture period. No murine proteins
were detected in HEx.
In parallel, the soluble somatic protein extract (HEx) of the
worm was analysed, yielding 446 identities thereby greatly
extending analysis beyond previously available information
Fig. 1 – 2-Dimensional analysis of H. polygyrus secreted proteins (HES) and soluble somatic extract (HEx). A. HES silver stain.
B. HEx silver stain. Note that themajor spots of 15–18 kDa have previously been identified asmyoglobins [24]. C. HES annotated
with spots analysed by MS/MS as presented in Table 1. D. Anti-VAL-1 rat polyclonal antibody on Western blot.
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Mascot score) and a full listing is given in Supplementary
Table A2. Complete mass spectrometric data for HES and HEx
are presented in Supplementary Tables A3 and A4 respectively.
In contrast to HES, many of the HEx products were ribosomal
proteins and protein synthesis factors, as well as cytoskeletal
components (actin, tropomyosin and tubulin) and also cytosolic99enzymes involved in glycolysis, lipid binding and redox re-
actions. GO annotation of HES and HEx (Fig. 2 and Supplemen-
tary Table A5) indicated that translation (GO:0006412) was the
most common “biological process” term for HEx, and struc-
tural component of ribosome (GO:0003735) was the most
common “molecular function”, indicative of the large number
of ribosomal proteins present. In contrast, proteolysis
Table 1 – Proteins identified in HES from spots.
Spot Identity Domain Hpb adult database Score Peptides Accession No
1 VAL-3.1 Double SCP isotig05790 64 2 JF914909
2 MEP-1 Zinc metalloprotease Peptidase M13 isotig02967 144 5 (truncated)
3 CHI-1 Chitinase Chitinase GH19 isotig04840 268 3 HE573246
4 VAL-3.1 Double SCP isotig05790 462 6 JF914909
5 VAL-2.1/2.2/2.3 (a) Double SCP isotig03106 43 1 JF914906
6 VAL-2.1/2.2/2.3 (a) Double SCP isotig03106 266 7 JF914906
7 VAL-2.1/2.2/2.3 (a) Double SCP isotig03106 206 6 JF914906
8 VAL-2.1/2.2/2.3 (a) Double SCP isotig03106 32 1 JF914906
9 VAL-2.1/2.2/2.3 (a) Double SCP isotig03106 429 7 JF914906
10 VAL-5 Double SCP isotig04839 186 8 JF914911
11 VAL-5 Double SCP isotig04839 146 10 JF914911
12 VAL-5 Double SCP isotig04839 132 8 JF914911
13 VAL-5 Double SCP isotig04839 145 5 JF914911
14 VAL-5 Double SCP isotig04839 169 7 JF914911
15 VAL-5 Double SCP isotig04839 121 4 JF914911
16 VAL-9 Double SCP isotig05765 495 10 JF914917
17 ACE-1 Acetylcholinesterase Esterase lipase isotig05694 21 1 JF439067
18 ACE-1 Acetylcholinesterase Esterase lipase isotig05694 32 2 JF439067
19 ACE-1 Acetylcholinesterase Esterase lipase isotig05694 53 2 JF439067
20 VAL-1.1 Double SCP isotig06320 16 1 JF914902
21A VAL-1.2 Double SCP isotig03069 43 1 JF914903
21B VAL-1.4 Double SCP isotig01653 38 1 JF914905
22A VAL-1.2 Double SCP isotig03069 129 4 JF914903
22B VAL-1.1 Double SCP isotig06320 103 4 JF914902
22 C VAL-1.4 Double SCP isotig01653 70 2 JF914905
23A VAL-1.2 Double SCP isotig03069 419 5 JF914903
23B VAL-1.1 Double SCP isotig06320 402 5 JF914902
24A VAL-1.1 Double SCP isotig06320 613 6 JF914902
24B VAL-1.2 Double SCP isotig03069 385 5 JF914903
25 VAL-6 Double SCP isotig03505 401 4 JF914912
26 Enolase (b) Enolase isotig06965 103 3 (truncated)
27 VAL-8.1 Double SCP isotig02308 257 6 JF914916
28 MEP-3 Zinc metalloprotease Peptidase M13 isotig05155 177 3 (truncated)
29 APY-1.1 Apyrase Apyrase isotig02250 68 3 JF721961
30 APY-3 Apyrase Apyrase isotig03589 188 5 JF721966
31 APY-2 Apyrase Apyrase isotig07051 213 6 JF721965
32 APY-2 Apyrase Apyrase isotig07051 323 3 JF721965
33 APY-2 Apyrase Apyrase isotig07051 185 5 JF721965
34 PHP-1, PHA-domain protein PHA02954 isotig03547 180 4 HE573241
35 VAL-4 Single SCP isotig10387 127 3 JF914910
36A LYS-1 Lysozyme Muramidase GH25 isotig08802 411 6 HE573247
36B LYS-3 Lysozyme Muramidase GH25 isotig08606 126 3 HE573249
37A LYS-1 Lysozyme Muramidase GH25 isotig08802 483 6 HE573247
37B LYS-3 Lysozyme Muramidase GH25 isotig08606 170 3 HE573249
38A VAL-7.3 Single SCP isotig02284 94 3 JF914915
38B VAL-7.2 Single SCP isotig01525 61 2 JF914914
39 VAL-7.2 Single SCP isotig01525 48 1 JF914914
40 VAL-7.1 Single SCP isotig01524 296 6 JF914913
41 NAS-1.1/1.2 Nematode Astacin (c) ZnMc astacin-like isotig04178 280 4 (truncated)
42 NAS-3.3 Nematode Astacin (d) ZnMc astacin-like isotig01791 141 2 (truncated)
43 Galectin Double GLECT isotig09082 219 4 (truncated)
44 VAL-10 Single SCP isotig04979 27 1 JF914918
45 LYS-2 Lysozyme Muramidase GH25 isotig05074 220 4 HE573248
46 LYS-2 Lysozyme Muramidase GH25 isotig05074 179 3 HE573248
47 Vitellogenin VWD contig00471 64 2 (truncated)
48 NSP-4 Novel Secreted Protein None isotig11873 60 1 HE573242
49 NSP-16 Novel Secreted Protein None isotig05257 39 2 HE573243
50 Myoglobin Globin isotig04274 64 1 HE573244
51 Myoglobin Globin isotig04274 125 3 HE573244
52 Myoglobin Globin isotig04274 94 3 HE573244
53 TTR-1 Transthyretin-related DUF290 isotig04612 452 6 HE573245
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were the most common biological process and molecular
function terms for HES. It is important to note that a greater
number of proteins in HES compared to HEx failed to match GO
terms (molecular function 54.8% HES Vs 23.5% HEx; biological
process 68.7%HESVs 41.3%HEx), consistentwith the specialised
nature of the parasite secretions unique to its intestinal niche,
and in contrast to the somatic extract which is generally
composed of proteins common to most eukaryotic organisms.
3.3. Comparison of proteins in HES and HEx reveals
preferentially secreted proteins
Only 104 of 374 (27.8%) HES proteins were detectable in HEx
(Table4). Themostabundantof these “somatic”proteinspresent
inHESwere themyoglobins and vitellogenins, both ofwhich are
extremely highly expressed by adult worms, the former
representing the dominant species on 2D profiles (Fig. 1B).
Hence, while the secreted components in HES in general
represent a selective subset of the whole worm proteome,
abundant somatic constituents such as myoglobin are also
found in the in vitro parasite culture medium. In this regard it is
noteworthy that both myoglobin and vitellogenin contain N-
terminal signal sequences. It is also possible that as core egg
proteins, vitellogenins diffuse from the eggs released by adult
females during in vitro culture, or are present in intrauterine
contents that accompany egg release. Comparison of exponen-
tially modified Protein Abundance Index (emPAI) values for the
104 proteins common to HES and HEx indicated that there were
large differences in the level of certain proteins between the two
parasite preparations (e.g.VAL-1 andVAL-2 variantswere highly
abundant in HES and detected at only trace amounts in HEx;
Table 4). This is not unexpected given that parasite secretions
originate from the worm itself.
3.4. HES and HEx components differ significantly in
proportion of predicted signal peptide sequences and in extent of
novel gene products
Of the 374 HES proteins identified, 291 (77.8%) contained a
predicted N-terminal signal peptide (Fig. 3). In addition, 100
(26.7%) did not correspond to any annotated gene in the NCBI
database, and of these 70 (18.7%) were novel proteins with no
database match. The remaining 30 sequences matched
predicted or hypothetical proteins of unknown function
from C. elegans or other nematodes, and were classified as
conserved nematode proteins. When these 100 secreted
proteins of unknown functionwere examined for the presence
of a potential signal peptide, approximately 85% of each (60/70
novel, 25/30 conserved) were signal peptide-positive, indi-
cating that an important set of novel secreted proteins areNotes to Table 1
Accession numbers from NCBI GenBank or European Nucleotide Archive
(a) Peptides are common to all three variants of VAL-2; isotig and Access
VAL-2.2 and -2.3 are isotig07425/JF914907 and isotig03105/JF914908.
(b) 1 additional peptide matches isotig18996 coding for N-terminal segm
(c) Peptides are common to NAS-1.1 and -1.2; latter is isotig04179.
(d) Two additional peptide matches to each of variants NAS 3.1 (isotig01
101present in HES. The novel proteins in particular were mostly
<150 amino acids, with an average predicted molecular
weight of 16.5 kDa (range 5.4–55.5 kDa). In contrast to HES,
only 25.1% (112/446) of proteins identified in HEx encoded
signal peptides, and HEx also contained noticeably fewer
proteins of unknown function, with only 15 conserved
nematode proteins (of which 4 were also detected in HES)
and 9 novel proteins (4 detected in HES).
3.5. VAL proteins are associated with the parasite surface
In parallel with HES analysis, we also investigated the adult
parasite surface proteins accessible to radio-iodination of live
worms. When surface iodination was employed, solubilised
proteins were analysed by 2D gel electrophoresis and autora-
diography, and showed mobilities similar to VAL-1 and -2
(compare Fig. 4A with Fig. 1C) which could be specifically
immunoprecipitated with monoclonal and polyclonal anti-
bodies specific for VAL-1 and VAL-2 (Fig. 4B), indicating that
both VAL-1 and VAL-2, highly enriched in HES, are present on
the surface of the adult worm. In contrast, we did not detect
surface expression of the similarly abundantly secretedVAL-4.
The distribution of VAL-1 and -2 was then investigated using
monoclonal antibodies specific for each protein [64] to stain
frozen sections of adult worms (Fig. 4C–F). Both antibodies gave a
highly restricted punctate pattern of labelling the body wall, in a
series of structures at contralateral sites that may represent
longitudinal neuronal fibres or secretory tissues. Interestingly, in
A. caninum, different VAL (ASP) products showed distinct
localization patterns, with anti-Ac-ASP-4 staining the cuticle of
adult worms, while antibodies to ASP-3 and -6 bind to glandular
structures, and anti-ASP-5 to the gut, yet all four proteins are also
found in adult worm ES [65].
3.6. Sequence analysis of the H. polygyrus VAL gene family
The most striking characteristic of HES is the predominance of
members of the VAL gene family, both in terms of the
abundance of certain members, particularly VAL-1, 2, 3, 4 and
7, as well as the large number (25) of different VAL proteins
detected. VAL proteins show a conserved overall structure built
around the SCP modular domain of ~200 amino acids (sperm-
coating protein; pfam accession PF00188), typically containing 5
disulphide bonds. Members of this gene family generally
contain either a single SCP domain, or two tandem domains,
which are not necessarily closely related to each other in
sequence. Fig. 5 shows a schematic of the 25 secreted VAL
proteins of adult H. polygyrus, including 21 full length
proteins, 8 of which (VAL-4, 7, 10, 15, 19, 21, 22 and 25) are
single domain and 13 double domain (VAL-1, 2, 3, 5, 6, 8, 9, 12,
13, 14, 16, 17 and 20). Phylogenetically, the single- and double-(ENA) are given where full-length sequences are available.
ion number given are for VAL-2.1. Isotig and accession numbers for
ent of Enolase separated from isotig 06965 by gap of ~27 nt.
799) and NAS-3.4 (isotig 01793).
Table 2 – Top 100 proteins identified in HES by LC–MS/MS.
Rank Identity Conserved domains Code Score SP
1 VAL-1.1 SCP (Double) isotig06320 6546 SP
2 VAL-1.2 SCP (Double) isotig03069 5788 SP*
3 VAL-2.2 SCP (Double) isotig07425 5149 SP*
4 VAL-2.3 SCP (Double) isotig03105 5039 SP
5 VAL-3.1 SCP (Double) isotig05790 4754 SP
6 VAL-2.1 SCP (Double) isotig03106 4003 SP
7 Vitellogenin Vitellogenin, DUF1943 contig00471 3997 SP
8 LYS-1 Lysozyme Muramidase GH25 isotig08802 3615 SP
9 VAL-7.2 Single SCP isotig01525 3369 SP
10 VAL-7.5 Single SCP isotig01526 3367 SP
11 VAL-7.3 Single SCP isotig02284 3051 SP
12 LYS-2 Lysozyme Muramidase GH25 isotig05074 2947 SP
13 VAL-1.3 Double SCP isotig06456 2668 SP
14 VAL-7.4 Single SCP isotig02282 2604 SP
15 VAL-7.1 Single SCP isotig01524 2593 SP
16 TTR-1 Transthyretin-related DUF290 isotig04612 2130 SP
17 VAL-1.4 Double SCP isotig01653. 1841 SP
18 APY-1.1 Apyrase Apyrase isotig02250 1833 SP
19 APY-1.2 Apyrase Apyrase isotig07986 1818 SP
20 VAL-13 Double SCP isotig06642 1809 SP
21 VAL-4 Single SCP isotig10387 1770 SP
22 MEP-1 Zinc metalloprotease Peptidase M13 isotig02967 1624 SP*
23 VAL-1.5 Double SCP isotig01652 1596 SP*
24 NSP-1 Novel Secreted Protein with SP None isotig11973 1584 SP
25 APY-1.3 Apyrase Apyrase isotig05261 1583 SP
26 Myoglobin Globin isotig04274 1579 SP
27 Peritrophin-A-like protein Chitin-binding type 2 Isotig05677 1561 SP*
28 Vitellogenin DUF1943 contig00207 1552 SP*
29 ACE-1 Acetylcholinesterase Esterase lipase isotig05694 1527 SP
30 NPA-1 Nematode polyprotein allergen None isotig02438 1498 SP
31 APY-2 Apyrase Apyrase isotig07051 1474 SP
32 Myoglobin Globin isotig11742 1446 SP
33 VAL-9 Double SCP isotig05765 1431 SP
34 Myoglobin Globin isotig04273 1390 SP
35 VAL-11 Single SCP isotig05330 1303 SP*
36 MSP-1 Major Sperm Protein Motile Sperm isotig01565 1278 NO
37 MEP-2 Zinc metalloprotease Pep0, Peptidase M13 N isotig05366 1232 SP
38 Vitellogenin Vitellogenin N, LPN N contig00203 1205 SP*
39 Vitellogenin VWD contig00477 1204 SP*
40 VAL-8.1 Double SCP isotig02308 1200 SP
41 TTR-2 Transthyretin-related DUF290 isotig13558 1156 SP
42 NAS-1.1 Nematode Astacin protease ZnMc astacin-like isotig04178 1148 SP*
43 ACE-2 Acetylcholinesterase Esterase lipase isotig00868 1122 SP
44 PHP-1 PHA domain protein PHA02954 isotig03547 1120 SP
45 NAS-1.2 Nematode Astacin protease ZnMc astacin-like isotig04179 1095 SP*
46 Myoglobin Globin isotig05169 1094 SP
47 VAL-8.2 Double SCP isotig02308 1040 SP*
48 MEP-3 Zinc metalloprotease Peptidases M13, M13N isotig05155 1007 SP*
49 ACE-3 Acetylcholinesterase Esterase lipase isotig00869 1006 SP
50 Deoxyribonuclease II Dnase_II isotig08122 1006 SP*
51 VAL-6 Double SCP isotig03505 996 SP
52 CHI-1 Chitinase Chitinase GH19 isotig04840 988 SP
53 Astacin protease (fragment) None isotig01219 956 SP*
54 Trypsin family protein Trypsin SPc isotig03474 919 NO
55 Vitellogenin VWD contig00212 918 SP*
56 Aspartyl protease (necepsin) Pepsin/retropepsin-like isotig06497 884 SP
57 Trypsin family protein Trypsin SPc isotig03473 883 NO
58 VAL-1.6 Double SCP isotig01655 867 SP
59 NAS-2.1 Nematode Astacin protease ZnMc astacin-like isotig01336 858 SP*
60 MFH-1 Ascaris MFP2b homologue MFP2b isotig07283 845 NO
61 NAS-2.2 Nematode Astacin protease ZnMc astacin-like isotig01334 836 SP*
62 NAS-3.1 Nematode Astacin protease ZnMc astacin-like isotig01799 832 SP*
63 NAS-4 Nematode Astacin protease ZnMc astacin-like isotig00214 830 SP*
64 Enolase Enolase isotig06965 826 NO
65 VAL-17 Double SCP isotig05765 825 SP*
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Table 2 (continued)
Rank Identity Conserved domains Code Score SP
66 TTR-3 Transthyretin-related DUF290 isotig14171 821 SP
67 MEP-4 Zinc metalloprotease Peptidases M13, M13 N isotig05402 806 SP
68 VAL-12 Double SCP isotig06637 803 SP
69 NSP-2 Novel Secreted Protein with SP None isotig12022 802 SP
70 NSP-3 Novel Secreted Protein with SP None isotig12137 802 SP
71 NAS-5.1 Nematode Astacin protease ZnMc astacin-like, CUB isotig01596 779 SP*
72 NSN-1 Novel Secreted Non-signal-peptide protein None isotig18405 777 NFL
73 VAL-5 None isotig04839 746 SP
74 Chondroitin-like protein None isotig01493 710 SP
75 Vitellogenin Vitellogenin N contig00199 696 SP
76 NAS-5.2 Nematode Astacin protease ZnMc astacin-like, CUB isotig01598 691 SP*
77 VAL-14 Double SCP isotig04896 689 SP
78 LYS-3 Lysozyme Muramidase GH25 isotig08606 683 SP*
79 NAS-6 Nematode Astacin protease ZnMc astacin-like, CUB isotig07866 681 SP*
80 Myoglobin Globin isotig11666 683 SP
81 NSP-4 Novel Secreted Protein None isotig05257 681 SP
82 MFH-2 Ascaris MFP2b homologue MFP2b isotig07373 647 NO
83 APY-3 Apyrase-3 Apyrase isotig03589 644 SP
84 Complement regulatory protein CCP isotig13827 632 SP
85 Aldolase FBP Aldolase 1a isotig04915 627 NO
86 Complement regulatory protein CCP isotig12552 611 SP*
87 NSP-5 Novel Secreted Protein None isotig12800 599 SP
88 NSP-6 Novel Secreted Protein None isotig12832 596 SP
89 NSP-7 Novel Secreted Protein None isotig12576 592 SP
90 NSN-2 Novel Secreted Non-signal-peptide protein None isotig14195 589 NFL
91 FAR-1 Fatty acid/retinol binding protein Gp-FAR-1 isotig11475 577 SP*
92 HEX-1 Hexokinase Hexokinases 1, 2 isotig05973 563 NO
93 NSP-8 Novel Secreted Protein None isotig16252 557 SP
94 NSP-9 Novel Secreted Protein None isotig09200 529 SP
95 SCP-1 Serine carboxypeptidase Esterase lipase isotig05975 529 SP
96 CSP-1 Conserved nematode Secreted protein None isotig13235 528 SP*
97 SPN-1 Serpin Serpin isotig08233 512 NFL
98 NAS-3.2 Nematode Astacin protease ZnMc astacin-like isotig01792 509 SP*
99 CSP-2 Conserved nematode Secreted Protein None isotig09016 502 SP
100 NAS-3.3 Nematode Astacin protease ZnMc astacin-like isotig01791 498 SP*
SCP denotes the PFAM Sperm Coat Protein domain found in either single or double formation in VAL proteins. SS denotes presence of predicted
signal sequence; SS* indicates that the sequence is truncated but homologous to known proteins containing signal sequences; NFL denotes
transcripts which are not full length and for which no database homologues were found with signal sequences (in the case of novel proteins, no
homologues were found at all). Note that VAL-8.1 corresponds to a sequence similar but not identical to isotig02308, while VAL-8.2 matches
exactly.
1581J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 1 5 7 3 – 1 5 9 4domain proteins appear to have diversified independently,
although the single-domain VAL-19 is most likely to have
evolved from a double-domain ancestor (Fig. 5). Double-
domain VAL proteins include an inter-domain linker “hinge”
region, which in the case of VAL-1, 2 and 5 comprise multiple
Ser/Thr residues bearing a common antigenic O-glycan [64].
Immunodominant serum antibodies target this glycan early
in infection, although anti-peptide antibodies such as those
tested in Fig. 4 are also represented [64]. Similar stretches of
predicted O-glycosylation are present in other secreted VAL
proteins, particularly VAL-11, 17 and 20 (Fig. 5).
Analysis of individual H. polygyrus VAL amino acid sequences
reveals extensive variation between genes: for example, within
the C-terminal domains of the 13 double-domain proteins, only
15/189 amino acid residues are completely conserved (8%), and a
further10altered inonly1genesequence,while in theN-terminal
SCP-1 domain there are only 7 identical positions (of which 6 are
cysteines). Similarly, for the single domainVALproteins there are
only 8 fully conserved amino acids, and 7 differing at only 1
position. Additionally, transcriptomic studies have identified103significant micro-sequence variation within individual VAL pro-
teins (Harcus et al. manuscript in preparation), and this was
evident with respect to proteomic data. For example, five
alternative VAL-1 sequences verified by proteomic data are
presented in Fig. 6. Note the extensive sequence diversity,
particularly in the first SCP domain, suggesting that domain 1 is
either under diversifying selection, or that intra-genic recombi-
nation is taking place. Similar sequence variation, with multiple
variants matching the peptide data, was observed for VAL-2 and
VAL-7.As the full genomeof thisparasitehasyet tobeassembled,
we cannot yet determine whether the micro-variation is due to
either allelic polymorphism or recent duplication of the relevant
gene loci. Sequence variation has previously been reported for
VALs of A. caninum [66], Cooperia punctata [67] and H.contortus [22].
3.7. Non-VAL gene families represented in HES
In addition to the 25 VAL proteins, a number of conserved gene
family proteins are well represented in HES with particular
prominence of the following functional groups.
Table 3 – Top 100 Proteins identified in HEx by LC–MS/MS.
Rank Identity Code Score SS
1 Vitellogenin contig00471 3369
2 Myoglobin isotig11742 3366
3 Myoglobin isotig13336 3098
4 Actin isotig01642 2585
5 Actin isotig01640 2251
6 Myoglobin isotig04274 2208
7 Myoglobin isotig11356 2113
8 Myoglobin isotig05169 1977
9 Myoglobin isotig04273 1833
10 HSP90 isotig04714 1831
11 Major sperm protein isotig01565 1820
12 Phosphoenolpyruvate
carboxykinase
isotig05532 1713
13 Aldolase isotig04915 1611
14 Myoglobin isotig11666 1607
15 Nematode polyprotein
allergen NPA-1
isotig02438 1562
16 Enolase isotig06965 1476
17 Protein disulphide isomerase isotig05787 1465 ✓
18 Vitellogenin contig00207 1301
19 Vitellogenin contig00212 1295
20 Eukaryotic translation
elongation factor 1A
isotig06220 1223
21 14-3-3 family member isotig07975 1218
22 Actin isotig08179 1212
23 Eukaryotic translation
elongation factor 1A
isotig02523 1187
24 Beta-tubulin isotig06421 1179
25 HSP70 isotig07134 1167
26 Vitellogenin contig00203 1040
27 Vitellogenin EST
Hp_ADY001C04
1025
28 Eukaryotic translation
elongation factor 2
isotig05363 1015
29 Ribosomal protein 60S P0 isotig01358 965
30 HSP60 isotig06093 958
31 Protein disulphide isomerase isotig01916 902 ✓
32 Vitellogenin contig00199 884
33 AAA family ATPase isotig05378 857
34 HSP90 isotig05404 851
35 Serpin isotig02225 788
36 Ribosomal protein 40S S8 isotig10482 785
37 Thioredoxin peroxidase isotig05188 771
38 Alpha-tubulin isotig06550 736
39 Arginine kinase isotig06694 736
40 Fumarase isotig02533 717
41 Myoglobin isotig12632 698
42 Actin isotig08340 695
43 Cystathionine beta-synthase isotig05473 681
44 Glyceraldehyde 3-phosphate
dehydrogenase
isotig03503 646
45 Calreticulin Hpb-CRT 636
46 Glutamate dehydrogenase isotig06500 634
48 HSP70 isotig05458 585
49 Tropomyosin Hpb-TRP 585
50 Nucleosome assembly
protein
isotig04959 573
51 Chondroitin family member isotig01493 571
52 Malate dehydrogenase isotig05076 561
53 Phosphoglycerate_kinase isotig06484 533
54 Myoglobin isotig13442 531
55 Ribosomal protein 60S L6 isotig11208 524
56 Vitellogenin EST
Hp_ADY_001G11
523
57 Myoglobin (fragment) isotig19571 521
Table 3 (continued)
Rank Identity Code Score SS
58 Fatty acid and retinol binding
protein
isotig11475 515
59 Alpha-tubulin isotig06165 512
60 C-type lectin isotig02337 499 ✓
61 Phosphatidylethanolamine-
binding protein
isotig05126 469 ✓
62 Ribosomal protein 60S L18 isotig10630 465
63 Ribosomal protein 40S S4 isotig05116 463
64 CSN-2 Conserved secreted
protein, No signal sequence
isotig04423 449
65 Chondroitin family member isotig06559 433
66 Eukaryotic translation
initiation factor 4A
isotig06491 432
67 Retinol binding protein Hpb-RBP 419
68 Enolase (fragment) isotig18996 404
69 Nucleoside diphosphate
kinase
isotig05236 401
70 Ribosomal protein 60S L7a isotig09109 397
71 CSN-5 Conserved secreted
protein, No signal sequence
isotig03664 393
72 Glutathione S-transferase isotig10292 389
73 Macrophage migration
inhibitory factor
isotig14093 383
74 Vitellogenin contig00211 372
75 Cyclophilin isotig11124 364
76 Dehydrogenase isotig03780 363
77 Cytochrome C isotig11144 361
78 Ribosomal protein 60S L14 isotig14543 359
79 RACK family member isotig07754 358
80 Aspartyl protease inhibitor isotig05063 355
81 Glutathione S-transferase isotig07073 351
82 VAL-3.1 isotig05790 349 ✓
83 Ribosomal protein 60S L10 isotig12696 346
84 Transketolase isotig02953 346
85 HSP70 isotig13132 345
86 Ribosomal protein 40S S3 isotig09688 345
87 Aldehyde dehydrogenase
family member
isotig04738 339
88 Oxidoreductase isotig08193 323
89 Glutathione S-transferase isotig11588 322
90 Adenosylhomocysteinase isotig08907 308
91 TTR-13 Transthyretin-
related
isotig13284 304
92 Glutathione S-transferase isotig04128 302
93 Ureidopropionase isotig08079 300
94 HSP70 isotig08182 296
95 CSN-6 Conserved secreted
protein, No signal sequence
isotig04424 288
96 Fructose-1,6-bisphosphatase isotig07764 284
97 NAC domain-containing
protein
isotig10507 283
98 Alpha-tubulin isotig06090 282
99 Isocitrate lyase-malate
synthase
isotig05351 282
100 Ribosomal protein 60S L12 isotig11621 278
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Three acetylcholinesterases are among the 100 most abun-
dant HES proteins (Table 2), with Hpb-ACE-1 represented by 3
distinct spots (Table 1). Two additional proteins, ACE-2 and -3,
differ by only 18 amino acids (3.1%) from each other but show
~32% divergence from ACE-1. The secretion of AChE by adult
Fig. 2 – GO distribution of the proteins in HES and HEx. All identified proteins in HES and HEx were analysed by Gene Ontology
and categorised firstly into 4 broad categories: cell localation (Red), molecular function (Blue), biological process (Green), and no
recognised GO similarity (Yellow). Within each category, the most frequent term is shown (darker colours). Some proteins are
included in more than one category. A more detailed listing of GO identifications is given in Supplementary Table A3.
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feature of most nematode ES products [69]. In N. brasiliensis,
the expression of three AChE isoforms has been shown to be
differentially regulated according to the immune status of the
host [70–73], and the 3 H. polygyrus proteins show highest
similarity to isoform A of N. brasiliensis.
3.7.2. Apyrases
Four distinct apyrases were identified, one of which (Hpb-
APY-1) was found as three minor sequence variants, all but
one in the most abundant 100 HES proteins. Apyrases are
adenosine diphosphatases, similar to mammalian CD73-like
proteins, which catalyse the hydrolysis of ATP/ADP to AMP,
and can often act also on other NDPs. Two recent reports
have identified arthropod (Cimex)-like apyrases from related
trichostrongylid nematodes T. circumcincta [74] and Ostertagia
ostertagi [75] sharing 92% amino acid identity; in the latter case
the enzymewas localised to the oesophageal glands. While all
4 H. polygyrus apyrases are homologous to these enzymes,
levels of amino acid identity are less than 60%, indicating
considerable diversification since divergence of the murine
and ruminant parasites.
3.7.3. Lipid-binding proteins
Several structurally unrelated lipid-binding protein families are
represented inHES.HEScontains twodistincthomologuesof the
Fatty acid/Retinol-binding (FAR) protein that has been recorded
inES ofmanyother parasitic nematodes [76,77] andwhich in the
case of A. caninum FAR-1 has been shown to functionally bind
fatty acids and retinol [78]. A nematode polyprotein allergen
(NPA) is also secreted byH. polygyrus, homologues of which bind
the same ligands inAscaris [79] and Dictyocaulus viviparus [80]. In
addition, a total of 12 transthyretins are represented in HES,
members of a widespread and diverse family of small proteins
believed to recognise small hydrophobic ligands such as thyroid
hormone, retinol or phosphatidylserine [81–83].
3.7.4. Lysozymes
Lysozymes or muramidases are present in multiple forms in
HES, with 8 distinct gene products identified. All are related to105C. elegans and the 7 full-length sequences contain a potential
signal peptide. In other organisms, lysozymes degrade the gly-
cosidic bond linking N-acetylglucosamine and N-acetylmuramic
acid in themurein proteoglycan of bacterial cell walls. Since adult
H. polygurus cohabit with microbial flora, and Gram-positive
bacteria are more susceptible to lysozyme-mediated lysis, it is
possible that these lysozymes modify the bacterial population
sharing the intestinal niche of the worm.
3.7.5. Proteases
Five aspartyl proteases (PF00026) in HES correspond to amajor
enzymatic class from parasitic nematodes. Aspartyl proteases
play a key role in the ability of A. caninum hookworms to
degrade haemoglobin [84], and are the target of protective
antibodies against the human parasite Necator americanus [85].
We identified no fewer than 20 astacins, Zn-metalloproteases
distributed across the animal kingdom with particular fre-
quency in nematodes [86,87].
Cysteine proteases have amajor role in nematode parasites,
particularly within the hookworm family. However, while 7 ES
cathepsin B products have been defined in H. contortus [88], part
of a larger gene family which show a particularly high level of
transcription in intestinal tissue [89], only 4 are found in HES, a
cathepsin B-like cysteine protease, a homologue of N. americanus
necpain and two legumains (asparaginyl endopeptidases). Serine
proteasesarealso lessprominent inHES thanaspartyl ormetallo-
enzymes, but include Cathepsin A, aminopeptidase, serine
carboxypeptidases, trypsin family proteases and dipeptidyl
peptidase four (DPF) proteins.
3.7.6. Protease inhibitors
Three broad classes of protease inhibitor are found in HES.
Cystatins are a broadly conserved family of cysteine protease
inhibitors found across plant and animal phyla, with an
especial role in immune modulation by parasitic nematodes
[90,91]. Inhibition of the protease active site involves a QVVAG
sequence which is perfectly conserved in the H. polygyrus
homologue, as also in Nippocystatin from N. brasiliensis ES [92]
and in B. malayi Bm-CPI-2 [93]. However, while Bm-CPI-2 has
a second inhibitory motif (SND) that blocks the legumain
Table 4 – Proteins common to both HES and HEx.
Rank Name CODE HES
score
HES
emPAI
HEx
score
HEx
emPAI
HES/HEx
emPAI
1 VAL-2.1 isotig03106 5149 8.35 103 0.12 69.6
2 TTR-1 Transthyretin-related isotig04612 2130 29.24 144 0.86 34.0
3 VAL-1.3 isotig06456 2668 1.97 47 0.06 32.8
4 VAL-7.5 isotig01526 3367 11.23 100 0.35 32.1
5 VAL-1.1 isotig06320 6546 4.05 77 0.18 22.5
6 NAS-3.1 Astacin protease isotig01799 832 2.02 47 0.12 16.8
7 VAL-3.1 isotig05790 4754 3.66 349 0.25 14.6
8 VAL-7.1 isotig01524 2593 8.84 129 0.64 13.8
9 NSN-1 Novel secreted protein, No SP isotig18405 777 4.03 40 0.31 13.0
10 Astacin protease family member isotig01791 419 1.41 67 0.12 11.8
11 CSP-4 Conserved secreted protein with SP isotig13290 482 1.82 37 0.16 11.4
12 VAL-4 isotig10387 1770 4.08 53 0.42 9.7
13 Aspartyl protease (necepsin) isotig06497 884 1.17 136 0.18 6.5
14 Kunitz inhibitor isotig01217 273 0.76 88 0.12 6.3
15 VAL-12 isotig06637 803 1.02 130 0.19 5.4
16 Astacin protease family member (fragment) isotig01219 956 3.05 89 0.59 5.2
17 Superoxide dismutase isotig09104 235 0.47 48 0.10 4.7
18 C-type lectin mannose receptor-like isotig00496 366 0.97 61 0.23 4.2
19 MFH-1 Ascaris MFP2b homologue isotig07283 845 1.17 137 0.29 4.0
20 Cystatin isotig02700 261 0.41 71 0.12 3.4
21 CSP-2 Conserved secreted protein with SP isotig09016 502 0.57 434 0.20 2.9
22 Motile sperm domain containing protein isotig16097 175 0.50 144 0.22 2.3
23 Galectin isotig09082 120 0.20 44 0.09 2.2
24 TIL domain-containing protein isotig00779 98 0.27 42 0.13 2.1
25 Arginine kinase isotig05009 212 0.65 193 0.33 2.0
26 Motile sperm domain containing protein isotig16375 220 0.89 160 0.53 1.7
27 ERM family member isotig02815 79 0.08 100 0.05 1.6
28 Cyclophilin isotig09088 111 0.31 71 0.20 1.6
29 Actin depolymerising factor isotig07522 145 0.23 144 0.15 1.5
30 Macrophage migration inhibitory factor isotig14093 256 0.96 383 0.65 1.5
31 TTR-5 Transthyretin-like isotig13207 397 0.89 88 0.61 1.5
32 MFH-3 Ascaris MFP2b homologue isotig07980 463 0.84 148 0.58 1.4
33 TTR-10 Transthyretin-like isotig11792 108 0.67 84 0.47 1.4
34 NSP-30 Novel secreted protein with SP isotig12701 194 0.99 166 0.73 1.4
35 Chondroitin family member isotig01493 710 0.48 571 0.38 1.3
36 Ferritin isotig15727 117 0.74 140 0.73 1.0
37 NSP-39 Novel secreted protein with SP isotig16333 108 0.78 187 0.77 1.0
38 Vitellogenin contig00207 1552 5.73 1301 5.70 1.0
39 Myoglobin (fragment) isotig19571 415 3.10 521 3.09 1.0
40 Calmodulin isotig07710 53 0.07 57 0.07 1.0
41 Cathepsin-B like cysteine protease isotig07017 147 0.06 136 0.06 1.0
42 Galectin isotig09713 81 0.10 69 0.10 1.0
43 Kunitz inhibitor isotig02721 82 0.13 82 0.13 1.0
44 Kunitz inhibitor isotig02378 35 0.20 36 0.20 1.0
45 ML-domain containing protein isotig10098 110 0.23 88 0.23 1.0
46 Motile sperm domain containing protein isotig16212 138 0.22 92 0.22 1.0
47 NSP-59 Novel secreted protein with SP isotig13319 38 0.16 35 0.16 1.0
48 Triose phosphate isomerase isotig05016 276 0.44 198 0.44 1.0
49 VAL-15 isotig02149 133 0.20 200 0.20 1.0
50 Chondroitin family member isotig08745 82 0.21 92 0.22 1.0
51 NPA-1 Nematode polyprotein allergen isotig02438 1498 0.67 1562 0.75 0.9
52 Vitellogenin contig00471 3997 3.05 3369 3.74 0.8
53 Nucleoside diphosphate kinase isotig05236 462 1.18 401 1.55 0.8
54 TTR-6 Transthyretin related isotig05212 304 0.62 210 0.83 0.7
55 Rab GDP dissociation inhibitor isotig06129 54 0.16 168 0.22 0.7
56 Chondroitin family member isotig06559 284 0.48 433 0.66 0.7
57 Vitellogenin contig00199 696 2.38 884 3.29 0.7
58 Myoglobin isotig11742 1446 3.31 3366 4.60 0.7
59 Enolase isotig06965 826 2.13 1476 3.02 0.7
60 Transaldolase isotig07176 59 0.14 62 0.21 0.7
61 Vitellogenin contig00203 1205 4.87 1040 7.34 0.7
62 Aldolase isotig04899 67 0.13 114 0.20 0.7
63 Vitellogenin (fragment) sing00711 131 1.60 179 2.57 0.6
64 Myoglobin isotig05169 1094 1.64 1977 2.64 0.6
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score
HES
emPAI
HEx
score
HEx
emPAI
HES/HEx
emPAI
65 Myoglobin isotig04274 1579 3.13 2208 5.07 0.6
66 TTR-11 Transthyretin related isotig04258 83 0.29 95 0.47 0.6
67 Ribosomal protein 60S L40/Ubiquitin isotig13199 108 0.34 116 0.56 0.6
68 Serpin isotig02225 281 0.33 788 0.59 0.6
69 Vitellogenin contig00212 918 2.24 1295 4.24 0.5
70 Vitellogenin contig00211 263 1.29 374 2.46 0.5
71 Chondroitin family member isotig04525 51 0.13 75 0.27 0.5
72 Fatty acid/retinol binding protein isotig11475 577 1.47 515 3.12 0.5
73 Fatty acid/retinol binding protein (fragment) sing12372 71 0.27 78 0.61 0.4
74 Phosphatidylethanolamine-binding protein isotig05126 339 0.64 469 1.67 0.4
75 Independent phosphoglycerate mutase isotig01699 48 0.05 136 0.14 0.4
76 Vitellogenin Hp_ADY_001G11 144 2.05 523 5.75 0.4
77 Cyclophilin isotig11124 256 0.87 364 2.48 0.4
78 Thioredoxin peroxidase isotig05188 498 1.79 771 5.19 0.3
79 Enolase (fragment) isotig18996 326 1.08 404 3.30 0.3
80 Glutathione S-transferase isotig11588 219 0.47 322 1.45 0.3
81 HSP70 (fragment) isotig13132 148 0.35 345 1.11 0.3
82 Myoglobin isotig11356 398 0.63 2113 2.00 0.3
83 Calreticulin Hpb-CRT 74 0.21 636 0.67 0.3
84 Lipocalin domain-containing protein isotig05316 104 0.34 229 1.09 0.3
85 Myoglobin isotig11666 683 4.48 1607 14.53 0.3
86 CSN-5 Conserved secreted protein, No SP isotig03664 43 0.08 393 0.27 0.3
87 Aldolase isotig04915 627 0.77 1611 3.00 0.3
88 Major sperm protein isotig01565 1278 2.10 1820 8.59 0.2
89 HSP60 isotig06093 195 0.43 958 1.76 0.2
90 Piwi domain-containing protein isotig04875 77 0.06 167 0.25 0.2
91 14-3-3 family member isotig07975 324 0.94 1218 3.98 0.2
92 CSN-2 Conserved secreted protein, No SP isotig04423 127 1.08 449 4.75 0.2
93 Actin isotig08340 102 0.27 695 1.38 0.2
94 Cytochrome C isotig11144 50 0.13 361 0.86 0.2
95 Actin isotig01640 340 0.47 2251 3.21 0.1
96 Eukaryotic translation elongation factor 2 isotig05363 86 0.09 1015 0.87 0.1
97 Protein disulfide isomerase isotig01916 81 0.16 902 1.62 0.1
98 Eukaryotic translation elongation factor 1A isotig02523 44 0.12 1187 1.64 0.1
99 Protein disulfide isomerase isotig05787 133 0.24 1465 3.42 0.1
100 HSP70 isotig07134 100 0.22 1167 3.18 0.1
101 Glutathione S-transferase isotig10292 47 0.24 389 3.88 0.1
102 Malate dehydrogenase isotig05076 44 0.07 561 1.31 0.1
103 Ribosomal protein 60S P0 isotig01358 38 0.04 965 0.77 0.1
104 Retinol binding protein Hpb-RBP 29 0.16 419 5.15 0.0is altered in H. polygyrus (SNA) and may therefore not function
in an identical fashion. Seven Kunitz type serine protease
inhibitors are represented in HES, and again this gene is found
in multiple forms in many helminth products [94]. Notably, a
related secreted product from adult A. ceylanicum (AceK1) acts
against a broad range of serine proteases, including trypsin,
chymotrypsin and pancreatic elastase [95,96]. In C. elegans, a
Kunitz-type inhibitor is important in collagen processing for
cuticle formation, with mutations causing the blister-5 (bli-5)
phenotype [97]. A structurally unrelated family of serine
inhibitors are the serpins, large globular proteins that include
most dominant ES antigen of B. malayi MF [98,99]. Three HES
serpins were identified but are only distantly related to Bm-
SPN-2, all being most similar to a serpin from Trichostrongylus
vitrinus.
3.8. Similarity to other Strongylid nematodes
The overall profile of gene sets represented in HES shows many
similarities to those reported in Trichostrongylid nematode107parasites of ruminant livestock such as H. contortus [22] andT. circumcincta[30] aswell as themore distantly related hookworm
Ancylostoma caninum[28], as shown in Table 5, and a number of
specific homologies are noted above. In each species, VAL family
members predominate, and similar findings have been reported
for other members of the Trichostronglyid taxon such as
Ostertagia ostertagi [100].4. Discussion
The secretome of extracellular pathogens provides fascinating
insights into the biological strategy of infectious organisms, in
particular those such as long-lived helminth species thatmust
attain an optimal physiological and immunological balance
with their hosts [7]. The spectrum of parasite secreted proteins
represents the elaborate adaptions demanded by the parasitic
mode of life, over and above nematode-specific functions
evident in free-living relatives such as C. elegans, many of
which are likely to have evolved to interact with a precise host
pathway, often with a specific ligand or receptor, and each of
Fig. 3 – Novel genes and signal peptides of the proteins in HES and HEx. Upper diagrams: Distribution of signal peptide-
containing protein sequences. Lower diagrams: Proportions of novel and nematode-conserved genes containing signal
peptides.
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and therapy.
The analytical power of modern proteomics enabled us to
identify 374 ES products of adult H. polygyrus, holding open the
prospect of a complete “worm pharmacopoeia” of potential
host-modulating proteins [101]. Comparisons with the whole
worm somatic protein extracts indicate a high level of
selectivity,withmany proteins only detectable in the secretions
of the parasite, and conversely most somatic products being
absent from HES. The likelihood that HES collected in vitro
faithfully reflects release in vivo, is supported by recent work
detecting circulating HES antigen in the serum of infectedmice
(Hewitson, unpublished), and demonstrating that host antibody
responses are predominantly directed against HES, rather than
HEx, antigens [64]. Validation of themethodological focus on ES
products is further offered by the contrast in signal peptide-
positive sequences within HES compared to HEx. Moreover, the
concept that ES proteins may have evolved more rapidly to
interactwithhost systems is supportedby thehighernumber of
novel (and novel signal peptide-positive) gene sequences
among HES proteins than in the general body components, as
previously noted in N. brasiliensis [13].
Wealsoestablished that twoof themajorHESproteins,VAL-1
and -2, are represented on the surface of adult parasites. This
finding reiterates work with other nematode species that108found concordance between surface and secreted proteins of
adultB.malayi [63,102] and larvalT. canis [103,104]. These studies
raise interesting questions regarding the route of secretion by
live parasitic nematodes: while they possess specialised secre-
tory apparatus such as oesophageal glands [103,105], there is
also evidence of direct trans-cuticular secretion deriving from
the syncytial hypodermal tissue underlying the extracellular
cuticle [106].Nowthat theadult ESproteinsarewelldefined, and
with a number of monoclonal antibodies to these proteins
[64], these issues can be directly addressed at themicroscopic
level.
Themost striking featureof theHESanalysis is thedominance
ofmultiple VAL proteins. The VAL family is an extraordinary one
in being so widely distributed in nature, with alternative names
from diverse systems including Cysteine-RIch Secretory Protein
(CRISP), Sperm Coat Protein (SCP) in mammals and plant
Pathogenesis-Related protein (PR), without any clear indication
as to their functional role(s) [107,108]. Within the nematodes, the
archetypal VAL protein is the Ancylostoma secreted protein (ASP),
a homologue ofwhich (ASP-2) has been taken forward for human
hookworm vaccine trials [109]. Interestingly, in Ancylostoma
species from dogs and humans, multiple and divergent ASPs
are known. For example, some 25 distinct VAL family transcripts
were identifiedbyMitrevaandcolleagues fromA. caninum [16]. For
potential vaccines, it is important to target products of the initial
Fig. 4 – Surface labelling of adult H. polygyrus reveals VAL-1 and VAL-2 are surface associated. A. Surface iodination, 2D gel.
B. Immunoprecipitation of surface labelled VAL-1 and -2 with specific antibodies. C. Anti-VAL-1 monoclonal antibody on adult
worm section. D. Anti-VAL-2 monoclonal antibody on adult worm section. E and F. MOPC control antibody on adult worm
section with corresponding bright field image.
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with H. polygyrus will investigate VAL gene expression in
immature as well as adult stages of the parasite. Additionally,
we are currently assessing the protective potential of both the
total adult secretions and individual VAL proteins.
VALgenesarealsoexpressed innon-parasiticorganisms,but
with an intriguing association with the interface between
different species, as for example in snake and insect venoms
and haematophagous insect saliva, aswell as in the response of
plants tomicrobial infection. Moreover, numerous homologues
exist in the free-living nematode C. elegans [108], arguing that
these genes must have many functions outside the frame of
host–parasite interactions. Indeed, lon-1 is such a gene that
controls body length downstream of TGF-β signalling [110]. It
is plausible, therefore, that the SCP domain is simply an
adaptable protein framework that facilitates the evolution of109diverse specialised functions, and that such diversity is accentu-
ated by inter-species interactions; certainly the extensive radia-
tion within the H. polygyrus lineage is consistent with this
notion. Intriguingly, VAL proteins found in HES differ from
those of C. elegans in terms of both the enrichment of double
domain proteins and in the presence of a serine/threonine rich
linker region between SCP domains, the site of highly antigenic
O-glycans in the HES proteins [64].
The comparison with related nematode species (Table 5) is
instructive, notonly inconfirming thatdominantVALsecretion is
shared among different members of the taxon, but also iden-
tifyingmany common, and some particular, gene sets associated
with intestinal parasitism. Most conspicuous across all these
species is the level of protease production, predominantly
astacins and other metalloproteases, but also including the
aspartyl, cysteine and serine protease classes. Together with the
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Fig. 6 – Sequence variation within H polygyrus VAL-1 proteins. Mature proteins with signal cleavage site and N and C-terminal
SCP domains indicated.
1589J O U R N A L O F P R O T E O M I C S 7 4 ( 2 0 1 1 ) 1 5 7 3 – 1 5 9 4release of a series of protease inhibitors (cystatins, serpins, Kunitz
inhibitors etc.) this suggests that nematodes can reset the
hydrolytic and proteolytic environment of the gastrointestinal
tract, possibly toavoidenzymatic attackbut alsoquiteprobably toFig. 5 – Schematic of relatedness ofH. polygyrusHESVAL-1-25, andV
-26 are depicted including signal sequences, linker regions (predic
homology domains (N-terminal red, C-terminal blue). Single SCP d
related toN (red) orC-terminal (blue) SCPdomains.Divergent sequen
indicated by (−\\−).
111degrade host mediators and obstacles such as mucins, immuno-
globulins and innate defence molecules.
A further set of parallels are seen with the production of
apyrases, with four different proteins identified. WhilstAL-26 identified inHEx. The domain structure ofHpb-VAL-1 to
ted O-glycosylation is indicated with green circles) and SCP
omain proteins are coloured according to whether they are
cesequallydistinct frombotharewhite.Sequence truncationis
Table 5 – Table of common ES proteins between H. polygyrus, Ancylostoma caninum, Haemonchus contortus and Teladorsagia
circumcincta.
A. caninum H. contortus H. polygyrus T. circumcincta (L4 not adult)
[28] [22] Hewitson, this paper [30]
n 105 107 374 32
VAL/ASP 24 13 25 8
Metalloproteases/Astacins/Aminopeptidases 4 14 25 2
Transthyretins 5 2 12 0
Lysozymes 2 0 8 0
Serine proteases 0 8 8 0
Galectins 2 0 5 0
Aspartyl proteases 1 1 5 0
Cysteine proteases/necpains 3 0 4 13
CTLs 3 0 3 0
15-kDa ES 8 21 2 0
Cyclophilins 0 2 2 0
Protein disulphide isomerases 1 0 2 2
Nucleoside diphosphate kinases 0 1 1 0
GA1 0 21 0 0
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clotting by blood feeding insects [111], they do not appear to
be secreted by blood feeding hookworms [28]. An alternative
role may be immunomodulatory through conversion of pro-
inflammatory ATP/ADP to anti-inflammatory AMP [112].
ATP, released by intestinal bacteria, can activate dendritic
cells (DC) to secrete the pro-inflammatory cytokines IL-6 and
IL-23, resulting in the induction of inflammatory Th17 cells
[113]. Similarly, ATP-dependent DC activation is essential for
Th2-dependent lung pathology in asthma models, and this
can be inhibited through the administration of an apyrase
[114]. In this context, adenosine generation may both induce
Foxp3+ regulatory T cells and be used by this cell type as a
mechanism of suppression [115]. Finally, in C. elegans, an
endo-apyrase, APY-1, fulfils a more homeostatic role in the
stress response of the organism [116], a role that cannot be
excluded for H. polygyrus homologues.
Whilst we have catalogued the identity of several hundred
of the most abundant proteins in the search for helminth
immunomodulators, we did not detect expression of the
TGFβ family member encoded by H. polygyrus, and expressed
by all mammalian stages [60]. Such activity appears linked to
the ability of HES to induce de novo Foxp3-positive regulatory
T cells [53]. This may be because TGFβ is active at sub-nM
levels, beyond the level of detection of our MS analysis.
Alternatively, it is not known whether the TGFβ activity in
HES is due to a true-TGFβ homolog. We are currently
fractionating HES to determine this. Another potential
immunomodulator previously considered is calreticulin,
which has been reported to drive the Th2 response that is
strongly provoked inH. polygyrus infection [58]; as calreticulin
is present at only low levels in HES, but is readily detectable in
worm extract, it remains to be determined if this product
emanates from active secretion or leakage from compro-
mised parasites.
In conclusion, we have embarked on a fine-detail molecular
dissection of an important nematode parasite, which serves as
an excellent model for both human and veterinary helminth
diseases. Whilst RNAi has not yet been successfully demon-
strated with H. polygyrus [117], more recent studies have112established that secretory proteinsmay be optimally positioned
for silencing in this way [118], which should allow functional
testing of the various potentially immunomodulatory proteins
described here. It is important to note that so far we have
analysed only adult HES, but that infection is initiated by L3
which embed in the intestinal submucosa and clearly elaborate
a set of equally fascinating mediators; hence in due course we
hope to analyse the ES of immature stages and complete the
proteomic characterization of this organism.
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Abstract
Gastrointestinal nematode parasites infect over 1 billion humans, with little evidence for generation of sterilising immunity.
These helminths are highly adapted to their mammalian host, following a developmental program through successive
niches, while effectively down-modulating host immune responsiveness. Larvae of Heligmosomoides polygyrus, for example,
encyst in the intestinal submucosa, before emerging as adult worms into the duodenal lumen. Adults release
immunomodulatory excretory-secretory (ES) products, but mice immunised with adult H. polygyrus ES become fully immune
to challenge infection. ES products of the intestinal wall 4th stage (L4) larvae are similarly important in host-parasite
interactions, as they readily generate sterile immunity against infection, while released material from the egg stage is
ineffective. Proteomic analyses of L4 ES identifies protective antigen targets as well as potential tissue-phase
immunomodulatory molecules, using as comparators the adult ES proteome and a profile of H. polygyrus egg-released
material. While 135 proteins are shared between L4 and adult ES, 72 are L4 ES-specific; L4-specific proteins correspond to
those whose transcription is restricted to larval stages, while shared proteins are generally transcribed by all life cycle forms.
Two protein families are more heavily represented in the L4 secretome, the Sushi domain, associated with complement
regulation, and the ShK/SXC domain related to a toxin interfering with T cell signalling. Both adult and L4 ES contain
extensive but distinct arrays of Venom allergen/Ancylostoma secreted protein-Like (VAL) members, with acetylcholines-
terases (ACEs) and apyrase APY-3 particularly abundant in L4 ES. Serum antibodies from mice vaccinated with L4 and adult
ES react strongly to the VAL-1 protein and to ACE-1, indicating that these two antigens represent major vaccine targets for
this intestinal nematode. We have thus defined an extensive and novel repertoire of H. polygyrus proteins closely implicated
in immune modulation and protective immunity.
Citation: Hewitson JP, Ivens AC, Harcus Y, Filbey KJ, McSorley HJ, et al. (2013) Secretion of Protective Antigens by Tissue-Stage Nematode Larvae Revealed by
Proteomic Analysis and Vaccination-Induced Sterile Immunity. PLoS Pathog 9(8): e1003492. doi:10.1371/journal.ppat.1003492
Editor: Thomas B. Nutman, National Institutes of Health, United States of America
Received January 25, 2013; Accepted May 28, 2013; Published August 15, 2013
Copyright:  2013 Hewitson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by the Wellcome Trust (grant number 090281), and by an MRC CASE studentship with UCB Celltech. The funders had no role
in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: rick.maizels@ed.ac.uk
Introduction
Gastro-intestinal nematode parasites are among the most
prevalent pathogens in the world, afflicting over 1 billion people
[1] and causing widespread disease in livestock [2]. Control
through drug therapy is compromised by rapid reinfection [3],
reflecting the lack of protective immunity generated during natural
exposure. Helminth infection is also associated with a wide suite of
immunological down-modulatory effects [4], which have evolved
to promote parasite survival. Although it is possible to vaccinate
animals against helminthiases, few protective antigens have been
defined and immunity reduces rather than eliminates worm loads
[1,5].
Heligmosomoides polygyrus is an ideal model species to study host-
parasite interactions in gastro-intestinal helminth infection [6–8].
The parasite follows an entirely intestinal course of infection,
entering orally, developing through larval stages before establish-
ing as long-lived adults in the lumen of the small intestine,
releasing eggs that are transmitted through feces for onward
transmission. Infected mice show multiple immuno-modulatory
changes including expansion of regulatory T cells [9–12], B cells
[13] and dendritic cells [14–16]. The immunoregulatory environ-
ment engendered by H. polygyrus extends to dampening bystander
immune responses to allergens, autoantigens and intestinal
antigens [4,17,18].
A critical point in infection is during the first 8–10 days, when
incoming larvae invade the intestinal tissue and become encysted
in the submucosa adjacent to the serosal membrane. Depending
on the genetic background of the murine host, a localised immune
reaction can envelop the larva, forming a macrophage-rich
granuloma. In primary infection however, parasites can escape
these inflammatory foci and successfully migrate to the lumen to
continue their life cycle [19].
How parasites evade immune attack in the tissues has yet to be
determined, but it is known that systemic immune suppression is
associated not only with the long-lived adult stage but also the
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larval stage in the intestinal wall [20]. Moreover, mice given
curative anthelminthic treatment prior to adult maturation [21],
or heavily irradiated infective larvae [22] develop protective
immunity to challenge infection. Hence, as well as being a source
of protective antigens, immature tissue-dwelling parasites actively
contribute to immunological down-regulation, and we hypothesise
that in the non-immune setting they are able to deflect or disable
immune mechanisms within the gut tissue.
The ability of parasites to modulate immunity is likely to be
dependent on the molecular components secreted into their
mammalian host, reproduced by the ‘‘excretory-secretory’’ (ES)
products collected from parasites maintained in vitro [23]. Global
proteomic analyses of the parasite ‘‘secretome’’ are proving to be
important and illuminating steps towards defining the host-
parasite interaction at the molecular level [24]. Thus, the
secretome of adult H. polygyrus has been found to contain more
than 300 proteins, including many enzymes and homologues of
host immune system genes, as well as novel proteins whose precise
function has yet to be defined [25,26].
Parasite ES products have also proven to be effective vaccines in
many settings [1,5], not least in the case of H. polygyrus in which
adult HES immunization elicits sterilizing immunity in mice [27].
An attractive hypothesis for this protective effect is that
vaccination generates neutralising antibodies that counter the
immunomodulatory molecules secreted from the host. If such
vaccines can also be directed against the immature stage of
helminths, such as the tissue-phase larvae of H. polygyrus, then
parasites may be eliminated before egg production and transmis-
sion can be attained.
We have therefore studied the released products of H. polygyrus
tissue phase larvae, both to identify individual protein compo-
nents, and to test their ability to induce immunity through
vaccination. As detailed below, this investigation identifies a shift
in secreted protein composition between the tissue and luminal
phases, with expansion and contraction of different gene sets, in
particular in the representation of the major multi-gene protein
families associated with nematode infection. Most importantly, the
larval secretions are fully immunogenic, induce complete sterilising
immunity, and have allowed us to identify key candidate protein
antigens that may form the basis of a subunit vaccine for protective
immunity.
Results
Secretome of 4th-stage H. polygyrus larvae
To identify the secretory products of the tissue-dwelling phase of
H. polygyrus, individual L4 larvae were isolated from the submucosa
of mice 5 days (120 hours) following oral infection with third-stage
(L3) infective larvae, at a point soon after the third molt (90–
96 hours) but prior to the fourth and final molt to the adult stage
(144–166 hours) [28]. Using serum-free media for cultivation, in
conditions previously reported for adult H. polygyrus [25], larvae
were cultured for 3 days and supernatants collected, concentrated
using centrifugal filters and analysed for recovered proteins. We
also collected material released by H. polygyrus eggs (ERM; egg
released material) harvested in vitro from adult worms collected
from the lumen of infected mice to act as an outgroup as the egg
stage has not previously been associated with immunity or
immunomodulation.
Proteins in ES or released material from the three life cycle
stages were first compared by 2-dimensional SDS-PAGE and
silver staining. As shown in Fig. 1, L4 ES (Fig. 1 A) was clearly
very distinct from egg-released material (ERM) (Fig. 1 B), but
bore a number of similarities with adult HES (Fig. 1 C). When L4
ES was compared to somatic extract from the same stage (Fig. 1
D), a number of proteins enriched or only visible in the secreted
fraction were apparent. In contrast, most spots appeared to be
shared between ERM (Fig. 1 B) and egg somatic extract (Fig. 1
E), suggesting in this case passive release rather than selective
secretion. In the comparison between L4 and adult ES, a number
of co-localising spots have previously been identified in HES
including members of the Venom allergen/Ancylostoma secreted
protein-Like (VAL) family and acetylcholinesterases (ACE) [25]).
MS analysis of individual L4 ES spots, detailed in Table 1,
confirmed the presence of two forms of ACE (ACE-1 and -2), as
well as several VAL proteins, particularly variants of VAL-7, the
lysozymes LYS-1 and LYS-2, apyrase APY-3, and the previously
described Th2-skewing protein calreticulin [29]. In addition,
proteins with no known homologs in other species were present,
including variants of a Novel Secreted Protein-3 (NSP-3) found in
adult HES [25] and a newly described Larval Secreted Protein
(LSP) not detected in HES.
Excretory-secretory products from 4th-stage larvae, but
not eggs, induce sterilising immunity to challenge
infection with H. polygyrus
Our first objective was to test whether L4 ES antigens were able
and sufficient to generate protective immunity in mice that are
normally susceptible to primary infection with H. polygyrus. We
have previously shown that vaccination with adult HES in alum
adjuvant generates sterile immunity against challenge [27]. We
therefore compared immunization with L4 ES, HES and egg-
derived ERM.
Immunity in vaccinated mice was measured both by fecal egg
output and worm burden at autopsy. Egg burdens measured
between 14 and 28 days of infection rapidly approached zero in
mice vaccinated with either L4 ES or HES (Fig. 2 A), while adult
worm burdens at day 28 showed that both conferred sterile
immunity on nearly all mice (Fig. 2 B). In contrast, ERM
immunization did not affect adult worm burdens or parasite
fecundity (Fig. 2 A, B). HES-immunized mice produced high levels
Author Summary
Intestinal helminth parasites are highly prevalent in
humans and animals, and survive for long periods by
deviating the host immune system. No vaccines are
currently available to control these infections. Many
helminths invade through barrier surfaces (such as the
skin or the digestive tract) and develop through tissue
larval stages before reaching their final niche such as the
intestinal lumen. We studied the tissue larval stage of a
mouse parasite, Heligmosomoides polygyrus, to test wheth-
er proteins released by this stage could elicit protective
immunity, and found that they indeed constitute very
effective vaccine antigens. Proteomic analysis to identify
the individual proteins released by the larvae demonstrat-
ed that while many products are shared between tissue-
dwelling larvae and adults occupying the intestinal lumen,
larvae express higher levels of two gene families linked to
immunomodulation, namely the Sushi protein family and
the ShK toxin family. Antibody analysis of serum from
vaccinated mice identified two major antigens recognised
by the protective immune response as VAL-1 and ACE-1,
which are respectively members of the venom allergen
and acetylcholinesterase families. This work establishes
that tissue larvae are the source of protective antigens for
future vaccines, and highlights their production of two
potentially immunomodulatory gene families.
Protective Antigens of Larval H. polygyrus
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of anti-HES IgG1 antibodies (Fig. 2 C), the isotype most important
in antibody-mediated immunity following secondary infection [30].
Notably, anti-HES IgG1 titers were similar in ERM- and HES-
immunized mice, showing that the failure of ERM immunization is
not due to any intrinsic lack of immunogenicity (Fig. 2 C). Instead,
this emphasised the importance of identifying specific molecular
targets following protective immunisation, a process that required
we first gain a deeper understanding of the individual protein
components in each ES preparation.
LC-MS identification and quantification of L4 and egg
secreted proteins
Taking advantage of an expanded H. polygyrus nucleotide
database based on .1 million cDNA sequences from 5 different
life-cycle stages of H. polygyrus (L3, day 3, day 5, adult and eggs)
including each of those from which the secreted proteins were
collected, we subjected L4 ES and ERM to LC-MS/MS analysis
and compared them to adult HES [25]. This analysis identified
Figure 1. 2-D gel electrophoresis of ES released material and somatic extracts from different stages of H. polygyrus, visualised by
silver staining. A. L4 ES. Identities of numbered spots are given in Table 1. B. Egg released material (ERM). C. Adult HES. Solid red boxes correspond
to the indicated protein products. D. L4 somatic extract. E. Egg somatic extract. Positions of molecular weight markers (kDa) are indicated.
doi:10.1371/journal.ppat.1003492.g001
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214 proteins present in L4 ES, and 209 in ERM, in comparison to
the secretion of 364 in adult HES. The number of proteins shared
between adult and L4 (63.1%=135/214 L4 ES proteins), and
adult and ERM (59.3%=124/209 ERM proteins) were broadly
similar (Fig. 3 A). Both L4 (33.6%=72/214) and ERM
(37.3%=78/209) contained a similar proportion of proteins
detected only in that stage. Very few proteins (7) were shared
between L4 ES and ERM but were not detected in HES, while a
core of 60 ES proteins was shared between the three different
lifecycle stages. Additionally, the proportion of novel proteins (i.e.
those proteins lacking homologs in other species) that were stage-
specific was enriched compared to the total secretions (Fig. 3 B;
HES 44.3%=27/61, L4 ES 42.5%=19/45, ERM 60.5%=23/
38). The vast majority of L4 ES proteins had a predicted signal
peptide (92.5%=198/214), greater than that seen for adult HES
(79.7%=290/364), whereas ERM was much lower (59.8%=125/
209), again suggesting that the latter contains constituents that are
not actively secreted.
Two parallel approaches were taken to quantify the relative
levels of proteins present in the different ES material and
determine selective expression, protein abundance and gene
expression profiling. Firstly, protein abundance was estimated by
emPAI (exponentially modified Protein Abundance Index [31]),
which provides an approximate protein ranking based on the
number of observed peptides relative to the known full-length
sequence. Because not all peptides are equally amenable to MS
detection, and not all sequences are full length, this method is not
infallible but provides a benchmark for further analysis and allows
direct comparison of the relative abundance of an individual
protein across different life-cycle stages.
Table 1. L4 ES protein spot identities.
Spot Identity Isotig and Isogroup Peptides Score
1 NSP-3.3 Hp_I01045_IG00068
Hp_I01047_IG00068
6 464
2 MPP-like Hp_I10549_IG03359
Hp_I10550_IG03359
1 98
3 NSP-3.2 Hp_I17967_IG09911 3 241
NSP-42 Hp_I02051_IG00167 1 69
4 Lysozyme-1 Hp_I08665_IG02417 5 522
5 VAL-7.4 Hp_I01449_IG00104 6 662
VAL-7.3 Hp_I01450_IG00104 6 592
6 VAL-7.5 Hp_I01454_IG00104 5 394
VAL-7.3 Hp_I01450_IG00104 4 293
VAL-7.2 Hp_I01453_IG00104 4 265
7 VAL-7.1 Hp_I01451_IG00104
Hp_I01452_IG00104
7 551
8 Sushi-like Hp_I08843_IG02506 2 246
NSP-62 Hp_I30075_IG22019 1 134
9 Lysozyme-2 Hp_I05758_IG01053 3 242
Deoxyribonuclease II Hp_I15874_IG07818 2 181
VAL-25 Hp_I10899_IG03534
Hp_I19276_IG11220
1 78
10 Calreticulin Hp_C00231_IG00001 3 213
11 ACE-2 Hp_I04629_IG00719 7 470
VAL-2.3 Hp_I07952_IG02060 1 77
12 VAL-9 Hp_I14221_IG06165 8 604
13 VAL-2.1/2.2/2.3 Hp_I07952_IG02060
Hp_I07953_IG02060
Hp_I15068_IG07012
3 214
14 APY-3 Hp_I06737_IG01430 5 622
15 Astacin protease Hp_I13832_IG05776 2 144
16 ACE-1 Hp_I12803_IG04747 6 618
17 VAL-13 Hp_I13967_IG05911 4 329
18 LSP-1 Hp_I03144_IG00345 8 664
19 Kunitz inhibitor Hp_I12299_IG04234 1 165
Spot numbers refer to those in Fig. 1 A. One identity is shown where the same peptides match multiple isotigs (i.e. variants). Additional identities are shown where
distinct peptides match either variants of the same protein or different proteins that co-localise within the same gel area. Number of unique peptides identifying each
protein is shown, as is the mascot score.
doi:10.1371/journal.ppat.1003492.t001
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Figure 2. Protective immunity following L4 ES or HES, but not ERM, immunization of C57BL/6 mice. A. Fecal egg burdens in mice at
days 14, 21 and 28 post-challenge. B. Adult worm recoveries at day 28 post-challenge. C. Anti-ES IgG1 titers in immunized mice prior to challenge.
Anti-HES (red), anti-L4 ES (blue) and anti-ERM (yellow) titers are shown following HES, L4 ES or ERM immunisation. Data in (A–B) are pooled from two
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Heat maps ranking the top 50 highest emPAI-scoring L4 ES,
HES and ERM are shown in Figure 4 A–C respectively, while
complete alphabetical lists are presented in Tables S1, S2, S3.
On the criterion of emPAI score, the most abundant L4 ES
constituents were two members of the Shk/SXC gene family
(PF01549) containing a conserved six-cysteine motif (SXC-like 1
and 2) and three isoforms of VAL-7 corresponding to 2D gel spots
(Fig. 1). Most of these were also prominently expressed by the
adult stage, although SXC-like proteins were highly upregulated in
L4 ES. Members of the novel NSP-3 family were also expanded in
the L4 stage. Most notably, a number of Sushi-domain containing
proteins were relatively highly represented in L4 ES but absent
from adult ES.
To form a broader picture of the functional pattern of each ES
compartment, we also analysed the constituent proteins for
domains corresponding to defined protein families in Pfam
(Fig. 4 D and Tables S4, S5). Statistical comparison with Pfam
domains detected in the total CDS of the H. polygyrus transcrip-
tome (Harcus et al, manuscript in preparation) confirmed the
selective release of protein families secreted by all parasite stages
(e.g. PF00188 CAP indicating widespread release of VAL
proteins). Furthermore, it also revealed regulation in the secretion
of key gene families through parasite development (e.g. expansion
of PF00084 Sushi and PF01549 ShK/SXC in L4 ES, and
PF00635 motile_sperm in ERM). Two-way clustering of abundant
proteins from the three ES preparations again shows close
association in proteins released by L4 and adult worms, but not
ERM, confirming the global similarity between larval and adult
released material (Fig. 4E).
It is interesting to note that visual inspection of the 2D SDS-
PAGE comparisons (Fig. 1) indicates a closer similarity between
L4 and adult HES than emerges from the full LC-MS proteomic
analysis, while ERM appears distinctly different. This reflects the
relative abundance of the proteins shared by the L4 and adult
stages. Moreover, a significant positive correlation was observed
between the emPAI values of shared L4 ES and HES proteins
(p,0.0001; Spearman r2 = 0.3478) but not between those of
shared ERM and HES proteins (n.s.; Spearman r2 = 0.1660; Fig.
S1 A, B); hence although certain proteins are present in both HES
and ERM, their abundance may be very different. This is well
illustrated by the heat map of emPAI values of the 60 proteins
shared between all three ES preparations showing clear differences
in expression level between the stages (Fig. S1 C). The identities
and relative abundances of proteins shared between HES and L4
ES (which both include protective antigens), as well as HES and
ERM (in which the latter is non-protective), are shown in Fig. S1
D and E.
Transcriptomic analysis of ES protein-encoding genes
An independent method of determining the stage-specific
expression of ES proteins was based on an extensive transcrip-
tomic database, using a normalised read count (RPKM; reads per
kb per million mapped reads [32]) to create a heat map
corresponding to relative gene expression across the five different
lifecycle stages (Fig. 5 A–C). This revealed most L4 and adult ES
proteins are encoded by genes that are relatively quiescent in the
free-living L3 stage, and transcription is either initiated or
upregulated following host entry. Generally, gene expression
analysis supports the proteomic data; expression of L4-specific ES
proteins is mostly at its highest in day 3 or 5 larvae, before
downregulation in the adult (Fig. 5 A), expression of shared L4 ES
and HES proteins is maintained in day 3, 5 and adult worms
(Fig. 5 B), and expression of HES-specific proteins is highest in
adult worms (Fig. S2 A). The expression of the ‘‘core 60’’ ES
proteins common to L4 ES, HES and ERM splits into two main
clusters, those that are expressed by all 5 stages and those mainly
expressed by d3, d5 and adult worms (Fig. 5 C). A small cluster of
ubiquitously expressed genes was also seen in ERM-specific
individual experiments with 5–10 mice per group, and data in (C) are representative of two individual experiments. Statistical significance refers to
ANOVA comparisons with PBS/alum group (*** p,0.001; n.s. = non-significant).
doi:10.1371/journal.ppat.1003492.g002
Figure 3. Shared and stage-specific ES proteins. A. Venn diagram of total secretome proteins from three stages, enumerating specific and
shared identities. B. Venn diagram of subset of total proteins showing no database similarity to known proteins in other species. Such proteins in
Adult HES (irrespective of presence in other stages) are designated as previously described [25] as Novel Secreted Proteins (NSPs), while those found
in L4 ES but not the adult are Larval Secreted Proteins (LSPs).
doi:10.1371/journal.ppat.1003492.g003
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proteins, but surprisingly the majority of ERM-specific proteins
were not actually expressed by the egg, and instead must be
derived from the adult worm where expression is greatest (Fig. S2
B). This includes sperm-derived proteins present in ERM, such as
the MSP-domain proteins (136) and MFP2 (46), as well as the egg
sac vitellogenins (5 variants).
Comparison of protein abundance (emPAI) with gene expres-
sion (RPKM) for all L4 ES proteins showed that protein levels
positively correlate with gene expression of day 5, but surprisingly
not day 3, larvae (Fig. S3 A–E). This reflects the major changes in
gene expression either side of the L3 to L4 molt, with new
transcription of many new genes being initiated (Harcus Y. et al,
manuscript in preparation). Notably, the significant correlation
between protein emPAI and mRNA RPKM within the L4 stage
lends further validation to these parameters as quantitative
measures of expression in the nematode worm.
Predominant and enriched protein families in L4 ES
The most highly represented proteins in both L4 and adult ES
are VAL (Venom allergen/Ancylostoma secreted protein-Like)
Figure 4. Comparison of protein abundance (emPAI) in each ES product. A. The 50 most abundant proteins in L4 ES, ranked by emPAI score
(left column) with corresponding emPA scores for HES (centre) and ERM (right column). Scores are coloured on a log2 scale with red maximum and
blue minimum. B. The 50 most abundant proteins in HES ranked as above (centre column) with corresponding scores for L4 ES and ERM. C. The 50
most abundant proteins in ERM ranked as above (right column) with corresponding scores for L4 ES (left column) and HES (centre). D. Protein family
(Pfam) enrichment within each ES, ranked by statistical significance (cut-off of p,0.001) compared to Pfam in total transcriptomic assembly. ‘‘Isotigs
with domain’’ indicates number of times domain present in indicated ES. Full analyses are provided in Table S5. E. Two-way clustering of the 10
most abundant proteins in the 3 ES preparations.
doi:10.1371/journal.ppat.1003492.g004
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family members; these are part of a larger CAP protein
superfamily (Pfam PF00188), which includes mammalian
sperm-coating protein (SCP) that lends its name to the canonical
domain structure. The CAP superfamily shows extensive
diversity in most species, with over 30 genes in mice and
humans [33]; in this respect, H. polygyrus is not exceptional in
expressing over 20 different VAL family members (numbered in
descending order of abundance in adult HES) although their
representation differs between adult and L4 ES. Generally, L4
ES contains lower levels of most VAL proteins compared to
HES, with just trace amounts of VAL-2 present, and there is no
abundant L4 ES VAL protein not previously described in adult
HES. Only the low abundance VAL proteins VAL-23, 25, 27, 28
and 29, as well as the moderately abundant VAL-10, are
enriched in L4 ES compared to HES, a pattern replicated at the
transcript level for the low abundance VAL proteins (Fig. 6 and
Table S1).
Using specific mAb, we confirmed by ELISA that L4 ES
contains little VAL-2, but that other abundant VAL proteins
(VAL-1, 3 and 4) are present at levels similar to adult HES (Fig.
S4 A–D). In contrast, little VAL-1 was detected in ERM (Fig. S4
A) despite LC-MS analysis showing the presence of several
variants (Table S3). This is suggestive of partial degradation,
consistent with the 2-D gel of ERM lacking the characteristic
stretch of VAL-1 isoforms readily identifiable in both HES and L4
ES (Fig. 1 A–C and [25]).
As has been noted in studies with other helminth species
[34,35], the VAL gene family shows extensive evolutionary
diversity within H. polygyrus, in both sequence and domain
structure (Fig. 6). Additionally, proteins expressed in a stage-
regulated manner do not form a clear structural subset within this
family as within Group 1 alone (Fig. 6) VAL-1 is preferentially
expressed by the adult, VAL-28 is restricted to the d3/d5 larval
transcriptome, whereas others (such as VAL-12) show a broader
pattern of expression. Such contrasting profiles may reflect fine
adaptation of different family members to specialised functional
roles. Notably, comparison with the closely related Ancylostoma and
Necator hookworm species reveals an intricate pattern of gene
expansion and contraction: Group 1 H. polygyrus VAL proteins are
clearly separated from the human and dog hookworm ASP-1-like
VAL-8, ASP-2-like VAL-3 and ASP-5-like VAL-2. Hence,
adaptation to the murine host may have resulted in an accelerated
radiation of VAL family members.
While the VAL family is less prominent in L4 ES than HES,
other protein families are distinguished by maximal representation
in the L4 stage. These include two conserved families, the Sushi-
like proteins and the ShK/SXC-like proteins, as well as a newly
defined set of Novel Secreted Protein-3 (NSP-3) variants.
Sushi domains (PF00084) are 60-amino acid consensus
sequences with 4 conserved cysteine residues, and are prevalent
in mammalian proteins that regulate complement activation,
hence the alternative domain name of complement control protein
Figure 5. Gene expression (RPKM) heat-maps of stage-specific and shared ES proteins. A. L4 ES stage-specific proteins, clustered by gene
expression profiles in a transcriptomic dataset based on 5 life cycle stages (infective L3, d3 post-infection L3, d5 post-infection L4, Adult, and Egg).
RPKM = Reads Per Kilobase Mapped. Scores are coloured on a log2 scale with red maximum and blue minimum. B. As above for proteins shared
between L4 ES and HES. C. As above for proteins shared between L4 ES, HES and ERM. The corresponding heat-maps for adult HES stage-specific
proteins, and for ERM-specific proteins, are presented in Suppl. Fig. 2 A and B respectively.
doi:10.1371/journal.ppat.1003492.g005
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(cd0003; [36]). Of note, Sushi domains in complement regulatory
proteins generally occur in repeated units (e.g. complement
receptor 1A, 30 repeats; factor H, 20 repeats), which is also
evident in an Ascaris complement factor H homolog (15 repeats;
ADY39830.1) and similar proteins in Loa loa (12 repeats;
XP_003143211.1) and C. elegans (11–16 repeats; Ce F36H2.3
isoforms A-G). Some 34 L4 ES proteins contained sequences
related to the Sushi domains (pfam 00084), which we have
collectively termed Sushi-like proteins as detailed in Fig. S5. Of
these, 18 are also present in HES albeit at lower levels, together
with an additional 5 not present in L4 ES. ERM contained only
two Sushi-like proteins at low levels. The majority of H. polygyrus
sushi-like proteins however, have only 1 or 2 sushi domains (Fig.
S5 A) more similar to those of cytokine receptors such as the alpha
subunits of the IL-2 (2 domains) and IL-15 (1 domain) receptors
[37].
ShK/SXC proteins have a 36 amino acid domain with 6
conserved cysteine residues, and are widely expressed by parasitic
and non-parasitic nematodes [38,39]. L4 ES contains 15 proteins
with ShK domains, with an additional one detected at low levels in
HES. Several of these domains (7/16) were fused to other
sequence motifs; 3 astacin metalloproteases and 4 homologs of
hypothetical (non-annotated) C. elegans proteins. In the latter cases,
proteins contained either 2 or 4 tandemly repeated ShK domains
Figure 6. Phylogeny and expression of VAL family members in H. polygyrus. Phylogenetic tree of H. polygyrus secreted VAL proteins and
those from selected other intestinal nematodes (Na =Necator americanus; Ac =Ancylostoma caninum; Ad =Ancylostoma duodenale; Ay =Ancylostoma
ceylanicum; Oo =Ostertagia ostertagi; Hc =Haemonchus contortus). Blue nodes represent single SCP domain VAL/ASP proteins whereas red nodes
indicate double SCP domain proteins; blue nodes are indicated as more similar to N-terminal (N) or C-terminal domains (C) as appropriate. Protein
(emPAI, top in same order as Fig. 4) and gene (RPKM, bottom, in same order as Fig. 5) expression profiles are indicated for Hp VAL proteins.
Expression profiles are for most abundant variant where more than one is present. H. polygyrus VAL-21 to 24 and VAL-29 have been omitted as their
sequences were either incomplete are did not unambiguously align with a single branch of the tree. On the basis of this phylogenetic analysis, 5
groups of VAL proteins are indicated. Note that this does not conform with a 3-group classification recently proposed [69] as we found the Groups 1
and 3 defined by these authors to be polyphyletic.
doi:10.1371/journal.ppat.1003492.g006
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(Fig. S6 A), in a pattern very similar to that observed in other
parasitic nematodes, such as T. canis mucins [39]. More unusually,
many ShK proteins (9/16) in H. polygyrus ES are found as short
single-domain proteins (full-length 63–67 aa, mature protein 41–
49 aa) consisting of no more than a signal sequence and the 6-
cysteine domain (Fig. S6 B). As this is reminiscent of Ostertagia
ostertagi SXC-1 (accession number CAC17797), we have termed
these proteins SXC-like. The parasite appears primed to produce
this group of proteins even before infection of the mammalian host
as gene expression is detected for 5/9 in the L3 stage, and peaks in
day 3–5 larvae.
L4 ES contains relatively high levels of several enzymes
including apyrases (particularly APY-3, but also low levels of a
new L4-specific APY-5), lysozymes and the three acetylcholines-
terase proteins (ACE-1, 2 and 3) previously identified in adult
secretions [25]. ACE levels in L4 ES were comparable to those in
HES, as determined by emPAI, an expression pattern confirmed
by RPKM transcript analysis, which revealed low or absent
expression in L3 and eggs, and peak expression by day 5 L4
parasites, maintained in adults (Tables S1, S2, S3). In contrast,
significant products which are preferentially secreted by the
luminal adults, and which have previously been reported to be
secreted by parasitic nematodes, include proteases such as astacins
and zinc metalloproteases [40–42], cathepsins [43,44] and trypsin-
like and other serine proteases [45–47], serpin [48] and Kunitz
protease inhibitors [49], and predicted chitinases and chitin-
binding proteins [50].
In common with most nematode transcriptomic analyses, a
large proportion of expressed protein genes either lack identifiable
homology to proteins of other species, or only match hypothetical
C. elegans proteins. These included over 80 distinct sequences
incorporating a canonical signal peptide and found in either or
both L4 ES and HES (Table S1). Those unique to L4 ES were
designated Larval Secreted Proteins (LSPs) while those present in
HES adhered to the earlier designation of Novel Secreted Proteins
(NSPs). Some 17 distinct LSPs were identified, while a further 17
L4 ES proteins were among a total of 50 NSPs present in the adult
HES. The L4-specific proteins LSP-1 and LSP-2 were similar to
the adult-specific ES constituents NSP-28 and NSP-53, indicating
micro-adaptation of sequences to the different niches. Similarly,
seven closely related variants of NSP-3 were also identified, one of
which was found only in the L4 ES and two other only in HES. A
further grouping was formed by three L4 ES NSP-4-like proteins,
with homology to adult secreted NSP-4, 6, 10, 12, 18 and 44.
Adult HES contains an as yet unidentified TGF-b -like molecule
that is able to directly induce Foxp3+ regulatory T cells in the
presence of a mitogenic stimulus [51]. Using a TGF-b reporter cell
line, L4 ES was also shown to possess TGF-b activity (59.4614%
of the level present in adult HES over multiple batches), whereas
this was undetectable in ERM (data not shown). Scrutiny of the
mass spectrometric data did not reveal any peptides matching
either mammalian TGFb, or members of the TGF-b superfamily
previously identified within the genome and transcriptome of H.
polygyrus [52]. Hence, it is possible that the ability of HES to ligate
the mammalian TGF-b receptor is mediated by one of the novel
secreted proteins described above.
Protective and non-protective antigens following ES
immunisation
We noted earlier that ERM induced similarly high titers of anti-
HES IgG1 antibodies to those generated by protective L4 ES or
HES immunisation (Fig. 2 C) while failing to induce immunity,
suggesting that non-protective but cross-reactive epitopes were
well represented in these antigen preparations. We have previously
identified two non-protective immunodominant carbohydrate
epitopes in H. polygyrus with monoclonal antibodies, namely
Glycan A, an O-linked sugar attached to several VAL proteins
(including VAL-1), and glycan B, a proteoglycan-like structure
abundant in the adult worm soma [27]. Using the same
monoclonal antibodies, we found that whilst L4 ES contained
markedly less of both Glycans A and B than adult HES,
confirming previous work [27], ERM contained substantially
more glycan B than the other preparations (Fig. S4 E–F).
Consistent with this, Western blot analysis revealed serum IgG1
from HES and ERM, but not L4 ES, immunised animals showed
strong reactivity to a 65 kDa spot representative of glycan B (Fig. 7
A–D). All three preparations induced IgG1 reactivity against
VAL-1 spots, suggesting class-switched antibodies binding to
glycan A. Additionally L4 ES immunisation resulted in Western
reactivity to spots corresponding to ACE-1 (Fig. 7 C).
To identify potential protective protein antigens, we analysed
immunised sera through an immunoprecipitation protocol which
captures responses to conformation-dependent protein epitopes
[27]. Immunoprecipitation of biotin-labelled ES with sera from
immunised mice revealed a more extensive profile of targeted
antigens, with sera from L4 ES and HES immunised mice binding
to a range of proteins in both L4 ES and HES (Fig. 8 A). In
contrast, ERM immunisation did not elicit such antibodies,
providing further evidence that the high anti-HES IgG1 titers
generated bind almost exclusively to non-protective cross-reactive
glycans. On 2-D analysis, it was found that while HES
immunisation generated strong antibody recognition of VAL-1,
2 and 3, as well as ACE-1, L4 ES only induced antibodies against
VAL-1 and ACE-1, and these appeared responsible for the vast
majority of the observed immunological cross-reactivity between
the two preparations (Fig. 8 B–E). These data argue that the
minimal requirement for protective immunity is recognition of a
single VAL protein (VAL-1) and ACE-1.
Discussion
The larval and adult stages of parasitic nematodes often colonise
different physiological niches. Distinct immune pressures exerted
in each environment will likely be reflected in the preferential
expression of key genes and protein families capable of modulating
host immunity. In this regard, the tissue-phase ES material of the
intestinal nematode H. polygyrus was characterised by increased
expression of proteins associated with the regulation of comple-
ment (sushi-like) and T cell activation (SXC-like), as well novel
proteins of unknown function (e.g. NSP-3 family). However, other
proteins are common to both L4 ES and HES, and it is two of
these (VAL-1 and ACE-1) that are major antigenic targets in mice
rendered fully immune to challenge infection by vaccination with
either of these preparations.
We originally hypothesised that protective immunity induced by
ES immunisation would function by neutralising parasite immu-
nomodulatory molecules. Although no common mechanistic
function has yet been attributed to VAL proteins or the CAP
superfamily, it is notable that they are most prominent at interfaces
between organisms (virally-infected plants, insect venoms, hel-
minth parasite secretions and the mammalian male gamete) and in
some instances are associated with immunological down-modula-
tion [53,54]. Alternatively, immunisation may inhibit proteins
(such as ACE-1) with key but uncharacterised roles in parasite
metabolism, migration, and coordination. It is also possible that
vaccine-elicited antibodies protect through their Fc domains by
recruiting innate immune cells to kill the invading larvae,
hypotheses we are currently testing. Potential immunomodulatory
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roles can also be ascribed to the Sushi and SXC-like proteins.
Homologs of sushi proteins from vaccinia viruses are able to
inhibit both the classical and alternative pathways of complement
[55], whereas a SXC protein homolog from the sea anemone
Stichodactyla helianthus was shown to block mammalian potassium
channels, and hence was named ShK [56]. ShK proteins and
related sequences can inhibit calcium-dependent lymphocyte
activation [57], suggesting a direct immunomodulatory role for
ShK homologues from nematode parasites.
Helminth pathogens regulate their physiological and immuno-
logical environment through a spectrum of released products that
are being characterised by new high throughput technologies. Our
study on the mouse model H. polygyrus directly complements many
datasets with major human pathogens such as Brugia malayi [58–
62] and the hookworm species [63,64], as well as economically
important trichostrongylid nematodes [65–67]. Each of these
parasites has evolved specialised strategies adapted to particular
host species, and niches within those species, that will be mirrored
in the repertoire of secreted products, and our study provides
many examples of protein families which are differentially
expressed, expanded or regulated during the course of a parasite
life cycle. Importantly, in view of the lack of anti-helminth vaccines
for human use, we have also tested ES products from larval and
adult stages for their ability to induce sterilising immunity and in
combination with the proteomic database, have now identified
potential vaccine antigens for future appraisal. Taken together,
these analyses have defined an extensive and novel repertoire of
protein candidates from H. polygyrus that can be taken forward for
functional and immunological testing in a tractable and naturally
adapted host-parasite model system.
Materials and Methods
Ethics statement
All animal protocols adhered to the guidelines of the UK Home
Office, complied with the Animals (Scientific Procedures) Act
1986, were approved by the University of Edinburgh Ethical
Review Committee, and were performed under the authority of
the UK Home Office Project Licence number 60/4105.
Parasite maintenance and preparation of ES material
CBAxC57BL/6F1 mice were infected by gavage with 500 L3
stage larvae of H. polygyrus bakeri (originally provided by Professor J
M Behnke, University of Nottingham, UK). Day 5 4th stage larvae
and day 14 adults were washed, cultured in serum free media and
the ES concentrated as before [25,27]. For egg released material
(ERM), in vitro released eggs from adult worms were washed and
cultured for 3 days in serum free media before concentration and
diafiltration into PBS using 5000 MWCO spin columns (Vivaspin).
L4 produced 1062 ng ES protein/larva/day, compared to adult
worm production of HES at 1862 ng/adult/day. Eggs cultivated
for 3 days in vitro released 56615 pg protein/egg/day. Somatic
extracts of L4 and egg were prepared with a Qiagen tissuelyser.
2-D gel electrophoresis, LC-MS/MS and bioinfomatics
L4 ES, adult HES, ERM, L4 extract and egg extract (10 mg)
were separated by 2-D gel electrophoresis, protein spots of interest
excised, trypsinised and analysed by MALDI, or trypsinised and
assessed by LC-MS/MS as previously described [25,27]. MS
spectra were submitted to a locally running copy of Mascot (v2.3,
Matrix Science) and searched against an improved in-house
BLASTx annotated database of .57K isotigs and .92K
singletons obtained by 454 sequencing of H. polygyrus infective
L3, day 3 larvae, day 5 larvae, adults and eggs, with additional full
length H. polygyrus sequences from NCBI and our own Sanger
sequencing (Harcus Y. et al, manuscript in preparation). Search
parameters required trypsin specificity, cysteine modification,
possible oxidation of methionine, and allowed one missed
cleavage. Gel spot identifications had a peptide tolerance of
100 ppm and MS/MS tolerance of 0.5 Da, with peptide expect
scores ,0.05. MudPit scoring was used for LC-MS with a ,0.05
Figure 7. ERM immunization elicits class-switched anti-glycan B antibodies. A–D Western blot analysis of IgG1 antibodies from (A) naı¨ve, or
pre-challenge (B) HES, (C) L4 ES and (D) ERM immunised mice. Spots corresponding to VAL-1/glycan A (blue), glycan B (orange) and ACE-1 (purple) are
shown. Molecular weight markers (kDa) are indicated.
doi:10.1371/journal.ppat.1003492.g007
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Figure 8. HES and L4 ES immunization both induce recognition of VAL-1 and ACE-1. A. 1-D immunoprecipitation (IP) of biotin-labelled
HES (Bio-HES) and L4 ES (Bio-L4ES) with naı¨ve mouse serum (nms) or sera from mice vaccinated with HES, L4 ES or ERM taken immediately before
challenge with live larvae. Total biotin-labelled L4 ES and HES are included for comparison. B–E. 2-D immunoprecipitation of biotin-labelled HES (B–
C) and L4 ES (D–E) with anti-HES (B, D) or anti-L4 ES (C, E). Spots corresponding to VAL-1 (blue), VAL-2 (red), VAL-3 (green) and ACE-1 (purple) are
shown. Molecular weight markers (kDa) are indicated.
doi:10.1371/journal.ppat.1003492.g008
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significance threshold. Single peptides were more stringently
filtered for expect values ,0.01. Each protein had at least one
peptide not present in higher ranked hits and was manually
inspected for open reading frames. Peptide false discovery rates
were estimated using a decoy database (0.88% L4 ES; 2.18%
HES; 1.5% ERM). Identified ORF were assessed for protein
domains (Pfam v26.0) and N-terminal signal peptides (SignalP
v4.0). The statistical significance of Pfam domain enrichment was
determined for selected subsets using the hypergeometric functions
of the ‘‘Category’’ Bioconductor package. Protein abundance was
estimated by emPAI (exponentially modified protein abundance
index [31] which calculates the ratio of observed:observable
peptides. Spectral counts were also included for comparison.
Sequence alignments and phylogenetic trees were carried out with
MacVector (v11.1.1) and COBALT (NCBI). Heat maps and
sequence clustering were generated with Artemis (Wellcome Trust
Sanger Institute). When analysing stage-specific expression,
proteins were treated as isogroups (i.e. closely related micro-
variants of the same protein, likely representing alleles), meaning
proteins were classed as shared even if the specific isotig was not
detected (‘‘shared isogroups’’). Such analysis ensured that the
determination of stage-specific protein expression was not skewed
by the presence or absence of closely related alleles, detection of
which likely depends on the relative abundance of the protein in
the sample rather than any biological significant difference.
Vaccinations
C57BL/6 female mice were immunized with 5 mg L4 ES, HES,
ERM or PBS control i.p. in alum adjuvant, boosted on days 28
and 35 with 1 mg in alum i.p., before oral challenge with 200 H.
polygyrus L3 at day 42. Fecal egg counts were determined at days
14, 21 and 28 post-challenge, and adult worms counted at day 28.
ELISAs, Western blots and IP
Serum was obtained by tail bleeds from vaccinated mice
immediately prior to challenge and assessed for anti-L4 ES, HES
or ERM IgG1 reactivity as described before [27]. VAL-1, 2 3, and
4, glycan A and B levels in the different ES preparations was
determined using specific mAb obtained from primary infection
(anti-VAL-1, 4-M15; anti-VAL-2, 4-S4; anti-VAL-4, 2–11; anti-
glycan A, 13.1), secondary infection (anti-VAL-3, 5-S1) and HES
immunisation (anti-glycan B, 9.1.3) ([27] and Filbey K.J et al,
manuscript in preparation]. Western blotting of unlabelled HES,
biotin-labelling and IP of ES material, followed by blotting and
strep-HPO visualisation was carried out as before [27].
TGF-b bioassay
MFB-F11 cells [68] were cultured as before [51]620 mg/ml ES
material or with varying amounts of rhTGF-b1 standard (R & D
systems). After 24 hours, supernatants were collected and alkaline
phosphatase activity determined with SEAP reporter assay kit
(InvivoGen) as per manufacturer’s instructions.
Statistical analysis
Statistical significance was determined by ANOVA or Mann-
Whitney test where indicated. Correlation was measured with
Spearman’s rank as emPAI values are non-parametric. All
statistical analysis were performed using Prism (v6.0)
Supporting Information
Figure S1 L4 ES protein composition is more similar to
HES than is ERM. A. Comparison of emPAI values for proteins
shared between L4 ES and HES. Spearman r values indicate
correlation coefficients, line indicates linear regression
(*** = p,0.001). B. As above for proteins shared between ERM
and HES (n.s. = non-significant). C. Heat map of emPAI values
for core 60 proteins shared between L4 ES, HES and ERM
indicating differential expression. D. As above, for L4ES-HES
shared proteins. E. As above, for HES-ERM shared proteins.
(EPS)
Figure S2 Gene expression (RPKM) heat-maps of HES-
specific and ERM proteins. A. HES -specific proteins,
clustered by gene expression profiles in a transcriptomic dataset
based on 5 life cycle stages (infective L3, d3 post-infection L3, d5
post-infection L4, Adult, and Egg). RPKM=Reads Per Kilobase
Mapped. Scores are coloured on a log2 scale with red maximum
and blue minimum. B. As above for proteins found only in ERM.
(EPS)
Figure S3 Stage-specific gene expression of L4 ES
proteins. Comparison of emPAI values of L4 ES proteins with
RPKM gene expression levels from: A. Infective stage L3 larvae
B. Day 3 post-infection L3 larvae C. Day 5 post-infection L4
larvae D. Adult worms E. Eggs. Spearman r values indicate
correlation co-efficients (*** = p,0.001; n.s. = non-significant).
(EPS)
Figure S4 A. Levels of VAL-1 in L4 ES (blue), HES (red)
and ERM (yellow) determined by reactivity with the
mAb 4-M15 [27]. B. As above for VAL-2 (mAb 4-S4). C. As
above for VAL-3 (mAb 5-S1). D. As above for VAL-4 (mAb 2–
11). E. As above for Glycan A (mAb 13.1). F. As above for Glycan
B (mAb 9.1.3).
(EPS)
Figure S5 Sushi-domain proteins. A. Phylogenetic tree of
Sushi-domain containing proteins in L4 ES and HES. Blue
domains indicate significant Pfam matches (E-value,0.01) to
Sushi domain (pf00084); green domains indicate lower level
similarities (E-value 0.01–0.05) retaining recognisable homology to
pf00084. Signal peptides are depicted in yellow, presumed N-
terminal truncations by broken lines, and stretches of .50 amino
acids without detectable homology are indicated by black bars. B.
Heat maps showing protein (emPAI) and transcript (RPKM)
expression of indicated sushi-like proteins.
(EPS)
Figure S6 ShK/SXC-like proteins. A. Cartoon indicating
domain structure of ShK/SXC-like proteins (top) compared to
other ShK domain proteins (bottom). ShK domain indicated by
orange, N-terminal signal sequence by yellow, astacin domains by
purple and presumed N-terminal truncation by broken lines. Heat
maps showing protein (emPAI) and transcript (RPKM) expression
of indicated proteins also shown. B. Sequence alignment of ShK/
SXC-like proteins indicating mature protein following removal of
N-terminal signal peptide. Positions of the canonical 6 conserved
cysteine residues are indicated in yellow.
(EPS)
Table S1 Full A-Z list of proteins identified in L4 ES.
‘‘emPAI rank’’ represents ranked abundance, ‘‘spectral count’’ is
total number of peptides mapped to the protein of interest,
whereas ‘‘peptides’’ is the number of different peptide sequences
detected. ‘‘SS?’’ shows +/2 N-terminal signal sequence, with *
indicating the sequence is N-terminally truncated but its closest
BLAST homolog is SS+ve. emPAI values for L4 ES, HES and
ERM are indicated, as are RPKM transcript levels for L3, day 3,
day 5, adult and egg. Proteins present only as ‘‘shared isogroups’’
(see materials and methods) are shared grey. One protein
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previously identified in HES, CSP-4, is present in 3 fragments in
the transcriptomic assembly, and is only counted once.
(XLSX)
Table S2 Full A-Z list of proteins identified in HES. As
above for HES.
(XLSX)
Table S3 Full A-Z list of proteins identified in ERM. As
above for ERM.
(XLSX)
Table S4 Full list of Pfam domains in different ES
preparations. Pfam domains present in ES proteins listed by
expression pattern. emPAI and RPKM values included to show
relative expression.
(XLSX)
Table S5 Enrichment of Pfam domains in different ES
preparations. Pfam domains present in ES proteins ranked by
statistical significance compared to their frequency in the H.
polygyrus transcriptome assembly.
(XLSX)
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939J O U R N A L O F P R O T E O M I C S 7 5 ( 2 0 1 2 ) 9 3 8 – 9 4 8pattern recognition receptors (PRRs) on the DC plasma mem-
brane leading to subsequent activation and maturation of the
DCs. Conversely, molecules from helminths, which are potent
inducers of Th2-type responses, stimulateDCswith a ‘modified’
phenotype [3–7] but it is unclear how/why these DCs promote
Th2-type immunity. Pro-Th2 DCs may have a distinct pheno-
type, defined by a unique profile of signature molecules [4,5],
or may resemble immature DCs, stimulating Th2 polarisation
via a ‘default’ pathway in the absence of Th1-inducing stimuli
[8]. An ‘inhibition model’ in which Th2-stimuli inhibit Th1
polarisation by DCs through competitive signalling pathways
has also been proposed [9].
Changes in DC gene expression correlate poorly with
changes in the level of protein expression [10,11]. Therefore, as
protein expression is a better indicator of cell phenotype and
function, a number of studies have examined the proteomes
of differentially matured DCs [12–15]. For example, 2-DE and
MS/MS have revealed changes in the proteome of pro-Th1 DCs
matured with LPS versus pro-Th2 DCs stimulated with excreto-
ry/secretory (E/S)material fromaparasitic helminth Schistosoma
mansoni [14]. This E/S material, released by the parasite during
infection and known as ‘0–3hRP’, is an important stimulant of
innate immune cells in the skin [16,17] enablingDCs to promote
Th2 responses in vitro and in vivo [7]. Proteomic analysis of pro-
Th1 DCs revealed up-regulated expression of cytoskeletal pro-
teins and chaperonemoleculeswhereas pro-Th2DCs, stimulat-
ed with 0–3hRP, exhibited a proteome intermediate between
that of immature DCs and pro-Th1 DCs; thus termed a ‘limited
maturation’ phenotype [14]. As soluble cytosolic molecules
dominated the cell extracts used in the study, immune-
associated proteins from the plasma membrane (e.g. PRRs, ad-
hesion molecules, MHC complexes and costimulatory mole-
cules) were not readily detected. Although such molecules are
likely to be highly relevant with respect to differential matura-
tion of DCs, their low abundance and hydrophobic nature
makes them difficult to isolate for proteomic characterisation.
In order to ‘home in’ on the detection of specific plasma
membraneproteinswhichare likely to be important in differen-
tial DC maturation, we compared proteins enriched from plas-
ma membranes of immature DCs, pro-Th1 DCs stimulated
with LPS and pro-Th2 DCs stimulatedwith schistosome egg an-
tigen (SEA) which is a well characterised pro-Th2 helminth
product [3]. First, DC plasma membrane-enriched fractions
were analysed by shotgun LC–MS/MS to establish a list of pro-
teins associated with DCs. Second, a gel-free technique using
iTRAQ [18,19] was used to quantify changes in protein expres-
sion following differential DC maturation. By performing three
biological replicates of each type of DCs and confirming proteo-
mic data by flow cytometry, we identified a number of proteins
that were differentially expressed by pro-Th1 versus pro-Th2
DCs.2. Materials and methods
2.1. Generation and maturation of DCs from bone marrow
Bone marrow-derived dendritic cells (BM-DCs) from female
C57BL/6 strain mice were cultured in RPMI medium containing
10% low endotoxin FCS plus 20 ng/mL GM-CSF (Peprotech,139London, UK) as previously described [7,14]. All experimental
procedures were undertaken with the guidelines of the United
KingdomAnimal's Scientific Procedures Act 1986 and approved
by the University of York Ethics committee. On day 6, immature
BM-DCs were seeded at 1×106/mL and cultured for 18 h
alone (MED-DCs), or in the presence of 40 μg/mL SEA [3]
(SEA-DCs), or 10 ng/mL LPS (from Escherichia coli strain 0111:B4,
Sigma-Aldrich, Poole, UK; LPS-DCs) [14]. After overnight culture,
cells were harvested and prepared for proteomic analysis.
2.2. Preparation of DC plasma membrane-enriched
fractions
Plasma membrane proteins from MED-DCs, SEA-DCs and
LPS-DCs were extracted andpurifiedusing a plasmamembrane
protein extraction kit (BioVision,Mountain View, USA). All steps
were performed at 4 °C. Briefly, BM-DCs were mechanically
homogenised in an ice-cold glass cell grinder and then spun at
700 g. The resulting supernatants were spun at 10,000 g for
30 min to yield total membrane protein (i.e. plasma and cellular
organelle membranes) enriched pellets which were re-
suspended in ‘Upper Phase solution’ and mixed with an equal
volume of ‘Lower Phase solution’ before centrifugation at
1000×g for 5 min. The upper phase was spun at 25,000 g for
10 min, and the resulting plasma membrane-enriched pellet
solubilised in 0.5% Triton X-100. Total protein content was
assessed by densitometry of SYPRO Ruby stained 1-D electro-
phoresis gels (NuPAGE 4–12%) against knownquantities of cyto-
solic fractions as standards separated on the same gel.
2.3. Digestion and iTRAQ labelling
Plasma membrane-enriched fractions (35–50 μg) were reduced
with 2 mM tris-(2-carboxyethyl)phosphine in 0.5 M triethylam-
monium bicarbonate (Sigma-Aldrich) pH8.5, at 60 °C for 1 h,
alkylatedwith 10 mMmethylmethanethiosulfonate (Sigma-Al-
drich) at room temperature for 10min and digested overnight
with sequencing-grade porcine trypsin (Promega, Madison,
USA) at 37 °C. The iTRAQ labelling reagents (114, 115, and 116;
Applied Biosystems, Framingham, USA) were reconstituted in
isopropanol and added to the digests. After 2 h, labelled pep-
tides were combined and purified using cation-exchange and
C18 cartridges. Although iTRAQ allows for the multiplexing of
several samples in a single run, comparison is performed in a
pair-wise manner. In this respect, a common reference sample
between iTRAQ analyses is essential. However, a pooled stan-
dard is not universally required if the samples are suitably sim-
ilar, as in our study, where MED-DC is taken as a common
standard across all runs [20].
2.4. LC–MS/MS
Peptides were separated using a Dionex polystyrene-
divinylbenzene column and fractions collected directly onto a
target plate with addition of CHCA matrix. Positive-ion MALDI
mass spectra were acquired using an Applied Biosystems 4700
Proteomics Analyzer in reflectron mode over a mass range of
m/z 800–4000. Monoisotopic masses were obtained from cen-
troids of raw, unsmoothed data. The 20 most intense peaks
with a S/N≥50 from each fraction were selected for CID-MS/MS
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mass window set to a relative resolution of 50 and metastable
suppressor enabled. MS/MS spectra were baseline-subtracted
(peak width 50) and smoothed (Savitsky–Golay; three points;
polynomial order 4); peak detection used S/N≥5, local noise
window 50m/z and minimum peak width 2.9 bins. Mascot
peak list files were generated using the TS2Mascot utility
(Matrix Science, version 1.0.0) with S/N≥10.
2.5. Protein identification and quantification
Peak lists were searched against the CDS (Celera Discovery Sys-
tem™, KBMS3.0.20040121) mouse database (65,307 sequences;
23,201,165 residues) using Mascot (Matrix Science Ltd., version
2.1). Search criteria specified: Enzyme, Trypsin; Maximum
missed cleavages, 1; Fixed modifications, Methylthio (C); Vari-
able modifications, Oxidation (M); Peptide tolerance, 0.3 Da;
MS/MS tolerance, 0.3 Da; Instrument, MALDI-TOF-TOF. When
searching iTRAQ peak lists the fixedmodifications, iTRAQ4plex
(N-term) and iTRAQ4plex (K), and the variable modification
iTRAQ4plex (Y), were also specified. The Mascot significance
threshold for protein identificationwas adjusted in each search
to give a false discovery rate of approximately 1%. Only peptides
that met or exceeded their identity score at this significance
threshold and had an expect score less than 0.05were accepted,
including single-peptide protein matches. Where peptides
match to multiple members of a protein family, the protein
that tops the Mascot protein group and hence has the highest
number of unique peptides, is reported. Mascot was used for
iTRAQ quantification with these options: normalisation by me-
dian ratio; automatic outlier removal; median ratios for protein
ratios. Fold changes were accepted only with three peptides.
Each iTRAQ experiment included three biological replicates.
2.6. Sub-cellular and Gene Ontology classification of proteins
Sub-cellular classificationswere performedwith GeneOntology
classification (http://www.ebi.ac.uk/GOA/) according to the ac-
cession number of protein identities in Uniprot. If no classifica-
tion was found, Mouse Genome Informatics website (http://
www.informatics.jax.org/) and the Proteome Analyst v3.0
(http://pa.cs.ualberta.ca:8080/pa/) were used. Finally, if no pre-
diction was available, we referred to published literature. Pro-
teins identified as ‘plasma membrane’ included formations
such as lipid rafts, endosomes, phagocytic cups and phago-
somes. ‘Cytosol’ comprised cytosolic, cytoplasmic proteins
and vesicles. Cytoskeletal proteins were given a particular col-
umn although most are also cytosolic. Ribosome proteins were
classified as belonging to the ‘ER’, whilst proteins associated
with the Golgi apparatus, late endosomes and lysosomes,
were defined as ‘Golgi’. However, classification of proteins into
discrete compartments is arbitrary depending upon original
allocation by bio-informatic interrogation andmay be best allo-
cated tomore than one classification. Protein hits that were ob-
served to be differentially regulated (i.e. SEA-DCs vs MED-DCs,
and LPS-DCs vs MED-DCs) were analysed according to Gene
Ontology (GO) classification using Visual Annotation Display
(VLAD; proto.informatics.jax.org/prototypes/vlad-1.0.3/). Signif-
icant hits were selected on the basis of their p-value and the
number of proteins(k) found within each category.1402.7. Validation of protein expression by flow cytometry
Differentially matured DCs were blocked with anti-CD16/32
mAb (BD Pharmingen, Oxford, UK) in PBS (supplemented with
1% FCS and 5mMEDTA) and subsequently labelledwith the fol-
lowing conjugated mAbs against: CD18-biotin (M18/2), CD29-PE
(HMb1-1), CD44-FITC (1C10), CD98-FITC (RL388), IA/IE-FITC (M5/
114.15.2), Galectin-3-biotin (M3/38; all from eBioscience,
Hatfield, UK), I-Ab biotin (28-16-8S; Caltag Medsystems,
Buckingham, UK) and CD301b-AF647 (ER-MP23; AbD Serotec,
Kidlington, UK). Biotin conjugated antibodies were probed
with streptavidin-APC (Caltag Medsystems). Unlabelled rabbit
polyclonal antibodies were used to probe for S100A10 (Abcam,
Cambridge, UK), YM-1 (STEMCELL Technologies, Grenoble,
France) and Rab-7 (Sigma-Aldrich), and were subsequently
detectedwith anti-rabbit AF488 antibody (eBioscience). All anti-
body concentrations were optimised and labelling was per-
formed alongside relevant isotype controls. Flow cytometric
acquisition and analysis was performed using a Cyan ADP ana-
lyser with Summit v4.3 (DakoCytomation, UK). Data were plot-
ted as means of the median fluorescence intensity (MFI) of
three separate DC cultures for each maturation stimulus.3. Results
3.1. Sub-cellular classification of proteins identified by
shotgun LC–MS/MS
Initial shotgun LC–MS/MS proteomic analyses of DC frac-
tions were performed to validate the isolation technique. In
MED-DCs, 119 significant hits were identified (Supp. Table 1)
of which 37% were classified by Gene Ontology as plasma
membrane (Fig. 1A). In SEA-DCs and LPS-DCs, 149 and 61 pro-
teins respectively were identified (Supp. Tables 2 and 3) with
32% and 52% from the plasma membrane (Fig. 1A). The frac-
tions also contained cytosolic (19%), cytoskeletal (15%) and
nuclear proteins whilst extracellular, ER and Golgi proteins
were only minor components. In six different purification ex-
periments, the enrichment for plasma membrane proteins in
the fractions, compared to the total cell, was 23.4±3.1. Conse-
quently, we concluded that the isolation technique yielded
fractions greatly enriched in plasma membrane molecules.
Plasma membrane molecules (shaded rows in bold text of
Supp. Tables 1, 2, and 3) comprised those with a CD prefix
(18%) and ras-related proteins (rho, rac, rab and rap; 17%)
which were highly represented from all three types of DC.
Other abundant molecules were MHC class I and II molecules
for LPS-DCs (13%) and guanine nucleotide-binding proteins
(GNBPs) in MED-DCs (11%). Annexins (1, 2, 4 and 5) and S100
proteins represented 10% and 5% respectively, of plasma
membrane proteomes of all DC types.
3.2. Plasma membrane proteomes of differentially matured
DCs after iTRAQ labelling
The number of hits identified after iTRAQ labelling in SEA-
DCs versus MED-DCs, and LPS-DCs versus MED-DCs increased
compared to the number of hits in SEA-DCs and LPS-DCs iden-
tified solely by LC–MS/MS (+66% and +46% respectively; Supp.
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Fig. 1 – Sub-cellular classification of the total identified proteins. Pie-charts showing the classification of total protein identities
in plasma membrane fractions obtained from MED-DCs, SEA-DCs and LPS-DCs determined by LC–MS/MS (A). Pie-charts
showing the classification of the total hits obtained from three technical replicates of iTRAQ experiments comparing SEA-DCs
or LPS-DCs versus MED-DCs (B).
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ome coverage and database searching of multiple peptides
per protein improved the confidence of the identifications.
Nevertheless, the proportion of hits identified after iTRAQ la-
belling and classed as plasma membrane were similar to that
revealed by shotgun LC–MS/MS.
Compilation of hits identified in the three separate iTRAQ
experiments of SEA-DCs versus MED-DCs showed that 222
proteins were significantly identified with 45% being classed
as plasma membrane components (Fig. 1B, Supp. Table 4)
while a similar proportion (44%) was identified in LPS-DCs ver-
susMED-DCs (Fig. 1B, Supp. Table 5). Overall, a greater propor-
tion of hits were identified as nuclear proteins in SEA-DCs
versus MED-DCs (18%) compared to LPS-DCs versus MED-DCs
(8%) whereas a greater proportion of proteins in LPS-DCs ver-
sus MED-DCs were mitochondrial, extracellular and associat-
ed with the Golgi apparatus.1413.3. Up- or down-regulated proteins from differentially
matured DC membrane-enriched proteomes
In order to assess variance in iTRAQ quantification experi-
ments, Spooncer et al. [21] devised a form of analysis to com-
pare separate preparations of the same biological material
[22]. Ratios obtained by comparing separate preparations of
the same material plotted against the number of peptides
identified (Fig. 2) should cluster around unity (i.e. protein
levels should be the same between replicates). The extent to
which values deviate from unity is an indication of the biolog-
ical and technical variance. This approach provided a power-
ful visual indication of where to set the significance threshold.
Our iTRAQ experimental design consisted of six label-
ling experiments (Table 1), in which three preparations of
SEA-DCs and three preparations of LPS-DCs were analysed.
MED-DC fractions were labelled with 114 and 116 iTRAQ
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Fig. 2 – Whetton's plot. iTRAQ reporter-ion ratios for all proteins in the control versus control comparisons using the 114 and
116 reagents. A total of 355 protein ratios were plotted against the number of peptides that contributed to the ratio. Shading
zones represent two levels of threshold: at log(ratio) values of ±0.1 (ratios 0.79–1.26 in mid-grey) and a less stringent threshold
of ±0.04 (ratios 0.9–1.1 in light grey).
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LPS-DC preparations were labelled with 115. All the protein
ratios from the six control–control (114:116) comparisons
(355 in total) are shown in Fig. 2. As a more stringent thresh-
old, we chose log(ratio) values of ±0.1, which correspond to
ratios of 1.26 and 0.79; a less stringent threshold of ±0.04,
which correspond to ratios of 1.1 and 0.9 was also used.
Only changes where the average log(ratio) ±SEM-95%
exceeded these thresholds were considered significant as
given for SEA-DCs versus MED-DCs (Fig. 3, Supp. Table 6)
and LPS-DCs versus MED-DCs (Fig. 4, Supp. Table 7). The
more stringent threshold is shown as shaded bars and rows.
In SEA-DCs versus MED-DCs, the greatest up-regulation
was for nuclear proteins (mainly histones) while several pro-
teins associated with antigen uptake, processing and presen-
tation (chaperones, clathrin, enzymes and the small GTPase
Rab-7) were also up-regulated (Fig. 3, Supp. Table 6). Other
molecules which were significantly up-regulated included:
S100A9, 14-3-3β/α (part of TGFβ family), lymphocyte cytosolic
protein 1 and lysozyme C. In contrast, decreased expression
was observed for FcεRI, Rap-1B, hematopoietic cell specific
lyn substrate 1, CD44, several annexins, MHC class II molecule
(I-A), subunit 2 of actin-related protein 2/3 (Arp2/3) complex,
lymphocyte-specific 1 protein (LSP1) and S100A10 (Fig. 3,
Supp. Table 6). Down-regulation was also recorded for certain
cytoskeletal proteins (ezrin, moesin, myosin and several iso-
forms of actin). Themost pronounced down-regulation affect-
ed a protein not expected to be expressed by DCs: NAP-22
(22 kDa neuronal tissue-enriched acidic protein). Finally, sev-
eral immune-related proteins were expressed at similar levels
between SEA-DCs andMED-DCs (Fig. 3) including the integrins
CD11b and CD18, the macrophage lectin CD301b, CD98
heavy chain, CD45, as well as MHC class I molecules (H-2Db
and H-2Kb) and their associated β2-microglobulin. Also
expressed at similar levels was the subunit 4 of Arp2/3 com-
plex, proteins involved in general cell metabolism and the
ras-related proteins Rac-1, -2, -3 together with cdc42.
Several proteins were highly up-regulated in LPS-DCs versus
MED-DCs (Fig. 4, Supp. Table 7) includingMHC class IImolecules142(IA-α representing the highest increase), CD98 heavy chain,
β2-microglobulin and transgelin 2. Intriguingly, NAP-22 was
up-regulated in LPS-DCs versus MED-DCs (it was down-
regulated in SEA-DCs versus MED-DCs). The integrin CD29
(β subunit of VLA-4) was also up-regulated but not identified
between SEA-DCs versus MED-DCs. Down-regulation affect-
ed S100A10, moesin and CD44, as also reported for SEA-DCs
versus MED-DCs. Additionally, we observed specific de-
creased expression of CD18, both chains of ATP synthase
and the precursor of cathepsin D. Significantly, expression
of the secretory protein YM-1, associated with ‘alternative-
ly-activated’ macrophages, was also highly down-regulated
in LPS-DCs versus MED-DCs. Proteins whose expression was
unchanged between LPS-DCs versus MED-DCs were GAPDH,
several ras-related proteins (including Rab-7), several actin
isoforms and galectin-3.
Analysis of protein classification according to GO terms
revealed that SEA-DCs had numerous (k=17) up-regulated pro-
teins related to cellular metabolism, in particular Nucleoside
phosphate metabolic processing (Table 2). These cells also
exhibited up-regulated proteins associated with cytoskeleton
remodelling specifically a number linked to the formation of
cell projections (k=13). On the other hand, SEA-DCs had
down-regulatedproteins associatedwith responses to chemical
stimulation (k=10) and GTPase activity (k=5). Interestingly,
down-regulated protein hits also mapped to those associated
with antigen processing, and regulation of the adaptive im-
mune response. In contrast, up-regulated proteins in LPS-DCs
mapped clearly to antigen presentation and the MHC protein
complex, whilst down-regulated proteins were associated with
transmembrane transporter activity, catabolic processes and
responses to wound healing (all k=3).
3.4. Extrapolated changes between pro-Th2 DCs and pro-
Th1 DCs
As we could not directly compare SEA-DCs versus LPS-DCs
(due to the constraints of the availability of only 3 iTRAQ la-
bels), we made an extrapolation of the above data in order to
Fig. 3 – Changes on plasma membrane enriched-proteome of SEA-DCs versus MED-DCs. Up- and down-regulation of DC
proteins as average log(ratio)±standard error-95%, obtained from three iTRAQ experiments with criteria for acceptance clearly
stated in the Results section.
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and pro-Th1 DCs (Table 3). Amongst the proteins identified
both in SEA-DCs versus MED-DCs and LPS-DCs versus
MED-DCs, moesin, CD18, CD44 and Rab-7 were increased in
SEA-DCs compared to LPS-DCs. Conversely, transgelin 2,
NAP-22, MHC class II, annexin A1 and A4, β2-microglobulin,
S100A10 protein, two actin isoforms and Rap-1b were down-
regulated. The only protein similarly expressed by both
types of differentially matured DCs was GAPDH.1433.5. Validation of protein expression by flow cytometry
Several proteins identified by our iTRAQ studies, for which
commercially available antibodies are available, were validat-
ed for changes in expression by flow cytometry (Fig. 5).
The MHC class II molecules IA-b and IA/IE were both signifi-
cantly up-regulated on LPS-DCs compared to SEA-DCs and
MED-DCs, confirming the changes in expression recorded
using iTRAQ. CD29 and S100A10 were also up-regulated on
Table 1 – Experimental design for iTRAQ. Summary of the
six experiments comparing plasma membrane proteins
from separate cultures of DCs grown in medium only
(MED #1–6), or stimulated with SEA (SEA #1–3) or LPS (LPS
# 1–3).
iTRAQ Label
Expt # 114 115 116
1 MED-1 SEA-1 MED-1
2 MED-2 SEA-2 MED-2
3 MED-3 SEA-3 MED-3
4 MED-4 LPS-1 MED-4
5 MED-5 LPS-2 MED-5
6 MED-6 LPS-3 MED-6
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analysis. Whilst CD98 was up-regulated in both LPS-DCs and
SEA-DCs compared to MED-DCs, CD18 was only up-regulated
in SEA-DCs and was more abundant than in LPS-DCs. CD44
was expressed at higher levels in SEA-DCs than LPS-DCs.
Several molecules were expressed at similar levels in all
three types of DCs (i.e. galectin-3 and CD301b) corroborating
proteomic analysis, although the expression of Rab-7 which
was elevated at the proteomic level in SEA-DCs compared to
LPS-DCs, was not differentially expressed as judged by flow
cytometry. Finally, the secretory molecule YM-1, which was
significantly down-regulated in LPS-DC versus MED-DC as de-
termined by iTRAQ, was also down-regulated as judged by
flow cytometry, although it was detected at slightly lower
levels in SEA-DCs compared to MED-DCs.4. Discussion
Over thepast decade, proteomicshas beenutilised todetermine
differences between various immune cells [23] and in particular
to study differences betweenwhole cell extracts from immature
DCs and differentially matured DCs with various PAMPs [24].
Mainly, these studies have employed 2-DE-based proteomics-0.50 -0.40 -0.30 -0.20 -0.10 -0.00
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144and highlighted changes in the expression of cytoskeletal and
cytoplasmic molecules needed for basic cellular functions
[12–14,25]. Such an approach favours soluble and abundant cy-
tosolic proteins but compromises the detection of scarcer and
detergent-soluble proteins, such as those present in plasma
membranes. In the present study, we focussed upon the pro-
teomes of plasmamembrane-enriched fractions of differential-
ly matured DCs. Although the fractions isolated were relatively
crude, they were clearly enriched in plasmamembrane compo-
nents (~30–50%).
Indeed, LC–MS/MS has several advantages in the analysis
of plasma membrane components. First, it requires only low
amounts of any given protein for MS analyses, so is suitable
for scarcer proteins. Second, digestion of enriched mem-
branes can be performed in the presence of trace amounts of
ionic detergents which, along with the use of reducing and
alkylating reagents, allows for improved trypsin cleavage
leading to higher sequence coverage for a given protein.
Furthermore, labelling peptides with iTRAQ tags prior to
LC–MS/MS allows the relative amounts of a protein to be de-
termined in different cell groups, which is difficult to be ac-
curately demonstrated by ‘label-free’ LC–MS/MS.
As revealed by our ‘label-free’ shotgun proteomics and
found in all three types of DCs, the most abundant molecules
associated with the plasma membrane including those with a
CD prefix, ras-related proteins, MHC molecules and GNBPs.
Others included proteins associated with membrane and ves-
icle trafficking such as the calcium-sensitive annexins [26]
and phagocyte-specific S100 calcium binding proteins which
are major damage associated molecular patterns [27]. The
three differentially matured DCs also all expressed lympho-
cyte cytosolic protein 1 (also called 65 kDa macrophage pro-
tein), LSP-1 (F-actin binding protein) and FcεRI, although
various immune associated proteins were only found in one
or two of the DC types. For instance, immature MED-DCs and
pro-Th2 SEA-DCs both expressed CD11b, CD44, CD45 and
CD48, while both pro-Th2 DCs and pro-Th1 DCs expressed
the heavy chain of CD98 which is involved in activation of
naive and memory CD4 and CD8 T cells [28], thereby arguing
against the ‘default’ hypothesis of pro-Th2 DCs.0.10 0.20 0.30 0.40 0.50
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Fig. 5 – Validation of protein expression on DCs judged by flow cytometry of antibody labelled cells. Various molecules
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comparison and quantification of changes in the plasma
membrane proteome, many of which being confirmed by
flow cytometry. As our study compared three biological repli-
cates of each type of DCs, we were able to determine whether
changes in the level of protein expression were reproducible.
Our study revealed significantly increased levels of MHC
class II molecules in pro-Th1 DCs, which were unchanged or
decreased in pro-Th2 DCs. Surprisingly, CD29 which mediates
the interaction of immature DCs with extracellular matrix
components, and thus with a likely role in the retention of
DCs in the periphery [29,30], was also highly expressed by
LPS-DCs versus immature DCs. Conversely, pro-Th2 SEA-DCs
expressed increased levels of proteins like CD18 and CD44.145The greatest decrease of any protein expressed in pro-Th2
SEA-DCs was for NAP-22 (also called BASP-1 or CAP-23) where-
as it was greatly up-regulated on pro-Th1 DCs. This molecule
was originally identified as a membrane/cytoskeletal protein
from rat brain and is a member of a family of motility associ-
ated proteins linked to actin reorganisation and neurite devel-
opment [31,32]. Recently, it has been defined in the context of
blocking oncogenic Myc protein-induced cell transformation
[33]. Although this molecule was not expected to be expressed
by DCs, and has not previously been identified as having de-
monstrable immune function, its differential distribution be-
tween pro-Th1 versus pro-Th2 is intriguing and warrants
further investigation. One of the most down-regulated mole-
cules in pro-Th1 LPS-DCs versus MED-DCs was YM-1 as
Table 2 – Analysis of differentially regulated proteins according to Gene Ontology term. Proteins were analysed for GO term
enrichment and presented as up-regulated (top panel), or down-regulated (bottom panel) for SEA-DCs and LPS-DCs.
Significance is given as p-value, whilst the number of different proteins identified within a given classification is presented
as k.
SEA-DCs versus MED-DCs LPS-DCs versus MED-DCs
Up-regulated Up-regulated
GO term p-value k GO term p-value k
Cell projection GO:0042995 1.49E−11 13 Antigen processing and presentation
of exogenous peptide antigen
GO:0002478 1.27E−08 3
Purine ribonucleoside triphosphate
binding
GO:0035639 1.34E−06 10 MHC protein complex GO:0042611 1.67E−08 3
Metabolic process GO:0008152 5.52E−05 17 Peptide antigen binding GO:0042605 5.42E−06 2
Nucleoside phosphate metabolic
process
GO:0006753 6.53E−05 5 Cellular developmental process GO:0048869 9.77E−04 4
Down-regulated Down-regulated
GO term p-value k GO term p-value k
Response to chemical stimulus GO:0042221 8.38E−07 10 Active transmembrane transporter
activity
GO:0022804 6.49E−05 3
GTPase activity GO:0003924 2.02E−07 5 Catabolic process GO:0009056 2.92E−04 4
Antigen processing and presentation of
exogenous peptide antigen via MHC class II
GO:0019886 5.49E−05 2 Response to wounding GO:0009611: 2.12E−04 3
Regulation of adaptive immune response GO:0002819 6.44E−05 3
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cytometry. This molecule has been associated with the de-
velopment of ‘alternatively-activated’ macrophages and
the recruitment of eosinophils [34], particularly after
multiple exposure to schistosome cercariae [35] and other
helminth infections which induce Th2-type immune re-
sponses [36,37].
A number of other changes in protein expression may help
explain the differential DC phenotype/function. For example,
SEA-DCs may be more efficient at antigen uptake and proces-
sing than immature MED-DCs as several chaperone proteins
and enzymes involved in protein folding were up-regulated in
pro-Th2 DCs compared to immature DCs (i.e. HSP-90α, two iso-
forms of hsc71, clathrin and Rab-7) although flow cytometry
analysis revealed intracellular Rab-7 expressionwas similar be-
tween pro-Th2 DCs and pro-Th1 DCs. Another molecule up-
regulated in SEA-DCs was protein disulfide isomerase which
not only participates in the editing ofMHC class I peptide reper-
toire [38] but also inhibits the transcriptional activity of NF-κB as
a downstream signal of IL-10 [39]. In contrast, most of the pro-
teins reported above were not identified in mature pro-Th1
DCs that have lost their capacity to take up and process antigen,
however they are poised to present antigens, as suggested by
our GO term enrichment analysis. Moreover, many enzymes
and transporters related to general cell metabolism (i.e.malate
dehydrogenase, pyruvate kinase 3, arginosuccinate synthase,
fructose-bisphosphate aldolase A, enolase 1 and two chains of
transporting ATPase Na+/K+) were up-regulated, or expressed
at similar levels, between SEA-DCs versus MED-DCs, while
their expression was mostly decreased in LPS-DCs versus
MED-DCs. This suggests that MED-DCs and pro-Th2 DCs are
more metabolically active compared to pro-Th1 LPS-DCs that
have matured into an ‘end state’. GO term enrichment analysis
confirmed that pro-Th2 DCs up-regulated proteins associated146with nucleotide metabolism, whilst at the same time had
down-regulated responses to chemical stimulus and regulation
of the adaptive immune response.
Many of the proteomic changes in pro-Th2 SEA-DCs affect-
ed cytoskeletal proteins confirming previous studies using
2-DE-based proteomics [14]. For example, vimentin, tubulin
β5, non-muscle myosin, talin and coactosin-like protein
were all up-regulated in SEA-DCs, whereas proteins associ-
ated to actin such as Arp2/3 with a role in membrane traf-
ficking [40] and ezrin–radixin–moesin complex that links
cytoskeletal components with plasma membrane proteins
[41] were down-regulated versus MED-DCs. Moreover, in
LPS-DCs few cytoskeletal proteins were identified, alterna-
tively they were down-regulated or expressed at similar
levels compared to MED-DCs (i.e. actin isoforms, destrin and
moesin). Finally, our study also reveals that SEA-DCs contain
twice as many nuclear proteins than LPS-DCs or immature
DCs. These proteins include initiation and elongation factors,
several histones, signalling proteins (MAPK3, Erk-1) indicating
that SEA may be a potent stimulus for DC proliferation.
Our study using iTRAQ labelling combined with LC–MS–MS
has provided a valuable appraisal of the repertoire of proteins
expressed by differentially matured DCs particularly within
the plasma membrane. This offered new insights into how
differentially matured DCs may function to promote Th1 or
Th2 polarisation of the adaptive immune response. A caveat
to studies using bone-marrow derived DCs is that whilst the
cells have a high level of purity and are of immature/neutral
status, they may not be representative of DCs from tissues in
vivo which are subject to many local factors, such as the
local cytokine environment [35], which influence their matu-
ration as pro-Th1 versus pro-Th2 DCs. However, we believe
that our combined approach has the potential to reveal the
identity of further molecules involved in DC differentiation,
Table 3 – Extrapolated proteins changes between SEA-DCs and LPS-DCs. List of proteins present both in Table 1 (SEA-DCs
versus MED-DCs) and Table 2 (LPS-DCs versusMED-DCs) with their respective average log(ratio): (1) and (2). The extrapolated
average log(ratio) for pro-Th2 SEA-DCs compared to pro-Th1 LPS-DCs equals (1)–(2). Shaded rowshighlightedmajor changes at
themost stringent threshold: log(ratio) values of ±0.1. The table presents the proteins from themost up-regulated at the top to
the most down-regulated at the bottom. The accession numbers were the ones given by the Mascot search against the CDS
mouse database.
Accession no. SEA versus
MED
LPS versus
MED
SEA versus
LPS
Protein hits
Up-regulation
/:spt|P26041| −0.079 −0.334 0.255 Moesin (Membrane-organising extension spike protein)
/:trm|Q80X37| −0.078 −0.285 0.207 CD44
/:pir|S04847| −0.021 −0.129 0.108 CD18, Integrin β-2 precursor (LFA-1/CR3/P150,95 β-subunit)
/:dbj|BAB23738.1| 0.072 −0.037 0.108 Ras-related protein Rab-7
No change
/:spt|P16858| 0.017 −0.023 0.040 Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
Down-regulation
/:rf|NP_077777.1| −0.062 0.021 −0.082 Ras-related protein Rap-1B
/:trm|Q9CXK3| −0.107 −0.017 −0.090 Actin, α, cardiac
/:rf|NP_031419.1| −0.112 −0.014 −0.098 Actin, β, cytoplasmic
/:spt|P08207| −0.155 −0.048 −0.107 S100 A10, calpactin I light chain
/:pdb|1BZ9_B| −0.040 0.067 −0.107 β-2-microglobulin precursor
/:trm|Q7TMN7| −0.038 0.086 −0.124 Annexin A4
/:spt|P10107| −0.098 0.031 −0.128 Annexin A1, calpactin II
/:trm|Q9TP17| −0.107 0.159 −0.266 H-2 class II histocompatibility antigen, A β chain precursor (I-A)
/:trm|Q91XV3| −0.208 0.078 −0.286 22 kDa neuronal tissue-enriched acidic protein, NAP-22, BASP-1
/:trm|Q91VU2| −0.062 0.269 −0.331 ~ transgelin 2 (SM22β)
947J O U R N A L O F P R O T E O M I C S 7 5 ( 2 0 1 2 ) 9 3 8 – 9 4 8especially if increased peptide sample fractionation coupled
to higher sensitivity mass spectrometry instrumentation is
employed. Accordingly, Segura et al. [42] recently reported
an extensive comparative list of membrane proteins from
immunopurified DCs using 2D liquid peptide fractionation fol-
lowed by MS/MS in an Orbitrap instrument. However, their
analysis was performed using only a single biological sample
and protein expression was inferred by spectral counting.
Their study also did not examine differential maturation
after stimulation of DCs with different PAMPs.
In conclusion, our study and resulting analysis of the pro-
teomic data support the view of a ‘limited maturation’ of
pro-Th2 DCs compared to pro-Th1 DCs. We also report evi-
dence of the expression of a restricted number of membrane
proteins which may be unexpected ‘signatures’ of pro-Th2
DCs and consequently warrant further investigation.
Supplementary materials related to this article can be
found online at doi:10.1016/j.jprot.2011.10.010.Acknowledgements
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Uridine at position 34 of bacterial transfer RNAs is commonly
modified to uridine-5-oxyacetic acid (cmo5U) to increase the
decoding capacity. The protein CmoA is involved in the
formation of cmo5U and was annotated as an S-adenosyl-l-
methionine-dependent (SAM-dependent) methyltransferase
on the basis of its sequence homology to other SAM-
containing enzymes. However, both the crystal structure of
Escherichia coli CmoA at 1.73 A˚ resolution and mass
spectrometry demonstrate that it contains a novel cofactor,
S-adenosyl-S-carboxymethyl-l-homocysteine (SCM-SAH), in
which the donor methyl group is substituted by a carboxy-
methyl group. The carboxyl moiety forms a salt-bridge
interaction with Arg199 that is conserved in a large group of
CmoA-related proteins but is not conserved in other SAM-
containing enzymes. This raises the possibility that a number
of enzymes that have previously been annotated as SAM-
dependent are in fact SCM-SAH-dependent. Indeed, inspec-
tion of electron density for one such enzyme with known
X-ray structure, PDB entry 1im8, suggests that the active site
contains SCM-SAH and not SAM.
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1. Introduction
Following transcription by RNA polymerase, a transfer RNA
transcript is converted into a mature tRNA through proces-
sing and nucleoside modification. Processing in bacteria
entails the removal of the 50 leader and 30 tail sequences and, if
necessary, the re-synthesis of the 30 CCA extension required
for aminoacylation. Nucleoside modification is part of the
maturation process that extends the physicochemical proper-
ties of tRNA by providing a wider complement of nucleosides
than the canonical four introduced by RNA polymerase
during transcription. Approximately 10% of nucleosides in a
typical tRNA are modified, which corresponds to around
seven modified nucleosides per tRNA (Ju¨hling et al., 2009). Of
the 109 modified nucleosides of RNA, 93 are found in tRNA,
making it the most diversely modified RNA (Cantara et al.,
2011). Modified nucleosides confer diverse properties upon
tRNA, but they generally fine-tune the structure and stability
such that it is optimized for functioning in processes such as
aminoacylation and translation (Motorin & Helm, 2010).
The anticodon stem loop (ASL) is one of the most heavily
modified regions of tRNA and is frequently modified at
positions 34 (the wobble position) and 37 (immediately after
the anticodon) (Ju¨hling et al., 2009). Modification of the ASL
reduces its flexibility and shifts its structure towards the
U-turn conformation; this has been seen in crystal structures
of mature tRNA, solution structures of isolated modified ASL
domains and structures of the 70S ribosome in complex with
tRNA and mRNA (Selmer et al., 2006; Shi & Moore, 2000;
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Vendeix et al., 2008). Because modifications impose this
conformation upon the ASL, the entropic penalty otherwise
associated with remodelling during translation is avoided
(Agris, 2008). A number of nucleoside modifications at posi-
tions 34 and 37 also expand the decoding capacity beyond
that predicted by the ‘Wobble hypothesis’ (Agris et al., 2007).
In bacteria, the 5-oxyuridine derivatives commonly found at
position 34 fall into this category because they allow the tRNA
to decode not only codons ending in A and G (as predicted
by the Wobble hypothesis), but also U and C, so that a single
tRNA can consequently decode all four codons within a single
box of the genetic code (Nasvall et al., 2004). The derivative
uridine-5-oxyacetic acid (cmo5U) has so far been found
in tRNAAla, tRNAPro, tRNASer and tRNAVal (Ju¨hling et al.,
2009). These modifications are therefore beneficial because
they not only reduce the entropic penalty associated with
translation but also reduce the number of different tRNAs
that a cell must produce for decoding.
While the function of cmo5U within the context of a tRNA
is well characterized, its synthesis has received relatively little
attention. The proposed biosynthetic pathway involves the
stepwise modification of U to cmo5U through the inter-
mediates 5-hydroxyuridine (ho5U) and 5-methoxyuridine
(mo5U) (Fig. 1). In keeping with the majority of other
nucleoside-modification pathways, it is likely that the substrate
base is modified while remaining part of the tRNA and is not
simply exchanged for a pre-modified base in a transglycosyl-
ation reaction. Mutations in the cmoB and cmoA genes result
in accumulation of ho5U and mo5U, respectively, indicating
that CmoB is involved in the modification of ho5U to mo5U
and that CmoA is involved in the modification of mo5U to
cmo5U (Nasvall et al., 2004). Both CmoA and CmoB contain
S-adenosylmethionine (SAM) binding motifs, hinting that
they are methyltransferases, but only one of the two C atoms
in the side chain of cmo5U is derived from SAM (Hagervall et
al., 1990). Furthermore, the synthesis of
5-oxyuridine derivatives is also depen-
dent upon chorismic acid, although the
nature of this dependency has not yet
been determined (Hagervall et al., 1990;
Nasvall et al., 2004). This suggests that
the modification pathway has not been
fully elucidated or that parts of the
cmo5U side chain may be derived from
other metabolites.
We decided to investigate the func-
tions of CmoA and CmoB in detail by
X-ray crystallography to help fill the
gaps in our understanding of cmo5U
biosynthesis. Although CmoA was
expected to be similar to the known
structure of its homologueHaemophilus
influenzae YecO, there is no sufficiently
high-quality model of CmoB in the
Protein Data Bank to form structure-
based hypotheses about the function of
the system. We hope to rectify this by
providing high-quality structures of both proteins from the
same target organism, allowing detailed models of the enzy-
matic pathway and RNA interactions to be constructed and
further tested. Here, we report the structure of Escherichia
coli CmoA, which unexpectedly reveals a cofactor that, to the
best of our knowledge, has not been observed before.
2. Materials and methods
2.1. Molecular biology and protein production
The coding sequence cmoA was amplified from OmniMax
II cells (Invitrogen) and cloned into the vector pOPINF using
the In-Fusion method to generate the construct OPPF7299
(Berrow et al., 2007). The final construct has an R100H point
mutation with respect to the deposited sequence of CmoA
from E. coli K-12 strain MG1655 (UniProt P76290), which
may be either a PCR mutation or a genuine difference in this
strain. Sequence analysis shows that amino acids with diverse
properties are found at this position in other UniProt CmoA-
family members. Once the X-ray structure had been deter-
mined, it became clear that this residue is located on the
surface of the protein on the side opposite to the dimer
interface and at a distance of 15 A˚ from the nearest atom of
the SCM-SAH cofactor. E. coli Rosetta pLysS (DE3) cells
were transformed with the resulting vector and grown in
Overnight Express Instant TB medium (Merck). The cells
were incubated at 310 K until an OD600nm of 0.6 was attained,
at which point the temperature was reduced to 298 K and the
cells were grown for a further 20 h. The cells were then
harvested by centrifugation and stored at 193 K.
2.2. Protein purification
The cells were resuspended in lysis buffer [500 mM NaCl,
50 mM Tris pH 7.5, 30 mM imidazole, 0.2%(v/v) Tween], lysed
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Figure 1
The proposed modification pathway of 5-oxyuridine derivatives. CmoA has been implicated in the
modification of mo5U to cmo5U (Nasvall et al., 2004), although this reaction involves more than the
addition of a single methyl group, indicating that either additional enzymes and/or cofactors are
involved. No enzymes involved in the conversion of U to ho5U or cmo5U to mcmo5U have been
identified.
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using a Basic Z cell disruptor (Constant Systems) and clarified
by centrifugation. The supernatant was loaded onto a 1 ml
HisTrap FF column (GE Healthcare) equilibrated with wash
buffer (500 mM NaCl, 50 mM Tris pH 7.5, 30 mM imidazole)
and bound protein was eluted with elution buffer (500 mM
NaCl, 50 mM Tris pH 7.5, 500 mM imidazole). Fractions
containing CmoA were concentrated and loaded onto a
Superdex 200 HiLoad 16/60 column (GE Healthcare) equili-
brated with gel-filtration buffer (200 mM NaCl, 20 mM Tris
pH 7.5). Fractions containing CmoA were pooled and the
N-terminal hexahistidine tag was removed by digesting the
protein with rhinovirus 3C protease. The mixture was then
reverse-purified by performing an additional round of Ni2+-
affinity chromatography as described above and collecting the
flowthrough. This protein was then buffer-exchanged into gel-
filtration buffer and concentrated to 20 mg ml1 for crystal-
lization.
2.3. Size-exclusion chromatography coupled with static light
scattering (SEC–SLS) analysis
The oligomeric state of CmoA in solution was analysed
using size-exclusion chromatography with a Superdex 200
column followed by light scattering using a Viscotek Tetra
Array Detector measuring refractive index, right-angle light
scattering and absorbance at 280 nm. A 100 ml sample at
0.77 mg ml1 was applied onto the size-exclusion column and
was observed to correspond to dimeric CmoA.
2.4. Crystallization
Sitting-drop experiments were performed in a CrystalQuick
crystallization plate (Greiner Bio-One) at 294 K. 100 nl CmoA
solution was mixed with 100 nl crystallization solution and
equilibrated against a reservoir of 200 ml crystallization solu-
tion. Crystals were grown in condition E8 of the Morpheus
crystallization screen (Molecular Dimensions): 0.3M diethy-
lene glycol, 0.3M triethylene glycol, 0.3M tetraethylene
glycol, 0.3M pentaethylene glycol, 0.1M MOPS/HEPES-Na
pH 7.5, 12.5%(w/v) PEG 1000, 12.5%(w/v) PEG 3350,
12.5%(w/v) MPD (Gorrec, 2009). Crystals grew after 5 h and
were flash-cooled in liquid nitrogen without any additional
cryoprotection.
2.5. Crystallography
Data were collected on beamline I04 of Diamond Light
Source, Didcot, England and were processed with xia2
(Winter, 2010, Evans, 2011; Leslie, 2006; Sauter et al., 2004;
Zhang et al., 2006). The structure was determined by mole-
cular replacement using the structure of H. influenzae YecO
(PDB entry 1im8; chain B; Lim et al., 2001) with both the SAM
cofactor and solvent molecules removed and the programs
CHAINSAW (Stein, 2008) and MOLREP (Vagin &
Teplyakov, 2010) as implemented in the MrBUMP pipeline
(Keegan & Winn, 2007). The molecular-replacement solution
contained two molecules of CmoA and had initial Rwork/Rfree
values of 45.9/45.5%. The model was then improved through
alternate cycles of manual rebuilding using Coot (Emsley et al.,
2010) and restrained refinement with REFMAC5 (Murshudov
et al., 2011) using an isotropic B factor for each atom and one
TLS group per chain (Winn et al., 2001). A restraints file
for S-adenosyl-S-carboxymethyl-l-homocysteine was created
using the PRODRG2 server (Schu¨ttelkopf & van Aalten,
2004).
The final model contains two molecules of CmoA (residues
19–247 in chain A and residues 20–244 in chain B), two
molecules of S-adenosyl-S-carboxymethyl-l-homocysteine,
two molecules of MPD and 273 water molecules. Model
statistics are provided in Table 1. The Ramachandran plot of
the model was calculated with RAMPAGE (Lovell et al., 2003)
and the figures were created with CCP4mg (McNicholas et al.,
2011) and the PoseView server (Stierand et al., 2006). The
coordinates and structure factors have been deposited in the
Protein Data Bank with accession code 4iwn.
2.6. Mass spectrometry
Samples of CmoA were purified as described above and
diluted to a concentration of 5 mM in 50%(v/v) aqueous
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Data collection
Wavelength (A˚) 0.9795
Space group P21212
Unit-cell parameters (A˚) a = 77.12, b = 91.38, c = 70.64
Resolution (A˚) 55.9–1.73 (1.78–1.73)
No. of reflections
Total 261435 (19274)
Unique 52750 (3856)
Completeness (%) 99.9 (100.0)
Multiplicity 5.0 (5.0)
hI/(I)i 15.1 (2.0)
Rmerge† 0.056 (0.648)
Rp.i.m.‡ 0.034 (0.366)
Wilson B factor (A˚2) 21.6
Refinement
Resolution (A˚) 55.9–1.73 (1.78–1.73)
No. of reflections
Working 50019 (3640)
Free 2687 (212)
No. of atoms
Total 3942
Protein 3593
SCM-SAH 60
Solvent 289
Rwork§ (%) 19.6 (29.6)
Rfree (%) 23.1 (31.9)
Mean B factor (A˚2)
Overall 31.1
Protein 30.7
SCM-SAH 29.6
Solvent 36.0
Geometry
R.m.s.d., bond lengths (A˚) 0.014
R.m.s.d., bond angles () 1.7
Ramachandran plot (%)
Favoured 98.2
Allowed 1.8
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rp.i.m. =P
hklf1=½NðhklÞ  1g1=2
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. § Rwork and Rfree =P
hkl

jFobsj  jFcalcj

=
P
hkl jFobsj. Rfree was calculated from a randomly chosen set of
reflections (5% of the total) excluded from the Rwork set used for refinement.
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acetonitrile containing 1% formic acid. These samples were
introduced into the mass spectrometer using a TriVersa
NanoMate ion source (Advion BioSciences) in positive-ion
mode. Mass spectra were acquired using a solariX FT-MS
(Bruker Daltonics) with a 9.4 T superconducting magnet.
TandemMS of the released ligand was performed by collision-
induced dissociation in the hexapole (Q-CID) with argon
collision gas. Spectra were processed using DataAnalysis
v.4.0 (Bruker Daltonics). Protein mass deconvolution was
performed using v.2.0 of the SNAP algorithm and mass
measurements from released ligand and fragmentation spectra
were calculated from centroided data.
2.7. Systematic name of the cofactor
The IUPAC name for the S-adenosyl-S-carboxymethyl-
l-homocysteine (SCM-SAH) cofactor is [(3S)-3-amino-
3-carboxypropyl]{[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-
dihydroxyoxolan-2-yl]methyl}(carboxymethyl)sulfanium.
3. Results and discussion
The crystal structure of E. coli CmoA was determined by
molecular replacement and was refined to Rwork and Rfree
values of 19.6 and 23.1%, respectively, using data to a reso-
lution of 1.73 A˚ (Table 1). The protein copurified with a
cofactor from the E. coli cells that we anticipated would be
either S-adenosylmethionine (SAM) or S-adenosylhomocys-
teine (SAH) on the basis of the S-adenosylmethionine-binding
motifs present in the sequence of CmoA. Unexpectedly, both
molecules of CmoA contain the novel derivative S-adenosyl-
S-carboxymethyl-l-homocysteine (SCM-SAH), which differs
from SAM by the substitution of the methyl donor group
(R = –CH3) by a carboxymethyl group (R = –CH2COOH).
There are two molecules of CmoA present in the asym-
metric unit that are related to each other by a noncrystallo-
graphic twofold rotational axis. Apart from minor differences
at the N- and C-termini, the two molecules adopt the same
conformation and superpose with an r.m.s.d. of 0.3 A˚ (225
aligned C atoms). Analysis of the structure with PISA
(Krissinel & Henrick, 2007) reveals that the interface between
the two molecules is extensive, with 1274 A˚2 of buried surface
area per monomer (Fig. 2). In addition to an antiparallel
-sheet formed by the 6 strands of both molecules, there are
additional interactions between helix 6 of one molecule and
helix 2 and strand 6 of the other molecule. Together, these
interactions comprise 15 hydrogen bonds and a number of
hydrophobic interactions, suggesting that the CmoA dimer
present in the asymmetric unit may also represent the oligo-
meric state of CmoA in solution. To confirm the existence of
this dimer in solution, purified CmoA was analysed by size-
exclusion chromatography and static light scattering (SEC–
SLS). A single species was visible on the chromatogram and
Figure 2
The overall structure of the CmoA dimer. (a) Two orthogonal views of the two monomers forming the dimer (green and blue ribbons). The S-adenosyl-S-
carboxymethyl-l-homocysteine (SCM-SAH) cofactor is shown with O atoms in red, N atoms in blue and C atoms in green. (b) The SEC-SLS
chromatogram that confirms that CmoA is a dimer in solution. The refractive index (RI; red line) and right-angle light scattering (RALS; green line)
traces are displayed. The molecular weight calculated by the OmniSEC software (MW; black line) is shown above the elution peak. The dispersity,
Mw/Mn, defined as the ratio of the weight average to number average molecular weights was reported to be 1.001, indicating a highly uniform sample.
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the molecular weight was calculated to be 52.5 kDa, which is
consistent with the theoretical molecular weight of 55.6 kDa
for the dimer (Fig. 2). Interestingly, PISA identifies an
equivalent dimer in the crystal structure ofH. influenzaeYecO
(PDB entry 1im8) between chain A and its symmetry mate
(x  y, y, z) with an interface area of 1194 A˚2 per
monomer (Lim et al., 2001). The conserved nature of this
interface indicates that the oligomeric state may be important
for the structure and function of CmoA.
3.1. CmoA contains a novel S-adenosylmethionine derivative
During the refinement of the structure, it became apparent
from inspection of both the 2mFo  DFc and the mFo  DFc
electron-density maps that the
putative active site of CmoA
contained a cofactor that was
neither S-adenosylmethionine
(SAM) nor S-adenosylhomocys-
teine (SAH). Prior to the model-
ling of the ligand, unambiguous
positive density was visible in the
mFo  DFc electron-density map
for all of the features expected for
SAM: l-methionine and both the
adenine and ribose rings were
visible at a contour level of 5,
while the S atom was visible at a
contour level of 18 (Fig. 3a).
However, additional positive
density was present at the end of
the methyl group, indicating that the cofactor was a covalently
modified derivative of SAM. This positive density was bifur-
cated, planar in shape and visible at a contour level of 7.
Because these maps were generated prior to the modelling of
any cofactor and no cofactor was present in the search model
that was used during molecular replacement, the presence of
this additional density was not a consequence of model bias.
The shape of the density was most consistent with an
S-adenosylmethionine derivative in which the methyl group
had been derivatized with a functional group with trigonal
planar geometry.
To confirm the presence of the cofactor and investigate its
identity, samples of CmoAwere analysed by Fourier transform
mass spectrometry (FT-MS). To exclude the possibility that
the modification occurred during crystallization or data
collection (as a result of the chemicals present in the crystal-
lization solution or of exposure to X-rays), the sample used for
analysis was not crystallized but was from the same prepara-
tion as that used for crystallization. A signal at m/z = 27 764.2
was assigned as a protonated molecular-ion peak for CmoA,
in agreement with the value of m/z = 27 763.9 estimated from
the sequence alone (a difference of 0.3 Da after accounting for
the proton). An additional signal at m/z = 443.1333 was
detected and this was isolated and further analysed by colli-
sion-induced dissociation. The resulting fragmentation spec-
trum contained three signals: a parent ion at m/z = 443.1336
and two fragments at m/z = 342.0863 and 250.0925 (Fig. 4a).
These are not consistent with the theoretical values for SAM
(m/z = 399.1445) or SAH (m/z = 385.1289), and the frag-
mentation spectrum featured no signals at these values. A
search of the PubChem database for compounds structurally
similar to SAH or SAM with a molecular weight of between
442.6 and 443.6 Da resulted in single hit: a SAM derivative in
which the methyl group is substituted by a carboxymethyl
group (CID 11212932; Fig. 4b). We refer to this derivative as
S-adenosyl-S-carboxymethyl-l-homocysteine (or S-carboxy-
methylated SAH), which could be further abbreviated as
SCM-SAH; the full IUPAC systematic name is given in x2.7.
The m/z values calculated for this compound are in close
agreement with those determined experimentally: the parent
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Figure 3
Structure of S-adenosyl-S-carboxymethyl-l-homocysteine (SCM-SAH). The final coordinates are
displayed with (a) the likelihood-weighted mFo  DFc difference electron-density maps contoured at 3
calculated prior to the modelling of SCM-SAH and (b) the 2mFo DFc electron-density maps contoured at
1.5. The SCM-SAH model is shown with C atoms in cyan, O atoms in red and N atoms in blue. C atoms of
protein residues are shown in green.
Figure 4
Mass spectrum of SCM-SAH. (a) The fragmentation spectrum and (b)
the chemical structure of SCM-SAH. Signals consistent with the entire
SCM-SAH cofactor as well as two fragments (in the blue and green
boxes) were detected.
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ion has a calculated value of m/z = 443.1336 (0.70 mDa
difference) and two potential fragments may be generated
with calculated values of m/z = 342.0867 and 250.0935 (0.33
and 0.93 mDa difference, respectively; Figs. 4a and 4b).
Restraints for the modelling and refinement of SCM-SAH
were generated with PRODRG2 and the ligand was then
modelled into the active site of each monomer (Fig. 3b).
Following refinement, there was no obvious distortion of the
ligand geometry with respect to the ideal geometry and there
were no significant positive or negative peaks in themFoDFc
difference electron-density map in the immediate vicinity of
the ligand. Taken together, the crystallographic and mass-
spectrometric data suggest that the active site of CmoA
contains an S-adenosylmethionine derivative in which the
methyl group is substituted by a carboxymethyl group.
3.2. Comparison with H. influenzae YecO
H. influenzae YecO (PDB entry 1im8) was identified as the
most similar deposited structure to CmoA by both sequence-
based (68% sequence identity) and structure-based (r.m.s.d. =
0.58 A˚ for 222 aligned C atoms) search methods (Krissinel &
Henrick, 2004). The structure of YecO was originally deter-
mined by multiple-wavelength anomalous diffraction (MAD)
using a selenomethionine derivative produced in E. coli B834
(DE3) cells grown in minimal medium in the presence of
l-selenomethionine (Lim et al., 2001). The authors noted that
in addition to the number of selenium sites expected on the
basis of the protein sequence, one additional selenium site per
monomer was detected during structure determination. This
was incorporated into the cofactor that copurified with YecO,
suggesting that the cofactor was derived from l-methionine
(in the case of cells grown in non-labelled medium) or
l-selenomethionine (in the case of cells grown in minimal
medium with l-selenomethionine). In the deposited structure
of YecO the cofactor was modelled as Se-substituted SAH
with a Cl ion 2.9 A˚ away from the Se atom.
Given the high degree of similarity between CmoA and
YecO, we re-examined both the coordinates and the structure
factors for YecO deposited in the PDB. Re-refinement of the
deposited structure resulted in Rwork and Rfree values of 19.2
and 24.8%, respectively, which are comparable with the values
of 18.6 and 25.5% originally reported (Fig. 5a). Refinement of
the YecO structure without any cofactor modelled results in
electron density in both the 2mFo  DFc and the mFo  DFc
electron-density maps into which the Se-substituted form of
the SCM-SAH cofactor found in CmoA can be modelled, and
the electron-density maps after refinement are also compa-
tible with the presence of this cofactor (Fig. 5b). However,
the electron density is not defined well enough to allow a
distinction between the possibilities of SAH and a Cl ion (as
modelled originally) or of SCM-SAH (as modelled in CmoA).
We note, however, that we were unable to find evidence of
SAH and an equivalently positioned Cl ion in a manual
inspection of PDB entries that are (i) annotated as methyl-
transferases (EC 2.1.1) and (ii) contain at least one Cl ion.
Furthermore, in the case of CmoA the electron-density maps
are better defined and the mass-spectrometric data argue
against the cofactor modelled in YecO.
3.3. Overall structure of CmoA
CmoA has a Rossmann fold that comprises seven -strands
and eight -helices. The -strands form a single sheet in which
all strands are parallel except 7. The majority of the -helices
pack against both faces of the -sheet, although helices 2, 6
and 7 form a compact lid-like structure that sits over the
region containing the SCM-SAH and renders it almost in-
accessible to solvent. Superposition of CmoA with the struc-
tures of the other RNA methyltransferases TrmA (PBD entry
3bt7) and RumA (RlmD; PDB entry 2bh2) reveals that while
the Rossmann-fold core is conserved between these enzymes,
the lid-like structure of CmoA obstructs the region used for
the binding of the RNA substrate in these methyltransferases
(Lee et al., 2005; Alian et al., 2008). The conserved location of
the substrate nucleoside with respect to the SAM cofactor in
TrmA, RumA and other DNA and RNA methyltransferases
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Figure 5
Modelling of SCM-SAH into YecO. The re-refined coordinates with
either (a) the originally modelled Se-substituted SAH and Cl ion or (b)
remodelled SCM-SAH are displayed along with the 2mFo  DFc
electron-density maps contoured at 1 and the mFo  DFc difference
electron-density maps contoured at 3. SCM-SAH is depicted with C
atoms in cyan, while C atoms of protein residues are shown in green.
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suggests that the binding mode is relatively fixed. In order to
place the substrate nucleoside in the corresponding position
with respect to the SCM-SAH cofactor in CmoA, the lid
would need to undergo a large conformational change to allow
access to the cofactor and to prevent significant clashes with
the neighbouring nucleotides of the tRNA substrate. An
alternative possibility is that CmoA acts using additional
factors which assist in the modification of the substrate uridine
and does not bind tRNA directly.
In common with many enzymes possessing a Rossmann
fold, the majority of the conserved residues are located at the
C-terminal ends of the -strands or in the loops which
immediately follow. In CmoA these residues are directly
involved in contacting the SAM derivative: the adenine ring is
hydrogen-bonded by the side chain of Asp117 and the main
chains of Asn90, Ile118 and Phe137 (via a water molecule), the
ribose is hydrogen bonded by the side chains of Ser66, Asp89
and Asn90 (via a water molecule), and the l-methionine is
hydrogen bonded by the side chains of Tyr39, Asp62 (via a
water molecule) and Asn132 and the main chains of Gly64,
Ala70 (via a water molecule) and Asn132 (Figs. 6a and 6b).
The negatively charged carboxylate of the carboxymethyl
group interacts with the positively charged guanidinium group
of Arg199 through a salt bridge with a length of 2.7 A˚. The
high conservation of these residues within members of the
UniProt CmoA family indicates that they are important for
binding the SAM derivative and may also play a role in its
biochemistry.
4. Conclusions
We have determined the structure of E. coli CmoA, a putative
methyltransferase that is involved in the post-transcriptional
modification of U34 in a number of bacterial tRNAs. While
the sequence motifs and Rossmann fold of the enzyme suggest
that it is a typical SAM-dependent methyltransferase, analysis
of the electron-density maps and mass-spectrometric data
revealed that the protein contains an atypical SAM derivative
in which the donor methyl group is replaced by a carboxy-
methyl group. We name this previously unobserved derivative
S-adenosyl-S-carboxymethyl-l-homocysteine (SCM-SAH).
According to the UniProt database, the CmoA family
currently contains 1566 proteins that are currently annotated
as putative SAM-dependent methyltransferases. However,
conservation of Arg199, the key residue of CmoA that
stabilizes the negative charge of the carboxyl group of the
SCM-SAH cofactor, suggests that these proteins contain the
SCM-SAH cofactor instead of SAM and are currently anno-
tated incorrectly. The equivalent residue in known SAM-
dependent methyltransferases is not conserved. Although
CmoA homologues are only found in bacteria, it is possible
that such SAM derivatives are widespread in nature, being
present in other enzymes currently annotated as methyl-
transferases.
Previous genetic studies have indicated that CmoA is
involved in the modification of mo5U to cmo5U, a reaction that
involves the addition of a carboxyl group onto the methoxy
group of mo5U but that cannot be catalysed solely by a
methyltransferase (Nasvall et al., 2004). Assuming that the
cofactor in CmoA is directly involved in modification of the
tRNA, we speculate that it may participate in the formation of
cmo5U by either (i) the transfer of just the carboxyl group of
SCM-SAH onto the methoxy group of mo5U or (ii) the
substitution of the methyl group of the side chain in mo5U by
the entire carboxymethyl group from SCM-SAH (Fig. 7). A
third possibility is that the carboxymethyl group is transferred
directly onto the hydroxyl group of ho5U. Although this
proposal is not supported by the observation that mutations in
cmoA result in accumulation of mo5U and not ho5U, this has
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Figure 6
Binding of SCM-SAH by CmoA. (a) SCM-SAH (cyan cylinders) interacts
with multiple main-chain and side-chain atoms of CmoA (green
cylinders) through hydrogen bonds (blue dashes). (b) A two-dimensional
schematic of the active site.
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been suggested previously (Murao et al., 1978) and a prece-
dent for the chemistry of this reaction can be found in the
O-methyltransferases. All three possibilities, however, would
be compatible with the observation that only one of the C
atoms in the side chain of cmo5U is derived from l-methio-
nine. The proposed mechanisms for SAM-dependent
methyltransferases often involve a general base. Super-
positions of CmoA with the 5-methyluridine methyltrans-
ferases TrmA and RumA show that the C5 atom of the
substrate uridine is neighboured by Glu164. This residue is
highly conserved in members of the CmoA family and the only
other amino acid found at this position is aspartic acid. As the
side chain of cmo5U derivatives is attached to the C5 atom of
the pyrimidine ring, this residue would potentially be able to
act as a general base during the reaction.
Although DNA and RNA methyltransferases are able to
use synthetic S-adenosylmethionine analogues with extended
carbon chains both in vitro and in vivo (Schlenk & Dainko,
1975; Klimasauskas & Weinhold, 2007; Motorin et al., 2011),
there do not appear to be any reports indicating that DNA or
RNA methyltransferases actually use such analogues in vivo
for the modification of nucleic acids. We hope that our findings
will lead to further characterization of the function and
mechanism of CmoA and its SCM-SAH cofactor.
During the final stages of preparation of our manuscript,
we became aware of PDB deposition 4gek by the New York
Structural Genomics Research Consortium, in which E. coli
CmoA is also observed in complex with SCM-SAH. A
comparison of these independently determined structures
adds support to the conclusions presented in this paper.
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Figure 7
Speculative roles for SCM-SAH in the modification of mo5U. The
modification might involve either (i) the addition of the carboxyl group
(red) from SCM-SAH onto the methoxy group of mo5U or (ii) the
substitution of the methyl group of mo5U with the entire carboxymethyl
group.
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PLANT SCIENCE
Morphinan biosynthesis in opium
poppy requires a P450-oxidoreductase
fusion protein
Thilo Winzer,1 Marcelo Kern,1 Andrew J. King,1 Tony R. Larson,1
Roxana I. Teodor,1 Samantha L. Donninger,1 Yi Li,1 Adam A. Dowle,2
Jared Cartwright,2 Rachel Bates,2 David Ashford,2 Jerry Thomas,2
Carol Walker,3 Tim A. Bowser,3 Ian A. Graham1*
Morphinan alkaloids from the opium poppy are used for pain relief. The direction of
metabolites to morphinan biosynthesis requires isomerization of (S)- to (R)-reticuline.
Characterization of high-reticuline poppy mutants revealed a genetic locus, designated
STORR [(S)- to (R)-reticuline] that encodes both cytochrome P450 and oxidoreductase
modules, the latter belonging to the aldo-keto reductase family. Metabolite analysis of
mutant alleles and heterologous expression demonstrate that the P450 module is
responsible for the conversion of (S)-reticuline to 1,2-dehydroreticuline, whereas the
oxidoreductase module converts 1,2-dehydroreticuline to (R)-reticuline rather than
functioning as a P450 redox partner. Proteomic analysis confirmed that these two
modules are contained on a single polypeptide in vivo. This modular assembly implies
a selection pressure favoring substrate channeling. The fusion protein STORR may
enable microbial-based morphinan production.
T
he naturally occurring opiates of the
morphinan subclass of benzylisoquinoline
alkaloids (BIAs) include morphine, codeine,
and thebaine. Morphine and codeine can
be directly used as analgesic painkillers,
and thebaine is widely used as a feedstock for
the synthesis of a number of semisynthetic opi-
ates, including hydrocodone, hydromorphone,
oxycodone, and oxymorphone, as well as the
opioid antagonist naloxone. The discovery and
isolation of morphine from the opium poppy
(Papaver somniferum L.) by Friedrich Sertürner
in 1806 (1) are a milestone in the history of
pharmacy. More than 200 years later, opiate
alkaloid–based pharmaceutical formulations
remain the most potent treatment for severe
pain, with sales totaling $US11.6 billion in
2013 (2).
BIAs are found in a number of species in the
Papaveraceae family, but morphine production
has only been reported in the opium poppy and
the closely relatedP. setigerum (3). Themorphinan
backbone contains five asymmetric carbon cen-
ters. Total chemical synthesis, although possible
(4), is not an economically viable means of pro-
duction. Consequently, morphinan alkaloids are
still exclusively sourced from the opium poppy
plant. Much effort has gone into the elucidation
of the morphinan branch of BIA metabolism
over the past 25 years, resulting in the identi-
fication of genes for all but the gateway step in-
volving the epimerization of (S)- to (R)-reticuline
(3, 5–14). Thus, although it has been possible to
produce both (S)- and racemic mixtures of (R,S)-
reticuline and morphinans in metabolically en-
gineered microbial systems (15–18), the clean
enzymatic conversion of (S)- to (R)-reticuline
remains the goal.
(S)-reticuline is the central intermediate of
BIA metabolism (fig. S1), and conversion to
its R epimer is believed to be a two-step pro-
cess (19, 20). The S epimer is first oxidized to
the quaternary positively charged amine 1,2-
dehydroreticuline, followed by reduction to
(R)-reticuline (Fig. 1A). Activities for each step
have been reported, but the identity of the cor-
responding proteins has not been established
(19, 20). We have combined a candidate gene
approach with genetic analyses of F2 popula-
tions of P. somniferum segregating for muta-
tions that are deficient in (S)- to (R)-reticuline
conversion and discovered that a fusion pro-
tein is responsible for sequentially catalyzing
both steps of the epimerization.
RNA interference (RNAi) knockdown of co-
deinone reductase in the opium poppy was re-
ported to cause accumulation of (S)-reticuline,
which is eight steps upstream of the codeinone
reductase substrate (21), a result the authors at-
tributed tometabolite channeling.We considered
an alternative hypothesis to be the off-target co-
silencing of a closely related oxidoreductase in-
volved in the conversion of (S)- to (R)-reticuline.
Using the sequence of the RNAi silencing con-
struct to query an in-house expressed sequence
tag (EST) library from stem and capsule tissue of
opium poppies (22), we identified a contiguous
assembly comprising a cytochrome P450 mono-
oxygenase that is 3′-linked to an oxidoreductase.
Sequencing cDNA clones from opiumpoppy stems
confirmed the in-frame fusion transcript (Fig. 1A
and fig. S2). The P450 module was designated
CYP82Y2.
To investigate whether the corresponding
gene is a candidate for one or both steps in the
epimerization of (S)- to (R)-reticuline, we se-
quenced corresponding cDNA clones from three
independent mutants identified from an ethyl
methanesulfonate–mutagenized population of a
high-morphine cultivar, HM2 (23). All three mu-
tants have lost the ability to produce morphinan
alkaloids and instead accumulate high levels of
(S)-reticuline as well as the (S)-reticuline–derived
alkaloids laudanine and laudanosine (Fig. 1, B
and D). We found that all three mutant lines
carry mutations in the corresponding gene lo-
cus (Fig. 1A), which we name STORR [(S)- to
(R)-reticuline]. The storr-1 allele carries a pre-
mature stop codon corresponding to amino acid
position W668 in the oxidoreductase module
of the predicted fusion protein. storr-1 plants
also contain low but significant levels of 1,2-
dehydroreticuline (Fig. 1C), which suggests that
the oxidoreductase module catalyzes the sec-
ond step of the epimerization, the reduction of
1,2-dehydroreticuline to (R)-reticuline. storr-2
and storr-3 are both disrupted in the CYP82Y2
module: storr-2 contains a premature stop at
codon position W278, and storr-3 contains a
missense mutation causing a glycine-to-arginine
substitution at position 550 (Fig. 1A). Dried
capsules of storr-2 and storr-3 accumulate (S)-
reticuline but not 1,2-dehydroreticuline, sug-
gesting that the CYP82Y2 module is responsible
for the first epimerization step, the oxidation
of (S)-reticuline to 1,2-dehydroreticuline. Com-
plementation tests and F2 segregation analysis
confirmed that a single genetic locus is respon-
sible for the high-reticuline phenotype, associ-
ation of the three recessive storr alleles with
the high-reticuline phenotype, and the consec-
utive roles of the CYP82Y2 and oxidoreductase
modules in the epimerization of (S)- to (R)-
reticuline (tables S2 and S3).
To establish whether the STORR locus is not
only transcribed but also translated as a fusion
protein, we used a quantitative mass spectrom-
etry approach after gel fractionation of crude
protein extract from HM2. Peptides from across
the entire STORR protein were found to be
most abundant in the gel regions covering the
100.65-kD predicted size of the fusion protein,
confirming this as the in vivo form (Fig. 2). For
direct functional characterization, the STORR
fusion protein and the separate modules were
expressed in Saccharomyces cerevisiae, and en-
zyme assays were performed on soluble extracts
andmicrosomal preparations (Fig. 3). We found
that 1,2-dehydroreticuline is converted to (R)-
reticuline with 100% conversion efficiency by both
the STORR fusion protein and the oxidoreductase
module, but not by the CYP82Y2module plus its
redox partner (Fig. 3A). In contrast, the CYP82Y2
module plus its redox partner catalyzed 97% con-
version of (S)-reticuline to 1,2-dehydroreticuline,
SCIENCE sciencemag.org 17 JULY 2015 • VOL 349 ISSUE 6245 309
1Centre for Novel Agricultural Products, Department of
Biology, University of York, York YO10 5DD, UK. 2Bioscience
Technology Facility, Department of Biology, University of
York, York YO10 5DD, UK. 3GlaxoSmithKline, 1061 Mountain
Highway, Post Office Box 168, Boronia, Victoria 3155,
Australia.
*Corresponding author. E-mail: ian.graham@york.ac.uk
RESEARCH | REPORTS
 
o
n
 
Ju
ly
 
6,
 
20
16
ht
tp
://
sc
ie
nc
e.
sc
ie
nc
em
ag
.o
rg
/
D
ow
nl
oa
de
d 
fro
m
 
166
310 17 JULY 2015 • VOL 349 ISSUE 6245 sciencemag.org SCIENCE
Fig. 1. Characterization of opium poppy mutants disrupted in
the conversion of (S)- to (R)-reticuline. (A) Schematic showing
epimerization of (S)- to (R)-reticuline and position of the storr-1,
storr-2, and storr-3mutations in the predicted fusion protein. (B)
Mean T SD capsule reticuline content in the HM2 wild-type
cultivar and storrmutants (HM2,n=5; storr-1,n=12; storr-2,n=17;
storr-3, n = 15). DW, dry weight. Reticuline content was verified as
>99.2% (S)-reticuline in all mutants by chiral high-performance
liquid chromatography (HPLC) (table S1). (C) 1,2-dehydroreticuline.
(D) All compounds >1% total alkaloids (n = 10) are individually
identified, with minor peaks (n = 379), grouped as “Other.”
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Fig. 2. Size determination of STORR pro-
tein in the opium poppy. Protein extracts
from three stem samples of HM2 wild type
were fractionated, together with size markers,
by SDS–polyacrylamide gel electrophoresis
(SDS-PAGE), and the three lanes were each
cut into 15 fractions (see horizontal lines on
one representative lane) to resolve the pre-
dicted fusion protein and putative individual
CYP450 and oxidoreductase modules (101,
65, and 36 kD, respectively). For relative
quantification, an equal amount of a tryptic
digest of 15N-labeled recombinant STORR
protein was spiked into the in-gel digest of
each SDS-PAGE fraction before HPLC mass
spectrometry (HPLC-MS). Ratios of peak
areas from extracted-ion chromatograms of
light (endogenous) to heavy (labeled) versions
of five peptides from across the STORR
protein sequence were compared. Ratios of
normalized peak areas from extracted-ion
chromatograms were converted to binary
logarithms for the calculation of means and
standard errors of the mean. Only measure-
ments where the respective peptides were
found in all three biological replicates are
shown.
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demonstrating that it acts as a 1,2-dehydro-
reticuline synthase (Fig. 3B). Microsomal prep-
arations harboring the entire STORR fusion
protein converted about 20% of the added
(S)-reticuline to (R)-reticuline, confirming the
bifunctional role of the protein in performing
sequential reactions in the epimerization of
reticuline. Kinetic analysis revealed that the
microsomal CYP82Y2 module alone and the
CYP82Y2-oxidoreductase fusion had similar
Michaelis constant values of 13 and 14 mM for
(S)-reticuline and 1,2-dehydroreticuline, respec-
tively (fig. S3). Consistent with the plant mutant
phenotypes, we found that microsomally ex-
pressed STORR carrying the storr-2 mutation
lacks both the P450 and oxidoreductase activ-
ities, the storr-3 mutation lacks the P450 acti-
vity but does still exhibit the oxidoreductase
activity, and the storr-1 mutation has lost the
oxidoreductase activity but maintains very low
levels of P450 activity (fig. S4).
P450-redox systems where the P450 enzyme
is covalently linked to redox partner reductase
components are well known in both prokaryotes
and lower eukaryotes (24). In the STORR fusion
protein, the P450 module is linked to a reduc-
tase, but rather than functioning as a redox
partner for the P450, this reductase catalyzes
the product of the P450 to complete a two-step
epimerization of (S)- to (R)-reticuline. Other forms
of bifunctional P450 fusions with oxygenase/
peroxidase, hydrolase, and dioxygenase modules
have been reported to occur in ascomycetes, and
all of these also appear to catalyze sequential
reactions (25–27). A possible explanation as to
why such fusion proteins evolve is that they fa-
cilitate efficient channeling of highly unstable
or reactive intermediates. Evidence for efficient
substrate channeling in the case of the STORR
fusion protein comes from the observation that
microsomal fractions harboring the fusion pro-
tein directly convert (S)- to (R)-reticuline, with
no detectable accumulation of 1,2-dehydroreticu-
line (Fig. 3B).
Phylogenetic analysis suggests that the STORR
fusion occurred after the split of the CYP82X
and the CYP82Y subfamilies and that the oxi-
doreductase module falls into subfamily 4 of
the aldo-keto reductases, with closest homol-
ogy to the codeinone reductase family from
P. somniferum (fig. S5). A query of the 1K plant
transcriptome resource (28) identified similar
predicted module arrangements in EST collec-
tions from two other morphinan-producing
Papaver species, P. bracteatum and P. setigerum,
but not in P. rhoeas, which does not make mor-
phinans (table S4). We hypothesize that the
STORR fusion was the key step in the evolution
of the morphinan branch of BIA metabolism.
After this step, other enzymes were recruited
and adapted, including dioxygenases and re-
ductases, ultimately giving rise to codeine and
morphine in P. somniferum and P. setigerum
(29). Thus, this morphinan biosynthetic path-
way, and probably other plant secondary meta-
bolic pathways, depends on the organization
of both individual gene structure and genome
rearrangement (22).
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Fig. 3. Functional characterization of the STORR fusion protein by
heterologous expression in S. cerevisiae. (A) HPLC-MS analysis of the
in vitro conversion of 1,2-dehydroreticuline to (R)-reticuline. Crude soluble
(sol) or microsomal (ms) preparations harboring the empty pESC-TRP
vector (green), vector containing the oxidoreductase module (purple), an
opium poppy cytochrome P450 reductase (CPR) redox partner (black), CPR
+ CYP82Y2 (blue), or CPR + the CYP82Y2-oxidoreductase fusion (red) were
assayed (21). The solid lines of the HPLC-MS chromatograms show the
normalized total ion count at a mass/charge ratio (m/z) of 328, corre-
sponding to 1,2-dehydroreticuline (substrate), whereas the dotted lines
show the normalized total ion count atm/z 330, corresponding to reticuline
(product). The inset panel shows the chiral analysis of reticuline: The gray
trace is for an (S)- and (R)-reticuline standard, and the purple and red traces
correspond to reticuline derived by activity of the oxidoreductase and
CYP82Y2-oxidoreductase fusion, respectively. (B) HPLC-MS analysis of the
conversion of (S)-reticuline into 1,2-dehydroreticuline and (R)-reticuline.
Crude microsomal preparations obtained from S. cerevisiae harboring
expression vector pESC-TRPcontaining CPRonly (black), CPR + a CYP82Y2
module (blue), or CPR + CYP82Y2-oxidoreductase fusion (red) were
assayed (21). The solid lines of the HPLC-MS chromatograms show the
normalized total ion count atm/z 328, corresponding to 1,2-dehydroreticu-
line, and the dotted lines show the normalized total ion count at m/z 330,
corresponding to reticuline. The inset panel shows the chiral analysis of
reticuline, with the same line colors as in the main panel.
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Abbreviations 
1D-PAGE One-dimensional polyacrylamide gel electrophoresis 
2D-FT-ICR-MS/MS Two-dimensional Fourier transform ion cyclotron resonance tandem mass 
spectrometry 
2D-PAGE Two-dimensional polyacrylamide gel electrophoresis 
A  Alanine 
ac  Acetylated 
BES  Brugia malayi excretory-secretory proteome 
BmA  Brugia malayi soluble somatic protein extract 
C  Cysteine 
cDNA  Complementary deoxyribonucleic acid 
CI  Confidence interval 
CID  Collision induced dissociation 
C-S  Carbon-sulfur 
D  Aspartic acid 
Da  Daltons 
DC  Dendritic cells 
DNA  Deoxyribonucleic acid 
E  Glutamic acid 
E. coli  Escherichia coli 
emPAI  Exponentially modified protein abundance index 
ERM  Egg-released material 
ES  Excretory-secretory 
EST  Expressed sequences tag 
ETD  Electron transfer dissociation 
F  Phenylalanine 
FA  Fred Antson 
FDR  False discovery rate 
FTICR-MS Fourier transform ion cyclotron resonance mass spectrometry 
FW  Fiona Whelan 
G  Glycine 
GD  Georgina Drury 
GO  Gene ontology 
Gy  Gray = one joule of radiation per kilogram 
H  Histidine 
HES  Heligmosomoides polygyrus excretory-secretory proteome 
Hex  Heligmosomoides polygyrus soluble somatic protein extract 
173
HILIC  Hydrophilic interaction liquid chromatography 
I  Isoleucine 
IS  Internal standard 
iBAQ  Intensity-based absolute quantification 
iTRAQ  Isobaric tags for relative and absolute quantification 
JC  Jared Cartwright 
JH  James Hewitson 
K  Lysine 
kDa  Kilodaltons 
L  Leucine 
L4 Larval stage four secreted Heligmosomoides polygyrus excretory-secretory 
proteome 
LC  Liquid chromatography 
LC-ESI-MS/MS Liquid chromatography-electrospray ionisation-tandem mass 
spectrometry 
LC-MALDI-MS/MS Liquid chromatography-matrix-assisted laser desorption/ionisation-
tandem mass spectrometry 
LC-MS  Liquid chromatography-mass spectrometry 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LOPIT  Localisation of organelle proteins using isotope tagging 
LPS  Lipopolysaccharide 
LPS-DCs Dendritic cells exposed to bacterial lipopolysaccharide 
M  Methionine 
MALDI  Matrix-assisted laser desorption/ionisation 
MALDI-TOF/TOF  Matrix-assisted laser desorption/ionisation-tandem time of flight mass 
spectrometry 
mM  Millimolar 
mDa  Millidaltons 
me  Methylated 
me2  Dimethylated 
MED  Culture medium 
MED-DCs Dendritic cells exposed to culture medium 
[M+H]+  Singly protonated 
MK  Marcello Kern 
MS  Mass spectrometry 
ms  Milliseconds 
MS/MS  Tandem mass spectrometry 
174
m/z  Mass-to-charge ratio 
N  Asparagine 
NCBI  National Center for Biotechnology Information 
N  Number (count) 
Nobs  Number of observed peptides 
Ntheo  Number of theoretically observable peptides 
P  Proline 
pI  Isoelectric point 
PLOS  Public library of science 
PMF  Peptide mass fingerprinting 
pos  Position 
Pr  Propionylated 
PTMs  Post translational modifications 
Q  Glutamine 
qCID  Collision induced dissociation in the hexapole 
QconCAT Concatamer of quantitative peptides 
qTOF  Quadrupole time of flight 
R  Arginine 
R  Rank 
RB  Robert Byrne 
RNA  Ribonucleic acid 
S  Serine 
s  Seconds 
s  Variance 
SCX  Strong cation exchange 
SDS  Sodium dodecyl sulfate 
SE  Standard error 
SEA  Schistosome egg antigen 
SEA-DCs Dendritic cells exposed to schistosome egg antigen 
SF-B  Stéphanie Ferret-Bernard 
sin  Sine 
SILAC  Stable isotope labeling with amino acids in cell culture 
SNAP  Sophisticated numerical annotation procedure 
STORR  (S)- to (R)-reticuline 
T  Threonine 
t  t-test statistic 
Th  T helper lymphocyte cells 
175
Th1  Type 1 immune response 
Th2  Type 2 immune response 
TOF  Time of flight 
TMT  Tandem mass tags 
TW  Thilo Winzer 
tRNA  Transfer ribonucleic acid 
V  Valine 
VAL  Venom allergen/ancylostoma secreted proteins 
v/v  Volume-to-volume ratio 
W  Tryptophan 
W  Wilcoxon signed-rank test statistic 
?̅?  Mean 
Y  Tyrosine 
∑  Sum 
  
176
References 
1. Drury GE, Dowle AA, Ashford DA, Waterworth WM, Thomas J, West CE. Dynamics of plant histone 
modifications in response to DNA damage. Biochem J. 2012 Aug 1; 445(3): 393-401 
2. Hewitson JP, Harcus YM, Curwen RS, Dowle AA, Atmadja AK, Ashton PD, Wilson A, Maizels RM. The 
secretome of the filarial parasite, Brugia malayi: proteomic profile of adult excretory-secretory 
products. Mol Biochem Parasitol. 2008 Jul; 160(1): 8-21. 
3. Hewitson JP, Harcus Y, Murray J, van Agtmaal M, Filbey KJ, Grainger JR, Bridgett S, Blaxter ML, Ashton 
PD, Ashford DA, Curwen RS, Wilson RA, Dowle AA, Maizels RM. Proteomic analysis of secretory 
products from the model gastrointestinal nematode Heligmosomoides polygyrus reveals dominance 
of venom allergen-like (VAL) proteins. J Proteomics. 2011 Aug 24; 74(9): 1573-94. 
4. Hewitson JP, Ivens AC, Harcus Y, Filbey KJ, McSorley HJ, Murray J, Bridgett S, Ashford D, Dowle AA, 
Maizels RM. Secretion of protective antigens by tissue-stage nematode larvae revealed by proteomic 
analysis and vaccination-induced sterile immunity. PLoS Pathog. 2013 Aug; 9(8): e1003492 
5. Ferret-Bernard S, Castro-Borges W, Dowle AA, Sanin DE, Cook PC, Turner JD, MacDonald AS, Thomas 
JR, Mountford AP. Plasma membrane proteomes of differentially matured dendritic cells identified 
by LC-MS/MS combined with iTRAQ labelling. J Proteomics. 2012 Jan 4; 75(3): 938-48. 
6. Byrne RT, Whelan F, Aller P, Bird LE, Dowle A, Lobley CM, Reddivari Y, Nettleship JE, Owens RJ, Antson 
AA, Waterman DG. S-Adenosyl-S-carboxymethyl-L-homocysteine: a novel cofactor found in the 
putative tRNA-modifying enzyme CmoA. Acta Crystallogr D Biol Crystallogr. 2013 Jun; 69(Pt6): 1090-
8.  
 
7. Winzer T, Kern M, King AJ, Larson TR, Teodor RI, Donninger SL, Li Y, Dowle AA, Cartwright J, Bates R, 
Ashford D, Thomas J, Walker C, Bowser TA, Graham IA. Morphinan biosynthesis in opium poppy 
requires a P450-oxidoreductase fusion protein. Science. 2015 Jul 17; 349(6245): 309-12.  
8. Wright GL Jr. High resolution two-dimensional polyacrylamide electrophoresis of human serum 
proteins. Am J Clin Pathol. 1972 Feb; 57(2): 173-85. 
9. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. JBiol Chem. 1975 May 25; 
250(10): 4007-21. 
 
10. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphery-
Smith I, Williams KL, Hochstrasser DF. From proteins to proteomes: large scale protein identification 
by two-dimensional electrophoresis and amino acid analysis. Biotechnology (N Y). 1996 Jan; 14(1): 
61-5. 
11. Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-
polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25; 244(16): 4406-12. 
12. Blakesley RW, Boezi JA. A new staining technique for proteins in polyacrylamide gels using coomassie 
brilliant blue G250. Anal Biochem. 1977 Oct; 82(2): 580-2. 
13. Porro M, Viti S, Antoni G, Saletti M. Ultrasensitive silver-stain method for the detection of proteins in 
polyacrylamide gels and immunoprecipitates on agarose gels. Anal Biochem. 1982 Dec; 127(2): 316-
21. 
14. Steinberg TH, Jones LJ, Haugland RP, Singer VL. SYPRO orange and SYPRO red protein gel stains: one-
step fluorescent staining of denaturing gels for detection of nanogram levels of protein. Anal 
Biochem. 1996 Aug 1; 239(2): 223-37. 
15. Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-
-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and 
radioiodinated protein A. Anal Biochem.  1981 Apr; 112(2): 195-203. 
177
16. Larsson T, Norbeck J, Karlsson H, Karlsson KA, Blomberg A. Identification of two-dimensional gel 
electrophoresis resolved yeast proteins by matrix-assisted laser desorption ionization mass 
spectrometry. Electrophoresis. 1997 Mar-Apr; 18(3-4): 418-23. 
17. Mørtz E, Vorm O, Mann M, Roepstorff P. Identification of proteins in polyacrylamide gels by mass 
spectrometric peptide mapping combined with database search. Biol Mass Spectrom. 1994 May; 
23(5): 249-61. 
18. Olsen JV, Ong SE, Mann M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol 
Cell Proteomics. 2004 Jun; 3(6): 608-14. 
19. Mann M, Højrup P, Roepstorff P. Use of mass spectrometric molecular weight information to identify 
proteins in sequence databases. Biol Mass Spectrom. 1993 Jun; 22(6): 338-45. 
20. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching 
sequence databases using mass spectrometry data. Electrophoresis. 1999 Dec; 20(18): 3551-67. 
21. Clauser KR, Baker P, Burlingame AL. Role of accurate mass measurement (+/- 10 ppm) in protein 
identification strategies employing MS or MS/MS and database searching. Anal Chem. 1999 Jul 15; 
71(14): 2871-82. 
22. Parker KC. Scoring methods in MALDI peptide mass fingerprinting: ChemScore, and the ChemApplex 
program. J Am Soc Mass Spectrom. 2002 Jan; 13(1): 22-39. 
23. McLafferty FW. Tandem mass spectrometry. Science. 1981 Oct 16; 214(4518): 280-7. 
24. Thorne GC, Gaskell SJ. Elucidation of some fragmentations of small peptides using sequential mass 
spectrometry on a hybrid instrument. Rapid Commun Mass Spectrom. 1989 Jul; 3(7): 217-21. 
25. Olsen JV, Macek B, Lange O, Makarov A, Horning S, Mann M. Higher-energy C-trap dissociation for 
peptide modification analysis. Nat Methods. 2007 Sep; 4(9): 709-12. 
26. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, Holle A. A novel MALDI LIFT-TOF/TOF 
mass spectrometer for proteomics. Anal Bioanal Chem. 2003 Aug; 376(7): 952-65. 
27. Tang XJ, Thibault P, Boyd RK. Fragmentation reactions of multiply-protonated peptides and 
implications for sequencing by tandem mass spectrometry with low-energy collision-induced 
dissociation. Anal Chem. 1993 Oct 15; 65(20):2 824-34. 
28. Lau KW, Hart SR, Lynch JA, Wong SC, Hubbard SJ, Gaskell SJ. Observations on the detection of b- and 
y-type ions in the collisionally activated decomposition  spectra of protonated peptides. Rapid 
Commun Mass Spectrom. 2009 May; 23(10): 1508-14. 
29. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of 
peptides. Biomed Mass Spectrom. 1984 Nov; 11(11): 601. 
30. Biemann K. Contributions of mass spectrometry to peptide and protein structure. Biomed Environ 
Mass Spectrom. 1988 Oct; 16(1-12): 99-111. 
31. Tang XJ, Boyd RK. An investigation of fragmentation mechanisms of doubly protonated tryptic 
peptides. Rapid Commun Mass Spectrom. 1992 Nov; 6(11) :651-7. 
32. McCormack AL, Somogyi A, Dongré AR, Wysocki VH. Fragmentation of protonated peptides: surface-
induced dissociation in conjunction with a quantum mechanical approach. Anal Chem. 1993 Oct 15; 
65(20): 2859-72. 
33. Tsaprailis G, Nair GH, Somogyi A, Wysocki VH, Zhong WQ, Futrell JH, Summerfield SG, Gaskell SJ. 
Influence of Secondary Structure on the Fragmentation of Protonated Peptides J. Am. Soc. Mass 
Spectrom, 1999; 121: 5142–5154 
34. Nesvizhskii AI. Protein identification by tandem mass spectrometry and sequence database searching. 
Methods Mol Biol. 2007; 367: 87-119. 
178
35. Washburn MP, Wolters D, Yates JR 3rd. Large-scale analysis of the yeast proteome by 
multidimensional protein identification technology. Nat Biotechnol. 2001 Mar; 19(3): 242-7. 
36. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC. The dynamic range of protein expression: a 
challenge for proteomic research. Electrophoresis. 2000 Apr; 21(6): 1104-15. 
37. Karas M, Bachmann D, Bahr U, Hillenkamp F. Matrix-assisted ultraviolet laser desorption of non-
volatile compounds Int. J. Mass Spectrom. 1987; (78): 53-68. 
38. Huang EC, Henion JD. LC/MS and LC/MS/MS determination of protein tryptic digests. J Am Soc Mass 
Spectrom. 1990 Apr; 1(2): 158-65. 
39. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry 
of large biomolecules. Science. 1989 Oct 6; 246(4926): 64-71. 
40. Hsieh EJ, Bereman MS, Durand S, Valaskovic GA, MacCoss MJ. Effects of column and gradient lengths 
on peak capacity and peptide identification in nanoflow LC-MS/MS of complex proteomic samples. J 
Am Soc Mass Spectrom. 2013 Jan; 24(1): 148-53. 
41. Wolters DA, Washburn MP, Yates JR 3rd. An automated multidimensional protein identification 
technology for shotgun proteomics. Anal Chem. 2001 Dec 1; 73(23): 5683-90. 
42. Boersema PJ, Divecha N, Heck AJ, Mohammed S. Evaluation and optimization of ZIC-HILIC-RP as an 
alternative MudPIT strategy. J Proteome Res. 2007 Mar; 6(3): 937-46. 
43. Yang F, Shen Y, Camp DG, Smith RD. High pH reversed-phase chromatography with fraction 
concatenation as an alternative to strong-cation exchange chromatography for two-dimensional 
proteomic analysis. Expert Review of Proteomics. 2012; 9(2): 129-134. 
44. Apffel A, Fischer S, Goldberg G, Goodley PC, Kuhlmann FE. Enhanced sensitivity for peptide mapping 
with electrospray liquid chromatography-mass spectrometry in the presence of signal suppression 
due to trifluoroacetic acid-containing mobile phases. J Chromatogr A. 1995 Sep 29; 712(1): 177-90. 
45. Beynon RJ, Pratt JM. Metabolic labeling of proteins for proteomics. Mol Cell Proteomics. 2005 Jul; 
4(7): 857-72. 
46. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M. Stable isotope labeling 
by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. 
Mol Cell Proteomics. 2002 May; 1(5): 376-86. 
47. Oda Y, Huang K, Cross FR, Cowburn D, Chait BT. Accurate quantitation of protein expression and site-
specific phosphorylation. Proc Natl Acad Sci USA. 1999 Jun 8; 96(12): 6591-6. 
48. Russell MR, Lilley KS. Pipeline to assess the greatest source of technical variance in quantitative 
proteomics using metabolic labelling. J Proteomics. 2012 Dec 21; 77: 441-54. 
49. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and 
phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci USA. 2003 Jun 10; 100(12): 6940-
5. 
50. Beynon RJ, Doherty MK, Pratt JM, Gaskell SJ. Multiplexed absolute quantification in proteomics using 
artificial QCAT proteins of concatenated signature peptides. Nat Methods. 2005 Aug; 2(8): 587-9. 
51. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B. Quantitative mass spectrometry in proteomics: 
a critical review. Anal Bioanal Chem. 2007 Oct; 389(4): 1017-31. 
52. Hsu JL, Huang SY, Chow NH, Chen SH. Stable-isotope dimethyl labeling for quantitative proteomics. 
Anal Chem. 2003 Dec 15; 75(24): 6843-52. 
53. Yao X, Freas A, Ramirez J, Demirev PA, Fenselau C. Proteolytic 18O labelling for comparative 
proteomics: model studies with two serotypes of adenovirus. Anal Chem. 2001 Jul 1; 73(13): 2836-
42. 
179
54. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein 
mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999 Oct; 17(10): 994-9. 
55. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels 
S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A, Pappin DJ. Multiplexed protein 
quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell 
Proteomics. 2004 Dec; 3(12): 1154-69. 
56. Choe L, D'Ascenzo M, Relkin NR, Pappin D, Ross P, Williamson B, Guertin S, Pribil P, Lee KH. 8-plex 
quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous 
immunoglobulin treatment for Alzheimer's disease. Proteomics. 2007 Oct; 7(20): 3651-60. 
57. T Thompson A, Schäfer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, 
Mohammed AK, Hamon C. Tandem mass tags: a novel quantification strategy for comparative 
analysis of complex protein mixtures by MS/MS. Anal Chem. 2003 Apr 15; 75(8): 1895-904. 
58. Dayon L, Hainard A, Licker V, Turck N, Kuhn K, Hochstrasser DF, Burkhard PR, Sanchez JC. Relative 
quantification of proteins in human cerebrospinal fluids by MS/MS using 6-plex isobaric tags. Anal 
Chem. 2008 Apr 15; 80(8): 2921-31. 
59. Werner T, Becher I, Sweetman G, Doce C, Savitski MM, Bantscheff M. High-resolution enabled TMT 
8-plexing. Anal Chem. 2012 Aug 21; 84(16): 7188-94. 
60. McAlister GC, Huttlin EL, Haas W, Ting L, Jedrychowski MP, Rogers JC, Kuhn K, Pike I, Grothe RA, 
Blethrow JD, Gygi SP. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues 
with isobaric masses. Anal Chem. 2012 Sep 4; 84(17): 7469-78. 
61. Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC, 
Haynes PA. Less label, more free: approaches in label-free quantitative mass spectrometry. 
Proteomics. 2011 Feb; 11(4): 535-53. 
62. Higgs RE, Knierman MD, Gelfanova V, Butler JP, Hale JE. Comprehensive label-free method for the 
relative quantification of proteins from biological samples. J Proteome Res. 2005 Jul-Aug; 4(4): 1442-
50. 
63. Cappadona S, Baker PR, Cutillas PR, Heck AJ, van Breukelen B. Current challenges in software solutions 
for mass spectrometry-based quantitative proteomics. Amino Acids. 2012 Sep; 43(3): 1087-108. 
64. Liu H, Sadygov RG, Yates JR 3rd. A model for random sampling and estimation of relative protein 
abundance in shotgun proteomics. Anal Chem. 2004 Jul 15; 76(14): 4193-201. 
65. Hoehenwarter W, Wienkoop S. Spectral counting robust on high mass accuracy mass spectrometers. 
Rapid Commun Mass Spectrom. 2010 Dec 30; 24(24): 3609-14. 
66. Cooper B, Feng J, Garrett WM. Relative, label-free protein quantitation: spectral counting error 
statistics from nine replicate MudPIT samples. J Am Soc Mass Spectrom. 2010 Sep; 21(9): 1534-46. 
67. Lundgren DH, Hwang SI, Wu L, Han DK. Role of spectral counting in quantitative proteomics. Expert 
Rev Proteomics. 2010 Feb; 7(1): 39-53. 
68. Manning G, Plowman GD, Hunter T, Sudarsanam S. Evolution of protein kinase signaling from yeast 
to man. Trends Biochem Sci. 2002 Oct; 27(10): 514-20. 
69. Choudhary C, Mann M. Decoding signalling networks by mass spectrometry-based proteomics. Nat 
Rev Mol Cell Biol. 2010; 11: 427–439. 
70. Dix MM, Simon GM, Wang C, Okerberg E, et al. Functional interplay between caspase cleavage and 
phosphorylation sculpts the apoptotic proteome. Cell. 2012; 150: 426–440. 
71. Doll S, Burlingame AL. Mass spectrometry-based detection and assignment of protein 
posttranslational modifications. ACS Chem Biol. 2015 Jan 16; 10(1): 63-71. 
180
72. Gnad F, de Godoy LM, Cox J, Neuhauser N, Ren S, Olsen JV, Mann M. High-accuracy identification and 
bioinformatic analysis of in vivo protein phosphorylation sites in yeast. Proteomics. 2009 Oct; 9(20): 
4642-52. 
73. Jenuwein T, Allis CD. Translating the histone code. Science. 2001 Aug 10; 293(5532): 1074-80. 
74. Kornberg RD, Lorch Y. Twenty-five years of the nucleosome, fundamental particle of the eukaryote 
chromosome. Cell. 1999 Aug 6; 98(3): 285-94.  
75. Vempati RK, Jayani RS, Notani D, Sengupta A, Galande S, Haldar D. p300-mediated acetylation of 
histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem. 2010 Sep 10; 
285(37): 28553-64. 
76. Kurdistani SK, Grunstein M. Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol. 
2003 Apr; 4(4): 276-84. 
77. Syka JE, Marto JA, Bai DL, Horning S, Senko MW, Schwartz JC, Ueberheide B, Garcia B, Busby S, 
Muratore T, Shabanowitz J, Hunt DF. Novel linear quadrupole ion trap/FT mass spectrometer: 
performance characterization and use in the comparative analysis of histone H3 post-translational 
modifications. J Proteome Res. 2004 May; 3(3): 621-6. 
78. Beausoleil SA, Villén J, Gerber SA, Rush J, Gygi SP. A probability-based approach for high-throughput 
protein phosphorylation analysis and site localization. Nat Biotechnol. 2006 Oct; 24(10): 1285-92.  
79. Savitski MM, Lemeer S, Boesche M, Lang M, Mathieson T, Bantscheff M, Kuster B. Confident 
phosphorylation site localization using the Mascot Delta Score. Mol Cell Proteomics. 2011 Feb; 10(2): 
M110.003830. 
80. Chalkley RJ, Clauser KR. Modification Site Localization Scoring: Strategies and Performance. Mol Cell 
Proteomics. 2012; 11(5): 3-14. 
81. Martin DM, Nett IR, Vandermoere F, Barber JD, Morrice NA, Ferguson MA. Prophossi: automating 
expert validation of phosphopeptide-spectrum matches from tandem mass spectrometry. 
Bioinformatics. 2010 Sep 1; 26(17): 2153-9. 
82. Johnson L, Mollah S, Garcia BA, Muratore TL, Shabanowitz J, Hunt DF, Jacobsen SE. Mass 
spectrometry analysis of Arabidopsis histone H3 reveals distinct combinations of post-translational 
modifications. Nucleic Acids Res. 2004 Dec 14; 32(22): 6511-8. 
83. Zhang K, Sridhar VV, Zhu J, Kapoor A, Zhu JK. Distinctive core histone post-translational modification 
patterns in Arabidopsis thaliana. PLoS One. 2007 Nov 21; 2(11): e1210. 
84. Earley KW, Shook MS, Brower-Toland B, Hicks L, Pikaard CS. In vitro specificities of Arabidopsis co-
activator histone acetyltransferases: implications for histone hyperacetylation in gene activation. 
Plant J. 2007 Nov; 52(4): 615-26. 
85. Tran JC, Zamdborg L, Ahlf DR, Lee JE, Catherman AD, Durbin KR, Tipton JD, Vellaichamy A, Kellie JF, Li 
M, Wu C, Sweet SM, Early BP, Siuti N, LeDuc RD, Compton PD, Thomas PM, Kelleher NL. Mapping 
intact protein isoforms in discovery mode using top-down proteomics. Nature. 2011 Oct 30; 
480(7376): 254-8. 
86. Catherman AD, Durbin KR, Ahlf DR, Early BP, Fellers RT, Tran JC, Thomas PM, Kelleher NL. Large-scale 
top-down proteomics of the human proteome: membrane proteins, mitochondria, and senescence. 
Mol Cell Proteomics. 2013 Dec; 12(12): 3465-73. 
87. Durbin KR, Fornelli L, Fellers RT, Doubleday PF, Narita M, Kelleher NL. Quantitation and Identification 
of Thousands of Human Proteoforms below 30 kDa. J Proteome Res. 2016 Mar 4; 15(3): 976-82.  
88. Smith KT, Workman JL. Chromatin proteins: key responders to stress. PLoS Biol. 2012; 10(7): 
e1001371. 
181
89. Gupta D, Eldakak M, Rohila JS, Basu C. Biochemical analysis of 'kerosene tree' Hymenaea courbaril L. 
under heat stress. Plant Signal Behav. 2014; 9(10): e972851. 
90. Sidler C, Li D, Kovalchuk O, Kovalchuk I. Development-dependent expression of DNA repair genes and 
epigenetic regulators in Arabidopsis plants exposed to ionizing radiation. Radiat Res. 2015 Feb; 
183(2): 219-32. 
91. Donà M, Mittelsten Scheid O. DNA Damage Repair in the Context of Plant Chromatin. Plant Physiol. 
2015 Aug; 168(4): 1206-18. 
92. Waterworth WM, Drury GE, Blundell-Hunter G, West CE. Arabidopsis TAF1 is an MRE11-interacting 
protein required for resistance to genotoxic stress and viability of the male gametophyte. Plant J. 
2015 Nov; 84(3): 545-57. 
93. Guo P, Qi YP, Yang LT, Ye X, Huang JH, Chen LS. Long-Term Boron-Excess-Induced Alterations of Gene 
Profiles in Roots of Two Citrus Species Differing in Boron-Tolerance Revealed by cDNA-AFLP. Front 
Plant Sci. 2016 Jun; 7: 898. 
94. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great 
neglected tropical diseases. J Clin Invest. 2008 Apr; 118(4): 1311-21. 
95. Maizels RM, Yazdanbakhsh M. Immune regulation by helminth parasites: cellular and molecular 
mechanisms. Nat Rev Immunol. 2003 Sep; 3(9): 733-44. 
96. Adisakwattana P, Saunders SP, Nel HJ, Fallon PG. Helminth-derived immunomodulatory molecules. 
Adv Exp Med Biol. 2009; 666: 95-107. 
97. H Hewitson JP, Filbey KJ, Grainger JR, Dowle AA, Pearson M, Murray J, Harcus Y, Maizels RM. 
Heligmosomoides polygyrus elicits a dominant nonprotective antibody response directed against 
restricted glycan and peptide epitopes. J Immunol. 2011 Nov 1; 187(9): 4764-77. 
98. Monroy FG, Enriquez FJ. Heligmosomoides polygyrus: a model for chronic gastrointestinal 
helminthiasis. Parasitol Today. 1992 Feb; 8(2): 49-54. 
99. Ghedin E, Wang S, Spiro D, Caler E, Zhao Q, Crabtree J, Allen JE, Delcher AL, Guiliano DB, Miranda-
Saavedra D, Angiuoli SV, Creasy T, Amedeo P, Haas B, El-Sayed NM, Wortman JR, Feldblyum T, Tallon 
L, Schatz M, Shumway M, Koo H, Salzberg SL, Schobel S, Pertea M, Pop M, White O, Barton GJ, Carlow 
CK, Crawford MJ, Daub J, Dimmic MW, Estes CF, Foster JM, Ganatra M, Gregory WF, Johnson NM, Jin 
J, Komuniecki R, Korf I, Kumar S, Laney S, Li BW, Li W, Lindblom TH, Lustigman S, Ma D, Maina CV, 
Martin DM, McCarter JP, McReynolds L, Mitreva M, Nutman TB, Parkinson J, Peregrín-Alvarez JM, 
Poole C, Ren Q, Saunders L, Sluder AE, Smith K, Stanke M, Unnasch TR, Ware J, Wei AD, Weil G, 
Williams DJ, Zhang Y, Williams SA, Fraser-Liggett C, Slatko B, Blaxter ML, Scott AL. Draft genome of 
the filarial nematode parasite Brugia malayi. Science. 2007 Sep 21; 317(5845): 1756-60. 
100. Chevallet M, Luche S, Rabilloud T. Silver staining of proteins in polyacrylamide gels. Nat Protoc. 2006; 
1(4): 1852-8. 
101. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M. Exponentially modified protein 
abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of 
sequenced peptides per protein. Mol Cell Proteomics. 2005 Sep; 4(9): 1265-72. 
102. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, Chen W, Selbach M. Global 
quantification of mammalian gene expression control. Nature. 2011 May 19; 473(7347): 337-42. 
103. Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by 
LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics. 2006 Jan; 5(1): 144-56. 
104. Gan CS, Chong PK, Pham TK, Wright PC. Technical, experimental, and biological variations in isobaric 
tags for relative and absolute quantitation (iTRAQ). J Proteome Res. 2007 Feb; 6(2): 821-7. 
105. Russell MR, Lilley KS. Pipeline to assess the greatest source of technical variance in quantitative 
proteomics using metabolic labelling. J Proteomics. 2012 Dec 21; 77: 441-54. 
182
106. Shen X, Hu Q, Li J, Wang J, Qu J. Experimental Null Method to Guide the Development of Technical 
Procedures and to Control False-Positive Discovery in Quantitative Proteomics. J Proteome Res. 2015 
Oct 2; 14(10): 4147-57. 
107. Hewitson JP, Rückerl D, Harcus Y, Murray J, Webb LM, Babayan SA, Allen JE, Kurniawan A, Maizels 
RM. The secreted triose phosphate isomerase of Brugia malayi is required to sustain microfilaria 
production in vivo. PLoS Pathog. 2014 Feb 27; 10(2): e1003930. 
108. Kim JY, Cho MK, Choi SH, Lee KH, Ahn SC, Kim DH, Yu HS. Inhibition of dextran sulfate sodium (DSS)-
induced intestinal inflammation via enhanced IL-10 and TGF-beta production by galectin-9 
homologues isolated from intestinal parasites. Mol Biochem Parasitol. 2010 Nov; 174(1): 53-61. 
109. Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria 
during chronic infection. FEMS Microbiol Rev. 2016 Apr 12 
110. Elkins KL, Cowley SC, Bosio CM. Innate and adaptive immunity to Francisella. Ann N Y Acad Sci. 2007 
Jun; 1105: 284-324. 
111. Cervi L, MacDonald AS, Kane C,Dzierszinski F, Pearce EJ. Cutting edge: dendritic cells coupled with 
microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct 
intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 
responses. J Immunol. 2004; 172: 2016–20. 
112. Ferret-Bernard S, Curwen RS, Mountford AP. Proteomic profiling reveals that Th2-inducing dendritic 
cells stimulated with helminth antigens have a ‘limited maturation’ phenotype. Proteomics 2008; 8: 
980–93. 
113. Cohen SL, Chait BT. Influence of matrix solution conditions on the MALDI-MS analysis of peptides and 
proteins. Anal Chem. 1996 Jan 1; 68(1): 31-7. 
114. Spooncer E, Brouard N, Nilsson SK, Williams B, Liu MC, Unwin RD, et al. Developmental fate 
determination and marker discovery in hematopoietic stem cell biology using proteomic 
fingerprinting. Mol Cell Proteomics 2008; 7: 573–81. 
115. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, Holle A. A novel MALDI LIFT-TOF/TOF 
mass spectrometer for proteomics. Anal Bioanal Chem. 2003 Aug; 376(7): 952-65. 
116. Ting L, Rad R, Gygi SP, Haas W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative 
proteomics. Nat Methods. 2011 Oct 2; 8(11): 937-40. 
117. McAlister GC, Nusinow DP, Jedrychowski MP, Wühr M, Huttlin EL, Erickson BK, Rad R, Haas W, Gygi 
SP. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression 
across cancer cell line proteomes. Anal Chem. 2014 Jul 15; 86(14): 7150-8. 
118. Levin Y. The role of statistical power analysis in quantitative proteomics. Proteomics. 2011 Jun; 
11(12): 2565-7. 
119. Luo R, Colangelo CM, Sessa WC, Zhao H. Bayesian Analysis of iTRAQ Data with Nonrandom 
Missingness: Identification of Differentially Expressed Proteins. Stat Biosci. 2009 Nov; 1(2): 228-245 
120. Goeminne LJ, Argentini A, Martens L, Clement L. Summarization vs Peptide-Based Models in Label-
Free Quantitative Proteomics: Performance, Pitfalls, and Data Analysis Guidelines. J Proteome Res. 
2015 Jun 5; 14(6): 2457-65. 
121. Dowle AA, Wilson J, Thomas JR. Comparing the Diagnostic Classification Accuracy of iTRAQ, Peak-
Area, Spectral-Counting, and emPAI Methods for Relative Quantification in Expression Proteomics. J 
Proteome Res. 2016 Oct 7; 15(10): 3550-3562. 
122. Christoforou A, Arias AM, Lilley KS. Determining protein subcellular localization in mammalian cell 
culture with biochemical fractionation and iTRAQ 8-plex quantification. Methods Mol Biol. 2014; 
1156: 157-74. 
183
123. Maekawa S, Kobayashi Y, Odagaki S, Makino M, Kumanogoh H, Nakamura S, Morita M, Hayashi F. 
Interaction of NAP-22 with brain glutamic acid decarboxylase (GAD). Neurosci Lett. 2013 Mar 14; 537: 
50-4. 
124. Plekhanov AY, Antonova OS, Petrova EI, Reznik SY, Klyueva NZ. The changes in metabolism of the 
regulatory brain protein NAP-22 at the early stages of postnatal ontogeny in spontaneous 
hypertensive and WKY rats born to females fed with calcium-deficient diet. Dokl Biol Sci. 2013 Sep; 
452: 261-5. 
125. Srivastava L, Tundup S, Choi BS, Norberg T, Harn D. Immunomodulatory glycan lacto-N-fucopentaose 
III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells. 
Infect Immun. 2014 May; 82(5): 1891-903. 
126. Lu R, Drubin DG, Sun Y. Clathrin-mediated endocytosis in budding yeast at a glance. J Cell Sci. 2016 
Apr 15; 129(8): 1531-6. 
127. Kliková K, Pilchova I, Stefanikova A, Hatok J, Dobrota D, Racay P. The Role of Heat Shock Proteins in 
Leukemia. Klin Onkol. 2016; 29(1): 29-38. 
128. Wu Q, Yuan H, Zhang L, Zhang Y. Recent advances on multidimensional liquid chromatography-mass 
spectrometry for proteomics: from qualitative to quantitative analysis – a review. Anal Chim Acta. 
2012 Jun 20; 731: 1-10. 
129. Hopkins RA, Connolly JE. The specialized roles of immature and mature dendritic cells in antigen cross-
presentation. Immunol Res. 2012 Sep; 53(1-3): 91-107. 
130. Shen XL, Zhang Y, Xu W, Liang R, Zheng J, Luo Y, Wang Y, Huang K. An iTRAQ-based mitoproteomics 
approach for profiling the nephrotoxicity mechanisms of ochratoxin A in HEK 293 cells. J Proteomics. 
2013 Jan 14; 78: 398-415. 
131. Hansson J, Krijgsveld J. Proteomic analysis of cell fate decision. Curr Opin Genet Dev. 2013 Oct; 23(5): 
540-7. 
132. Srivastava L, Tundup S, Choi BS, Norberg T, Harn D. Immunomodulatory glycan lacto-N-fucopentaose 
III requires clathrin-mediated endocytosis to induce alternative activation of antigen-presenting cells. 
Infect Immun. 2014 May; 82(5): 1891-903. 
133. Liang R, Shen XL, Zhang B, Li Y, Xu W, Zhao C, Luo Y, Huang K. Apoptosis signal-regulating kinase 1 
promotes Ochratoxin A-induced renal cytotoxicity. Sci Rep. 2015 Jan 28; 5: 8078. 
134. Sethi S, Chourasia D, Parhar IS. Approaches for targeted proteomics and its potential applications in 
neuroscience. J Biosci. 2015 Sep; 40(3): 607-27. 
135. Sanin DE, Prendergast CT, Mountford AP. IL-10 Production in Macrophages Is Regulated by a TLR-
Driven CREB-Mediated Mechanism That Is Linked to Genes Involved in Cell Metabolism. J Immunol. 
2015 Aug 1; 195(3): 1218-32. 
136. Mo Y, Hou H, Li D, Liang Y, Chen D, Zhou Y. Mitochondrial protein targets of radiosensitisation by 1,8-
dihydroxy-3-acetyl-6-methyl-9,10 anthraquinone on nasopharyngeal carcinoma cells. Eur J 
Pharmacol. 2014 Sep 5; 738: 133-41. 
137. Everts B, Pearce EJ. Metabolic control of dendritic cell activation and function: recent advances and 
clinical implications. Front Immunol. 2014 May 8; 5: 203. 
138. Jühling F, Mörl M, Hartmann RK, Sprinzl M, Stadler PF, Pütz J. tRNAdb 2009: compilation of tRNA 
sequences and tRNA genes. Nucleic Acids Res. 2009 Jan; 37: D159-62. 
139. Agris PF. Bringing order to translation: the contributions of transfer RNA anticodon-domain 
modifications. EMBO Rep. 2008 Jul; 9(7): 629-35. 
140. Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, McCann PP. S-adenosylmethionine 
and methylation. FASEB J. 1996 Mar; 10(4): 471-80. 
184
141. Tehlivets O, Hasslacher M, Kohlwein SD. S-adenosyl-L-homocysteine hydrolase in yeast: key enzyme 
of methylation metabolism and coordinated regulation with phospholipid synthesis. FEBS Lett. 2004 
Nov 19; 577(3): 501-6. 
142. Tehlivets O, Malanovic N, Visram M, Pavkov-Keller T, Keller W. S-adenosyl-L-homocysteine hydrolase 
and methylation disorders: yeast as a model system. Biochim Biophys Acta. 2013 Jan; 1832(1): 204-
15. 
143. Patching SG. Surface plasmon resonance spectroscopy for characterisation of membrane protein-
ligand interactions and its potential for drug discovery. Biochim Biophys Acta. 2014 Jan; 1838 (1 Pt A): 
43-55. 
144. Jecklin MC, Schauer S, Dumelin CE, Zenobi R. Label-free determination of protein-ligand binding 
constants using mass spectrometry and validation using surface plasmon resonance and isothermal 
titration calorimetry. J Mol Recognit. 2009 Jul-Aug; 22(4): 319-29. 
145. Stafford WF 3rd. Protein-protein and ligand-protein interactions studied by analytical 
ultracentrifugation. Methods Mol Biol. 2009; 490: 83-113. 
146. Vander Meulen KA, Horowitz S, Trievel RC, Butcher SE. Measuring the Kinetics of Molecular 
Association by Isothermal Titration Calorimetry. Methods Enzymol. 2016; 567: 181-213. 
147. Chen M, Yu J, Tanaka Y, Tanaka M, Tanaka I, Yao M. Structure of dihydrouridine synthase C (DusC) 
from Escherichia coli. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Aug; 69 (Pt 8): 834-8. 
148. Sousa FL, Martin WF. Biochemical fossils of the ancient transition from geoenergetics to bioenergetics 
in prokaryotic one carbon compound metabolism. Biochim Biophys Acta. 2014 Jul; 1837(7): 964-81. 
149. Björk GR, Hagervall TG. Transfer RNA Modification: Presence, Synthesis, and Function. EcoSal Plus. 
2014 May; 6(1). 
150. Chen X, Wang X, Feng J, Chen Y, Fang Y, Zhao S, Zhao A, Zhang M, Liu L. Structural insights into the 
catalytic mechanism of Synechocystis magnesium protoporphyrin IX O-methyltransferase (ChlM). J 
Biol Chem. 2014 Sep 12; 289(37): 25690-8. 
151. Sakai Y, Miyauchi K, Kimura S, Suzuki T. Biogenesis and growth phase-dependent alteration of 5-
methoxycarbonylmethoxyuridine in tRNA anticodons. Nucleic Acids Res. 2016 Jan 29; 44(2): 509-23. 
152. Hawkins KM, Smolke CD. Production of benzylisoquinoline alkaloids in Saccharomyces cerevisiae. Nat 
Chem Biol. 2008 Sep; 4(9): 564-73. 
153. Fossati E, Ekins A, Narcross L, Zhu Y, Falgueyret JP, Beaudoin GA, Facchini PJ, Martin VJ. Reconstitution 
of a 10-gene pathway for synthesis of the plant alkaloid dihydrosanguinarine in Saccharomyces 
cerevisiae. Nat Commun. 2014; 5: 3283. 
154. Fossati E, Narcross L, Ekins A, Falgueyret JP, Martin VJ. Synthesis of Morphinan Alkaloids in 
Saccharomyces cerevisiae. PLoS One. 2015 Apr 23; 10(4): e0124459. 
155. Sertürner, F. Darstellung der reinen Mohnsäure (Opiumsaure) nebst einer Chemishen Untersuchung 
des Opiums mit vorzüglicher Hinsucht auf einer darin neu endeckten Stoff und die dahnin gehörigen 
Bemerkugen J. Pharmacie 1806; 14: 47–93 
156. ten Have S, Boulon S, Ahmad Y, Lamond AI. Mass spectrometry-based immuno-precipitation 
proteomics - the user's guide. Proteomics. 2011 Mar; 11(6): 1153-9. 
157. Vikis HG, Guan KL. Glutathione-S-transferase-fusion based assays for studying protein-protein 
interactions. Methods Mol Biol. 2004; 261: 175-86. 
158. Floris F, van Agthoven M, Chiron L, Soulby AJ, Wootton CA, Lam YP, Barrow MP, Delsuc MA, O'Connor 
PB. 2D FT-ICR MS of Calmodulin: A Top-Down and Bottom-Up Approach. J Am Soc Mass Spectrom. 
2016 Sep; 27(9): 1531-8. 
185
159. Galanie S, Thodey K, Trenchard IJ, Filsinger Interrante M, Smolke CD. Complete biosynthesis of opioids 
in yeast. Science. 2015 Sep 4; 349(6252): 1095-100. 
160. Grogan G, Turner NJ. InspIRED by Nature: NADPH-Dependent Imine Reductases (IREDs) as Catalysts 
for the Preparation of Chiral Amines. Chemistry. 2016 Feb; 22(6): 1900-1907. 
161. Yang L, Yang C, Li C, Zhao Q, Liu L, Fang X, Chen XY. Recent advances in biosynthesis of bioactive 
compounds in traditional Chinese medicinal plants. Sci Bull (Beijing). 2016; 61: 3-17. 
162. Narcross L, Fossati E, Bourgeois L, Dueber JE, Martin VJ. Microbial Factories for the Production of 
Benzylisoquinoline Alkaloids. Trends Biotechnol. 2016 Mar; 34(3): 228-41. 
163. Schläger S, Dräger B. Exploiting plant alkaloids. Curr Opin Biotechnol. 2016 Feb; 37: 155-64. 
164. Kries H, O'Connor SE. Biocatalysts from alkaloid producing plants. Curr Opin Chem Biol. 2016 Apr; 31: 
22-30. 
165. Pyne ME, Liu X, Moo-Young M, Chung DA, Chou CP. Genome-directed analysis of prophage excision, 
host defence systems, and central fermentative metabolism in Clostridium pasteurianum. Sci Rep. 
2016 Sep 19; 6: 26228. 
166. Suástegui M, Shao Z. Yeast factories for the production of aromatic compounds: from building blocks 
to plant secondary metabolites. J Ind Microbiol Biotechnol. 2016 Nov;43(11):1611-1624. 
167. Nakagawa A, Matsumura E, Koyanagi T, Katayama T, Kawano N, Yoshimatsu K, Yamamoto K, Kumagai 
H, Sato F, Minami H. Total biosynthesis of opiates by stepwise fermentation using engineered 
Escherichia coli. Nat Commun. 2016 Feb 5; 7: 10390. 
168. Tan GY, Deng Z, Liu T. Recent advances in the elucidation of enzymatic function in natural product 
biosynthesis. Version 2. F1000Res. 2015 Dec 4 [revised 2016 Jan 1]; 4. pii: F1000 Faculty Rev-1399. 
169. Geetha S, Srinivasan D, Jayapriya V, Jeevidha B. Molecular and Protein characterization of Human 
cytochrome P450 expressed Recombinant E.Coli and its application in the synthesis of Tramadol 
metabolite. IJIPBART. 2015; 2(3): 237-248. 
170. Xu G, Cai W, Gao W, Liu C. A novel glucuronosyltransferase has an unprecedented ability to catalyse 
continuous two-step glucuronosylation of glycyrrhetinic acid to yield glycyrrhizin. New Phytol. 2016 
Oct; 212(1): 123-35. 
171. Nützmann HW, Huang A, Osbourn A. Plant metabolic clusters - from genetics to genomics. New 
Phytol. 2016 Aug; 211(3): 771-89. 
172. Morris JS, Dastmalchi M, Li J, Chang L, Chen X, Hagel JM, Facchini PJ. Plug-and-Play Benzylisoquinoline 
Alkaloid Biosynthetic Gene Discovery in Engineered Yeast. Methods Enzymol. 2016; 575: 143-78. 
173. Morris JS, Facchini PJ. Isolation and Characterization of Reticuline N-Methyltransferase Involved in 
Biosynthesis of the Aporphine Alkaloid Magnoflorine in Opium Poppy. J Biol Chem. 2016 Sep 15. pii: 
jbc.M116.750893. 
174. Pyne ME, Narcross L, Fossati E, Bourgeois L, Burton E, Gold ND, Martin VJ. Reconstituting Plant 
Secondary Metabolism in Saccharomyces cerevisiae for Production of High-Value Benzylisoquinoline 
Alkaloids. Methods Enzymol. 2016; 575: 195-224. 
175. Whitelaw DA, Tonkin R, Meints CE, Wolthers KR. Kinetic analysis of electron flux in cytochrome P450 
reductases reveals differences in rate-determining steps in plant and mammalian enzymes. Arch 
Biochem Biophys. 2015 Oct 15; 584: 107-15. 
176. Murata J, Matsumoto E, Morimoto K, Koyama T, Satake H. Generation of Triple-Transgenic Forsythia 
Cell Cultures as a Platform for the Efficient, Stable, and Sustainable Production of Lignans. PLoS One. 
2015 Dec 7; 10(12): e0144519. 
186
177. Tatsis EC, O'Connor SE. New developments in engineering plant metabolic pathways. Curr Opin 
Biotechnol. 2016 Apr 28; 42: 126-132. 
178. Han M, Yin H, Zou Y, Brock NL, Huang T, Deng Z, Chu Y, Lin S. An Acyl Transfer Reaction Catalyzed by 
an Epimerase MarH. ACS Catalysis. 2016 Jan 5; 6(2): 788-92. 
 
187
